data_2w1o_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2w1o _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.756 ' HA ' HD11 ' B' ' 12' ' ' LEU . 20.6 mmm180 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.681 0.277 . . . . 0.0 111.528 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.56 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 16.4 m-85 -91.04 -20.35 22.17 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.712 HG21 HD12 ' A' ' 46' ' ' LEU . 73.0 t -60.41 -37.24 73.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.087 0.47 . . . . 0.0 110.78 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' B' ' 8' ' ' LEU . . . -57.17 -54.61 44.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.392 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.512 ' HG ' ' HG ' ' A' ' 27' ' ' LEU . 0.8 OUTLIER -72.66 -35.83 67.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.975 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 46' ' ' LEU . 47.9 t80 -54.79 -50.91 67.36 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.847 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.791 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.9 mp -57.86 -55.88 29.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.69 HD11 HD11 ' B' ' 9' ' ' LEU . 12.5 mt -47.55 -50.33 24.09 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.29 88.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.66 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.2 -41.08 99.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.278 0.561 . . . . 0.0 110.776 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.3 mt -75.65 -23.25 56.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.312 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.83 10.2 53.02 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.612 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.37 -11.51 39.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.877 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 62.6 t30 -103.86 81.2 1.85 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.999 0.428 . . . . 0.0 109.913 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.542 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 26.2 t -64.16 -28.77 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.49 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 t -111.51 81.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 4.5 Cg_exo -79.8 137.52 12.69 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.688 2.925 . . . . 0.0 113.353 -170.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 23' ' ' ILE . 45.3 t -79.52 147.13 32.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.66 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.48 68.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.27 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 mmtm -67.16 -42.29 84.56 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.12 0.486 . . . . 0.0 110.291 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.668 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.5 m-20 -58.37 -45.33 88.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.308 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.624 HG13 HD13 ' A' ' 43' ' ' ILE . 41.4 mm -51.62 -50.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 59.0 mttm -53.86 -46.4 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.108 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -62.75 -41.85 99.4 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.285 0.564 . . . . 0.0 111.673 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 22' ' ' ASP . 13.0 mt -68.35 -36.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 110.081 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.617 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.6 mt -65.87 -35.91 81.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.141 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.75 -33.98 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.474 0.178 . . . . 0.0 110.992 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.97 -42.91 86.04 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.201 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.453 HG21 HG13 ' A' ' 32' ' ' ILE . 15.9 m -104.22 -3.25 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.726 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 50.37 4.09 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.496 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 59.2 mt -116.0 147.36 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.083 0.468 . . . . 0.0 111.343 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.12 159.53 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.472 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.57 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -159.25 117.28 2.81 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.9 176.97 9.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.624 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.95 -48.0 4.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.999 -0.438 . . . . 0.0 110.644 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.702 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 13.5 t70 -64.45 -60.75 2.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.409 ' O ' HG21 ' A' ' 42' ' ' VAL . 8.7 tpp180 -54.89 -40.51 69.86 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 123.439 0.462 . . . . 0.0 110.731 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.56 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 4.2 tp -61.33 -53.97 49.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.995 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.73 -30.14 70.57 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.51 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 29.3 mmtp -66.14 -47.74 73.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.761 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 38' ' ' ARG . 92.7 t -61.2 -43.63 96.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.609 . . . . 0.0 110.378 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.624 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.32 -44.39 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.09 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 -35.72 80.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -57.77 -53.57 56.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.752 HD22 ' HB ' ' A' ' 54' ' ' VAL . 42.0 mt -61.77 -29.85 70.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.45 -39.51 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.94 -23.16 59.99 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.584 ' HD2' HG23 ' A' ' 54' ' ' VAL . 94.3 mttt -113.75 -164.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.96 0.409 . . . . 0.0 109.954 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . 0.522 ' HB3' ' OE2' ' A' ' 52' ' ' GLU . 93.6 m-20 -93.21 146.84 23.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.556 HG13 HD21 ' A' ' 46' ' ' LEU . 1.5 mp -57.34 -47.46 84.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.215 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 1.019 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.9 OUTLIER -59.04 -40.97 86.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 -177.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 33.4 t70 -62.88 -56.56 16.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.752 ' HB ' HD22 ' A' ' 46' ' ' LEU . 53.0 t -58.23 -40.26 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.099 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.082 HD11 HD11 ' B' ' 55' ' ' ILE . 14.5 mt -60.44 -56.1 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 1.037 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.55 -14.13 62.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.575 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 96.4 mt-30 -88.97 -50.39 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.466 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.12 9.95 67.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.991 0.756 . . . . 0.0 114.991 -167.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.591 HD11 HG22 ' A' ' 55' ' ' ILE . 5.7 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 117.668 0.734 . . . . 0.0 110.696 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.754 ' HA ' HD11 ' A' ' 12' ' ' LEU . 20.5 mmm180 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.701 0.286 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.573 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 16.4 m-85 -90.91 -20.26 22.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.699 HG21 HD12 ' B' ' 46' ' ' LEU . 71.5 t -60.57 -37.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.92 -54.73 43.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.445 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.513 ' HG ' ' HG ' ' B' ' 27' ' ' LEU . 0.8 OUTLIER -72.69 -35.72 67.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.957 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.669 ' CD2' HD11 ' B' ' 46' ' ' LEU . 46.6 t80 -55.03 -50.77 68.23 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.794 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.8 mp -57.84 -55.88 29.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 9' ' ' LEU . 12.4 mt -47.6 -50.39 24.29 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.289 0.368 . . . . 0.0 111.918 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.611 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.51 -40.52 97.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.232 0.539 . . . . 0.0 110.869 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.794 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.2 mt -76.16 -22.6 55.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.409 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.47 10.88 53.83 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.719 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.71 -11.0 41.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.81 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.618 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 62.5 t30 -104.16 81.46 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.081 0.467 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 24.8 t -64.42 -28.65 69.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.387 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.9 t -111.67 82.01 3.63 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.618 ' HA ' ' ND2' ' B' ' 15' ' ' ASN . 4.3 Cg_exo -80.36 137.52 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.661 2.908 . . . . 0.0 113.374 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.417 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.5 t -79.53 147.23 32.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.633 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.403 ' HB3' ' CD2' ' B' ' 39' ' ' LEU . . . -62.75 -26.22 68.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.227 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 48.2 mmtm -67.15 -42.15 84.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.183 0.516 . . . . 0.0 110.23 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.65 ' O ' HG13 ' B' ' 26' ' ' ILE . 17.3 m-20 -58.3 -45.68 87.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.325 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.629 HG13 HD13 ' B' ' 43' ' ' ILE . 41.3 mm -51.47 -50.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.425 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 59.4 mttm -53.59 -46.48 70.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.137 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -62.85 -41.6 99.42 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 111.739 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.65 HG13 ' O ' ' B' ' 22' ' ' ASP . 12.6 mt -68.51 -36.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.18 0.514 . . . . 0.0 110.144 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.608 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.8 mt -65.87 -36.01 82.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.174 172.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.32 -34.4 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.496 0.189 . . . . 0.0 110.899 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.9 t -57.66 -43.06 84.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.278 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.446 HG21 HG13 ' B' ' 32' ' ' ILE . 15.9 m -104.12 -3.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 0.0 111.678 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.64 51.32 3.9 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.307 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 58.7 mt -116.48 147.57 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 111.358 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.43 159.44 33.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.583 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.575 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -159.38 116.68 2.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 112.935 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.62 177.09 9.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.666 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.0 -47.99 4.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.168 -0.333 . . . . 0.0 110.679 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.7 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 13.0 t70 -64.43 -60.93 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.258 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.423 ' O ' HG21 ' B' ' 42' ' ' VAL . 8.6 tpp180 -54.76 -40.63 69.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.785 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.573 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 4.2 tp -61.24 -54.08 48.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.76 -30.15 70.6 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.442 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 29.4 mmtp -66.26 -47.47 73.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.729 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.423 HG21 ' O ' ' B' ' 38' ' ' ARG . 91.7 t -61.36 -43.63 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.317 0.58 . . . . 0.0 110.435 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.629 HD13 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.24 -44.54 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.1 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 10.3 t -66.38 -35.68 80.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.706 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -57.78 -53.43 58.3 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.071 0.462 . . . . 0.0 109.814 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.776 HD22 ' HB ' ' B' ' 54' ' ' VAL . 42.1 mt -61.93 -29.72 70.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.986 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -77.56 -39.56 45.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.161 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.32 -22.53 60.43 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.297 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.588 ' HD2' HG23 ' B' ' 54' ' ' VAL . 94.3 mttt -114.1 -165.06 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . 0.519 ' HB3' ' OE2' ' B' ' 52' ' ' GLU . 93.4 m-20 -92.85 146.99 23.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.559 HG13 HD21 ' B' ' 46' ' ' LEU . 1.5 mp -57.59 -47.44 85.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.293 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 1.037 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -59.08 -40.79 86.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 -177.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' B' ' 57' ' ' GLN . 33.6 t70 -63.12 -56.6 15.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.08 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.776 ' HB ' HD22 ' B' ' 46' ' ' LEU . 54.6 t -57.85 -40.22 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.236 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 1.082 HD11 HD11 ' A' ' 55' ' ' ILE . 14.5 mt -60.63 -56.06 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 1.019 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.58 -13.94 62.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.623 -173.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' B' ' 53' ' ' ASP . 96.9 mt-30 -89.05 -50.67 6.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.88 9.76 68.26 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.599 HD11 HG22 ' B' ' 55' ' ' ILE . 5.7 mt . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 117.72 0.76 . . . . 0.0 110.584 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.665 ' HA ' HD11 ' B' ' 12' ' ' LEU . 42.6 ttm180 . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.474 ' HB3' HD11 ' A' ' 39' ' ' LEU . 39.2 m-85 -83.54 -16.56 44.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.307 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.688 HG23 HD13 ' A' ' 46' ' ' LEU . 91.7 t -64.0 -36.12 75.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.536 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.7 -54.85 41.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.508 0.671 . . . . 0.0 111.282 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.454 ' HG ' ' HG ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -71.72 -34.97 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.797 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 65.5 t80 -55.45 -47.82 75.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.837 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.739 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.0 mp -60.11 -57.26 13.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.329 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.816 HD11 HD11 ' B' ' 9' ' ' LEU . 14.9 mt -47.48 -50.8 22.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.65 -37.87 79.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.53 -40.92 96.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.8 mt -74.41 -24.5 59.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.385 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.35 -19.34 74.23 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.372 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.54 -33.8 1.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.045 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.8 m-20 -92.47 88.07 6.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.604 0.24 . . . . 0.0 110.645 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.609 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 6.2 m -60.87 -27.79 68.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.349 0.595 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 p -108.79 82.52 1.79 Allowed Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.8 Cg_exo -80.33 152.92 20.97 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.811 3.008 . . . . 0.0 113.038 -172.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.432 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 14.2 t -89.42 146.33 24.73 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -65.23 -23.76 67.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.537 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.755 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 50.5 tptt -64.6 -44.72 89.71 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.337 0.589 . . . . 0.0 110.357 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.694 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.5 m-20 -58.63 -45.12 89.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.828 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.667 HG13 HD13 ' A' ' 43' ' ' ILE . 44.3 mm -50.91 -50.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.3 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.755 ' HD2' ' HD2' ' A' ' 21' ' ' LYS . 60.7 mttm -52.27 -48.07 65.47 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.71 -40.38 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.12 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 22' ' ' ASP . 12.1 mt -67.95 -37.95 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 110.197 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 10.5 mt -63.9 -39.91 95.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.996 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.12 -32.28 71.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.322 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 t -66.7 -34.19 77.31 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.035 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 32' ' ' ILE . 15.5 m -103.04 -5.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.692 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.52 33.65 8.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.453 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 46.9 mt -102.91 129.69 54.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 122.631 -0.334 . . . . 0.0 110.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.5 144.83 51.24 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.182 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.13 156.97 44.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.467 0.651 . . . . 0.0 111.625 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 14.8 t70 -111.99 178.66 4.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.416 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -102.88 -53.01 2.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.221 0.534 . . . . 0.0 110.081 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.67 -49.27 41.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.043 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 12.6 tpp180 -63.44 -38.04 89.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.572 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 3.1 tp -65.84 -55.99 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.36 -30.05 69.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.2 tmtt? -62.49 -52.11 64.81 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.431 HG22 ' O ' ' A' ' 38' ' ' ARG . 78.7 t -60.83 -42.82 93.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 110.87 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.667 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.44 -41.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.398 175.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -68.26 -33.89 75.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.705 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 45.2 mt-10 -58.39 -53.4 58.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.75 HD22 ' HB ' ' A' ' 54' ' ' VAL . 19.7 mt -57.17 -43.31 82.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.69 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.81 -29.01 65.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.263 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.72 -21.23 64.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.548 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HB2' HG21 ' A' ' 54' ' ' VAL . 34.5 mttm -117.06 -97.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.741 0.782 . . . . 0.0 110.432 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.98 154.51 1.47 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.532 ' HA ' HD21 ' A' ' 46' ' ' LEU . 1.7 mp -57.64 -54.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.951 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.6 OUTLIER -61.44 -38.39 87.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -172.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 15.6 t70 -64.75 -53.79 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.75 ' HB ' HD22 ' A' ' 46' ' ' LEU . 28.7 t -58.7 -37.13 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.495 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.612 HG23 HG23 ' B' ' 55' ' ' ILE . 2.2 mm -56.56 -60.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 111.776 172.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.922 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.84 -15.29 63.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.651 -170.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.2 mm100 -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 173.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.81 -42.08 3.42 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.51 -171.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.602 HD11 ' HA ' ' A' ' 55' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 117.253 0.526 . . . . 0.0 110.827 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.719 ' HA ' HD11 ' A' ' 12' ' ' LEU . 42.6 ttm180 . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.471 ' HB3' HD11 ' B' ' 39' ' ' LEU . 39.7 m-85 -83.97 -16.51 43.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.164 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.678 HG23 HD13 ' B' ' 46' ' ' LEU . 91.9 t -63.92 -35.95 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.82 -54.97 40.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.519 0.676 . . . . 0.0 111.177 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.437 ' HG ' ' HG ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -71.86 -34.98 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.684 179.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.455 ' HA ' ' CD1' ' B' ' 23' ' ' ILE . 64.9 t80 -55.23 -48.15 74.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.9 mp -59.99 -57.29 13.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.279 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.816 HD11 HD11 ' A' ' 9' ' ' LEU . 14.8 mt -47.43 -50.54 22.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.99 80.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.23 -41.36 97.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.8 mt -74.07 -24.35 59.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.498 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.18 74.31 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.223 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.4 -33.26 2.0 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.22 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 85.9 m-20 -92.8 88.01 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.6 0.238 . . . . 0.0 110.647 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.601 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 6.1 m -60.79 -27.97 68.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.419 0.628 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 39.2 p -108.85 82.5 1.8 Allowed Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.215 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.6 Cg_exo -80.17 153.27 21.59 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.763 2.975 . . . . 0.0 112.814 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.445 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 15.4 t -89.59 146.71 24.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -65.49 -23.68 66.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.525 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.731 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 50.6 tptt -64.4 -44.8 90.13 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.255 0.55 . . . . 0.0 110.295 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.712 ' O ' HG13 ' B' ' 26' ' ' ILE . 2.6 m-20 -58.77 -44.72 90.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.91 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.645 HG13 HD13 ' B' ' 43' ' ' ILE . 44.5 mm -51.32 -50.39 27.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.266 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.731 ' HD2' ' HD2' ' B' ' 21' ' ' LYS . 60.9 mttm -51.97 -48.63 64.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.58 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.64 -40.28 95.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.061 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.712 HG13 ' O ' ' B' ' 22' ' ' ASP . 11.7 mt -67.86 -38.06 79.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.598 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 10.5 mt -63.71 -39.81 95.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.912 171.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.04 -32.86 72.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.234 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 12.9 t -66.12 -34.62 78.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.06 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.471 HG22 HG13 ' B' ' 32' ' ' ILE . 15.3 m -102.65 -5.69 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.706 0.289 . . . . 0.0 111.557 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.49 34.4 7.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.341 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 46.9 mt -103.41 129.72 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.969 0.385 . . . . 0.0 110.533 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.5 144.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.124 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.34 156.71 45.03 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.493 0.663 . . . . 0.0 111.746 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' B' ' 38' ' ' ARG . 14.7 t70 -111.62 178.9 4.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.614 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -103.12 -52.6 3.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.227 0.537 . . . . 0.0 110.278 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.98 -49.61 35.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.012 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' B' ' 35' ' ' ASP . 12.7 tpp180 -63.08 -38.31 90.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.497 ' CD2' ' HB3' ' B' ' 20' ' ' ALA . 3.1 tp -65.57 -56.16 13.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.25 -29.85 69.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 12.1 tmtt? -62.63 -52.14 64.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.438 HG22 ' O ' ' B' ' 38' ' ' ARG . 77.6 t -60.77 -43.04 94.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.564 0.697 . . . . 0.0 110.778 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.645 HD13 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.2 -41.31 83.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.382 175.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.679 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 46.0 mt-10 -58.42 -53.1 62.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.731 HD22 ' HB ' ' B' ' 54' ' ' VAL . 20.0 mt -57.35 -43.3 83.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.819 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.95 -29.22 65.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.71 -20.72 65.3 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.452 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' B' ' 54' ' ' VAL . 34.4 mttm -117.4 -97.96 0.46 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.66 0.743 . . . . 0.0 110.487 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.85 154.68 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.522 ' HA ' HD21 ' B' ' 46' ' ' LEU . 1.7 mp -57.64 -54.57 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.922 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -61.56 -38.16 86.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.734 0.302 . . . . 0.0 111.116 -172.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' B' ' 57' ' ' GLN . 15.7 t70 -64.69 -53.85 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.594 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.731 ' HB ' HD22 ' B' ' 46' ' ' LEU . 26.9 t -58.82 -37.1 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.538 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.613 ' HA ' HD11 ' B' ' 59' ' ' ILE . 2.2 mm -56.47 -60.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.346 0.593 . . . . 0.0 111.823 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.951 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.96 -15.19 63.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.5 -170.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' B' ' 53' ' ' ASP . 16.9 mm100 -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.66 -43.21 3.19 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.408 -171.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.613 HD11 ' HA ' ' B' ' 55' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 117.228 0.514 . . . . 0.0 110.867 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.017 0.436 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.53 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 49.6 m-85 -99.18 -11.13 21.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.972 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.687 HG23 HD13 ' A' ' 46' ' ' LEU . 60.9 t -57.13 -39.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.43 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -55.72 -55.41 32.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.855 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.865 ' HG ' HG21 ' A' ' 23' ' ' ILE . 2.1 p -70.55 -36.22 73.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.616 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 58.0 t80 -55.41 -49.62 71.9 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.936 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.776 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.7 mp -59.94 -55.96 27.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.558 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.85 HD13 HD13 ' B' ' 9' ' ' LEU . 15.1 mt -48.02 -49.99 29.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.175 0.297 . . . . 0.0 111.702 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.18 85.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.351 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 16' ' ' SER . . . -61.73 -38.53 88.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.349 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.6 mt -78.42 -25.9 46.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.721 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.74 10.7 50.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.574 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.07 -23.84 26.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.955 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.4 64.96 7.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.33 0.586 . . . . 0.0 109.575 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 15.7 m -64.48 -20.4 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.803 -175.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.89 78.21 4.0 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.0 Cg_exo -77.08 129.11 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.452 -167.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.5 t -72.09 142.24 49.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.69 -22.35 65.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.5 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 24.4 tptp -70.27 -41.01 73.99 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.157 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.668 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.1 t70 -63.37 -40.02 96.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.865 HG21 ' HG ' ' A' ' 6' ' ' SER . 47.6 mm -53.68 -49.76 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.327 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 75.5 mttt -55.2 -43.4 74.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -58.07 -47.48 83.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.396 0.617 . . . . 0.0 111.698 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.7 mt -67.43 -39.31 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.732 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.602 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 9.3 mt -62.87 -39.15 93.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.126 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -59.57 -39.46 84.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.251 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 t -59.91 -38.52 82.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.244 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.574 HG21 HG13 ' A' ' 32' ' ' ILE . 16.8 m -96.4 -10.31 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.271 . . . . 0.0 111.682 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 32.2 6.74 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.514 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 29.6 mt -107.24 132.87 53.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.931 0.365 . . . . 0.0 110.104 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.24 151.38 23.2 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -128.85 128.5 43.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.179 0.514 . . . . 0.0 112.318 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -92.29 122.9 35.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.187 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.91 -54.58 14.81 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 30.6 t70 -66.33 -48.42 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.437 -171.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.464 ' O ' HG21 ' A' ' 42' ' ' VAL . 21.8 tpp180 -64.88 -35.2 80.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.8 tp -63.73 -56.2 17.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.66 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -57.52 -32.57 67.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 4.2 tppt? -64.41 -54.59 30.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 38' ' ' ARG . 85.4 t -57.01 -43.92 81.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 110.635 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.621 HD12 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.02 -44.0 93.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.649 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 t -64.75 -35.28 80.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.814 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 42.1 mt-10 -59.12 -53.06 62.57 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.75 HD21 HG13 ' A' ' 51' ' ' ILE . 17.7 mt -64.99 -24.32 67.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.866 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.67 -33.41 58.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.991 0.424 . . . . 0.0 111.034 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.05 11.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.735 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.484 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 16.6 mtpp -115.28 176.06 5.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.46 141.66 55.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.75 HG13 HD21 ' A' ' 46' ' ' LEU . 1.6 mp -59.66 -45.84 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.277 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 1.044 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.07 -42.15 93.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 109.635 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.15 -53.59 47.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.542 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.7 ' HB ' HD22 ' A' ' 46' ' ' LEU . 42.2 t -59.88 -35.17 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.865 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.061 HD11 HD11 ' B' ' 55' ' ' ILE . 17.9 mt -65.41 -55.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.845 0.355 . . . . 0.0 111.887 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.987 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.63 -16.07 63.31 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.431 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.779 HE21 ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -91.77 -28.83 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.712 170.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.47 -45.5 5.23 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.312 0.485 . . . . 0.0 114.312 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.758 HD12 HG22 ' A' ' 55' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 117.565 0.683 . . . . 0.0 110.361 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttt85 . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 50.5 m-85 -99.01 -11.11 21.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.91 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.669 HG23 HD13 ' B' ' 46' ' ' LEU . 58.7 t -57.08 -39.56 67.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.369 . . . . 0.0 110.801 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.55 -55.72 28.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.655 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.877 ' HG ' HG21 ' B' ' 23' ' ' ILE . 2.1 p -70.43 -36.22 73.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.53 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' B' ' 23' ' ' ILE . 57.8 t80 -55.67 -49.11 73.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.952 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.783 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -60.5 -55.62 31.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.426 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.85 HD13 HD13 ' A' ' 9' ' ' LEU . 14.9 mt -48.37 -50.07 32.14 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.182 0.301 . . . . 0.0 111.641 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.14 83.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.498 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' B' ' 16' ' ' SER . . . -61.85 -38.64 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.26 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -78.44 -25.86 46.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.785 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.72 10.86 49.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.549 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.54 27.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.118 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 63.1 t30 -88.59 64.4 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' B' ' 11' ' ' ALA . 15.0 m -63.86 -20.27 65.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.971 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.99 78.06 4.06 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.4 Cg_exo -76.91 128.82 10.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.153 2.569 . . . . 0.0 113.631 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 31.4 t -71.49 141.79 50.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.48 -22.15 64.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.494 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 24.4 tptp -70.7 -40.73 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.105 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.671 ' O ' HG13 ' B' ' 26' ' ' ILE . 29.4 t70 -63.53 -39.98 95.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.877 HG21 ' HG ' ' B' ' 6' ' ' SER . 47.0 mm -53.61 -49.91 53.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.348 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 75.5 mttt -55.19 -43.29 74.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.654 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' B' ' 25' ' ' LYS . 11.0 mmmm -58.09 -47.78 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.728 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.671 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.7 mt -67.35 -39.18 82.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.697 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 9.4 mt -62.89 -38.96 92.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.043 172.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.03 -39.42 85.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 34.9 t -59.6 -38.54 81.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.257 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.565 HG21 HG13 ' B' ' 32' ' ' ILE . 16.6 m -96.54 -10.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 111.639 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 32.76 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.388 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 29.8 mt -107.63 132.63 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.974 0.387 . . . . 0.0 110.094 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -86.62 152.27 22.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.592 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -130.22 127.94 40.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 0.0 112.305 -174.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.08 122.64 34.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.258 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -48.85 -54.35 15.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' B' ' 41' ' ' LYS . 32.0 t70 -66.48 -48.09 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.638 -171.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.478 ' O ' HG21 ' B' ' 42' ' ' VAL . 21.7 tpp180 -65.18 -34.76 79.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.516 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.544 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.6 tp -63.96 -56.24 16.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.659 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -57.42 -32.67 67.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 4.4 tppt? -64.44 -54.49 31.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.801 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.478 HG21 ' O ' ' B' ' 38' ' ' ARG . 84.6 t -57.12 -43.68 81.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.527 0.679 . . . . 0.0 110.612 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.621 HD12 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.29 -43.98 94.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.717 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -64.06 -36.06 82.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.779 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 43.0 mt-10 -58.73 -53.03 62.98 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.731 HD21 HG13 ' B' ' 51' ' ' ILE . 17.4 mt -65.01 -24.52 67.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.936 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -76.85 -33.08 57.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 -29.12 11.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.718 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.488 ' HB2' ' CG2' ' B' ' 54' ' ' VAL . 16.8 mtpp -115.31 176.19 5.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.582 0.229 . . . . 0.0 110.403 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.59 141.81 55.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.731 HG13 HD21 ' B' ' 46' ' ' LEU . 1.6 mp -59.8 -45.65 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.273 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.987 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.34 -42.02 94.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.325 0.584 . . . . 0.0 109.59 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.93 -53.78 45.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.637 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.677 ' HB ' HD22 ' B' ' 46' ' ' LEU . 42.2 t -59.88 -35.23 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 1.061 HD11 HD11 ' A' ' 55' ' ' ILE . 18.8 mt -65.23 -55.9 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 175.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 1.044 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.82 -15.57 63.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.105 0.479 . . . . 0.0 111.48 -173.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.77 HE21 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -92.04 -28.21 17.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 170.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.2 -45.43 5.04 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.749 HD12 HG22 ' B' ' 55' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.464 0.267 0 CA-C-N 117.444 0.622 . . . . 0.0 110.263 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.584 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 19.0 tpp180 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 43.7 m-85 -105.62 -7.23 18.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 46' ' ' LEU . 97.8 t -69.34 -31.7 50.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.104 0.478 . . . . 0.0 109.999 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.55 -55.08 39.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.346 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.453 ' HA ' HD12 ' B' ' 9' ' ' LEU . 1.4 p -71.44 -36.32 71.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.56 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.601 ' CD1' HD11 ' A' ' 46' ' ' LEU . 70.3 t80 -55.14 -49.07 72.71 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.823 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.731 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.7 mp -59.18 -57.43 13.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 1.045 HD13 HD13 ' B' ' 9' ' ' LEU . 13.5 mt -48.79 -48.97 40.83 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.81 82.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.32 95.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.293 0.568 . . . . 0.0 110.808 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.2 mt -75.15 -15.63 60.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.3 1.24 81.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.189 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.23 -28.75 7.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.013 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.422 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 7.0 t30 -94.85 85.27 4.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.598 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 8.8 m -61.49 -25.85 67.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.57 81.68 3.35 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 16' ' ' SER . 9.1 Cg_exo -73.11 153.39 51.83 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.787 2.992 . . . . 0.0 113.041 -170.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p -104.84 147.46 27.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.783 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.26 -26.71 68.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.959 -168.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.43 -41.21 76.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 110.169 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.691 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.3 t70 -62.74 -42.31 99.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.668 HG13 HD12 ' A' ' 43' ' ' ILE . 41.8 mm -51.67 -51.2 28.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.562 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 89.9 mttt -56.39 -42.35 77.76 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.446 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.75 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.98 -43.74 98.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.311 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.691 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.5 mt -67.97 -39.78 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.6 mt -60.41 -43.24 96.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.75 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.29 -28.69 70.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -70.0 -24.86 63.36 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.24 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.518 HG22 HG13 ' A' ' 32' ' ' ILE . 14.2 m -112.87 -3.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.29 34.89 7.26 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.587 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 52.4 mt -105.41 138.6 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.037 0.419 . . . . 0.0 111.124 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.36 144.16 26.9 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.229 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.567 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -131.22 132.5 44.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.919 0.39 . . . . 0.0 111.978 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.8 m-20 -98.02 124.51 42.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . 0.423 ' CG ' ' HZ3' ' A' ' 24' ' ' LYS . 3.9 m-20 -46.73 -58.66 3.65 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.03 -49.71 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 42' ' ' VAL . 20.6 tpp180 -61.28 -39.27 89.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.138 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 3.7 tp -63.8 -56.16 17.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.016 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -60.3 -28.98 68.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -67.01 -49.85 63.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.566 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 71.9 t -61.54 -41.9 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.843 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.668 HD12 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.49 -40.21 85.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.844 0.83 . . . . 0.0 110.651 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -71.05 -35.84 72.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.365 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 13.5 pt-20 -69.55 -37.26 76.97 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 54' ' ' VAL . 35.9 mt -62.54 -41.53 98.94 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.272 173.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.01 -30.92 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.2 -38.46 25.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.389 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.501 ' HB2' HG22 ' A' ' 54' ' ' VAL . 73.3 mmtt -103.42 -156.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.072 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -100.63 159.95 14.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.516 ' HA ' HD21 ' A' ' 46' ' ' LEU . 1.3 mp -60.26 -50.76 79.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.838 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -57.55 -40.69 79.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.903 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.5 -55.51 26.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.844 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.717 ' HB ' HD22 ' A' ' 46' ' ' LEU . 24.6 t -58.79 -35.34 55.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.654 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.575 HG23 HG23 ' B' ' 55' ' ' ILE . 2.5 mm -59.16 -61.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.412 0.625 . . . . 0.0 111.782 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.848 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.41 -15.61 62.86 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.113 -169.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.51 -44.48 10.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.968 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -48.01 7.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.82 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 2.1 mp . . . . . 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.496 . . . . 0.0 110.039 -177.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.586 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 19.2 tpp180 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.478 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 43.9 m-85 -105.34 -7.39 18.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.663 HG21 HD12 ' B' ' 46' ' ' LEU . 99.3 t -69.46 -31.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 8' ' ' LEU . . . -58.84 -54.97 41.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.39 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.452 ' HA ' HD12 ' A' ' 9' ' ' LEU . 1.3 p -71.39 -36.34 71.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.506 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.601 ' CD1' HD11 ' B' ' 46' ' ' LEU . 70.8 t80 -55.28 -49.12 72.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.801 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.7 mp -58.97 -57.54 12.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.588 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 1.045 HD13 HD13 ' A' ' 9' ' ' LEU . 13.4 mt -48.87 -48.99 41.62 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.74 81.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.29 95.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -75.37 -15.62 60.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.541 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.74 0.71 81.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.319 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.66 -29.04 6.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.13 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 7.2 t30 -94.56 85.22 4.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.578 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 12.5 m -61.66 -25.59 67.48 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.52 81.41 3.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' B' ' 16' ' ' SER . 9.4 Cg_exo -73.28 153.3 50.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.674 2.916 . . . . 0.0 113.11 -170.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.406 ' O ' HG12 ' B' ' 23' ' ' ILE . 2.7 p -104.33 147.33 27.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.964 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.93 -27.29 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.951 -169.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -68.69 -40.98 79.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.057 0.456 . . . . 0.0 110.463 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.687 ' O ' HG13 ' B' ' 26' ' ' ILE . 5.4 t70 -63.34 -42.37 98.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.672 HG13 HD12 ' B' ' 43' ' ' ILE . 41.5 mm -51.5 -51.17 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.605 174.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 89.8 mttt -56.35 -42.13 77.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.696 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.761 ' HA ' ' HE3' ' B' ' 25' ' ' LYS . 0.1 OUTLIER -62.1 -44.02 97.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.687 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.5 mt -67.79 -40.14 83.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.041 0.448 . . . . 0.0 110.491 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.4 mt -60.05 -43.17 95.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.889 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.32 -28.29 69.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.053 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -70.7 -24.33 62.63 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.514 HG22 HG13 ' B' ' 32' ' ' ILE . 14.0 m -113.23 -3.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.295 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.56 6.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.469 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 51.8 mt -105.89 138.64 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.42 143.86 27.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.275 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.574 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -130.98 132.62 45.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.938 0.399 . . . . 0.0 111.894 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' B' ' 38' ' ' ARG . 7.7 m-20 -98.37 124.46 43.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.42 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.475 ' CG ' ' HZ3' ' B' ' 24' ' ' LYS . 3.9 m-20 -46.24 -59.2 3.05 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.65 -49.74 73.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.291 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.456 ' O ' HG22 ' B' ' 42' ' ' VAL . 20.7 tpp180 -61.37 -39.11 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.478 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 3.7 tp -63.83 -56.25 16.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -60.12 -28.81 68.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -67.27 -49.88 62.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.551 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 72.9 t -61.4 -42.01 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.828 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.672 HD12 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.53 -40.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.816 0.817 . . . . 0.0 110.585 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -70.49 -35.91 73.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.485 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' B' ' 42' ' ' VAL . 13.3 pt-20 -69.57 -37.39 76.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.707 HD22 ' HB ' ' B' ' 54' ' ' VAL . 36.1 mt -62.21 -41.66 98.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.359 172.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.87 -31.19 70.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.75 -38.95 26.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.306 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.507 ' HB2' HG22 ' B' ' 54' ' ' VAL . 73.4 mmtt -103.46 -156.12 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.163 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.96 159.38 15.26 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.525 ' HA ' HD21 ' B' ' 46' ' ' LEU . 1.3 mp -59.88 -50.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.848 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -57.72 -40.6 79.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.927 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.64 -55.59 25.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.902 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.707 ' HB ' HD22 ' B' ' 46' ' ' LEU . 24.8 t -58.63 -35.23 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.665 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.575 HG23 HG23 ' A' ' 55' ' ' ILE . 2.5 mm -59.36 -61.81 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.514 0.673 . . . . 0.0 111.675 173.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.838 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.36 -15.63 62.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.224 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.49 -44.44 10.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.72 -48.49 7.14 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.807 -171.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 2.0 mp . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.99 -177.884 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.554 ' HA ' HD11 ' B' ' 12' ' ' LEU . 4.7 mtp85 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 27.8 m-85 -102.04 -10.89 19.32 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.667 HG21 HD12 ' A' ' 46' ' ' LEU . 99.1 t -70.05 -33.42 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.992 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.86 -54.57 42.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.47 0.652 . . . . 0.0 111.417 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.405 ' HA ' HD13 ' B' ' 9' ' ' LEU . 0.4 OUTLIER -71.92 -36.64 70.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.869 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.674 ' CD2' HD11 ' A' ' 46' ' ' LEU . 63.2 t80 -55.48 -48.76 74.05 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.758 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.748 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.6 mp -57.09 -58.96 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.516 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.914 HD11 HD11 ' B' ' 9' ' ' LEU . 15.5 mt -48.67 -50.24 34.01 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 18' ' ' PRO . . . -59.45 -37.9 79.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.799 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.37 -39.67 94.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -78.57 -26.51 45.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.857 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.67 -19.27 64.83 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.723 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.57 -18.03 4.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 52.9 t30 -99.55 88.65 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 14.1 m -65.35 -17.86 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.726 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 t -112.39 78.52 2.62 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 16' ' ' SER . 15.9 Cg_exo -68.29 125.24 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.093 2.529 . . . . 0.0 112.975 -169.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.552 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 34.6 t -76.59 140.39 41.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.274 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.07 -21.09 63.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.194 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.2 mmmm -68.08 -45.26 74.26 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.728 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.1 m-20 -57.34 -46.53 83.19 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.562 HG13 HD13 ' A' ' 43' ' ' ILE . 40.3 mm -50.73 -52.98 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.711 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 34.2 mttm -52.42 -45.88 66.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.817 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -67.02 -42.68 84.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.335 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.728 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.2 mt -65.84 -38.37 82.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.118 0.485 . . . . 0.0 110.05 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.59 HD12 ' HB1' ' A' ' 34' ' ' ALA . 14.1 mt -62.9 -38.76 92.25 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.967 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.73 -30.86 71.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -64.75 -39.39 93.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.893 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 32' ' ' ILE . 15.6 m -102.2 -4.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.661 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.84 44.55 6.02 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.422 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 62.9 mt -108.81 136.75 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.92 139.77 41.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.82 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.59 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -127.91 132.78 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.359 0.6 . . . . 0.0 111.744 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.92 114.92 29.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.996 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -48.82 -50.0 36.49 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.5 0.5 . . . . 0.0 112.25 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 20.7 t70 -62.31 -58.23 8.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.621 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.515 ' O ' HG22 ' A' ' 42' ' ' VAL . 20.6 tpp180 -61.97 -29.8 70.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.7 tp -60.87 -56.5 20.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -58.51 -34.01 70.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 34.0 mmtp -63.42 -51.11 67.12 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.286 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.523 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 74.8 t -59.78 -42.65 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.697 0.76 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.562 HD13 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.52 -40.15 83.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.308 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -68.51 -34.25 75.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.792 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.523 ' OE1' ' HA ' ' A' ' 42' ' ' VAL . 44.4 mt-10 -58.38 -51.07 71.38 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.727 HD22 ' HB ' ' A' ' 54' ' ' VAL . 43.4 mt -64.36 -23.57 67.34 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.565 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.86 -25.92 56.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.011 0.434 . . . . 0.0 110.883 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.81 -41.83 18.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.537 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.572 ' HB2' HG21 ' A' ' 54' ' ' VAL . 7.7 mtpt -116.6 -156.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -94.64 173.57 7.54 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.515 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 1.3 mp -64.91 -52.13 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.438 -174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.88 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.6 -39.35 80.16 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 111.024 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.27 -57.47 12.76 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.985 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.727 ' HB ' HD22 ' A' ' 46' ' ' LEU . 42.6 t -63.47 -31.81 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.96 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.476 HG23 HG23 ' B' ' 55' ' ' ILE . 2.7 mm -58.7 -60.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.48 0.657 . . . . 0.0 111.211 170.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.72 -17.68 62.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.455 -169.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -94.23 -26.2 16.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.85 -50.59 3.05 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.808 -173.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 117.395 0.598 . . . . 0.0 109.822 -178.417 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.553 ' HA ' HD11 ' A' ' 12' ' ' LEU . 4.8 mtp85 . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.511 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 27.7 m-85 -102.01 -11.06 19.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.644 HG21 HD12 ' B' ' 46' ' ' LEU . 99.5 t -70.06 -33.39 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.033 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.9 -54.56 43.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.468 0.652 . . . . 0.0 111.479 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -36.61 69.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.868 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' B' ' 46' ' ' LEU . 63.0 t80 -55.42 -48.77 73.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.881 175.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.754 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.7 mp -57.12 -59.05 5.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.48 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.914 HD11 HD11 ' A' ' 9' ' ' LEU . 15.5 mt -48.33 -50.65 29.5 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' B' ' 18' ' ' PRO . . . -59.26 -37.9 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.893 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.28 -39.97 95.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.3 mt -78.04 -27.06 48.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.855 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.09 -19.69 64.01 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.74 -17.98 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 53.1 t30 -99.55 88.84 3.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.553 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 14.4 m -65.32 -17.95 64.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.563 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.7 t -112.67 78.57 2.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' B' ' 16' ' ' SER . 16.2 Cg_exo -68.09 125.66 13.35 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.142 2.561 . . . . 0.0 112.861 -169.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.538 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 33.3 t -76.83 140.84 40.78 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.319 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.96 -20.5 63.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.609 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.3 mmmm -68.22 -45.43 73.32 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.102 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.734 ' O ' HG13 ' B' ' 26' ' ' ILE . 13.3 m-20 -57.13 -46.76 82.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.555 HG13 HD13 ' B' ' 43' ' ' ILE . 40.4 mm -50.56 -53.14 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.677 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 33.9 mttm -52.24 -45.85 65.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.03 -42.56 84.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.734 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.3 mt -66.07 -38.28 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 109.947 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.592 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 14.1 mt -62.92 -38.98 93.18 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.967 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -31.28 72.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.35 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.8 t -64.29 -39.5 94.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.916 0.388 . . . . 0.0 110.812 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.504 HG21 HG13 ' B' ' 32' ' ' ILE . 15.7 m -102.1 -4.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.579 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.17 44.21 6.03 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.379 173.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.592 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 63.3 mt -108.57 136.75 43.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.909 0.355 . . . . 0.0 111.047 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.81 139.33 41.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.067 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.576 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -127.14 133.3 50.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -104.67 114.64 28.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.023 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -48.4 -50.33 31.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.676 0.61 . . . . 0.0 112.168 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.63 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 20.6 t70 -62.19 -58.28 8.36 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.569 0.543 . . . . 0.0 110.546 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.515 ' O ' HG22 ' B' ' 42' ' ' VAL . 20.6 tpp180 -62.13 -29.58 70.44 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.055 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.511 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.8 tp -60.83 -56.71 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.29 -33.73 69.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 34.0 mmtp -63.7 -51.12 66.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.29 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.515 HG22 ' O ' ' B' ' 38' ' ' ARG . 73.0 t -59.83 -42.43 89.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.73 0.776 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.555 HD13 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.64 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.3 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.2 t -68.78 -33.87 74.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.945 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.504 ' OE1' ' HA ' ' B' ' 42' ' ' VAL . 44.4 mt-10 -58.54 -51.06 71.5 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' B' ' 54' ' ' VAL . 43.5 mt -64.54 -23.83 67.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.63 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.8 -25.79 56.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.965 0.412 . . . . 0.0 110.741 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.71 -42.52 17.01 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.39 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.57 ' HB2' HG21 ' B' ' 54' ' ' VAL . 7.8 mtpt -115.67 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -94.35 174.07 7.32 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.522 ' HA ' HD21 ' B' ' 46' ' ' LEU . 1.3 mp -65.3 -52.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.228 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.18 -57.2 13.9 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.137 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.723 ' HB ' HD22 ' B' ' 46' ' ' LEU . 42.6 t -63.9 -31.6 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.975 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.476 HG23 HG23 ' A' ' 55' ' ' ILE . 2.7 mm -58.82 -60.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.495 0.664 . . . . 0.0 111.201 170.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.88 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.53 -18.08 62.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.388 -169.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -94.03 -25.92 17.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 173.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -50.71 3.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.864 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 117.281 0.541 . . . . 0.0 109.664 -178.295 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.66 ' HA ' HD11 ' B' ' 12' ' ' LEU . 35.0 ttm180 . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.521 ' CZ ' ' HD2' ' A' ' 2' ' ' ARG . 28.1 m-85 -86.8 -24.45 25.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.115 -171.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.701 HG23 HD13 ' A' ' 46' ' ' LEU . 75.8 t -58.96 -36.25 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 0.0 110.557 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.89 -55.17 38.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.358 0.599 . . . . 0.0 111.744 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.402 ' HA ' HD13 ' B' ' 9' ' ' LEU . 1.2 p -72.3 -37.39 68.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.671 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.508 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 54.7 t80 -54.12 -48.7 70.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.679 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.79 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.4 mp -58.59 -58.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.372 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.898 HD11 HD11 ' B' ' 9' ' ' LEU . 14.1 mt -48.59 -48.83 38.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB1' ' CD1' ' A' ' 26' ' ' ILE . . . -60.53 -37.41 81.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.31 -39.35 92.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.749 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -80.43 -17.52 51.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.13 -14.56 78.92 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.973 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.9 -27.14 3.51 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.252 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 44.9 t30 -93.42 98.02 10.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 0.0 110.693 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 18' ' ' PRO . 15.2 m -74.6 -3.64 32.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.51 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -123.3 71.65 46.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HD3' ' C ' ' A' ' 16' ' ' SER . 14.9 Cg_exo -69.2 126.36 13.58 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.322 2.681 . . . . 0.0 112.542 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' HG12 ' A' ' 23' ' ' ILE . 62.5 p -78.05 147.87 34.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.03 -26.78 69.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.37 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.94 -39.37 69.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.999 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 26' ' ' ILE . 15.6 t70 -62.03 -44.67 96.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.588 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.704 HG13 HD13 ' A' ' 43' ' ' ILE . 41.1 mm -50.63 -50.46 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.517 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 94.0 mttt -55.88 -43.61 77.35 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.091 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HB3' ' HZ3' ' A' ' 25' ' ' LYS . 4.3 mmmp? -65.53 -38.99 91.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 22' ' ' ASP . 11.2 mt -68.16 -39.38 81.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.071 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.607 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.4 mt -61.91 -39.98 93.89 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 171.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 4.7 t70 -59.41 -35.44 73.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.722 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 t -64.8 -35.3 80.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.655 0.264 . . . . 0.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.483 HG22 HG13 ' A' ' 32' ' ' ILE . 16.8 m -102.33 -8.78 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.17 44.13 4.18 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.374 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.607 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.9 mt -116.34 135.18 57.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.868 0.334 . . . . 0.0 110.214 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.89 155.5 21.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.628 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -134.77 130.97 36.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.256 0.551 . . . . 0.0 112.07 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -94.63 116.25 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.208 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -42.32 -64.12 0.65 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.45 -45.62 93.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.61 -173.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.446 ' O ' HG21 ' A' ' 42' ' ' VAL . 16.6 tpp180 -64.09 -36.83 85.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.026 0.441 . . . . 0.0 110.649 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.505 HD13 HG13 ' A' ' 43' ' ' ILE . 5.8 tp -65.04 -56.77 11.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.23 -32.85 68.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -60.85 -57.59 12.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.542 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 38' ' ' ARG . 93.2 t -56.03 -44.58 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.778 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.704 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.78 -47.61 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.399 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.1 p -69.0 -28.21 66.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.123 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.39 -37.16 60.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.322 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.701 HD13 HG23 ' A' ' 4' ' ' VAL . 43.1 mt -63.17 -33.93 76.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.068 0.461 . . . . 0.0 110.614 172.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.06 -42.51 63.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -37.3 67.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.254 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -103.47 -151.48 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 22.1 m120 -114.46 141.36 47.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.495 HG13 HD21 ' A' ' 46' ' ' LEU . 1.7 mp -46.9 -56.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.395 0.435 . . . . 0.0 111.368 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.782 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 27.8 mt-10 -55.07 -36.24 65.39 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.485 0.491 . . . . 0.0 111.864 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.41 -52.46 18.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.691 ' HB ' HD22 ' A' ' 46' ' ' LEU . 54.0 t -62.27 -29.32 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.435 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.55 HD11 HD11 ' B' ' 55' ' ' ILE . 2.1 mm -60.43 -61.13 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.097 0.475 . . . . 0.0 111.459 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.779 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -72.36 -9.54 58.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.432 -170.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.82 -19.89 13.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.757 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.09 -35.08 4.33 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.442 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.517 ' HB ' ' HG2' ' B' ' 52' ' ' GLU . 1.8 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 117.916 0.858 . . . . 0.0 109.088 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.697 ' HA ' HD11 ' A' ' 12' ' ' LEU . 34.8 ttm180 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.99 0.424 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.515 ' CZ ' ' HD2' ' B' ' 2' ' ' ARG . 28.4 m-85 -86.92 -24.42 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.178 -171.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.707 HG23 HD13 ' B' ' 46' ' ' LEU . 75.3 t -58.98 -36.07 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 8' ' ' LEU . . . -58.0 -55.36 35.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.655 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.406 ' HA ' HD13 ' A' ' 9' ' ' LEU . 1.2 p -72.24 -37.3 69.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.618 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.507 ' HA ' ' CD1' ' B' ' 23' ' ' ILE . 54.9 t80 -54.3 -48.6 71.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.729 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.3 mp -58.74 -58.34 9.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.372 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.898 HD11 HD11 ' A' ' 9' ' ' LEU . 14.2 mt -48.36 -48.7 36.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.423 ' HB3' ' CD1' ' B' ' 26' ' ' ILE . . . -60.9 -37.75 83.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.78 -39.34 93.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 0.0 110.777 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.0 mt -80.44 -17.49 51.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.619 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.09 -14.6 78.84 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.998 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.1 -27.53 3.43 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.126 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 45.2 t30 -92.95 98.44 11.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.413 ' C ' ' HD3' ' B' ' 18' ' ' PRO . 17.0 m -75.18 -3.17 31.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.515 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.9 t -123.51 71.69 48.29 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' B' ' 16' ' ' SER . 15.0 Cg_exo -69.44 126.01 13.01 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.237 2.625 . . . . 0.0 112.746 -171.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.566 ' O ' HG12 ' B' ' 23' ' ' ILE . 64.6 p -77.8 147.98 34.99 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.671 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -63.15 -27.01 69.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.275 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.88 -39.26 69.74 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.352 0.596 . . . . 0.0 110.002 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.671 ' O ' HG13 ' B' ' 26' ' ' ILE . 15.7 t70 -62.02 -44.86 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.683 HG13 HD12 ' B' ' 43' ' ' ILE . 41.2 mm -50.53 -50.38 22.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.591 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 93.9 mttt -55.98 -43.71 77.87 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.535 ' HB3' ' HZ3' ' B' ' 25' ' ' LYS . 4.3 mmmp? -65.16 -39.27 92.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.671 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.1 -39.19 80.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 0.0 110.136 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.4 mt -62.09 -39.92 94.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.679 171.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' B' ' 25' ' ' LYS . 5.6 t70 -59.59 -35.24 73.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.928 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 10.0 t -64.76 -35.48 81.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.872 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.477 HG21 HG13 ' B' ' 32' ' ' ILE . 17.1 m -102.28 -8.62 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.277 . . . . 0.0 111.622 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.7 44.75 4.15 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.281 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 37.9 mt -116.98 135.49 57.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.82 0.31 . . . . 0.0 110.295 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.96 155.97 21.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.641 0.258 . . . . 0.0 110.576 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.569 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -135.43 130.51 34.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.313 0.578 . . . . 0.0 111.985 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.23 116.37 28.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.326 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . 0.432 ' CG ' ' HZ3' ' B' ' 24' ' ' LYS . 4.0 m-20 -42.53 -64.04 0.67 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.2 -45.93 91.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.809 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.465 ' O ' HG21 ' B' ' 42' ' ' VAL . 16.4 tpp180 -64.11 -36.5 84.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 110.598 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.498 HD13 HG13 ' B' ' 43' ' ' ILE . 5.7 tp -65.27 -56.72 11.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.86 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -58.41 -32.78 68.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -60.78 -57.73 11.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.465 HG21 ' O ' ' B' ' 38' ' ' ARG . 94.3 t -56.03 -44.59 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.129 0.49 . . . . 0.0 110.888 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.683 HD12 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.69 -47.6 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.444 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -68.86 -28.15 66.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.156 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.57 -37.1 60.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.33 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.707 HD13 HG23 ' B' ' 4' ' ' VAL . 43.7 mt -63.14 -34.1 76.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 110.635 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -72.96 -42.07 63.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.379 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.02 -37.29 64.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.128 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -103.67 -151.49 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -114.23 141.69 47.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.492 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.7 mp -47.06 -56.73 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.274 0.359 . . . . 0.0 111.338 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.779 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 27.8 mt-10 -55.16 -35.92 65.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.16 0.505 . . . . 0.0 111.989 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.51 -52.5 17.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.13 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.703 ' HB ' HD22 ' B' ' 46' ' ' LEU . 55.0 t -62.38 -29.22 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.529 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 55' ' ' ILE . 2.1 mm -60.45 -61.19 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.086 0.47 . . . . 0.0 111.53 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.782 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -72.26 -9.92 59.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.529 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -104.33 -20.35 13.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.652 170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.73 -35.65 4.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.285 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' HG2' ' A' ' 52' ' ' GLU . 1.8 mp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 117.91 0.855 . . . . 0.0 109.023 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.43 ' NH1' ' HH ' ' A' ' 3' ' ' TYR . 79.7 mtp180 . . . . . 0 C--O 1.226 -0.148 0 CA-C-O 121.019 0.437 . . . . 0.0 110.477 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 19.5 m-85 -90.99 -20.69 21.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -168.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 46' ' ' LEU . 97.3 t -63.28 -33.78 63.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.043 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.57 -54.85 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.519 0.676 . . . . 0.0 111.075 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.841 ' HG ' HG21 ' A' ' 23' ' ' ILE . 1.2 p -70.37 -35.16 73.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.856 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.653 ' CD2' HD11 ' A' ' 46' ' ' LEU . 55.2 t80 -56.6 -47.51 79.44 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.758 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.4 mp -60.1 -57.64 11.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.514 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.887 HD11 HD11 ' B' ' 9' ' ' LEU . 14.3 mt -46.4 -49.83 17.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.83 84.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.15 -37.34 87.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.038 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.758 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.0 mt -81.46 -24.18 36.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.673 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.77 -21.27 74.9 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.9 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.63 -15.37 3.14 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.269 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.576 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 60.4 t30 -108.41 86.62 2.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.592 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 16.3 m -61.81 -27.75 68.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.736 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -108.63 82.62 1.76 Allowed Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.7 Cg_exo -78.73 147.8 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.348 2.699 . . . . 0.0 112.489 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 23' ' ' ILE . 89.7 p -94.14 156.96 16.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.45 -25.58 67.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.463 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -45.09 83.55 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.027 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.732 ' O ' HG13 ' A' ' 26' ' ' ILE . 55.5 m-20 -55.22 -50.9 68.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.841 HG21 ' HG ' ' A' ' 6' ' ' SER . 37.2 mm -50.39 -51.1 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.957 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 88.3 mttt -52.89 -49.65 65.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 123.754 0.659 . . . . 0.0 110.943 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -66.68 -35.99 81.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.6 mt -68.62 -38.25 78.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 0.0 110.02 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 13.3 mt -62.11 -41.15 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.067 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.22 -38.6 73.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.218 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -60.37 -35.78 76.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.743 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 32' ' ' ILE . 14.6 m -103.33 -9.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.98 39.02 4.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.11 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 17.5 mt -117.69 149.42 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.56 167.76 9.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -139.57 133.54 30.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.354 0.597 . . . . 0.0 112.02 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -97.84 113.97 25.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -42.53 -58.61 2.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 12.6 m-20 -60.98 -54.71 41.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.477 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.408 ' O ' HG21 ' A' ' 42' ' ' VAL . 23.2 tpp180 -55.31 -43.33 74.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.145 0.498 . . . . 0.0 110.808 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.533 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 6.1 tp -58.44 -54.83 42.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.27 -34.23 70.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 73.5 mmtt -65.19 -53.09 50.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.086 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 38' ' ' ARG . 89.2 t -57.04 -44.18 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.407 0.623 . . . . 0.0 110.578 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.703 HD13 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -59.16 -45.99 92.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.292 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.0 t -65.57 -33.22 75.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.104 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 46.6 mt-10 -67.52 -44.25 78.85 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.743 HD22 ' HB ' ' A' ' 54' ' ' VAL . 45.6 mt -62.14 -41.72 98.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.377 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.26 -22.93 64.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.065 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 4.39 56.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.672 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.503 ' HD2' HG23 ' A' ' 54' ' ' VAL . 66.4 mttm -142.21 -163.62 1.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.27 144.99 25.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.524 HG13 HD21 ' A' ' 46' ' ' LEU . 1.2 mp -54.52 -50.04 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.334 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.828 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.38 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.426 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -65.75 -53.47 40.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.859 0.362 . . . . 0.0 110.284 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.743 ' HB ' HD22 ' A' ' 46' ' ' LEU . 70.7 t -62.01 -29.65 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.376 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.599 HG23 HG23 ' B' ' 55' ' ' ILE . 2.5 mm -61.6 -61.09 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.279 0.561 . . . . 0.0 111.564 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.813 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -71.04 -13.87 62.13 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.466 -170.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -97.65 -27.97 14.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.135 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.86 -33.16 7.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.943 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 117.311 0.556 . . . . 0.0 109.559 177.119 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.434 ' NH1' ' HH ' ' B' ' 3' ' ' TYR . 79.5 mtp180 . . . . . 0 C--O 1.227 -0.116 0 CA-C-O 121.057 0.456 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 19.2 m-85 -90.96 -20.81 21.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.671 HG21 HD12 ' B' ' 46' ' ' LEU . 98.5 t -63.27 -33.64 62.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.119 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.71 -54.78 42.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.817 ' HG ' HG21 ' B' ' 23' ' ' ILE . 1.1 p -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.818 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.655 ' CD2' HD11 ' B' ' 46' ' ' LEU . 56.7 t80 -56.29 -47.75 78.01 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.4 mp -60.03 -57.48 12.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.557 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.887 HD11 HD11 ' A' ' 9' ' ' LEU . 14.4 mt -46.66 -50.01 18.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.286 0.366 . . . . 0.0 111.976 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.89 -38.93 83.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.891 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.32 -36.68 84.91 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.0 mt -81.71 -24.29 36.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.97 -21.04 75.16 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.861 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.84 -15.94 3.07 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.28 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 60.7 t30 -107.88 86.78 2.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.597 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 15.4 m -61.85 -27.98 69.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.656 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -108.32 82.32 1.56 Allowed Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.8 Cg_exo -78.37 147.82 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.37 2.713 . . . . 0.0 112.428 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.482 ' O ' HG12 ' B' ' 23' ' ' ILE . 94.3 p -93.77 157.47 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.82 -25.72 67.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.456 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.401 ' HB3' ' HZ1' ' B' ' 21' ' ' LYS . 0.8 OUTLIER -65.81 -45.0 83.96 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.086 0.469 . . . . 0.0 110.147 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.725 ' O ' HG13 ' B' ' 26' ' ' ILE . 55.6 m-20 -55.14 -51.0 67.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.817 HG21 ' HG ' ' B' ' 6' ' ' SER . 37.1 mm -50.43 -50.87 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.02 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 87.6 mttt -52.9 -49.55 65.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.869 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -66.86 -36.1 81.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.007 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.725 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.8 mt -68.65 -38.3 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 110.03 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.592 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 13.7 mt -62.03 -41.07 97.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.009 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -57.52 -38.36 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.22 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -60.39 -35.93 76.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.583 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.555 HG22 HG13 ' B' ' 32' ' ' ILE . 14.0 m -103.3 -9.14 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.75 39.56 4.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.075 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.592 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 17.9 mt -118.03 149.45 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -101.46 168.14 9.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.489 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -139.47 133.67 31.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.312 0.577 . . . . 0.0 112.14 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -97.97 113.76 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.69 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -42.27 -58.22 2.25 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 12.8 m-20 -61.5 -54.49 42.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.453 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.414 ' O ' HG21 ' B' ' 42' ' ' VAL . 23.2 tpp180 -55.33 -43.24 74.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.019 0.437 . . . . 0.0 110.822 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 6.3 tp -58.45 -54.94 41.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.099 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.07 -34.1 69.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.477 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 73.4 mmtt -65.32 -53.17 47.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.099 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.414 HG21 ' O ' ' B' ' 38' ' ' ARG . 86.2 t -56.83 -44.2 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 110.596 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.687 HD13 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.22 -46.07 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.236 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -65.37 -33.42 75.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.07 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 45.2 mt-10 -67.49 -44.45 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.713 HD22 ' HB ' ' B' ' 54' ' ' VAL . 44.9 mt -61.99 -41.67 98.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.397 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -68.34 -22.6 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.142 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.53 5.28 54.6 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.522 ' HD2' HG23 ' B' ' 54' ' ' VAL . 66.4 mttm -142.55 -163.12 1.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.89 145.05 25.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.506 HG13 HD21 ' B' ' 46' ' ' LEU . 1.2 mp -54.37 -50.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.364 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.813 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.49 69.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.509 -175.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -65.57 -53.69 38.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.874 0.368 . . . . 0.0 110.131 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.713 ' HB ' HD22 ' B' ' 46' ' ' LEU . 71.6 t -62.05 -29.6 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.495 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.599 HG23 HG23 ' A' ' 55' ' ' ILE . 2.5 mm -61.56 -61.16 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.37 0.605 . . . . 0.0 111.587 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.828 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.94 -13.92 62.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.632 -170.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -97.59 -28.38 13.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.053 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.28 -33.29 8.18 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.751 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 1.9 mp . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 117.506 0.653 . . . . 0.0 109.345 177.563 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 26.8 m-85 -111.01 -9.01 14.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 55' ' ' ILE . 54.0 t -62.89 -36.5 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.162 0.506 . . . . 0.0 110.359 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' B' ' 8' ' ' LEU . . . -57.63 -54.98 40.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.69 -36.51 73.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.471 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 68.6 t80 -55.49 -49.54 72.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.986 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.791 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.2 mp -59.84 -55.9 28.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.452 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.814 HD11 HD11 ' B' ' 9' ' ' LEU . 15.5 mt -48.54 -50.45 32.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.04 81.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.73 -38.37 90.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.081 0.467 . . . . 0.0 111.014 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.8 mt -79.93 -30.27 39.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.998 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.64 -23.94 73.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.437 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.67 -27.07 1.64 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.867 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 18' ' ' PRO . 2.4 t-20 -89.54 73.49 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.544 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m -60.47 -20.34 59.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.486 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.8 p -112.5 75.34 1.75 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 16' ' ' SER . 20.3 Cg_exo -66.17 139.68 56.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.168 2.579 . . . . 0.0 113.553 -166.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 23' ' ' ILE . 10.7 p -96.54 142.17 28.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.224 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.46 -24.47 67.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.21 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . 0.594 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.4 mmmm -64.52 -46.18 84.02 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.392 0.615 . . . . 0.0 110.134 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.723 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.1 t70 -59.06 -46.25 88.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.748 HG13 HD13 ' A' ' 43' ' ' ILE . 43.9 mm -50.95 -51.55 20.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.049 176.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 43.6 mttm -52.98 -44.27 67.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.808 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HB3' ' HZ3' ' A' ' 25' ' ' LYS . 4.4 mmmp? -70.03 -35.28 74.2 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.723 HG13 ' O ' ' A' ' 22' ' ' ASP . 8.9 mt -69.93 -40.91 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.065 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 ' HB1' ' A' ' 34' ' ' ALA . 12.8 mt -61.86 -38.05 86.82 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 11.8 t70 -61.81 -34.91 76.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.731 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.66 -36.12 81.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 32' ' ' ILE . 16.2 m -98.94 -10.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.07 0.462 . . . . 0.0 111.152 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.77 44.01 5.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.24 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 30' ' ' VAL . 87.6 mt -102.65 126.87 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.26 0.552 . . . . 0.0 111.642 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.9 127.75 33.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.944 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -126.64 124.47 39.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.968 0.413 . . . . 0.0 111.796 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -92.35 121.34 33.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.14 -57.68 8.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.18 -45.27 95.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 -172.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.337 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.53 HD13 HG13 ' A' ' 43' ' ' ILE . 5.3 tp -58.99 -56.81 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.668 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.66 -34.96 71.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.0 109.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.6 tmtt? -63.98 -55.38 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.448 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.92 -44.38 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.883 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.748 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.01 -46.11 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.198 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -66.16 -34.27 77.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.756 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 16.8 mm-40 -61.03 -52.12 66.3 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.775 HD22 ' HB ' ' A' ' 54' ' ' VAL . 22.7 mt -60.35 -37.56 81.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.762 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.96 -25.02 60.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.027 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.18 -30.24 12.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.289 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB2' HG22 ' A' ' 54' ' ' VAL . 74.0 mmtt -106.98 -157.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -98.69 149.37 22.89 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.657 HG13 HD21 ' A' ' 46' ' ' LEU . 1.3 mp -61.33 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.809 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 1.118 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.04 -44.63 87.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.849 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.46 -56.03 26.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.775 ' HB ' HD22 ' A' ' 46' ' ' LEU . 74.1 t -60.0 -29.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.741 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 1.092 HD11 HD11 ' B' ' 55' ' ' ILE . 18.0 mt -69.15 -56.23 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 173.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 1.106 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -68.69 -14.89 63.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.169 0.509 . . . . 0.0 111.044 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -94.24 -32.75 13.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.62 169.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.95 -34.86 13.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.755 0.662 . . . . 0.0 114.755 -170.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.84 HD12 HG22 ' A' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--O 1.233 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.701 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.52 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 26.9 m-85 -111.14 -8.89 14.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -168.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.675 HG12 HG12 ' B' ' 55' ' ' ILE . 54.2 t -63.06 -36.3 75.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.61 -55.26 37.13 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.639 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -70.36 -36.52 74.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.535 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.471 ' HA ' ' CD1' ' B' ' 23' ' ' ILE . 69.1 t80 -55.27 -49.74 71.3 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.791 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.3 mp -59.97 -55.73 30.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.814 HD11 HD11 ' A' ' 9' ' ' LEU . 15.5 mt -48.73 -50.37 33.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.757 0.313 . . . . 0.0 111.623 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.53 82.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.25 -38.58 91.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.8 mt -79.97 -30.01 39.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.005 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.83 73.94 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.404 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.55 -27.73 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.902 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.555 ' OD1' ' HA ' ' B' ' 18' ' ' PRO . 2.5 t-20 -89.02 73.91 8.19 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 13.5 m -60.79 -20.62 61.86 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.394 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -112.23 75.63 1.7 Allowed Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.555 ' HA ' ' OD1' ' B' ' 15' ' ' ASN . 19.4 Cg_exo -66.06 139.79 57.4 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.287 2.658 . . . . 0.0 113.386 -166.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.441 ' O ' HG12 ' B' ' 23' ' ' ILE . 11.6 p -97.05 141.97 29.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.277 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -62.25 -24.64 67.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.194 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . 0.606 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.4 mmmm -64.42 -46.17 84.4 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.384 0.611 . . . . 0.0 110.122 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.724 ' O ' HG13 ' B' ' 26' ' ' ILE . 4.9 t70 -59.25 -46.13 89.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.235 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.763 HG13 HD13 ' B' ' 43' ' ' ILE . 44.0 mm -51.05 -51.47 21.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.089 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.606 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 43.6 mttm -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.577 ' HB3' ' HZ3' ' B' ' 25' ' ' LYS . 4.5 mmmp? -69.88 -35.38 74.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.724 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.0 mt -70.1 -40.76 78.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.025 0.44 . . . . 0.0 110.004 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.567 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 12.8 mt -62.01 -38.06 87.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.462 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' B' ' 25' ' ' LYS . 10.9 t70 -61.76 -34.65 76.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.747 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.98 -36.08 81.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.249 . . . . 0.0 111.042 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.559 HG21 HG13 ' B' ' 32' ' ' ILE . 16.2 m -98.84 -10.14 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 111.382 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 44.45 5.5 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.028 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 88.1 mt -103.03 126.27 57.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.668 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -65.07 127.98 33.86 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.953 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.565 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -127.13 124.08 38.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.0 111.775 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -92.35 121.5 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.742 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.88 -58.35 6.72 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -60.64 -45.09 95.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -62.81 -38.88 92.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.405 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.541 HD13 HG13 ' B' ' 43' ' ' ILE . 5.3 tp -59.0 -57.01 14.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.635 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.5 -35.11 71.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.922 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.605 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 6.7 tmtt? -63.78 -55.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 75.6 t -55.97 -44.22 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.362 0.601 . . . . 0.0 110.87 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.763 HD13 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.37 -45.68 89.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.202 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.4 t -66.48 -33.99 76.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.68 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 15.3 mm-40 -61.26 -52.14 65.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.176 0.512 . . . . 0.0 109.801 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.767 HD22 ' HB ' ' B' ' 54' ' ' VAL . 22.4 mt -60.46 -37.48 81.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.704 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.05 -24.63 60.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.7 -30.02 12.44 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.22 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG22 ' B' ' 54' ' ' VAL . 74.1 mmtt -106.86 -157.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -99.18 149.31 23.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.648 HG13 HD21 ' B' ' 46' ' ' LEU . 1.4 mp -61.47 -45.31 98.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.762 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 1.106 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.2 mp0 -58.22 -44.27 88.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -60.67 -56.07 25.74 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.27 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.767 ' HB ' HD22 ' B' ' 46' ' ' LEU . 75.5 t -59.92 -29.73 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.707 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 55' ' ' ILE . 17.5 mt -69.33 -56.25 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 1.118 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -68.36 -15.61 63.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.49 -33.41 13.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.695 169.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.2 -35.34 15.16 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.856 HD12 HG22 ' B' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--O 1.234 0.268 0 CA-C-N 117.977 0.889 . . . . 0.0 109.471 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.78 ' HA ' HD11 ' B' ' 12' ' ' LEU . 9.6 ptp180 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 15.9 m-85 -79.26 -26.3 42.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.968 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.649 HG21 HD12 ' A' ' 46' ' ' LEU . 62.1 t -71.66 -32.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.186 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.8 -54.86 41.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.475 ' HG ' ' HG ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -72.66 -35.33 67.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.823 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.574 ' CD2' HD11 ' A' ' 46' ' ' LEU . 54.9 t80 -55.47 -48.19 74.93 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.782 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.6 mp -57.4 -61.08 2.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.221 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.862 HD11 HD11 ' B' ' 9' ' ' LEU . 16.5 mt -46.98 -49.08 21.4 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB1' HD12 ' A' ' 26' ' ' ILE . . . -63.05 -35.63 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.397 . . . . 0.0 110.944 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.78 -37.95 87.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 3.4 mt -81.77 -18.42 44.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.922 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.63 12.92 42.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.574 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.14 -76.38 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.819 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 40.0 t30 -145.88 143.8 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.844 -0.209 . . . . 0.0 110.796 -170.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -77.22 44.3 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' SER . . . . . 0.405 ' N ' ' HD3' ' A' ' 18' ' ' PRO . 14.7 t -165.84 65.64 1.01 Allowed Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 17' ' ' SER . 3.4 Cg_exo -78.07 143.47 20.36 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.903 3.069 . . . . 0.0 112.691 -171.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 46.7 t -77.51 143.23 38.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.965 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.4 66.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.287 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.62 -40.77 76.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.71 ' O ' HG13 ' A' ' 26' ' ' ILE . 18.6 m-20 -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.227 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.608 HG13 HD12 ' A' ' 43' ' ' ILE . 28.2 mm -52.08 -51.2 31.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -52.73 -48.82 66.42 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.764 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.15 -46.68 82.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.71 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.6 mt -68.11 -37.88 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.055 0.455 . . . . 0.0 110.574 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.587 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 11.2 mt -63.18 -41.48 99.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.012 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.46 -26.77 68.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.6 m -70.68 -25.26 62.9 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.644 0.259 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.53 HG21 HG13 ' A' ' 32' ' ' ILE . 16.5 m -112.17 -9.28 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.692 0.282 . . . . 0.0 111.453 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.4 5.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.497 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 39.2 mt -111.3 136.5 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.012 0.406 . . . . 0.0 110.873 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -76.78 158.4 30.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.55 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.57 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -150.22 138.82 20.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -85.68 -178.02 6.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.792 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.51 -52.93 2.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.198 0.523 . . . . 0.0 109.851 167.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.49 -58.19 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.837 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . 0.451 ' O ' HG21 ' A' ' 42' ' ' VAL . 18.5 tpp180 -60.6 -35.95 77.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.5 tp -63.57 -55.63 22.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -62.24 -28.54 69.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.669 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -64.87 -49.92 68.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.324 176.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 38' ' ' ARG . 88.8 t -62.15 -41.32 90.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.683 0.754 . . . . 0.0 110.725 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.608 HD12 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.45 -41.39 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.714 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t -70.42 -34.95 73.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.311 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.24 -37.12 69.2 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.107 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.818 HD22 ' HB ' ' A' ' 54' ' ' VAL . 17.8 mt -57.14 -46.3 82.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.158 169.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -71.28 -3.6 21.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.554 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.24 -14.86 40.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.727 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.531 ' HB2' HG22 ' A' ' 54' ' ' VAL . 13.7 mmmm -133.72 -146.89 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -105.03 162.38 13.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 166.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.463 ' CG2' HD13 ' A' ' 8' ' ' LEU . 1.6 mp -58.91 -50.9 77.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.175 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.911 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.8 mp0 -59.25 -39.06 81.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.296 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.2 -54.32 48.27 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.246 0.546 . . . . 0.0 110.02 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.818 ' HB ' HD22 ' A' ' 46' ' ' LEU . 50.9 t -65.91 -32.14 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.778 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.594 HG23 HG23 ' B' ' 55' ' ' ILE . 2.5 mm -58.09 -60.65 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.489 0.661 . . . . 0.0 111.286 170.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.908 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.44 -14.84 62.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.382 -170.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -100.6 -18.1 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.743 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.08 -40.09 3.15 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.486 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . 0.49 ' HB ' ' CG ' ' B' ' 52' ' ' GLU . 1.9 mp . . . . . 0 C--O 1.234 0.27 0 CA-C-N 117.689 0.744 . . . . 0.0 110.078 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.741 ' HA ' HD11 ' A' ' 12' ' ' LEU . 9.5 ptp180 . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 15.7 m-85 -78.91 -26.32 43.74 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.956 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.634 HG21 HD12 ' B' ' 46' ' ' LEU . 61.2 t -71.66 -32.42 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.283 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.03 -54.75 43.21 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.482 0.658 . . . . 0.0 110.847 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.496 ' HG ' ' HG ' ' B' ' 27' ' ' LEU . 0.4 OUTLIER -72.51 -35.46 68.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.572 ' CD2' HD11 ' B' ' 46' ' ' LEU . 54.4 t80 -55.21 -48.14 74.3 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.786 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -57.82 -60.69 3.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.862 HD11 HD11 ' A' ' 9' ' ' LEU . 16.2 mt -47.27 -48.8 24.6 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . 0.428 ' HB3' HD12 ' B' ' 26' ' ' ILE . . . -63.1 -35.89 81.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -65.67 -37.93 87.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 110.849 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 3.4 mt -81.75 -18.37 44.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.943 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.87 12.97 41.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.738 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.93 -75.37 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.203 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 39.1 t30 -147.02 143.78 28.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.919 -0.165 . . . . 0.0 110.782 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -76.59 44.11 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.254 0.55 . . . . 0.0 111.118 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' SER . . . . . 0.404 ' H ' ' C ' ' B' ' 15' ' ' ASN . 15.9 t -165.93 66.06 1.02 Allowed Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' B' ' 17' ' ' SER . 3.5 Cg_exo -78.63 143.51 18.99 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.817 3.011 . . . . 0.0 112.632 -171.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.461 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 46.3 t -77.61 143.81 37.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.822 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.2 -25.32 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.228 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -40.38 76.3 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.091 0.472 . . . . 0.0 110.016 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.7 ' O ' HG13 ' B' ' 26' ' ' ILE . 16.4 m-20 -60.91 -44.25 97.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.151 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.608 HG13 HD12 ' B' ' 43' ' ' ILE . 27.3 mm -52.01 -51.08 31.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.492 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -52.92 -48.27 67.38 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.912 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.58 -46.64 83.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.684 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.7 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.09 -38.11 79.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.441 . . . . 0.0 110.571 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.589 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 11.3 mt -62.97 -41.23 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.149 172.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.04 -26.03 68.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -71.34 -24.79 62.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.69 0.281 . . . . 0.0 111.234 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.53 HG21 HG13 ' B' ' 32' ' ' ILE . 17.0 m -112.71 -8.86 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 111.519 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 34.64 5.58 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.669 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.589 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 39.3 mt -110.69 136.73 45.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.076 0.438 . . . . 0.0 110.777 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.84 158.51 30.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.498 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.56 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -150.29 138.62 20.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -85.55 -177.73 6.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.582 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.71 -52.95 2.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.175 0.512 . . . . 0.0 109.828 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.24 -57.83 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.863 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.445 ' O ' HG21 ' B' ' 42' ' ' VAL . 18.5 tpp180 -61.27 -35.86 78.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.503 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.5 tp -63.52 -55.59 22.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.724 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.19 -28.49 69.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.647 ' HA ' ' HE3' ' B' ' 41' ' ' LYS . 0.1 OUTLIER -64.74 -50.38 67.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.408 176.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . 0.445 HG21 ' O ' ' B' ' 38' ' ' ARG . 88.6 t -61.77 -41.53 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.686 0.755 . . . . 0.0 110.684 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.608 HD12 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.29 -41.4 89.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.76 175.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -70.7 -34.82 72.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.258 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.41 -36.87 68.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.163 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.845 HD22 ' HB ' ' B' ' 54' ' ' VAL . 17.9 mt -57.44 -45.97 84.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.967 0.413 . . . . 0.0 110.258 169.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.66 -3.15 20.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.5 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.71 -14.55 40.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.867 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' B' ' 54' ' ' VAL . 13.6 mmmm -133.8 -147.06 0.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -104.91 162.2 13.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 165.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.466 ' CG2' HD13 ' B' ' 8' ' ' LEU . 1.6 mp -58.67 -50.9 77.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.108 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.908 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 mp0 -59.46 -38.79 81.69 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.127 0.267 . . . . 0.0 111.18 -174.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -59.14 -54.98 40.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.04 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.845 ' HB ' HD22 ' B' ' 46' ' ' LEU . 52.8 t -65.17 -32.34 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.594 HG23 HG23 ' A' ' 55' ' ' ILE . 2.5 mm -58.18 -60.46 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.458 0.647 . . . . 0.0 111.337 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.911 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.2 -15.42 62.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.448 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -99.88 -18.72 16.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.618 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -39.66 3.29 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.98 -0.629 . . . . 0.0 114.454 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . 0.467 ' HB ' ' CG ' ' A' ' 52' ' ' GLU . 1.9 mp . . . . . 0 C--O 1.235 0.315 0 CA-C-N 117.878 0.839 . . . . 0.0 110.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ARG . . . . . 0.67 ' HA ' HD11 ' B' ' 12' ' ' LEU . 96.3 mtt180 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.373 0.606 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 21.3 m-85 -78.37 -26.58 46.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.388 -168.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . 0.669 HG21 HD12 ' A' ' 46' ' ' LEU . 60.0 t -64.2 -31.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.809 0.338 . . . . 0.0 110.827 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.67 -54.58 44.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.473 0.654 . . . . 0.0 111.064 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' SER . . . . . 0.405 ' HG ' ' HG ' ' A' ' 27' ' ' LEU . 1.3 p -72.38 -34.99 68.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.759 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CD1' HD11 ' A' ' 46' ' ' LEU . 48.7 t80 -55.34 -47.96 74.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.664 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.782 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.3 mp -58.19 -59.68 4.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.275 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.891 HD13 HD13 ' B' ' 9' ' ' LEU . 16.2 mt -46.34 -49.93 17.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.24 89.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.72 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -62.72 -37.82 88.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 110.773 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.7 mt -80.07 -28.64 39.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.354 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.78 -28.57 73.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.969 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.86 -33.17 0.48 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.848 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 3.7 p30 -96.99 107.41 19.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' SER . . . . . 0.454 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 11.6 m -69.88 -19.68 63.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.519 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p -117.14 78.6 10.18 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.426 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 16' ' ' SER . 10.7 Cg_exo -73.14 140.87 31.7 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.609 2.873 . . . . 0.0 112.607 -171.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' SER . . . . . 0.502 ' O ' HG12 ' A' ' 23' ' ' ILE . 54.2 p -87.92 151.37 22.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.5 -25.03 68.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.166 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -69.41 -40.56 77.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 110.273 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.695 ' O ' HG13 ' A' ' 26' ' ' ILE . 46.2 m-20 -58.49 -46.88 85.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.729 HG13 HD13 ' A' ' 43' ' ' ILE . 39.6 mm -52.31 -49.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.888 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 84.5 mttt -59.37 -41.71 89.92 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HZ1' ' HA ' ' A' ' 22' ' ' ASP . 28.2 mtmm -58.03 -46.98 84.44 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 111.13 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.695 HG13 ' O ' ' A' ' 22' ' ' ASP . 7.3 mt -70.43 -42.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.765 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LEU . . . . . 0.573 HD12 ' HB1' ' A' ' 34' ' ' ALA . 13.8 mt -61.25 -36.77 80.9 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.02 -39.99 96.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 98.6 p -62.65 -37.08 84.96 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.474 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' VAL . . . . . 0.494 HG21 HG13 ' A' ' 32' ' ' ILE . 19.5 m -94.68 -10.24 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.203 0.525 . . . . 0.0 110.8 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 46.69 5.43 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.982 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 81.2 mt -104.58 131.43 53.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.04 0.42 . . . . 0.0 111.756 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.4 127.52 33.31 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.997 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -125.87 136.05 52.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -102.61 120.9 41.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.3 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -45.38 -59.59 2.6 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.903 0.752 . . . . 0.0 112.64 -171.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 8.9 p-10 -67.6 -50.28 58.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.089 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -56.32 -36.51 68.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 4.1 tp -58.64 -56.27 24.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.958 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -58.07 -33.73 69.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.591 0.234 . . . . 0.0 110.767 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.0 mmmm -64.56 -50.47 67.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.96 -42.63 90.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.465 0.65 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.729 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.24 -43.26 89.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.859 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -66.98 -35.39 79.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.608 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 54.7 mm-40 -57.53 -50.9 71.58 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.726 HD22 ' HB ' ' A' ' 54' ' ' VAL . 30.5 mt -60.58 -35.19 75.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.997 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.36 -29.42 63.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.113 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.74 -34.64 15.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.129 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 66.6 mttm -102.93 -152.24 0.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 0.0 110.288 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.23 152.04 30.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ILE . . . . . 0.516 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 1.5 mp -55.91 -54.98 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLU . . . . . 0.895 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.35 -34.55 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 110.715 -174.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 30.7 t70 -66.45 -53.58 33.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.863 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.726 ' HB ' HD22 ' A' ' 46' ' ' LEU . 70.7 t -61.28 -31.2 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.608 HG23 HG23 ' B' ' 55' ' ' ILE . 2.9 mm -59.6 -61.26 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.415 0.626 . . . . 0.0 111.427 171.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.912 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.36 -18.71 63.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.447 -169.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 83.2 mt-30 -93.51 -27.49 16.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 172.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.59 -36.5 6.47 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.278 -0.487 . . . . 0.0 114.134 -171.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.197 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' ARG . . . . . 0.687 ' HA ' HD11 ' A' ' 12' ' ' LEU . 96.2 mtt180 . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 121.333 0.587 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' TYR . . . . . 0.461 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 21.3 m-85 -78.44 -26.64 46.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.337 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' VAL . . . . . 0.657 HG21 HD12 ' B' ' 46' ' ' LEU . 61.1 t -64.19 -31.87 55.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 110.938 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.67 -54.52 45.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.419 0.628 . . . . 0.0 110.909 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' SER . . . . . 0.404 ' HG ' ' HG ' ' B' ' 27' ' ' LEU . 1.3 p -72.4 -35.31 68.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.584 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' TYR . . . . . 0.686 ' CD1' HD11 ' B' ' 46' ' ' LEU . 49.1 t80 -55.12 -47.91 74.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.704 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' LEU . . . . . 0.78 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.3 mp -58.06 -59.82 4.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.2 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' LEU . . . . . 0.891 HD13 HD13 ' A' ' 9' ' ' LEU . 16.5 mt -46.44 -49.86 17.59 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.21 89.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.703 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -62.93 -37.81 88.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.694 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.6 mt -79.84 -28.92 40.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.326 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.03 -29.82 75.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.92 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.44 -32.99 0.45 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.994 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' ASN . . . . . 0.644 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 3.6 p30 -97.25 107.33 19.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.228 0.537 . . . . 0.0 110.859 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 8.1 m -69.62 -19.72 63.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.269 0.557 . . . . 0.0 110.654 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 41.1 p -117.38 78.76 11.12 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.246 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' B' ' 16' ' ' SER . 11.2 Cg_exo -73.23 140.62 31.04 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.521 2.814 . . . . 0.0 112.657 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' SER . . . . . 0.492 ' O ' HG12 ' B' ' 23' ' ' ILE . 55.9 p -87.66 152.14 22.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -64.33 -24.43 67.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.133 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -69.6 -40.32 76.74 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.302 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' ASP . . . . . 0.697 ' O ' HG13 ' B' ' 26' ' ' ILE . 48.6 m-20 -58.65 -47.1 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ILE . . . . . 0.75 HG13 HD13 ' B' ' 43' ' ' ILE . 39.2 mm -51.97 -49.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.99 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 84.1 mttt -59.59 -41.59 90.63 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' LYS . . . . . 0.446 ' HZ1' ' HA ' ' B' ' 22' ' ' ASP . 28.1 mtmm -58.11 -46.95 84.7 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.521 0.677 . . . . 0.0 111.099 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' ILE . . . . . 0.697 HG13 ' O ' ' B' ' 22' ' ' ASP . 7.2 mt -70.54 -42.26 78.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.807 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' LEU . . . . . 0.586 HD12 ' HB1' ' B' ' 34' ' ' ALA . 13.6 mt -61.07 -36.92 80.91 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.15 -39.51 94.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.451 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 94.6 p -62.5 -37.62 86.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' VAL . . . . . 0.494 HG21 HG13 ' B' ' 32' ' ' ILE . 19.3 m -94.45 -10.32 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.3 46.91 5.4 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.91 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 81.6 mt -104.58 131.69 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.439 . . . . 0.0 111.615 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.78 127.64 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.146 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -125.93 135.73 52.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.99 0.424 . . . . 0.0 111.765 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -102.22 120.83 41.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -45.09 -59.87 2.39 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.868 0.73 . . . . 0.0 112.674 -171.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 8.7 p-10 -67.62 -50.0 60.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.129 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -56.36 -36.61 68.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.951 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 39' ' ' LEU . . . . . 0.461 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 4.1 tp -58.5 -56.48 21.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.993 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -58.17 -33.26 69.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.473 0.178 . . . . 0.0 110.617 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 41' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 13.9 mmmm -65.0 -50.61 65.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.008 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.8 -42.39 88.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.563 0.697 . . . . 0.0 110.816 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 43' ' ' ILE . . . . . 0.75 HD13 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.42 -43.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.834 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -66.32 -35.55 80.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.5 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 45' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 61.1 mm-40 -57.45 -51.19 70.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.223 0.535 . . . . 0.0 109.701 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 46' ' ' LEU . . . . . 0.709 HD22 ' HB ' ' B' ' 54' ' ' VAL . 30.5 mt -60.45 -35.32 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.018 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.9 -29.44 64.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.004 0.43 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.65 -34.79 15.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.087 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 49' ' ' LYS . . . . . 0.489 ' HB2' ' CG2' ' B' ' 54' ' ' VAL . 66.5 mttm -102.86 -151.9 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.935 0.398 . . . . 0.0 110.22 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.54 152.16 30.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 51' ' ' ILE . . . . . 0.52 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.5 mp -55.83 -55.06 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 52' ' ' GLU . . . . . 0.912 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.36 -34.67 74.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.909 0.385 . . . . 0.0 110.69 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 53' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' B' ' 57' ' ' GLN . 28.9 t70 -66.41 -53.66 33.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.697 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 54' ' ' VAL . . . . . 0.709 ' HB ' HD22 ' B' ' 46' ' ' LEU . 69.8 t -61.16 -31.33 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.449 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 55' ' ' ILE . . . . . 0.608 HG23 HG23 ' A' ' 55' ' ' ILE . 2.9 mm -59.47 -61.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.386 0.612 . . . . 0.0 111.419 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 56' ' ' ALA . . . . . 0.895 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.69 -18.36 63.54 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.36 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 57' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' B' ' 53' ' ' ASP . 83.6 mt-30 -93.58 -27.48 16.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 172.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.99 -36.26 6.43 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.351 -0.452 . . . . 0.0 114.035 -171.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 59' ' ' ILE . . . . . . . . . . . . . 1.7 mp . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.041 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.932 0.396 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.716 ' HB3' HG12 ' A' ' 59' ' ' ILE . 24.6 ptm -98.24 -5.27 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.293 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.756 ' HA ' HD11 ' B' ' 12' ' ' LEU . 20.6 mmm180 -57.37 -47.07 82.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.528 -175.269 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.56 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 16.4 m-85 -91.04 -20.35 22.17 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.712 HG21 HD12 ' A' ' 46' ' ' LEU . 73.0 t -60.41 -37.24 73.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.087 0.47 . . . . 0.0 110.78 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.443 ' HB1' ' HB3' ' B' ' 8' ' ' LEU . . . -57.17 -54.61 44.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.392 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.512 ' HG ' ' HG ' ' A' ' 27' ' ' LEU . 0.8 OUTLIER -72.66 -35.83 67.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.975 -179.324 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.686 ' CD2' HD11 ' A' ' 46' ' ' LEU . 47.9 t80 -54.79 -50.91 67.36 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.847 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.791 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.9 mp -57.86 -55.88 29.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.69 HD11 HD11 ' B' ' 9' ' ' LEU . 12.5 mt -47.55 -50.33 24.09 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.29 88.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.66 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.485 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.2 -41.08 99.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.278 0.561 . . . . 0.0 110.776 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.3 mt -75.65 -23.25 56.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.312 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.83 10.2 53.02 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.612 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.37 -11.51 39.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.877 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.614 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 62.6 t30 -103.86 81.2 1.85 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.999 0.428 . . . . 0.0 109.913 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.542 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 26.2 t -64.16 -28.77 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.49 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 t -111.51 81.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 4.5 Cg_exo -79.8 137.52 12.69 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.688 2.925 . . . . 0.0 113.353 -170.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.426 ' O ' HG12 ' A' ' 23' ' ' ILE . 45.3 t -79.52 147.13 32.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.66 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.48 68.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.27 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.467 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 mmtm -67.16 -42.29 84.56 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.12 0.486 . . . . 0.0 110.291 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.668 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.5 m-20 -58.37 -45.33 88.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.308 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.624 HG13 HD13 ' A' ' 43' ' ' ILE . 41.4 mm -51.62 -50.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 59.0 mttm -53.86 -46.4 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.108 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -62.75 -41.85 99.4 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.285 0.564 . . . . 0.0 111.673 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 22' ' ' ASP . 13.0 mt -68.35 -36.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 110.081 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.617 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.6 mt -65.87 -35.91 81.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.141 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.75 -33.98 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.474 0.178 . . . . 0.0 110.992 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.97 -42.91 86.04 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.201 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.453 HG21 HG13 ' A' ' 32' ' ' ILE . 15.9 m -104.22 -3.25 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.726 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 50.37 4.09 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.496 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.617 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 59.2 mt -116.0 147.36 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.083 0.468 . . . . 0.0 111.343 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.12 159.53 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.472 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.57 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -159.25 117.28 2.81 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.9 176.97 9.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.624 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.95 -48.0 4.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.999 -0.438 . . . . 0.0 110.644 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.702 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 13.5 t70 -64.45 -60.75 2.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.409 ' O ' HG21 ' A' ' 42' ' ' VAL . 8.7 tpp180 -54.89 -40.51 69.86 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 123.439 0.462 . . . . 0.0 110.731 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.56 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 4.2 tp -61.33 -53.97 49.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.995 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.73 -30.14 70.57 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.51 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.702 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 29.3 mmtp -66.14 -47.74 73.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.761 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.409 HG21 ' O ' ' A' ' 38' ' ' ARG . 92.7 t -61.2 -43.63 96.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.609 . . . . 0.0 110.378 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.624 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.32 -44.39 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.09 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 -35.72 80.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -57.77 -53.57 56.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.752 HD22 ' HB ' ' A' ' 54' ' ' VAL . 42.0 mt -61.77 -29.85 70.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.45 -39.51 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.94 -23.16 59.99 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.584 ' HD2' HG23 ' A' ' 54' ' ' VAL . 94.3 mttt -113.75 -164.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.96 0.409 . . . . 0.0 109.954 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.522 ' HB3' ' OE2' ' A' ' 52' ' ' GLU . 93.6 m-20 -93.21 146.84 23.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.804 ' HB ' ' HB2' ' B' ' 63' ' ' ALA . 1.5 mp -57.34 -47.46 84.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.215 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 1.019 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.9 OUTLIER -59.04 -40.97 86.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 -177.411 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 33.4 t70 -62.88 -56.56 16.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.752 ' HB ' HD22 ' A' ' 46' ' ' LEU . 53.0 t -58.23 -40.26 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.099 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.082 HD11 HD11 ' B' ' 55' ' ' ILE . 14.5 mt -60.44 -56.1 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 1.037 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.55 -14.13 62.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.575 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 96.4 mt-30 -88.97 -50.39 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.466 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.12 9.95 67.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.991 0.756 . . . . 0.0 114.991 -167.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.716 HG12 ' HB3' ' A' ' 1' ' ' MET . 5.7 mt -103.39 -65.6 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.668 0.734 . . . . 0.0 110.696 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.37 -156.02 52.72 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.307 178.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -75.21 12.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.357 . . . . 0.0 111.816 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.24 -21.27 58.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.79 ' HB3' ' HB ' ' B' ' 51' ' ' ILE . . . -64.96 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.161 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.5 p -129.76 133.71 47.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.261 0.553 . . . . 0.0 111.42 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.613 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -89.24 145.49 34.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 17.9 Cg_endo -60.19 88.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.19 2.593 . . . . 0.0 112.69 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.86 101.19 12.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.802 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.89 51.12 4.12 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.751 -1.027 . . . . 0.0 111.528 -177.261 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.935 0.398 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.715 ' HB3' HG12 ' B' ' 59' ' ' ILE . 24.4 ptm -97.8 -5.24 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 0.0 111.379 -174.966 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.754 ' HA ' HD11 ' A' ' 12' ' ' LEU . 20.5 mmm180 -57.46 -47.31 82.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.476 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.573 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 16.4 m-85 -90.91 -20.26 22.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.699 HG21 HD12 ' B' ' 46' ' ' LEU . 71.5 t -60.57 -37.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.445 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.92 -54.73 43.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.445 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.513 ' HG ' ' HG ' ' B' ' 27' ' ' LEU . 0.8 OUTLIER -72.69 -35.72 67.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.957 -179.311 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.669 ' CD2' HD11 ' B' ' 46' ' ' LEU . 46.6 t80 -55.03 -50.77 68.23 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.794 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.8 mp -57.84 -55.88 29.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.69 HD11 HD11 ' A' ' 9' ' ' LEU . 12.4 mt -47.6 -50.39 24.29 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.289 0.368 . . . . 0.0 111.918 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.611 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.491 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.51 -40.52 97.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.232 0.539 . . . . 0.0 110.869 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.794 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.2 mt -76.16 -22.6 55.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.409 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.47 10.88 53.83 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.719 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.71 -11.0 41.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.81 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.618 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 62.5 t30 -104.16 81.46 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.081 0.467 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.539 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 24.8 t -64.42 -28.65 69.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.387 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.9 t -111.67 82.01 3.63 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.618 ' HA ' ' ND2' ' B' ' 15' ' ' ASN . 4.3 Cg_exo -80.36 137.52 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.661 2.908 . . . . 0.0 113.374 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.417 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.5 t -79.53 147.23 32.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.633 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.403 ' HB3' ' CD2' ' B' ' 39' ' ' LEU . . . -62.75 -26.22 68.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.227 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.464 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 48.2 mmtm -67.15 -42.15 84.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.183 0.516 . . . . 0.0 110.23 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.65 ' O ' HG13 ' B' ' 26' ' ' ILE . 17.3 m-20 -58.3 -45.68 87.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.325 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.629 HG13 HD13 ' B' ' 43' ' ' ILE . 41.3 mm -51.47 -50.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.425 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.464 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 59.4 mttm -53.59 -46.48 70.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.137 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -62.85 -41.6 99.42 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 111.739 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.65 HG13 ' O ' ' B' ' 22' ' ' ASP . 12.6 mt -68.51 -36.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.18 0.514 . . . . 0.0 110.144 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.608 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.8 mt -65.87 -36.01 82.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.174 172.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.32 -34.4 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.496 0.189 . . . . 0.0 110.899 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.9 t -57.66 -43.06 84.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.278 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.446 HG21 HG13 ' B' ' 32' ' ' ILE . 15.9 m -104.12 -3.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 0.0 111.678 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.64 51.32 3.9 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.307 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.608 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 58.7 mt -116.48 147.57 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 111.358 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.43 159.44 33.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.583 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.575 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -159.38 116.68 2.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 112.935 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.62 177.09 9.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.666 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.0 -47.99 4.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.168 -0.333 . . . . 0.0 110.679 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.7 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 13.0 t70 -64.43 -60.93 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.258 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.423 ' O ' HG21 ' B' ' 42' ' ' VAL . 8.6 tpp180 -54.76 -40.63 69.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.785 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.573 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 4.2 tp -61.24 -54.08 48.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.76 -30.15 70.6 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.442 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.7 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 29.4 mmtp -66.26 -47.47 73.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.729 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.423 HG21 ' O ' ' B' ' 38' ' ' ARG . 91.7 t -61.36 -43.63 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.317 0.58 . . . . 0.0 110.435 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.629 HD13 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.24 -44.54 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.1 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 10.3 t -66.38 -35.68 80.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.706 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -57.78 -53.43 58.3 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.071 0.462 . . . . 0.0 109.814 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.776 HD22 ' HB ' ' B' ' 54' ' ' VAL . 42.1 mt -61.93 -29.72 70.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.986 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -77.56 -39.56 45.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.161 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.32 -22.53 60.43 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.297 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.588 ' HD2' HG23 ' B' ' 54' ' ' VAL . 94.3 mttt -114.1 -165.06 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . 0.519 ' HB3' ' OE2' ' B' ' 52' ' ' GLU . 93.4 m-20 -92.85 146.99 23.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.189 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.79 ' HB ' ' HB3' ' A' ' 63' ' ' ALA . 1.5 mp -57.59 -47.44 85.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.293 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 1.037 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -59.08 -40.79 86.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 -177.482 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.514 ' O ' ' HG3' ' B' ' 57' ' ' GLN . 33.6 t70 -63.12 -56.6 15.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.08 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.776 ' HB ' HD22 ' B' ' 46' ' ' LEU . 54.6 t -57.85 -40.22 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.236 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 1.082 HD11 HD11 ' A' ' 55' ' ' ILE . 14.5 mt -60.63 -56.06 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 1.019 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.58 -13.94 62.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.623 -173.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.514 ' HG3' ' O ' ' B' ' 53' ' ' ASP . 96.9 mt-30 -89.05 -50.67 6.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.88 9.76 68.26 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.715 HG12 ' HB3' ' B' ' 1' ' ' MET . 5.7 mt -103.17 -65.55 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.72 0.76 . . . . 0.0 110.584 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.03 -156.3 53.14 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.452 179.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.96 12.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 111.778 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.07 -21.51 58.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.804 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . . . -64.86 -78.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.084 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -129.87 133.5 46.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.119 0.485 . . . . 0.0 111.394 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.616 HG23 ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -89.29 145.65 34.51 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.616 ' HD2' HG23 ' B' ' 65' ' ' VAL . 18.4 Cg_endo -60.35 89.2 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.102 2.535 . . . . 0.0 112.715 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.96 100.67 12.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.807 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.93 51.77 3.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.063 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.835 0 CA-C-O 119.002 -0.888 . . . . 0.0 111.506 -177.401 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.519 ' HB1' HG21 ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.696 0.284 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.699 ' SD ' HG13 ' A' ' 59' ' ' ILE . 18.4 ttt -119.16 115.84 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.519 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.665 ' HA ' HD11 ' B' ' 12' ' ' LEU . 42.6 ttm180 175.36 -55.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.148 172.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.474 ' HB3' HD11 ' A' ' 39' ' ' LEU . 39.2 m-85 -83.54 -16.56 44.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.307 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.688 HG23 HD13 ' A' ' 46' ' ' LEU . 91.7 t -64.0 -36.12 75.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.536 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.7 -54.85 41.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.508 0.671 . . . . 0.0 111.282 179.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.454 ' HG ' ' HG ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -71.72 -34.97 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.797 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.465 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 65.5 t80 -55.45 -47.82 75.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.837 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.739 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.0 mp -60.11 -57.26 13.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.329 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.816 HD11 HD11 ' B' ' 9' ' ' LEU . 14.9 mt -47.48 -50.8 22.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.65 -37.87 79.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.563 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.53 -40.92 96.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.739 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.8 mt -74.41 -24.5 59.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.385 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.35 -19.34 74.23 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.372 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.54 -33.8 1.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.045 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.563 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.8 m-20 -92.47 88.07 6.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.604 0.24 . . . . 0.0 110.645 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.609 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 6.2 m -60.87 -27.79 68.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.349 0.595 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 p -108.79 82.52 1.79 Allowed Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.8 Cg_exo -80.33 152.92 20.97 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.811 3.008 . . . . 0.0 113.038 -172.136 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.432 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 14.2 t -89.42 146.33 24.73 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.552 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -65.23 -23.76 67.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.537 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.755 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 50.5 tptt -64.6 -44.72 89.71 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.337 0.589 . . . . 0.0 110.357 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.694 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.5 m-20 -58.63 -45.12 89.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.828 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.667 HG13 HD13 ' A' ' 43' ' ' ILE . 44.3 mm -50.91 -50.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.3 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.755 ' HD2' ' HD2' ' A' ' 21' ' ' LYS . 60.7 mttm -52.27 -48.07 65.47 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.71 -40.38 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.12 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.694 HG13 ' O ' ' A' ' 22' ' ' ASP . 12.1 mt -67.95 -37.95 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 110.197 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.578 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 10.5 mt -63.9 -39.91 95.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.996 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.12 -32.28 71.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.322 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 t -66.7 -34.19 77.31 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.035 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.47 HG21 HG13 ' A' ' 32' ' ' ILE . 15.5 m -103.04 -5.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.692 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.52 33.65 8.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.453 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.578 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 46.9 mt -102.91 129.69 54.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 122.631 -0.334 . . . . 0.0 110.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.5 144.83 51.24 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.182 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.13 156.97 44.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.467 0.651 . . . . 0.0 111.625 -178.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.455 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 14.8 t70 -111.99 178.66 4.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.416 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -102.88 -53.01 2.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.221 0.534 . . . . 0.0 110.081 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.67 -49.27 41.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.043 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.455 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 12.6 tpp180 -63.44 -38.04 89.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.572 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.494 ' CD2' ' HB3' ' A' ' 20' ' ' ALA . 3.1 tp -65.84 -55.99 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.36 -30.05 69.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.2 tmtt? -62.49 -52.11 64.81 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.519 HG21 ' HB1' ' A' ' -1' ' ' ALA . 78.7 t -60.83 -42.82 93.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 110.87 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.667 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.44 -41.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.398 175.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -68.26 -33.89 75.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.705 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 45.2 mt-10 -58.39 -53.4 58.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.75 HD22 ' HB ' ' A' ' 54' ' ' VAL . 19.7 mt -57.17 -43.31 82.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.69 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.81 -29.01 65.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.263 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.72 -21.23 64.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.548 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.466 ' HB2' HG21 ' A' ' 54' ' ' VAL . 34.5 mttm -117.06 -97.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.741 0.782 . . . . 0.0 110.432 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.98 154.51 1.47 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.729 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.7 mp -57.64 -54.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.951 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.6 OUTLIER -61.44 -38.39 87.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -172.972 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.443 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 15.6 t70 -64.75 -53.79 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.75 ' HB ' HD22 ' A' ' 46' ' ' LEU . 28.7 t -58.7 -37.13 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.495 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.612 HG23 HG23 ' B' ' 55' ' ' ILE . 2.2 mm -56.56 -60.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 111.776 172.613 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.922 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.84 -15.29 63.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.651 -170.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.443 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.2 mm100 -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 173.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.81 -42.08 3.42 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.51 -171.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.699 HG13 ' SD ' ' A' ' 1' ' ' MET . 1.6 mp -62.06 -63.11 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.253 0.526 . . . . 0.0 110.827 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.7 -124.2 35.3 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.517 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -79.21 9.37 4.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -173.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 61.2 mt -89.04 -8.95 52.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 174.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.713 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -96.93 23.48 7.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.538 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.1 m -98.29 129.0 45.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.607 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -150.27 146.55 20.17 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.607 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 18.1 Cg_endo -61.01 93.64 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.967 2.445 . . . . 0.0 111.855 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.57 104.93 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.615 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.72 128.67 12.75 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.964 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.839 -0.978 . . . . 0.0 111.283 179.548 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . 0.529 ' HB1' HG21 ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.574 0.226 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.709 ' SD ' HG13 ' B' ' 59' ' ' ILE . 18.5 ttt -119.74 115.16 23.34 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.922 0.392 . . . . 0.0 111.566 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.719 ' HA ' HD11 ' A' ' 12' ' ' LEU . 42.6 ttm180 175.7 -55.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.168 172.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.471 ' HB3' HD11 ' B' ' 39' ' ' LEU . 39.7 m-85 -83.97 -16.51 43.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.164 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.678 HG23 HD13 ' B' ' 46' ' ' LEU . 91.9 t -63.92 -35.95 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.82 -54.97 40.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.519 0.676 . . . . 0.0 111.177 179.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.437 ' HG ' ' HG ' ' B' ' 27' ' ' LEU . 0.3 OUTLIER -71.86 -34.98 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.684 179.197 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.455 ' HA ' ' CD1' ' B' ' 23' ' ' ILE . 64.9 t80 -55.23 -48.15 74.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.735 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.9 mp -59.99 -57.29 13.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.279 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.816 HD11 HD11 ' A' ' 9' ' ' LEU . 14.8 mt -47.43 -50.54 22.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.99 80.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.23 -41.36 97.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.735 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.8 mt -74.07 -24.35 59.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.498 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.18 74.31 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.223 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.4 -33.26 2.0 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.22 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 85.9 m-20 -92.8 88.01 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.6 0.238 . . . . 0.0 110.647 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.601 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 6.1 m -60.79 -27.97 68.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.419 0.628 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 39.2 p -108.85 82.5 1.8 Allowed Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.215 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.601 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.6 Cg_exo -80.17 153.27 21.59 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.763 2.975 . . . . 0.0 112.814 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.445 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 15.4 t -89.59 146.71 24.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.541 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -65.49 -23.68 66.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.525 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.731 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 50.6 tptt -64.4 -44.8 90.13 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.255 0.55 . . . . 0.0 110.295 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.712 ' O ' HG13 ' B' ' 26' ' ' ILE . 2.6 m-20 -58.77 -44.72 90.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.91 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.645 HG13 HD13 ' B' ' 43' ' ' ILE . 44.5 mm -51.32 -50.39 27.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.266 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.731 ' HD2' ' HD2' ' B' ' 21' ' ' LYS . 60.9 mttm -51.97 -48.63 64.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.58 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.64 -40.28 95.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.061 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.712 HG13 ' O ' ' B' ' 22' ' ' ASP . 11.7 mt -67.86 -38.06 79.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.598 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 10.5 mt -63.71 -39.81 95.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.912 171.346 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.04 -32.86 72.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.234 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 12.9 t -66.12 -34.62 78.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.06 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.471 HG22 HG13 ' B' ' 32' ' ' ILE . 15.3 m -102.65 -5.69 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.706 0.289 . . . . 0.0 111.557 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.49 34.4 7.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.341 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 46.9 mt -103.41 129.72 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.969 0.385 . . . . 0.0 110.533 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.5 144.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.124 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . . . . . . . . . . . -131.34 156.71 45.03 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.493 0.663 . . . . 0.0 111.746 -178.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.45 ' HB3' ' HB3' ' B' ' 38' ' ' ARG . 14.7 t70 -111.62 178.9 4.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.614 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -103.12 -52.6 3.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.227 0.537 . . . . 0.0 110.278 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.98 -49.61 35.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.012 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.45 ' HB3' ' HB3' ' B' ' 35' ' ' ASP . 12.7 tpp180 -63.08 -38.31 90.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.497 ' CD2' ' HB3' ' B' ' 20' ' ' ALA . 3.1 tp -65.57 -56.16 13.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.25 -29.85 69.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.548 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 12.1 tmtt? -62.63 -52.14 64.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.529 HG21 ' HB1' ' B' ' -1' ' ' ALA . 77.6 t -60.77 -43.04 94.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.564 0.697 . . . . 0.0 110.778 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.645 HD13 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.2 -41.31 83.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.382 175.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.679 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.548 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 46.0 mt-10 -58.42 -53.1 62.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.731 HD22 ' HB ' ' B' ' 54' ' ' VAL . 20.0 mt -57.35 -43.3 83.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.819 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.95 -29.22 65.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.71 -20.72 65.3 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.452 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.445 ' HB2' HG21 ' B' ' 54' ' ' VAL . 34.4 mttm -117.4 -97.96 0.46 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.66 0.743 . . . . 0.0 110.487 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.85 154.68 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.713 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.7 mp -57.64 -54.57 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.922 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -61.56 -38.16 86.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.734 0.302 . . . . 0.0 111.116 -172.897 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.438 ' O ' ' HG2' ' B' ' 57' ' ' GLN . 15.7 t70 -64.69 -53.85 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.594 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.731 ' HB ' HD22 ' B' ' 46' ' ' LEU . 26.9 t -58.82 -37.1 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.538 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.613 ' HA ' HD11 ' B' ' 59' ' ' ILE . 2.2 mm -56.47 -60.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.346 0.593 . . . . 0.0 111.823 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.951 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.96 -15.19 63.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.5 -170.321 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.438 ' HG2' ' O ' ' B' ' 53' ' ' ASP . 16.9 mm100 -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.66 -43.21 3.19 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.408 -171.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.709 HG13 ' SD ' ' B' ' 1' ' ' MET . 1.6 mp -61.35 -63.26 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.228 0.514 . . . . 0.0 110.867 -174.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.51 -124.09 34.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.491 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -79.26 8.85 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 62.1 mt -88.68 -8.77 53.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.432 0.634 . . . . 0.0 110.133 174.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.729 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -97.02 23.73 6.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.551 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 32.1 m -98.73 128.93 45.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.611 ' CG2' ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -150.2 146.74 20.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.611 ' HD2' ' CG2' ' B' ' 65' ' ' VAL . 18.1 Cg_endo -60.96 93.67 0.11 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.025 2.483 . . . . 0.0 112.008 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.75 103.77 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.68 128.24 14.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.052 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.941 -0.921 . . . . 0.0 111.595 179.375 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.577 ' HB1' HG23 ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.571 0.224 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.743 ' SD ' HG13 ' A' ' 59' ' ' ILE . 13.1 ttt -91.92 110.18 21.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.965 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 -179.44 -56.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.704 0.627 . . . . 0.0 109.961 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.53 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 49.6 m-85 -99.18 -11.13 21.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.972 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.687 HG23 HD13 ' A' ' 46' ' ' LEU . 60.9 t -57.13 -39.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.43 ' CB ' ' HG ' ' B' ' 9' ' ' LEU . . . -55.72 -55.41 32.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.855 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.865 ' HG ' HG21 ' A' ' 23' ' ' ILE . 2.1 p -70.55 -36.22 73.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.616 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 58.0 t80 -55.41 -49.62 71.9 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.936 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.776 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.7 mp -59.94 -55.96 27.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.558 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.85 HD13 HD13 ' B' ' 9' ' ' LEU . 15.1 mt -48.02 -49.99 29.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.175 0.297 . . . . 0.0 111.702 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.18 85.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.351 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.547 ' HA ' ' HA ' ' A' ' 16' ' ' SER . . . -61.73 -38.53 88.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.349 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.776 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.6 mt -78.42 -25.9 46.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.721 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.74 10.7 50.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.574 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.07 -23.84 26.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.955 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.4 64.96 7.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.33 0.586 . . . . 0.0 109.575 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.547 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 15.7 m -64.48 -20.4 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.803 -175.433 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.89 78.21 4.0 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.478 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.0 Cg_exo -77.08 129.11 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.452 -167.679 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.5 t -72.09 142.24 49.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.69 -22.35 65.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.5 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 24.4 tptp -70.27 -41.01 73.99 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.157 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.668 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.1 t70 -63.37 -40.02 96.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.865 HG21 ' HG ' ' A' ' 6' ' ' SER . 47.6 mm -53.68 -49.76 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.327 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 75.5 mttt -55.2 -43.4 74.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 10.9 mmmm -58.07 -47.48 83.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.396 0.617 . . . . 0.0 111.698 177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.668 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.7 mt -67.43 -39.31 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.732 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.602 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 9.3 mt -62.87 -39.15 93.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.126 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -59.57 -39.46 84.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.251 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 t -59.91 -38.52 82.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.244 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.574 HG21 HG13 ' A' ' 32' ' ' ILE . 16.8 m -96.4 -10.31 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.271 . . . . 0.0 111.682 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 32.2 6.74 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.514 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 29.6 mt -107.24 132.87 53.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.931 0.365 . . . . 0.0 110.104 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.24 151.38 23.2 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.584 ' HB2' HD12 ' A' ' 27' ' ' LEU . . . -128.85 128.5 43.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.179 0.514 . . . . 0.0 112.318 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -92.29 122.9 35.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.187 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.91 -54.58 14.81 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 30.6 t70 -66.33 -48.42 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.437 -171.917 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.464 ' O ' HG21 ' A' ' 42' ' ' VAL . 21.8 tpp180 -64.88 -35.2 80.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.53 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.8 tp -63.73 -56.2 17.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.66 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -57.52 -32.57 67.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.484 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 4.2 tppt? -64.41 -54.59 30.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.577 HG23 ' HB1' ' A' ' -1' ' ' ALA . 85.4 t -57.01 -43.92 81.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 110.635 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.621 HD12 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.02 -44.0 93.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.649 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 t -64.75 -35.28 80.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.814 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.484 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 42.1 mt-10 -59.12 -53.06 62.57 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.75 HD21 HG13 ' A' ' 51' ' ' ILE . 17.7 mt -64.99 -24.32 67.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.866 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.67 -33.41 58.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.991 0.424 . . . . 0.0 111.034 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.05 11.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.735 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.484 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 16.6 mtpp -115.28 176.06 5.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.46 141.66 55.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.75 HG13 HD21 ' A' ' 46' ' ' LEU . 1.6 mp -59.66 -45.84 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.277 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 1.044 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.07 -42.15 93.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 109.635 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.15 -53.59 47.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.542 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.7 ' HB ' HD22 ' A' ' 46' ' ' LEU . 42.2 t -59.88 -35.17 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.865 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.061 HD11 HD11 ' B' ' 55' ' ' ILE . 17.9 mt -65.41 -55.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.845 0.355 . . . . 0.0 111.887 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.987 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.63 -16.07 63.31 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.431 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.779 HE21 ' HA ' ' A' ' 57' ' ' GLN . 0.0 OUTLIER -91.77 -28.83 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.712 170.826 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.47 -45.5 5.23 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.312 0.485 . . . . 0.0 114.312 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.758 HD12 HG22 ' A' ' 55' ' ' ILE . 1.7 mp -64.89 -61.98 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 117.565 0.683 . . . . 0.0 110.361 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.39 -124.82 36.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.05 47.51 1.51 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.73 -176.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.417 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 6.0 mt -125.81 -6.43 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.113 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.704 ' HB2' HG23 ' A' ' 59' ' ' ILE . . . -86.8 -118.54 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.0 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -83.63 49.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.992 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.798 ' CB ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -71.34 -61.82 2.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.756 0.788 . . . . 0.0 111.146 177.626 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.798 ' HD3' ' CB ' ' A' ' 65' ' ' VAL . 9.1 Cg_endo -95.75 29.93 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 126.093 4.529 . . . . 0.0 111.932 -175.717 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.65 -8.0 45.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.68 -116.94 3.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.938 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.933 -0.926 . . . . 0.0 111.555 -179.527 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . 0.59 ' HB1' HG23 ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.54 0.21 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.737 ' SD ' HG13 ' B' ' 59' ' ' ILE . 13.2 ttt -91.55 110.42 21.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.001 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttt85 -179.87 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.734 0.646 . . . . 0.0 109.902 176.333 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.544 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 50.5 m-85 -99.01 -11.11 21.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.91 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.669 HG23 HD13 ' B' ' 46' ' ' LEU . 58.7 t -57.08 -39.56 67.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.369 . . . . 0.0 110.801 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.433 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.55 -55.72 28.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.655 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.877 ' HG ' HG21 ' B' ' 23' ' ' ILE . 2.1 p -70.43 -36.22 73.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.53 179.911 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.461 ' HA ' ' CD1' ' B' ' 23' ' ' ILE . 57.8 t80 -55.67 -49.11 73.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.952 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.783 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -60.5 -55.62 31.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.426 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.85 HD13 HD13 ' A' ' 9' ' ' LEU . 14.9 mt -48.37 -50.07 32.14 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.182 0.301 . . . . 0.0 111.641 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.14 83.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.498 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.566 ' HA ' ' HA ' ' B' ' 16' ' ' SER . . . -61.85 -38.64 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.26 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -78.44 -25.86 46.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.785 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.72 10.86 49.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.549 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.54 27.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.118 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.405 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 63.1 t30 -88.59 64.4 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.071 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.566 ' HA ' ' HA ' ' B' ' 11' ' ' ALA . 15.0 m -63.86 -20.27 65.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.971 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.99 78.06 4.06 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.4 Cg_exo -76.91 128.82 10.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.153 2.569 . . . . 0.0 113.631 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 31.4 t -71.49 141.79 50.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.63 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.48 -22.15 64.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.494 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 24.4 tptp -70.7 -40.73 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.105 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.671 ' O ' HG13 ' B' ' 26' ' ' ILE . 29.4 t70 -63.53 -39.98 95.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.877 HG21 ' HG ' ' B' ' 6' ' ' SER . 47.0 mm -53.61 -49.91 53.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.348 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.63 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 75.5 mttt -55.19 -43.29 74.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.654 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.416 ' HE2' ' HB3' ' B' ' 25' ' ' LYS . 11.0 mmmm -58.09 -47.78 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.728 177.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.671 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.7 mt -67.35 -39.18 82.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.697 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 9.4 mt -62.89 -38.96 92.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.043 172.72 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.03 -39.42 85.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 34.9 t -59.6 -38.54 81.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.257 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.565 HG21 HG13 ' B' ' 32' ' ' ILE . 16.6 m -96.54 -10.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 111.639 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 32.76 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.388 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 29.8 mt -107.63 132.63 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.974 0.387 . . . . 0.0 110.094 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -86.62 152.27 22.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.592 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -130.22 127.94 40.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 0.0 112.305 -174.46 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.08 122.64 34.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.258 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -48.85 -54.35 15.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.409 ' O ' ' HB2' ' B' ' 41' ' ' LYS . 32.0 t70 -66.48 -48.09 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.638 -171.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.478 ' O ' HG21 ' B' ' 42' ' ' VAL . 21.7 tpp180 -65.18 -34.76 79.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.516 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.544 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.6 tp -63.96 -56.24 16.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.659 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -57.42 -32.67 67.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 4.4 tppt? -64.44 -54.49 31.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.801 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.59 HG23 ' HB1' ' B' ' -1' ' ' ALA . 84.6 t -57.12 -43.68 81.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.527 0.679 . . . . 0.0 110.612 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.621 HD12 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.29 -43.98 94.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.717 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -64.06 -36.06 82.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.779 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 43.0 mt-10 -58.73 -53.03 62.98 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.731 HD21 HG13 ' B' ' 51' ' ' ILE . 17.4 mt -65.01 -24.52 67.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.936 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -76.85 -33.08 57.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 -29.12 11.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.718 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.488 ' HB2' ' CG2' ' B' ' 54' ' ' VAL . 16.8 mtpp -115.31 176.19 5.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.582 0.229 . . . . 0.0 110.403 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.59 141.81 55.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.731 HG13 HD21 ' B' ' 46' ' ' LEU . 1.6 mp -59.8 -45.65 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.273 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.987 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.34 -42.02 94.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.325 0.584 . . . . 0.0 109.59 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.93 -53.78 45.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.637 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.677 ' HB ' HD22 ' B' ' 46' ' ' LEU . 42.2 t -59.88 -35.23 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 1.061 HD11 HD11 ' A' ' 55' ' ' ILE . 18.8 mt -65.23 -55.9 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 175.126 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 1.044 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.82 -15.57 63.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.105 0.479 . . . . 0.0 111.48 -173.175 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.77 HE21 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -92.04 -28.21 17.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 170.599 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.2 -45.43 5.04 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.749 HD12 HG22 ' B' ' 55' ' ' ILE . 1.7 mp -64.85 -62.09 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.444 0.622 . . . . 0.0 110.263 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 60.77 -124.89 36.88 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.472 -179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.19 47.71 1.53 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 110.627 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.41 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 6.0 mt -125.76 -6.66 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.093 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.72 ' HB1' HG23 ' B' ' 59' ' ' ILE . . . -86.58 -118.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.014 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -83.38 50.49 1.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.881 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.794 ' CB ' ' HD3' ' B' ' 66' ' ' PRO . 0.2 OUTLIER -72.19 -62.04 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.756 0.789 . . . . 0.0 111.071 177.238 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.794 ' HD3' ' CB ' ' B' ' 65' ' ' VAL . 8.8 Cg_endo -95.24 29.52 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 1 C-N-CA 126.21 4.607 . . . . 0.0 111.973 -175.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.57 -8.5 44.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.163 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.78 -116.86 3.32 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.979 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.75 -1.028 . . . . 0.0 111.671 -179.148 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.506 ' HB1' ' CG2' ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.532 ' SD ' HG13 ' A' ' 59' ' ' ILE . 24.9 ptm -116.85 -14.7 10.7 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.584 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 19.0 tpp180 -52.09 -40.92 61.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.47 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 43.7 m-85 -105.62 -7.23 18.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.657 HG21 HD12 ' A' ' 46' ' ' LEU . 97.8 t -69.34 -31.7 50.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.104 0.478 . . . . 0.0 109.999 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -58.55 -55.08 39.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.346 178.296 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.453 ' HA ' HD12 ' B' ' 9' ' ' LEU . 1.4 p -71.44 -36.32 71.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.56 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.601 ' CD1' HD11 ' A' ' 46' ' ' LEU . 70.3 t80 -55.14 -49.07 72.71 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.823 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.731 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.7 mp -59.18 -57.43 13.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 1.045 HD13 HD13 ' B' ' 9' ' ' LEU . 13.5 mt -48.79 -48.97 40.83 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.81 82.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.32 95.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.293 0.568 . . . . 0.0 110.808 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.731 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.2 mt -75.15 -15.63 60.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.3 1.24 81.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.189 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.23 -28.75 7.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.013 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.422 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 7.0 t30 -94.85 85.27 4.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.598 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 8.8 m -61.49 -25.85 67.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.57 81.68 3.35 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.598 ' HD3' ' O ' ' A' ' 16' ' ' SER . 9.1 Cg_exo -73.11 153.39 51.83 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.787 2.992 . . . . 0.0 113.041 -170.802 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 2.4 p -104.84 147.46 27.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.783 177.761 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.546 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.26 -26.71 68.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.959 -168.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.43 -41.21 76.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 110.169 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.691 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.3 t70 -62.74 -42.31 99.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.668 HG13 HD12 ' A' ' 43' ' ' ILE . 41.8 mm -51.67 -51.2 28.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.562 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.546 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 89.9 mttt -56.39 -42.35 77.76 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.446 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.75 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.98 -43.74 98.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.311 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.691 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.5 mt -67.97 -39.78 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.595 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.6 mt -60.41 -43.24 96.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.75 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 22.0 t70 -63.29 -28.69 70.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -70.0 -24.86 63.36 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.24 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.518 HG22 HG13 ' A' ' 32' ' ' ILE . 14.2 m -112.87 -3.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.29 34.89 7.26 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.587 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.595 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 52.4 mt -105.41 138.6 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.037 0.419 . . . . 0.0 111.124 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.36 144.16 26.9 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.229 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.567 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -131.22 132.5 44.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.919 0.39 . . . . 0.0 111.978 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.8 m-20 -98.02 124.51 42.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . 0.423 ' CG ' ' HZ3' ' A' ' 24' ' ' LYS . 3.9 m-20 -46.73 -58.66 3.65 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.615 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.03 -49.71 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.454 ' O ' HG22 ' A' ' 42' ' ' VAL . 20.6 tpp180 -61.28 -39.27 89.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.138 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.47 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 3.7 tp -63.8 -56.16 17.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.016 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -60.3 -28.98 68.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -67.01 -49.85 63.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.566 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 71.9 t -61.54 -41.9 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.843 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.668 HD12 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.49 -40.21 85.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.844 0.83 . . . . 0.0 110.651 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -71.05 -35.84 72.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.365 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.566 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 13.5 pt-20 -69.55 -37.26 76.97 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.717 HD22 ' HB ' ' A' ' 54' ' ' VAL . 35.9 mt -62.54 -41.53 98.94 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.272 173.136 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.01 -30.92 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.2 -38.46 25.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.389 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.501 ' HB2' HG22 ' A' ' 54' ' ' VAL . 73.3 mmtt -103.42 -156.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.072 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -100.63 159.95 14.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.794 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.3 mp -60.26 -50.76 79.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.838 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -57.55 -40.69 79.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.903 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.5 -55.51 26.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.844 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.717 ' HB ' HD22 ' A' ' 46' ' ' LEU . 24.6 t -58.79 -35.34 55.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.654 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.575 HG23 HG23 ' B' ' 55' ' ' ILE . 2.5 mm -59.16 -61.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.412 0.625 . . . . 0.0 111.782 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.848 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.41 -15.61 62.86 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.113 -169.929 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.51 -44.48 10.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.968 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -48.01 7.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.82 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.741 HG23 ' HB2' ' A' ' 63' ' ' ALA . 2.1 mp -63.08 -41.15 91.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.496 . . . . 0.0 110.039 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.58 -96.83 0.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.771 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -146.59 27.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 110.56 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.442 ' O ' HD21 ' A' ' 62' ' ' LEU . 2.0 tt -81.11 -22.74 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.792 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -60.59 -75.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.889 -1.05 . . . . 0.0 113.732 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t -106.91 177.8 4.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 -168.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.619 HG23 ' HD2' ' A' ' 66' ' ' PRO . 1.7 p -169.48 146.61 2.92 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.619 ' HD2' HG23 ' A' ' 65' ' ' VAL . 40.7 Cg_endo -67.1 66.61 0.61 Allowed 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.39 2.726 . . . . 0.0 112.712 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.34 64.19 7.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.33 44.3 1.22 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.62 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.162 -1.355 . . . . 0.0 111.305 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . 0.503 ' HB1' ' CG2' ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.528 ' SD ' HG13 ' B' ' 59' ' ' ILE . 24.8 ptm -117.12 -14.82 10.54 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.586 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 19.2 tpp180 -52.21 -40.87 62.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.478 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 43.9 m-85 -105.34 -7.39 18.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.663 HG21 HD12 ' B' ' 46' ' ' LEU . 99.3 t -69.46 -31.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.414 ' CB ' ' HB3' ' A' ' 8' ' ' LEU . . . -58.84 -54.97 41.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.39 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.452 ' HA ' HD12 ' A' ' 9' ' ' LEU . 1.3 p -71.39 -36.34 71.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.506 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.601 ' CD1' HD11 ' B' ' 46' ' ' LEU . 70.8 t80 -55.28 -49.12 72.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.801 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.732 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.7 mp -58.97 -57.54 12.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.588 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 1.045 HD13 HD13 ' A' ' 9' ' ' LEU . 13.4 mt -48.87 -48.99 41.62 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.74 81.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.29 95.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.732 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -75.37 -15.62 60.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.541 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.74 0.71 81.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.319 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.66 -29.04 6.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.13 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.417 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 7.2 t30 -94.56 85.22 4.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.578 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 12.5 m -61.66 -25.59 67.48 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.52 81.41 3.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' B' ' 16' ' ' SER . 9.4 Cg_exo -73.28 153.3 50.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.674 2.916 . . . . 0.0 113.11 -170.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.406 ' O ' HG12 ' B' ' 23' ' ' ILE . 2.7 p -104.33 147.33 27.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.964 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.538 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.93 -27.29 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.951 -169.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -68.69 -40.98 79.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.057 0.456 . . . . 0.0 110.463 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.687 ' O ' HG13 ' B' ' 26' ' ' ILE . 5.4 t70 -63.34 -42.37 98.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.672 HG13 HD12 ' B' ' 43' ' ' ILE . 41.5 mm -51.5 -51.17 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.605 174.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.538 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 89.8 mttt -56.35 -42.13 77.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.696 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.761 ' HA ' ' HE3' ' B' ' 25' ' ' LYS . 0.1 OUTLIER -62.1 -44.02 97.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.687 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.5 mt -67.79 -40.14 83.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.041 0.448 . . . . 0.0 110.491 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.4 mt -60.05 -43.17 95.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.889 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -63.32 -28.29 69.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.053 179.175 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -70.7 -24.33 62.63 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.514 HG22 HG13 ' B' ' 32' ' ' ILE . 14.0 m -113.23 -3.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.295 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.56 6.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.469 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 51.8 mt -105.89 138.64 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.42 143.86 27.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.275 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.574 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -130.98 132.62 45.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.938 0.399 . . . . 0.0 111.894 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' B' ' 38' ' ' ARG . 7.7 m-20 -98.37 124.46 43.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.42 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.475 ' CG ' ' HZ3' ' B' ' 24' ' ' LYS . 3.9 m-20 -46.24 -59.2 3.05 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.638 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.65 -49.74 73.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.291 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.456 ' O ' HG22 ' B' ' 42' ' ' VAL . 20.7 tpp180 -61.37 -39.11 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.478 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 3.7 tp -63.83 -56.25 16.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -60.12 -28.81 68.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -67.27 -49.88 62.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.551 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.565 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 72.9 t -61.4 -42.01 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.828 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.672 HD12 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.53 -40.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.816 0.817 . . . . 0.0 110.585 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -70.49 -35.91 73.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.485 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.565 ' HG2' ' O ' ' B' ' 42' ' ' VAL . 13.3 pt-20 -69.57 -37.39 76.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.707 HD22 ' HB ' ' B' ' 54' ' ' VAL . 36.1 mt -62.21 -41.66 98.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.359 172.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.87 -31.19 70.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.75 -38.95 26.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.306 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.507 ' HB2' HG22 ' B' ' 54' ' ' VAL . 73.4 mmtt -103.46 -156.12 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.163 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.96 159.38 15.26 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.792 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.3 mp -59.88 -50.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.848 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -57.72 -40.6 79.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.927 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.64 -55.59 25.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.902 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.707 ' HB ' HD22 ' B' ' 46' ' ' LEU . 24.8 t -58.63 -35.23 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.665 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.575 HG23 HG23 ' A' ' 55' ' ' ILE . 2.5 mm -59.36 -61.81 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.514 0.673 . . . . 0.0 111.675 173.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.838 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.36 -15.63 62.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.224 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.49 -44.44 10.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.72 -48.49 7.14 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.807 -171.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.744 HG23 ' HB1' ' B' ' 63' ' ' ALA . 2.0 mp -62.61 -41.41 92.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.99 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.66 -96.9 0.6 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.709 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 33.0 mmtm -146.51 27.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.159 0.504 . . . . 0.0 110.574 176.167 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.462 ' O ' HD21 ' B' ' 62' ' ' LEU . 2.0 tt -81.3 -22.55 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.578 0.704 . . . . 0.0 109.163 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.794 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -60.84 -76.11 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.646 -173.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.9 t -106.99 177.87 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.318 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.613 ' CG2' ' HD2' ' B' ' 66' ' ' PRO . 1.6 p -169.44 146.38 2.9 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.613 ' HD2' ' CG2' ' B' ' 65' ' ' VAL . 40.5 Cg_endo -67.03 66.72 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.335 2.69 . . . . 0.0 112.579 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.41 65.35 8.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.04 43.3 1.3 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.4 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . 0.467 ' HB1' ' CG2' ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.526 0.679 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.777 ' HE2' ' HG ' ' B' ' 8' ' ' LEU . 0.8 OUTLIER -58.84 -41.53 87.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.126 -173.628 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.554 ' HA ' HD11 ' B' ' 12' ' ' LEU . 4.7 mtp85 -48.22 -45.92 34.68 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 27.8 m-85 -102.04 -10.89 19.32 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.667 HG21 HD12 ' A' ' 46' ' ' LEU . 99.1 t -70.05 -33.42 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.992 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.86 -54.57 42.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.47 0.652 . . . . 0.0 111.417 176.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.405 ' HA ' HD13 ' B' ' 9' ' ' LEU . 0.4 OUTLIER -71.92 -36.64 70.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.869 -179.839 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.674 ' CD2' HD11 ' A' ' 46' ' ' LEU . 63.2 t80 -55.48 -48.76 74.05 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.758 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.783 ' HG ' ' HE2' ' B' ' 1' ' ' MET . 6.6 mp -57.09 -58.96 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.516 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.914 HD11 HD11 ' B' ' 9' ' ' LEU . 15.5 mt -48.67 -50.24 34.01 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.484 ' HB2' ' HB3' ' A' ' 18' ' ' PRO . . . -59.45 -37.9 79.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.799 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.412 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.37 -39.67 94.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.748 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -78.57 -26.51 45.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.857 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.67 -19.27 64.83 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.723 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.57 -18.03 4.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 52.9 t30 -99.55 88.65 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 14.1 m -65.35 -17.86 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.726 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 t -112.39 78.52 2.62 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.549 ' HD3' ' O ' ' A' ' 16' ' ' SER . 15.9 Cg_exo -68.29 125.24 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.093 2.529 . . . . 0.0 112.975 -169.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.552 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 34.6 t -76.59 140.39 41.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.274 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.07 -21.09 63.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.194 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.618 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.2 mmmm -68.08 -45.26 74.26 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.728 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.1 m-20 -57.34 -46.53 83.19 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.562 HG13 HD13 ' A' ' 43' ' ' ILE . 40.3 mm -50.73 -52.98 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.711 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.618 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 34.2 mttm -52.42 -45.88 66.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.817 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.1 tppt? -67.02 -42.68 84.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.335 -179.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.728 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.2 mt -65.84 -38.37 82.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.118 0.485 . . . . 0.0 110.05 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.59 HD12 ' HB1' ' A' ' 34' ' ' ALA . 14.1 mt -62.9 -38.76 92.25 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.967 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.73 -30.86 71.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 179.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -64.75 -39.39 93.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.893 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.509 HG21 HG13 ' A' ' 32' ' ' ILE . 15.6 m -102.2 -4.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.661 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.84 44.55 6.02 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.422 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.586 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 62.9 mt -108.81 136.75 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.92 139.77 41.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.82 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.59 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -127.91 132.78 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.359 0.6 . . . . 0.0 111.744 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.92 114.92 29.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.996 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -48.82 -50.0 36.49 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.5 0.5 . . . . 0.0 112.25 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.633 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 20.7 t70 -62.31 -58.23 8.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.621 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.515 ' O ' HG22 ' A' ' 42' ' ' VAL . 20.6 tpp180 -61.97 -29.8 70.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.7 tp -60.87 -56.5 20.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -58.51 -34.01 70.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.633 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 34.0 mmtp -63.42 -51.11 67.12 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.286 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.523 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 74.8 t -59.78 -42.65 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.697 0.76 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.562 HD13 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.52 -40.15 83.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.308 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -68.51 -34.25 75.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.792 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.523 ' OE1' ' HA ' ' A' ' 42' ' ' VAL . 44.4 mt-10 -58.38 -51.07 71.38 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.727 HD22 ' HB ' ' A' ' 54' ' ' VAL . 43.4 mt -64.36 -23.57 67.34 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.565 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.86 -25.92 56.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.011 0.434 . . . . 0.0 110.883 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.81 -41.83 18.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.537 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.572 ' HB2' HG21 ' A' ' 54' ' ' VAL . 7.7 mtpt -116.6 -156.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -94.64 173.57 7.54 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.65 ' HB ' ' HB3' ' B' ' 63' ' ' ALA . 1.3 mp -64.91 -52.13 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.438 -174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.88 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.6 -39.35 80.16 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 111.024 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.27 -57.47 12.76 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.985 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.727 ' HB ' HD22 ' A' ' 46' ' ' LEU . 42.6 t -63.47 -31.81 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.96 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.476 HG23 HG23 ' B' ' 55' ' ' ILE . 2.7 mm -58.7 -60.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.48 0.657 . . . . 0.0 111.211 170.644 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.883 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.72 -17.68 62.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.455 -169.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -94.23 -26.2 16.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.85 -50.59 3.05 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.808 -173.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.7 HG22 ' HB2' ' A' ' 62' ' ' LEU . 1.9 mp -57.82 -50.79 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 117.395 0.598 . . . . 0.0 109.822 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.48 -101.42 0.24 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.371 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.467 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 42.1 tptt -101.35 53.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.707 0.765 . . . . 0.0 110.308 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.7 ' HB2' HG22 ' A' ' 59' ' ' ILE . 49.2 mt -137.15 -151.46 0.4 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.58 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.657 ' HB1' ' HB ' ' B' ' 51' ' ' ILE . . . 69.41 45.45 0.83 Allowed 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.37 0.419 . . . . 0.0 110.755 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 t 68.82 -175.54 0.2 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.033 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.596 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 3.1 m -127.78 161.78 53.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.596 ' HD2' ' HB ' ' A' ' 65' ' ' VAL . 6.7 Cg_endo -43.82 -57.9 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 124.049 3.166 . . . . 0.0 112.787 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.99 142.93 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.918 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.83 32.82 0.34 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.158 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.465 -178.81 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . 0.478 ' HB1' ' CG2' ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 121.673 0.749 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.783 ' HE2' ' HG ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -58.26 -41.65 84.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.302 -173.721 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.553 ' HA ' HD11 ' A' ' 12' ' ' LEU . 4.8 mtp85 -48.27 -45.64 34.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -171.078 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.511 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 27.7 m-85 -102.01 -11.06 19.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.644 HG21 HD12 ' B' ' 46' ' ' LEU . 99.5 t -70.06 -33.39 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.033 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -55.9 -54.56 43.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.468 0.652 . . . . 0.0 111.479 176.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -36.61 69.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.868 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.677 ' CD2' HD11 ' B' ' 46' ' ' LEU . 63.0 t80 -55.42 -48.77 73.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.881 175.253 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.777 ' HG ' ' HE2' ' A' ' 1' ' ' MET . 6.7 mp -57.12 -59.05 5.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.48 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.914 HD11 HD11 ' A' ' 9' ' ' LEU . 15.5 mt -48.33 -50.65 29.5 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.467 ' HB1' ' HB3' ' B' ' 18' ' ' PRO . . . -59.26 -37.9 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.893 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.28 -39.97 95.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.754 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.3 mt -78.04 -27.06 48.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.855 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.09 -19.69 64.01 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.74 -17.98 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 53.1 t30 -99.55 88.84 3.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.553 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 14.4 m -65.32 -17.95 64.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.563 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.7 t -112.67 78.57 2.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.553 ' HD3' ' O ' ' B' ' 16' ' ' SER . 16.2 Cg_exo -68.09 125.66 13.35 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.142 2.561 . . . . 0.0 112.861 -169.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.538 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 33.3 t -76.83 140.84 40.78 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.319 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.429 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.96 -20.5 63.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.609 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.3 mmmm -68.22 -45.43 73.32 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.102 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.734 ' O ' HG13 ' B' ' 26' ' ' ILE . 13.3 m-20 -57.13 -46.76 82.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.555 HG13 HD13 ' B' ' 43' ' ' ILE . 40.4 mm -50.56 -53.14 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.677 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.609 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 33.9 mttm -52.24 -45.85 65.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.03 -42.56 84.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.734 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.3 mt -66.07 -38.28 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 109.947 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.592 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 14.1 mt -62.92 -38.98 93.18 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.967 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -31.28 72.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.35 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.8 t -64.29 -39.5 94.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.916 0.388 . . . . 0.0 110.812 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.504 HG21 HG13 ' B' ' 32' ' ' ILE . 15.7 m -102.1 -4.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.579 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.17 44.21 6.03 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.379 173.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.592 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 63.3 mt -108.57 136.75 43.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.909 0.355 . . . . 0.0 111.047 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.81 139.33 41.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.067 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.576 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -127.14 133.3 50.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -104.67 114.64 28.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.023 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -48.4 -50.33 31.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.676 0.61 . . . . 0.0 112.168 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.63 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 20.6 t70 -62.19 -58.28 8.36 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.569 0.543 . . . . 0.0 110.546 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.515 ' O ' HG22 ' B' ' 42' ' ' VAL . 20.6 tpp180 -62.13 -29.58 70.44 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.055 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.511 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.8 tp -60.83 -56.71 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.29 -33.73 69.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.63 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 34.0 mmtp -63.7 -51.12 66.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.29 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.515 HG22 ' O ' ' B' ' 38' ' ' ARG . 73.0 t -59.83 -42.43 89.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.73 0.776 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.555 HD13 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.64 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.3 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.2 t -68.78 -33.87 74.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.945 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.504 ' OE1' ' HA ' ' B' ' 42' ' ' VAL . 44.4 mt-10 -58.54 -51.06 71.5 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.723 HD22 ' HB ' ' B' ' 54' ' ' VAL . 43.5 mt -64.54 -23.83 67.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.63 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.8 -25.79 56.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.965 0.412 . . . . 0.0 110.741 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.71 -42.52 17.01 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.39 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.57 ' HB2' HG21 ' B' ' 54' ' ' VAL . 7.8 mtpt -115.67 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -94.35 174.07 7.32 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.657 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 1.3 mp -65.3 -52.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.228 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.883 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.18 -57.2 13.9 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.137 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.723 ' HB ' HD22 ' B' ' 46' ' ' LEU . 42.6 t -63.9 -31.6 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.975 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.476 HG23 HG23 ' A' ' 55' ' ' ILE . 2.7 mm -58.82 -60.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.495 0.664 . . . . 0.0 111.201 170.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.88 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.53 -18.08 62.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.388 -169.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -94.03 -25.92 17.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 173.552 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -50.71 3.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.864 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.686 HG22 ' HB2' ' B' ' 62' ' ' LEU . 1.8 mp -57.57 -50.61 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 117.281 0.541 . . . . 0.0 109.664 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.33 -100.76 0.2 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.658 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.449 ' HA ' ' HD2' ' B' ' 61' ' ' LYS . 42.2 tptt -101.98 53.53 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.769 0.795 . . . . 0.0 110.343 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.686 ' HB2' HG22 ' B' ' 59' ' ' ILE . 49.3 mt -136.86 -151.48 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.451 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.65 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . 69.16 45.83 0.85 Allowed 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.364 0.415 . . . . 0.0 110.643 176.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 22.1 t 68.85 -175.17 0.2 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.585 ' HB ' ' HD2' ' B' ' 66' ' ' PRO . 3.1 m -128.15 161.8 54.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' B' ' 65' ' ' VAL . 6.6 Cg_endo -43.92 -57.85 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.977 3.118 . . . . 0.0 112.749 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.14 142.82 17.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.92 33.1 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.035 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.858 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.481 -178.863 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.084 0.469 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.647 ' HG3' HG13 ' A' ' 59' ' ' ILE . 17.4 ttt -76.58 91.81 3.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.987 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.66 ' HA ' HD11 ' B' ' 12' ' ' LEU . 35.0 ttm180 -158.75 -59.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.521 ' CZ ' ' HD2' ' A' ' 2' ' ' ARG . 28.1 m-85 -86.8 -24.45 25.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.115 -171.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.701 HG23 HD13 ' A' ' 46' ' ' LEU . 75.8 t -58.96 -36.25 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 0.0 110.557 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.89 -55.17 38.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.358 0.599 . . . . 0.0 111.744 179.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.402 ' HA ' HD13 ' B' ' 9' ' ' LEU . 1.2 p -72.3 -37.39 68.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.671 -179.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.508 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 54.7 t80 -54.12 -48.7 70.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.679 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.79 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.4 mp -58.59 -58.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.372 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.898 HD11 HD11 ' B' ' 9' ' ' LEU . 14.1 mt -48.59 -48.83 38.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.432 ' HB1' ' CD1' ' A' ' 26' ' ' ILE . . . -60.53 -37.41 81.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.554 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.31 -39.35 92.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.749 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -80.43 -17.52 51.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.13 -14.56 78.92 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.973 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.9 -27.14 3.51 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.252 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.554 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 44.9 t30 -93.42 98.02 10.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 0.0 110.693 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.431 ' C ' ' HD3' ' A' ' 18' ' ' PRO . 15.2 m -74.6 -3.64 32.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.51 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -123.3 71.65 46.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HD3' ' C ' ' A' ' 16' ' ' SER . 14.9 Cg_exo -69.2 126.36 13.58 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.322 2.681 . . . . 0.0 112.542 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.562 ' O ' HG12 ' A' ' 23' ' ' ILE . 62.5 p -78.05 147.87 34.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.567 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.03 -26.78 69.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.37 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.94 -39.37 69.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.999 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 26' ' ' ILE . 15.6 t70 -62.03 -44.67 96.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.588 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.704 HG13 HD13 ' A' ' 43' ' ' ILE . 41.1 mm -50.63 -50.46 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.517 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.567 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 94.0 mttt -55.88 -43.61 77.35 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.091 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.509 ' HB3' ' HZ3' ' A' ' 25' ' ' LYS . 4.3 mmmp? -65.53 -38.99 91.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 22' ' ' ASP . 11.2 mt -68.16 -39.38 81.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.071 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.607 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.4 mt -61.91 -39.98 93.89 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 171.229 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.416 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 4.7 t70 -59.41 -35.44 73.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.722 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 t -64.8 -35.3 80.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.655 0.264 . . . . 0.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.483 HG22 HG13 ' A' ' 32' ' ' ILE . 16.8 m -102.33 -8.78 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.17 44.13 4.18 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.374 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.607 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.9 mt -116.34 135.18 57.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.868 0.334 . . . . 0.0 110.214 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.89 155.5 21.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.628 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.568 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -134.77 130.97 36.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.256 0.551 . . . . 0.0 112.07 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -94.63 116.25 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.208 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -42.32 -64.12 0.65 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.45 -45.62 93.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.61 -173.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.446 ' O ' HG21 ' A' ' 42' ' ' VAL . 16.6 tpp180 -64.09 -36.83 85.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.026 0.441 . . . . 0.0 110.649 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.505 HD13 HG13 ' A' ' 43' ' ' ILE . 5.8 tp -65.04 -56.77 11.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.23 -32.85 68.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -60.85 -57.59 12.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.542 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.446 HG21 ' O ' ' A' ' 38' ' ' ARG . 93.2 t -56.03 -44.58 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.778 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.704 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.78 -47.61 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.399 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.1 p -69.0 -28.21 66.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.123 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.39 -37.16 60.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.322 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.701 HD13 HG23 ' A' ' 4' ' ' VAL . 43.1 mt -63.17 -33.93 76.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.068 0.461 . . . . 0.0 110.614 172.73 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.06 -42.51 63.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -37.3 67.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.254 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.43 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -103.47 -151.48 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . 0.541 ' HA ' ' OG ' ' B' ' 64' ' ' SER . 22.1 m120 -114.46 141.36 47.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.775 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.7 mp -46.9 -56.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.395 0.435 . . . . 0.0 111.368 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.782 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 27.8 mt-10 -55.07 -36.24 65.39 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.485 0.491 . . . . 0.0 111.864 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.41 -52.46 18.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.691 ' HB ' HD22 ' A' ' 46' ' ' LEU . 54.0 t -62.27 -29.32 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.435 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.55 HD11 HD11 ' B' ' 55' ' ' ILE . 2.1 mm -60.43 -61.13 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.097 0.475 . . . . 0.0 111.459 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.779 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -72.36 -9.54 58.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.432 -170.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.82 -19.89 13.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.757 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.09 -35.08 4.33 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.442 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.663 HG22 ' HB2' ' A' ' 63' ' ' ALA . 1.8 mp -69.78 -48.39 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 117.916 0.858 . . . . 0.0 109.088 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.97 68.37 1.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.95 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.584 ' HB3' ' HZ1' ' A' ' 61' ' ' LYS . 0.1 OUTLIER 70.31 2.36 3.98 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.914 0.486 . . . . 0.0 112.047 172.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 6.9 mt -78.0 -10.18 59.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.951 0.881 . . . . 0.0 108.795 169.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.755 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -88.88 83.54 6.64 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.862 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.51 ' OG ' ' HA ' ' B' ' 50' ' ' ASN . 35.7 p 53.97 178.97 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.394 1.059 . . . . 0.0 113.044 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.629 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 10.4 m -135.47 175.27 3.73 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.629 ' HD2' ' HB ' ' A' ' 65' ' ' VAL . 9.2 Cg_endo -50.21 84.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.109 2.539 . . . . 0.0 112.418 168.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.17 76.32 10.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.153 0.501 . . . . 0.0 110.707 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.5 59.69 4.79 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.002 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.667 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.033 0.444 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.639 ' HG3' HG13 ' B' ' 59' ' ' ILE . 17.5 ttt -76.14 91.85 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.159 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.697 ' HA ' HD11 ' A' ' 12' ' ' LEU . 34.8 ttm180 -159.06 -59.72 0.07 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.667 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.515 ' CZ ' ' HD2' ' B' ' 2' ' ' ARG . 28.4 m-85 -86.92 -24.42 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.178 -171.294 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.707 HG23 HD13 ' B' ' 46' ' ' LEU . 75.3 t -58.98 -36.07 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.405 ' CB ' ' HB3' ' A' ' 8' ' ' LEU . . . -58.0 -55.36 35.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.655 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.406 ' HA ' HD13 ' A' ' 9' ' ' LEU . 1.2 p -72.24 -37.3 69.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.618 -179.431 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.507 ' HA ' ' CD1' ' B' ' 23' ' ' ILE . 54.9 t80 -54.3 -48.6 71.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.729 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.3 mp -58.74 -58.34 9.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.372 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.898 HD11 HD11 ' A' ' 9' ' ' LEU . 14.2 mt -48.36 -48.7 36.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.423 ' HB3' ' CD1' ' B' ' 26' ' ' ILE . . . -60.9 -37.75 83.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.78 -39.34 93.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 0.0 110.777 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.0 mt -80.44 -17.49 51.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.619 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.09 -14.6 78.84 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.998 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.1 -27.53 3.43 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.126 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 45.2 t30 -92.95 98.44 11.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.413 ' C ' ' HD3' ' B' ' 18' ' ' PRO . 17.0 m -75.18 -3.17 31.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.515 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.9 t -123.51 71.69 48.29 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.413 ' HD3' ' C ' ' B' ' 16' ' ' SER . 15.0 Cg_exo -69.44 126.01 13.01 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.237 2.625 . . . . 0.0 112.746 -171.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.566 ' O ' HG12 ' B' ' 23' ' ' ILE . 64.6 p -77.8 147.98 34.99 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.671 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -63.15 -27.01 69.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.275 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.88 -39.26 69.74 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.352 0.596 . . . . 0.0 110.002 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.671 ' O ' HG13 ' B' ' 26' ' ' ILE . 15.7 t70 -62.02 -44.86 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.683 HG13 HD12 ' B' ' 43' ' ' ILE . 41.2 mm -50.53 -50.38 22.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.591 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.558 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 93.9 mttt -55.98 -43.71 77.87 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.535 ' HB3' ' HZ3' ' B' ' 25' ' ' LYS . 4.3 mmmp? -65.16 -39.27 92.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.671 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.1 -39.19 80.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 0.0 110.136 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.4 mt -62.09 -39.92 94.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.679 171.05 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.425 ' HB3' ' O ' ' B' ' 25' ' ' LYS . 5.6 t70 -59.59 -35.24 73.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.928 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 10.0 t -64.76 -35.48 81.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.872 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.477 HG21 HG13 ' B' ' 32' ' ' ILE . 17.1 m -102.28 -8.62 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.277 . . . . 0.0 111.622 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.7 44.75 4.15 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.281 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 37.9 mt -116.98 135.49 57.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.82 0.31 . . . . 0.0 110.295 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.96 155.97 21.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.641 0.258 . . . . 0.0 110.576 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.569 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -135.43 130.51 34.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.313 0.578 . . . . 0.0 111.985 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.23 116.37 28.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.326 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . 0.432 ' CG ' ' HZ3' ' B' ' 24' ' ' LYS . 4.0 m-20 -42.53 -64.04 0.67 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.2 -45.93 91.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.809 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.465 ' O ' HG21 ' B' ' 42' ' ' VAL . 16.4 tpp180 -64.11 -36.5 84.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 110.598 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.498 HD13 HG13 ' B' ' 43' ' ' ILE . 5.7 tp -65.27 -56.72 11.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.86 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -58.41 -32.78 68.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -60.78 -57.73 11.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.465 HG21 ' O ' ' B' ' 38' ' ' ARG . 94.3 t -56.03 -44.59 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.129 0.49 . . . . 0.0 110.888 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.683 HD12 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.69 -47.6 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.444 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -68.86 -28.15 66.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.156 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.57 -37.1 60.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.33 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.707 HD13 HG23 ' B' ' 4' ' ' VAL . 43.7 mt -63.14 -34.1 76.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 110.635 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -72.96 -42.07 63.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.379 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.02 -37.29 64.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.128 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.419 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -103.67 -151.49 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . 0.51 ' HA ' ' OG ' ' A' ' 64' ' ' SER . 23.0 m120 -114.23 141.69 47.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.755 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.7 mp -47.06 -56.73 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.274 0.359 . . . . 0.0 111.338 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.779 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 27.8 mt-10 -55.16 -35.92 65.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.16 0.505 . . . . 0.0 111.989 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.51 -52.5 17.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.13 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.703 ' HB ' HD22 ' B' ' 46' ' ' LEU . 55.0 t -62.38 -29.22 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.529 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.55 HD11 HD11 ' A' ' 55' ' ' ILE . 2.1 mm -60.45 -61.19 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.086 0.47 . . . . 0.0 111.53 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.782 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -72.26 -9.92 59.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.529 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -104.33 -20.35 13.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.652 170.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.73 -35.65 4.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.285 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.666 HG22 ' HB1' ' B' ' 63' ' ' ALA . 1.8 mp -69.06 -49.03 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.91 0.855 . . . . 0.0 109.023 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.39 68.14 1.79 Allowed Glycine 0 C--O 1.236 0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.774 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . 0.544 ' HZ1' ' HB3' ' B' ' 61' ' ' LYS . 0.1 OUTLIER 70.65 2.08 3.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.932 0.493 . . . . 0.0 112.069 172.536 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 6.7 mt -77.99 -10.12 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.015 0.912 . . . . 0.0 108.7 169.482 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.775 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -89.04 83.49 6.57 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.85 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' SER . . . . . 0.541 ' OG ' ' HA ' ' A' ' 50' ' ' ASN . 35.0 p 54.09 179.18 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.591 1.182 . . . . 0.0 113.079 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.625 ' HB ' ' HD2' ' B' ' 66' ' ' PRO . 10.5 m -135.87 175.17 3.77 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' B' ' 65' ' ' VAL . 9.2 Cg_endo -50.46 84.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.155 2.57 . . . . 0.0 112.459 169.301 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.06 76.61 10.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.128 0.49 . . . . 0.0 110.642 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.04 59.9 4.84 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.01 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.916 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.551 179.145 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.55 ' HE3' HD23 ' B' ' 12' ' ' LEU . 21.9 ttt -89.66 76.35 7.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.972 0.415 . . . . 0.0 111.111 -175.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.43 ' NH1' ' HH ' ' A' ' 3' ' ' TYR . 79.7 mtp180 -141.97 -58.54 0.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.477 175.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.533 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 19.5 m-85 -90.99 -20.69 21.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -168.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.685 HG21 HD12 ' A' ' 46' ' ' LEU . 97.3 t -63.28 -33.78 63.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.043 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.57 -54.85 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.519 0.676 . . . . 0.0 111.075 178.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.841 ' HG ' HG21 ' A' ' 23' ' ' ILE . 1.2 p -70.37 -35.16 73.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.856 179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.653 ' CD2' HD11 ' A' ' 46' ' ' LEU . 55.2 t80 -56.6 -47.51 79.44 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.758 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.4 mp -60.1 -57.64 11.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.514 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.887 HD11 HD11 ' B' ' 9' ' ' LEU . 14.3 mt -46.4 -49.83 17.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.14 -38.83 84.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.418 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.15 -37.34 87.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.038 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.758 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.0 mt -81.46 -24.18 36.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.673 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.77 -21.27 74.9 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.9 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.63 -15.37 3.14 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.269 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.576 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 60.4 t30 -108.41 86.62 2.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.592 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 16.3 m -61.81 -27.75 68.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.736 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -108.63 82.62 1.76 Allowed Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.592 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.7 Cg_exo -78.73 147.8 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.348 2.699 . . . . 0.0 112.489 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.479 ' O ' HG12 ' A' ' 23' ' ' ILE . 89.7 p -94.14 156.96 16.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.45 -25.58 67.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.463 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -45.09 83.55 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.027 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.732 ' O ' HG13 ' A' ' 26' ' ' ILE . 55.5 m-20 -55.22 -50.9 68.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.841 HG21 ' HG ' ' A' ' 6' ' ' SER . 37.2 mm -50.39 -51.1 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.957 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.571 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 88.3 mttt -52.89 -49.65 65.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 123.754 0.659 . . . . 0.0 110.943 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -66.68 -35.99 81.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.397 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.6 mt -68.62 -38.25 78.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 0.0 110.02 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.601 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 13.3 mt -62.11 -41.15 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.067 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.22 -38.6 73.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.218 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -60.37 -35.78 76.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.743 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.556 HG22 HG13 ' A' ' 32' ' ' ILE . 14.6 m -103.33 -9.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.98 39.02 4.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.11 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.601 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 17.5 mt -117.69 149.42 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.56 167.76 9.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.485 ' HB2' ' CD1' ' A' ' 27' ' ' LEU . . . -139.57 133.54 30.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.354 0.597 . . . . 0.0 112.02 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -97.84 113.97 25.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -42.53 -58.61 2.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 12.6 m-20 -60.98 -54.71 41.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.477 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.408 ' O ' HG21 ' A' ' 42' ' ' VAL . 23.2 tpp180 -55.31 -43.33 74.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.145 0.498 . . . . 0.0 110.808 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.533 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 6.1 tp -58.44 -54.83 42.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.27 -34.23 70.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 73.5 mmtt -65.19 -53.09 50.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.086 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.408 HG21 ' O ' ' A' ' 38' ' ' ARG . 89.2 t -57.04 -44.18 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.407 0.623 . . . . 0.0 110.578 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.703 HD13 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -59.16 -45.99 92.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.292 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.0 t -65.57 -33.22 75.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.104 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.518 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 46.6 mt-10 -67.52 -44.25 78.85 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.743 HD22 ' HB ' ' A' ' 54' ' ' VAL . 45.6 mt -62.14 -41.72 98.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.377 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.26 -22.93 64.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.065 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 4.39 56.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.672 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.503 ' HD2' HG23 ' A' ' 54' ' ' VAL . 66.4 mttm -142.21 -163.62 1.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.27 144.99 25.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.371 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.726 ' HB ' ' HB1' ' B' ' 63' ' ' ALA . 1.2 mp -54.52 -50.04 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.334 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.828 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.38 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.426 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -65.75 -53.47 40.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.859 0.362 . . . . 0.0 110.284 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.743 ' HB ' HD22 ' A' ' 46' ' ' LEU . 70.7 t -62.01 -29.65 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.376 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.599 HG23 HG23 ' B' ' 55' ' ' ILE . 2.5 mm -61.6 -61.09 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.279 0.561 . . . . 0.0 111.564 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.813 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -71.04 -13.87 62.13 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.466 -170.476 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -97.65 -27.97 14.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.135 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.86 -33.16 7.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.943 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.624 HG23 ' HB3' ' A' ' 63' ' ' ALA . 1.9 mp -76.41 -58.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 117.311 0.556 . . . . 0.0 109.559 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.26 64.53 4.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.618 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm 66.44 10.21 7.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.401 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -81.74 -7.14 59.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.078 0.942 . . . . 0.0 108.596 171.705 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.743 ' HB2' ' HB ' ' B' ' 51' ' ' ILE . . . -67.02 -74.91 0.1 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.679 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 p -159.82 179.86 8.45 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.082 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.613 HG23 ' HD2' ' A' ' 66' ' ' PRO . 1.5 p -143.6 145.03 29.73 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.613 ' HD2' HG23 ' A' ' 65' ' ' VAL . 18.9 Cg_endo -59.62 89.91 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.175 2.583 . . . . 0.0 112.443 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.61 64.44 4.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 110.868 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.96 -167.37 16.94 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.404 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.479 -178.497 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.616 0.246 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.537 ' HE3' HD23 ' A' ' 12' ' ' LEU . 21.9 ttt -88.58 76.42 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.078 0.466 . . . . 0.0 111.321 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.434 ' NH1' ' HH ' ' B' ' 3' ' ' TYR . 79.5 mtp180 -142.17 -58.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.309 174.945 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 19.2 m-85 -90.96 -20.81 21.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.671 HG21 HD12 ' B' ' 46' ' ' LEU . 98.5 t -63.27 -33.64 62.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.119 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.71 -54.78 42.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.817 ' HG ' HG21 ' B' ' 23' ' ' ILE . 1.1 p -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.818 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.655 ' CD2' HD11 ' B' ' 46' ' ' LEU . 56.7 t80 -56.29 -47.75 78.01 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.4 mp -60.03 -57.48 12.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.557 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.887 HD11 HD11 ' A' ' 9' ' ' LEU . 14.4 mt -46.66 -50.01 18.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.286 0.366 . . . . 0.0 111.976 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.89 -38.93 83.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.891 -178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.408 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.32 -36.68 84.91 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.0 mt -81.71 -24.29 36.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.97 -21.04 75.16 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.861 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.84 -15.94 3.07 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.28 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.556 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 60.7 t30 -107.88 86.78 2.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.597 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 15.4 m -61.85 -27.98 69.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.656 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -108.32 82.32 1.56 Allowed Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.597 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.8 Cg_exo -78.37 147.82 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.37 2.713 . . . . 0.0 112.428 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.482 ' O ' HG12 ' B' ' 23' ' ' ILE . 94.3 p -93.77 157.47 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.575 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.82 -25.72 67.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.456 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.401 ' HB3' ' HZ1' ' B' ' 21' ' ' LYS . 0.8 OUTLIER -65.81 -45.0 83.96 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.086 0.469 . . . . 0.0 110.147 178.75 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.725 ' O ' HG13 ' B' ' 26' ' ' ILE . 55.6 m-20 -55.14 -51.0 67.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.817 HG21 ' HG ' ' B' ' 6' ' ' SER . 37.1 mm -50.43 -50.87 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.02 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.575 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 87.6 mttt -52.9 -49.55 65.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.869 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -66.86 -36.1 81.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.007 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.725 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.8 mt -68.65 -38.3 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 110.03 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.592 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 13.7 mt -62.03 -41.07 97.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.009 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -57.52 -38.36 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.22 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -60.39 -35.93 76.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.583 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.555 HG22 HG13 ' B' ' 32' ' ' ILE . 14.0 m -103.3 -9.14 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.75 39.56 4.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.075 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.592 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 17.9 mt -118.03 149.45 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -101.46 168.14 9.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.489 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -139.47 133.67 31.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.312 0.577 . . . . 0.0 112.14 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -97.97 113.76 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.69 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -42.27 -58.22 2.25 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.541 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 12.8 m-20 -61.5 -54.49 42.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.453 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.414 ' O ' HG21 ' B' ' 42' ' ' VAL . 23.2 tpp180 -55.33 -43.24 74.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.019 0.437 . . . . 0.0 110.822 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 6.3 tp -58.45 -54.94 41.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.099 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.07 -34.1 69.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.477 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.541 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 73.4 mmtt -65.32 -53.17 47.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.099 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.414 HG21 ' O ' ' B' ' 38' ' ' ARG . 86.2 t -56.83 -44.2 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 110.596 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.687 HD13 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.22 -46.07 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.236 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -65.37 -33.42 75.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.07 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.504 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 45.2 mt-10 -67.49 -44.45 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.713 HD22 ' HB ' ' B' ' 54' ' ' VAL . 44.9 mt -61.99 -41.67 98.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.397 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -68.34 -22.6 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.142 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.53 5.28 54.6 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.522 ' HD2' HG23 ' B' ' 54' ' ' VAL . 66.4 mttm -142.55 -163.12 1.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.89 145.05 25.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.743 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 1.2 mp -54.37 -50.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.364 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.813 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.49 69.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.509 -175.528 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -65.57 -53.69 38.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.874 0.368 . . . . 0.0 110.131 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.713 ' HB ' HD22 ' B' ' 46' ' ' LEU . 71.6 t -62.05 -29.6 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.495 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.599 HG23 HG23 ' A' ' 55' ' ' ILE . 2.5 mm -61.56 -61.16 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.37 0.605 . . . . 0.0 111.587 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.828 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.94 -13.92 62.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.632 -170.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -97.59 -28.38 13.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.053 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.28 -33.29 8.18 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.751 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.621 HG23 ' HB2' ' B' ' 63' ' ' ALA . 1.9 mp -76.43 -58.42 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.506 0.653 . . . . 0.0 109.345 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.72 64.09 4.68 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.735 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm 66.36 10.64 7.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -82.02 -7.26 59.6 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.738 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.726 ' HB1' ' HB ' ' A' ' 51' ' ' ILE . . . -66.93 -74.83 0.1 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.666 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.3 p -159.65 -179.67 8.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.606 HG23 ' HD2' ' B' ' 66' ' ' PRO . 1.5 p -144.19 144.81 27.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.606 ' HD2' HG23 ' B' ' 65' ' ' VAL . 19.3 Cg_endo -59.3 90.25 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.321 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 64.79 4.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 110.783 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.54 -167.96 16.64 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.357 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.819 -0.989 . . . . 0.0 111.665 -178.411 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.616 ' SD ' HG13 ' A' ' 59' ' ' ILE . 20.5 ttt -77.8 -29.49 50.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -49.06 -43.93 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 26.8 m-85 -111.01 -9.01 14.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.692 HG12 HG12 ' A' ' 55' ' ' ILE . 54.0 t -62.89 -36.5 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.162 0.506 . . . . 0.0 110.359 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . 0.426 ' HB1' ' HB3' ' B' ' 8' ' ' LEU . . . -57.63 -54.98 40.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.69 -36.51 73.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.471 ' HA ' ' CD1' ' A' ' 23' ' ' ILE . 68.6 t80 -55.49 -49.54 72.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.986 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.791 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.2 mp -59.84 -55.9 28.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.452 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.814 HD11 HD11 ' B' ' 9' ' ' LEU . 15.5 mt -48.54 -50.45 32.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.04 81.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.453 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.73 -38.37 90.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.081 0.467 . . . . 0.0 111.014 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.8 mt -79.93 -30.27 39.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.998 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.64 -23.94 73.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.437 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.67 -27.07 1.64 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.867 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.538 ' OD1' ' HA ' ' A' ' 18' ' ' PRO . 2.4 t-20 -89.54 73.49 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.544 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m -60.47 -20.34 59.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.486 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.8 p -112.5 75.34 1.75 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 16' ' ' SER . 20.3 Cg_exo -66.17 139.68 56.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.168 2.579 . . . . 0.0 113.553 -166.38 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.444 ' O ' HG12 ' A' ' 23' ' ' ILE . 10.7 p -96.54 142.17 28.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.224 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.465 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.46 -24.47 67.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.21 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . 0.594 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.4 mmmm -64.52 -46.18 84.02 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.392 0.615 . . . . 0.0 110.134 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.723 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.1 t70 -59.06 -46.25 88.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.748 HG13 HD13 ' A' ' 43' ' ' ILE . 43.9 mm -50.95 -51.55 20.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.049 176.237 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.594 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 43.6 mttm -52.98 -44.27 67.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.808 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.539 ' HB3' ' HZ3' ' A' ' 25' ' ' LYS . 4.4 mmmp? -70.03 -35.28 74.2 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.723 HG13 ' O ' ' A' ' 22' ' ' ASP . 8.9 mt -69.93 -40.91 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.065 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.579 HD12 ' HB1' ' A' ' 34' ' ' ALA . 12.8 mt -61.86 -38.05 86.82 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . 0.429 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 11.8 t70 -61.81 -34.91 76.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.731 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.66 -36.12 81.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.572 HG21 HG13 ' A' ' 32' ' ' ILE . 16.2 m -98.94 -10.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.07 0.462 . . . . 0.0 111.152 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.77 44.01 5.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.24 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.572 HG13 HG21 ' A' ' 30' ' ' VAL . 87.6 mt -102.65 126.87 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.26 0.552 . . . . 0.0 111.642 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.9 127.75 33.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.944 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.579 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -126.64 124.47 39.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.968 0.413 . . . . 0.0 111.796 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -92.35 121.34 33.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.14 -57.68 8.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.18 -45.27 95.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 -172.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 12.3 tpp180 -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.337 178.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.53 HD13 HG13 ' A' ' 43' ' ' ILE . 5.3 tp -58.99 -56.81 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.668 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.66 -34.96 71.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.0 109.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.589 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.6 tmtt? -63.98 -55.38 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.448 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 77.2 t -55.92 -44.38 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.883 178.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.748 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.01 -46.11 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.198 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -66.16 -34.27 77.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.756 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 16.8 mm-40 -61.03 -52.12 66.3 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.775 HD22 ' HB ' ' A' ' 54' ' ' VAL . 22.7 mt -60.35 -37.56 81.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.762 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.96 -25.02 60.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.027 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.18 -30.24 12.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.289 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.414 ' HB2' HG22 ' A' ' 54' ' ' VAL . 74.0 mmtt -106.98 -157.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -98.69 149.37 22.89 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.669 ' HB ' ' HB2' ' B' ' 63' ' ' ALA . 1.3 mp -61.33 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.809 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 1.118 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.04 -44.63 87.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.849 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.46 -56.03 26.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.775 ' HB ' HD22 ' A' ' 46' ' ' LEU . 74.1 t -60.0 -29.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.741 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 1.092 HD11 HD11 ' B' ' 55' ' ' ILE . 18.0 mt -69.15 -56.23 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 173.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 1.106 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -68.69 -14.89 63.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.169 0.509 . . . . 0.0 111.044 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -94.24 -32.75 13.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.62 169.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.95 -34.86 13.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.755 0.662 . . . . 0.0 114.755 -170.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.84 HD12 HG22 ' A' ' 55' ' ' ILE . 1.7 mp -71.71 -50.37 39.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.701 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.75 -91.86 0.43 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.482 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.6 mmtp -134.64 22.96 3.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.317 0.58 . . . . 0.0 110.456 -179.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 mt -91.18 -8.06 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.73 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.699 ' HB2' ' HB ' ' B' ' 51' ' ' ILE . . . -69.71 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.019 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -176.75 -172.5 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.589 HG23 ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -144.9 141.31 17.23 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.589 ' HD2' HG23 ' A' ' 65' ' ' VAL . 12.0 Cg_endo -56.4 -30.93 83.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.955 3.103 . . . . 0.0 113.134 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.51 57.07 6.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.686 0.617 . . . . 0.0 111.514 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.46 122.78 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.163 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.592 -1.116 . . . . 0.0 111.867 179.392 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.603 0.24 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.609 ' SD ' HG13 ' B' ' 59' ' ' ILE . 20.5 ttt -77.09 -29.28 54.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -49.57 -43.69 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.52 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 26.9 m-85 -111.14 -8.89 14.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -168.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.675 HG12 HG12 ' B' ' 55' ' ' ILE . 54.2 t -63.06 -36.3 75.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . 0.431 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.61 -55.26 37.13 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.639 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -70.36 -36.52 74.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.535 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.471 ' HA ' ' CD1' ' B' ' 23' ' ' ILE . 69.1 t80 -55.27 -49.74 71.3 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.791 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.3 mp -59.97 -55.73 30.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.814 HD11 HD11 ' A' ' 9' ' ' LEU . 15.5 mt -48.73 -50.37 33.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.757 0.313 . . . . 0.0 111.623 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.53 82.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.462 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.25 -38.58 91.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.791 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.8 mt -79.97 -30.01 39.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.005 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.83 73.94 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.404 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.55 -27.73 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.902 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.555 ' OD1' ' HA ' ' B' ' 18' ' ' PRO . 2.5 t-20 -89.02 73.91 8.19 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.548 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 13.5 m -60.79 -20.62 61.86 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.394 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -112.23 75.63 1.7 Allowed Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.555 ' HA ' ' OD1' ' B' ' 15' ' ' ASN . 19.4 Cg_exo -66.06 139.79 57.4 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.287 2.658 . . . . 0.0 113.386 -166.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.441 ' O ' HG12 ' B' ' 23' ' ' ILE . 11.6 p -97.05 141.97 29.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.277 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.464 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -62.25 -24.64 67.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.194 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . 0.606 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.4 mmmm -64.42 -46.17 84.4 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.384 0.611 . . . . 0.0 110.122 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.724 ' O ' HG13 ' B' ' 26' ' ' ILE . 4.9 t70 -59.25 -46.13 89.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.235 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.763 HG13 HD13 ' B' ' 43' ' ' ILE . 44.0 mm -51.05 -51.47 21.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.089 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.606 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 43.6 mttm -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.577 ' HB3' ' HZ3' ' B' ' 25' ' ' LYS . 4.5 mmmp? -69.88 -35.38 74.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.724 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.0 mt -70.1 -40.76 78.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.025 0.44 . . . . 0.0 110.004 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.567 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 12.8 mt -62.01 -38.06 87.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.462 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . 0.446 ' HB3' ' HA ' ' B' ' 25' ' ' LYS . 10.9 t70 -61.76 -34.65 76.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.747 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.98 -36.08 81.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.249 . . . . 0.0 111.042 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.559 HG21 HG13 ' B' ' 32' ' ' ILE . 16.2 m -98.84 -10.14 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 111.382 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 44.45 5.5 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.028 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.567 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 88.1 mt -103.03 126.27 57.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.668 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -65.07 127.98 33.86 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.953 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.565 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -127.13 124.08 38.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.0 111.775 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -92.35 121.5 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.742 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.88 -58.35 6.72 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -168.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -60.64 -45.09 95.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 12.4 tpp180 -62.81 -38.88 92.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.405 178.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.541 HD13 HG13 ' B' ' 43' ' ' ILE . 5.3 tp -59.0 -57.01 14.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.635 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.5 -35.11 71.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.922 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.605 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 6.7 tmtt? -63.78 -55.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 75.6 t -55.97 -44.22 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.362 0.601 . . . . 0.0 110.87 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.763 HD13 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.37 -45.68 89.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.202 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.4 t -66.48 -33.99 76.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.68 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.605 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 15.3 mm-40 -61.26 -52.14 65.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.176 0.512 . . . . 0.0 109.801 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.767 HD22 ' HB ' ' B' ' 54' ' ' VAL . 22.4 mt -60.46 -37.48 81.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.704 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.05 -24.63 60.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.7 -30.02 12.44 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.22 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG22 ' B' ' 54' ' ' VAL . 74.1 mmtt -106.86 -157.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -99.18 149.31 23.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.699 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 1.4 mp -61.47 -45.31 98.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.762 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 1.106 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.2 mp0 -58.22 -44.27 88.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -60.67 -56.07 25.74 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.27 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.767 ' HB ' HD22 ' B' ' 46' ' ' LEU . 75.5 t -59.92 -29.73 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.707 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 1.092 HD11 HD11 ' A' ' 55' ' ' ILE . 17.5 mt -69.33 -56.25 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 1.118 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -68.36 -15.61 63.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.49 -33.41 13.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.695 169.434 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.2 -35.34 15.16 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.856 HD12 HG22 ' B' ' 55' ' ' ILE . 1.7 mp -71.19 -50.98 37.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.977 0.889 . . . . 0.0 109.471 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.05 -92.43 0.47 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.288 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -134.13 22.38 3.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.295 0.569 . . . . 0.0 110.415 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.92 -7.68 51.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.606 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.669 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . . . -69.76 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.924 -176.257 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 16.6 p -176.61 -172.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.591 HG23 ' HD2' ' B' ' 66' ' ' PRO . 0.9 OUTLIER -145.29 141.18 16.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.543 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.591 ' HD2' HG23 ' B' ' 65' ' ' VAL . 12.0 Cg_endo -56.34 -30.93 83.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.904 3.069 . . . . 0.0 113.156 -176.68 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.38 56.81 6.94 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.748 0.655 . . . . 0.0 111.764 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.26 123.15 6.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.12 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.484 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.819 0.343 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.61 ' SD ' ' HB3' ' A' ' 62' ' ' LEU . 22.8 ttt -135.08 -45.2 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.78 ' HA ' HD11 ' B' ' 12' ' ' LEU . 9.6 ptp180 -55.51 -41.38 73.01 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -170.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.497 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 15.9 m-85 -79.26 -26.3 42.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.968 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.649 HG21 HD12 ' A' ' 46' ' ' LEU . 62.1 t -71.66 -32.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.186 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -56.8 -54.86 41.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.475 ' HG ' ' HG ' ' A' ' 27' ' ' LEU . 0.3 OUTLIER -72.66 -35.33 67.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.823 179.783 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.574 ' CD2' HD11 ' A' ' 46' ' ' LEU . 54.9 t80 -55.47 -48.19 74.93 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.782 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.6 mp -57.4 -61.08 2.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.221 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.862 HD11 HD11 ' B' ' 9' ' ' LEU . 16.5 mt -46.98 -49.08 21.4 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.426 ' HB1' HD12 ' A' ' 26' ' ' ILE . . . -63.05 -35.63 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.397 . . . . 0.0 110.944 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.78 -37.95 87.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 3.4 mt -81.77 -18.42 44.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.922 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.63 12.92 42.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.574 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.14 -76.38 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.819 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 40.0 t30 -145.88 143.8 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.844 -0.209 . . . . 0.0 110.796 -170.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -77.22 44.3 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' SER . . . . . 0.405 ' N ' ' HD3' ' A' ' 18' ' ' PRO . 14.7 t -165.84 65.64 1.01 Allowed Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.405 ' HD3' ' N ' ' A' ' 17' ' ' SER . 3.4 Cg_exo -78.07 143.47 20.36 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.903 3.069 . . . . 0.0 112.691 -171.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.473 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 46.7 t -77.51 143.23 38.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.965 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.4 66.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.287 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.62 -40.77 76.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.71 ' O ' HG13 ' A' ' 26' ' ' ILE . 18.6 m-20 -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.227 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.608 HG13 HD12 ' A' ' 43' ' ' ILE . 28.2 mm -52.08 -51.2 31.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -52.73 -48.82 66.42 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.764 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.15 -46.68 82.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.71 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.6 mt -68.11 -37.88 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.055 0.455 . . . . 0.0 110.574 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.587 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 11.2 mt -63.18 -41.48 99.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.012 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.46 -26.77 68.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.6 m -70.68 -25.26 62.9 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.644 0.259 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.53 HG21 HG13 ' A' ' 32' ' ' ILE . 16.5 m -112.17 -9.28 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.692 0.282 . . . . 0.0 111.453 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.4 5.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.497 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.587 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 39.2 mt -111.3 136.5 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.012 0.406 . . . . 0.0 110.873 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -76.78 158.4 30.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.55 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.57 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -150.22 138.82 20.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -85.68 -178.02 6.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.792 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.51 -52.93 2.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.198 0.523 . . . . 0.0 109.851 167.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.49 -58.19 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.837 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . 0.451 ' O ' HG21 ' A' ' 42' ' ' VAL . 18.5 tpp180 -60.6 -35.95 77.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.497 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.5 tp -63.57 -55.63 22.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -62.24 -28.54 69.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.669 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -64.87 -49.92 68.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.324 176.476 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.451 HG21 ' O ' ' A' ' 38' ' ' ARG . 88.8 t -62.15 -41.32 90.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.683 0.754 . . . . 0.0 110.725 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.608 HD12 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.45 -41.39 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.714 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t -70.42 -34.95 73.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.311 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.24 -37.12 69.2 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.107 178.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.818 HD22 ' HB ' ' A' ' 54' ' ' VAL . 17.8 mt -57.14 -46.3 82.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.158 169.707 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -71.28 -3.6 21.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.554 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.24 -14.86 40.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.727 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.531 ' HB2' HG22 ' A' ' 54' ' ' VAL . 13.7 mmmm -133.72 -146.89 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 25.1 m-80 -105.03 162.38 13.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 166.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.688 ' HB ' ' HB2' ' B' ' 63' ' ' ALA . 1.6 mp -58.91 -50.9 77.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.175 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.911 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.8 mp0 -59.25 -39.06 81.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.296 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.2 -54.32 48.27 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.246 0.546 . . . . 0.0 110.02 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.818 ' HB ' HD22 ' A' ' 46' ' ' LEU . 50.9 t -65.91 -32.14 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.778 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.594 HG23 HG23 ' B' ' 55' ' ' ILE . 2.5 mm -58.09 -60.65 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.489 0.661 . . . . 0.0 111.286 170.604 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.908 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.44 -14.84 62.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.382 -170.643 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -100.6 -18.1 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.743 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.08 -40.09 3.15 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.486 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.588 HG22 ' HB3' ' A' ' 63' ' ' ALA . 1.9 mp -69.12 -63.67 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 117.689 0.744 . . . . 0.0 110.078 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.6 -67.24 2.61 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 114.046 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -129.86 -23.16 2.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.902 0.382 . . . . 0.0 111.541 -173.099 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.61 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -67.33 -28.33 67.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -172.857 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.683 ' HB2' ' HB ' ' B' ' 51' ' ' ILE . . . -47.68 -59.11 3.52 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 123.32 0.388 . . . . 0.0 111.433 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 m 62.84 -168.67 0.2 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.573 0.546 . . . . 0.0 111.201 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.603 HG23 ' HD2' ' A' ' 66' ' ' PRO . 1.3 p -172.51 142.27 1.14 Allowed Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.603 ' HD2' HG23 ' A' ' 65' ' ' VAL . 19.2 Cg_endo -59.08 113.06 1.42 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.31 2.673 . . . . 0.0 112.428 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.15 81.85 5.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.3 0.571 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.13 -125.73 1.59 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.591 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.542 -1.143 . . . . 0.0 111.519 179.496 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.719 0.295 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.606 ' SD ' ' HB3' ' B' ' 62' ' ' LEU . 22.6 ttt -135.11 -45.24 0.71 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.741 ' HA ' HD11 ' A' ' 12' ' ' LEU . 9.5 ptp180 -55.51 -41.55 73.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -170.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.503 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 15.7 m-85 -78.91 -26.32 43.74 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.956 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.634 HG21 HD12 ' B' ' 46' ' ' LEU . 61.2 t -71.66 -32.42 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.283 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -57.03 -54.75 43.21 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.482 0.658 . . . . 0.0 110.847 175.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.496 ' HG ' ' HG ' ' B' ' 27' ' ' LEU . 0.4 OUTLIER -72.51 -35.46 68.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 179.58 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.572 ' CD2' HD11 ' B' ' 46' ' ' LEU . 54.4 t80 -55.21 -48.14 74.3 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.786 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -57.82 -60.69 3.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.862 HD11 HD11 ' A' ' 9' ' ' LEU . 16.2 mt -47.27 -48.8 24.6 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . 0.428 ' HB3' HD12 ' B' ' 26' ' ' ILE . . . -63.1 -35.89 81.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.579 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -65.67 -37.93 87.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 110.849 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.786 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 3.4 mt -81.75 -18.37 44.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.943 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.87 12.97 41.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.738 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.93 -75.37 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.203 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.579 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 39.1 t30 -147.02 143.78 28.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.919 -0.165 . . . . 0.0 110.782 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -76.59 44.11 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.254 0.55 . . . . 0.0 111.118 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' SER . . . . . 0.404 ' H ' ' C ' ' B' ' 15' ' ' ASN . 15.9 t -165.93 66.06 1.02 Allowed Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.404 ' HD3' ' N ' ' B' ' 17' ' ' SER . 3.5 Cg_exo -78.63 143.51 18.99 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.817 3.011 . . . . 0.0 112.632 -171.322 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.461 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 46.3 t -77.61 143.81 37.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.822 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.2 -25.32 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.228 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -40.38 76.3 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.091 0.472 . . . . 0.0 110.016 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.7 ' O ' HG13 ' B' ' 26' ' ' ILE . 16.4 m-20 -60.91 -44.25 97.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.151 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.608 HG13 HD12 ' B' ' 43' ' ' ILE . 27.3 mm -52.01 -51.08 31.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.492 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -52.92 -48.27 67.38 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.912 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.58 -46.64 83.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.684 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.7 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.09 -38.11 79.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.441 . . . . 0.0 110.571 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.589 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 11.3 mt -62.97 -41.23 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.149 172.499 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.04 -26.03 68.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -71.34 -24.79 62.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.69 0.281 . . . . 0.0 111.234 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.53 HG21 HG13 ' B' ' 32' ' ' ILE . 17.0 m -112.71 -8.86 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 111.519 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 34.64 5.58 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.669 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.589 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 39.3 mt -110.69 136.73 45.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.076 0.438 . . . . 0.0 110.777 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.84 158.51 30.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.498 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.56 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -150.29 138.62 20.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -85.55 -177.73 6.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.582 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.71 -52.95 2.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.175 0.512 . . . . 0.0 109.828 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.24 -57.83 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.863 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.445 ' O ' HG21 ' B' ' 42' ' ' VAL . 18.5 tpp180 -61.27 -35.86 78.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.503 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.5 tp -63.52 -55.59 22.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.724 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.19 -28.49 69.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.647 ' HA ' ' HE3' ' B' ' 41' ' ' LYS . 0.1 OUTLIER -64.74 -50.38 67.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.408 176.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . 0.445 HG21 ' O ' ' B' ' 38' ' ' ARG . 88.6 t -61.77 -41.53 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.686 0.755 . . . . 0.0 110.684 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.608 HD12 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.29 -41.4 89.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.76 175.356 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -70.7 -34.82 72.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.258 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.41 -36.87 68.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.163 177.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.845 HD22 ' HB ' ' B' ' 54' ' ' VAL . 17.9 mt -57.44 -45.97 84.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.967 0.413 . . . . 0.0 110.258 169.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.66 -3.15 20.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.5 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.71 -14.55 40.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.867 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.538 ' HB2' HG22 ' B' ' 54' ' ' VAL . 13.6 mmmm -133.8 -147.06 0.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 27.1 m-80 -104.91 162.2 13.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 165.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.683 ' HB ' ' HB2' ' A' ' 63' ' ' ALA . 1.6 mp -58.67 -50.9 77.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.108 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.908 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 mp0 -59.46 -38.79 81.69 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.127 0.267 . . . . 0.0 111.18 -174.767 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -59.14 -54.98 40.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.04 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.845 ' HB ' HD22 ' B' ' 46' ' ' LEU . 52.8 t -65.17 -32.34 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.594 HG23 HG23 ' A' ' 55' ' ' ILE . 2.5 mm -58.18 -60.46 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.458 0.647 . . . . 0.0 111.337 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.911 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.2 -15.42 62.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.448 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -99.88 -18.72 16.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.618 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -39.66 3.29 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.98 -0.629 . . . . 0.0 114.454 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.581 HG22 ' HB3' ' B' ' 63' ' ' ALA . 1.9 mp -69.36 -63.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 117.878 0.839 . . . . 0.0 110.137 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.75 -67.12 2.67 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.358 -0.449 . . . . 0.0 114.032 170.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -129.76 -23.15 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.678 0.275 . . . . 0.0 111.46 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.606 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 0.5 OUTLIER -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -172.688 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.688 ' HB2' ' HB ' ' A' ' 51' ' ' ILE . . . -47.31 -58.93 3.58 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.407 0.442 . . . . 0.0 111.457 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m 62.44 -168.63 0.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.501 0.501 . . . . 0.0 111.213 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.602 HG23 ' HD2' ' B' ' 66' ' ' PRO . 1.2 p -172.43 142.45 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.602 ' HD2' HG23 ' B' ' 65' ' ' VAL . 18.4 Cg_endo -59.45 112.76 1.35 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.406 2.738 . . . . 0.0 112.385 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.1 82.66 5.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.284 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.47 -125.11 1.51 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.472 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.562 179.33 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.128 0.489 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.637 ' HG3' HG13 ' A' ' 59' ' ' ILE . 19.2 ttt -78.45 79.82 4.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.194 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ARG . . . . . 0.67 ' HA ' HD11 ' B' ' 12' ' ' LEU . 96.3 mtt180 -144.48 -62.72 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.373 0.606 . . . . 0.0 110.271 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TYR . . . . . 0.462 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 21.3 m-85 -78.37 -26.58 46.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.388 -168.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . 0.669 HG21 HD12 ' A' ' 46' ' ' LEU . 60.0 t -64.2 -31.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.809 0.338 . . . . 0.0 110.827 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.67 -54.58 44.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.473 0.654 . . . . 0.0 111.064 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' SER . . . . . 0.405 ' HG ' ' HG ' ' A' ' 27' ' ' LEU . 1.3 p -72.38 -34.99 68.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.759 179.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' TYR . . . . . 0.689 ' CD1' HD11 ' A' ' 46' ' ' LEU . 48.7 t80 -55.34 -47.96 74.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.664 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.782 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.3 mp -58.19 -59.68 4.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.275 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.891 HD13 HD13 ' B' ' 9' ' ' LEU . 16.2 mt -46.34 -49.93 17.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.24 89.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.72 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.647 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -62.72 -37.82 88.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 110.773 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.7 mt -80.07 -28.64 39.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.354 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.78 -28.57 73.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.969 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.86 -33.17 0.48 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.848 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ASN . . . . . 0.647 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 3.7 p30 -96.99 107.41 19.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' SER . . . . . 0.454 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 11.6 m -69.88 -19.68 63.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.519 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p -117.14 78.6 10.18 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.426 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . 0.454 ' HD3' ' O ' ' A' ' 16' ' ' SER . 10.7 Cg_exo -73.14 140.87 31.7 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.609 2.873 . . . . 0.0 112.607 -171.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' SER . . . . . 0.502 ' O ' HG12 ' A' ' 23' ' ' ILE . 54.2 p -87.92 151.37 22.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.573 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.5 -25.03 68.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.166 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -69.41 -40.56 77.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 110.273 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.695 ' O ' HG13 ' A' ' 26' ' ' ILE . 46.2 m-20 -58.49 -46.88 85.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.729 HG13 HD13 ' A' ' 43' ' ' ILE . 39.6 mm -52.31 -49.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.888 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . 0.573 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 84.5 mttt -59.37 -41.71 89.92 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . 0.406 ' HZ1' ' HA ' ' A' ' 22' ' ' ASP . 28.2 mtmm -58.03 -46.98 84.44 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 111.13 177.087 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.695 HG13 ' O ' ' A' ' 22' ' ' ASP . 7.3 mt -70.43 -42.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.765 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LEU . . . . . 0.573 HD12 ' HB1' ' A' ' 34' ' ' ALA . 13.8 mt -61.25 -36.77 80.9 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.02 -39.99 96.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 98.6 p -62.65 -37.08 84.96 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.474 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' VAL . . . . . 0.494 HG21 HG13 ' A' ' 32' ' ' ILE . 19.5 m -94.68 -10.24 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.203 0.525 . . . . 0.0 110.8 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 46.69 5.43 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.982 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.572 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 81.2 mt -104.58 131.43 53.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.04 0.42 . . . . 0.0 111.756 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.4 127.52 33.31 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.997 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ALA . . . . . 0.573 ' HB1' HD12 ' A' ' 27' ' ' LEU . . . -125.87 136.05 52.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -102.61 120.9 41.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.3 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -45.38 -59.59 2.6 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.903 0.752 . . . . 0.0 112.64 -171.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 8.9 p-10 -67.6 -50.28 58.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.089 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -56.32 -36.51 68.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.462 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 4.1 tp -58.64 -56.27 24.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.958 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -58.07 -33.73 69.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.591 0.234 . . . . 0.0 110.767 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LYS . . . . . 0.655 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.0 mmmm -64.56 -50.47 67.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.96 -42.63 90.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.465 0.65 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.729 HD13 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.24 -43.26 89.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.859 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -66.98 -35.39 79.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.608 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.506 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 54.7 mm-40 -57.53 -50.9 71.58 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.726 HD22 ' HB ' ' A' ' 54' ' ' VAL . 30.5 mt -60.58 -35.19 75.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.997 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.36 -29.42 63.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.113 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.74 -34.64 15.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.129 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . 0.481 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 66.6 mttm -102.93 -152.24 0.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 0.0 110.288 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.23 152.04 30.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ILE . . . . . 0.667 ' HB ' ' HB3' ' B' ' 63' ' ' ALA . 1.5 mp -55.91 -54.98 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.08 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLU . . . . . 0.895 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.35 -34.55 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 110.715 -174.036 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 30.7 t70 -66.45 -53.58 33.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.863 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.726 ' HB ' HD22 ' A' ' 46' ' ' LEU . 70.7 t -61.28 -31.2 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.608 HG23 HG23 ' B' ' 55' ' ' ILE . 2.9 mm -59.6 -61.26 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.415 0.626 . . . . 0.0 111.427 171.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.912 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.36 -18.71 63.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.447 -169.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 83.2 mt-30 -93.51 -27.49 16.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 172.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.59 -36.5 6.47 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.278 -0.487 . . . . 0.0 114.134 -171.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ILE . . . . . 0.637 HG13 ' HG3' ' A' ' 1' ' ' MET . 1.7 mp -69.29 -46.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 -104.63 0.74 Allowed Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.003 -0.998 . . . . 0.0 114.321 168.003 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -89.86 -1.94 58.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.939 0.4 . . . . 0.0 111.289 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . 0.444 ' CD1' ' HB3' ' A' ' 1' ' ' MET . 53.7 mt -88.44 -152.88 0.23 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.218 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.654 ' HB1' ' HB ' ' B' ' 51' ' ' ILE . . . 64.91 30.3 12.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.529 0.681 . . . . 0.0 110.165 -174.892 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -78.29 74.54 4.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.186 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . 0.638 ' CG2' ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -73.72 146.54 85.79 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.638 ' HD2' ' CG2' ' A' ' 65' ' ' VAL . 1.7 Cg_endo -43.13 -57.89 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.548 2.832 . . . . 0.0 112.737 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 49.54 46.78 23.29 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.613 0.57 . . . . 0.0 111.29 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.9 -38.97 2.88 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.855 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.633 -1.093 . . . . 0.0 112.024 179.417 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.163 0.506 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' MET . . . . . 0.623 ' HG3' HG13 ' B' ' 59' ' ' ILE . 19.2 ttt -78.29 79.77 4.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -176.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' ARG . . . . . 0.687 ' HA ' HD11 ' A' ' 12' ' ' LEU . 96.2 mtt180 -144.55 -62.73 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 0.0 110.25 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' TYR . . . . . 0.461 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 21.3 m-85 -78.44 -26.64 46.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.337 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' VAL . . . . . 0.657 HG21 HD12 ' B' ' 46' ' ' LEU . 61.1 t -64.19 -31.87 55.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 110.938 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ALA . . . . . . . . . . . . . . . -59.67 -54.52 45.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.419 0.628 . . . . 0.0 110.909 178.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' SER . . . . . 0.404 ' HG ' ' HG ' ' B' ' 27' ' ' LEU . 1.3 p -72.4 -35.31 68.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.584 179.392 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' TYR . . . . . 0.686 ' CD1' HD11 ' B' ' 46' ' ' LEU . 49.1 t80 -55.12 -47.91 74.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.704 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' LEU . . . . . 0.78 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.3 mp -58.06 -59.82 4.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.2 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' LEU . . . . . 0.891 HD13 HD13 ' A' ' 9' ' ' LEU . 16.5 mt -46.44 -49.86 17.59 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.21 89.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.703 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' ALA . . . . . 0.644 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -62.93 -37.81 88.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.694 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' LEU . . . . . 0.78 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.6 mt -79.84 -28.92 40.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.326 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.03 -29.82 75.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.92 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.44 -32.99 0.45 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.994 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' ASN . . . . . 0.644 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 3.6 p30 -97.25 107.33 19.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.228 0.537 . . . . 0.0 110.859 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' SER . . . . . 0.448 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 8.1 m -69.62 -19.72 63.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.269 0.557 . . . . 0.0 110.654 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 41.1 p -117.38 78.76 11.12 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.246 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' PRO . . . . . 0.448 ' HD3' ' O ' ' B' ' 16' ' ' SER . 11.2 Cg_exo -73.23 140.62 31.04 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.521 2.814 . . . . 0.0 112.657 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' SER . . . . . 0.492 ' O ' HG12 ' B' ' 23' ' ' ILE . 55.9 p -87.66 152.14 22.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' ALA . . . . . 0.576 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -64.33 -24.43 67.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.133 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -69.6 -40.32 76.74 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.302 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' ASP . . . . . 0.697 ' O ' HG13 ' B' ' 26' ' ' ILE . 48.6 m-20 -58.65 -47.1 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ILE . . . . . 0.75 HG13 HD13 ' B' ' 43' ' ' ILE . 39.2 mm -51.97 -49.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.99 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' LYS . . . . . 0.576 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 84.1 mttt -59.59 -41.59 90.63 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' LYS . . . . . 0.446 ' HZ1' ' HA ' ' B' ' 22' ' ' ASP . 28.1 mtmm -58.11 -46.95 84.7 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.521 0.677 . . . . 0.0 111.099 176.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' ILE . . . . . 0.697 HG13 ' O ' ' B' ' 22' ' ' ASP . 7.2 mt -70.54 -42.26 78.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.807 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' LEU . . . . . 0.586 HD12 ' HB1' ' B' ' 34' ' ' ALA . 13.6 mt -61.07 -36.92 80.91 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.15 -39.51 94.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.451 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 94.6 p -62.5 -37.62 86.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' VAL . . . . . 0.494 HG21 HG13 ' B' ' 32' ' ' ILE . 19.3 m -94.45 -10.32 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.3 46.91 5.4 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.91 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 81.6 mt -104.58 131.69 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.439 . . . . 0.0 111.615 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.78 127.64 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.146 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' ALA . . . . . 0.586 ' HB1' HD12 ' B' ' 27' ' ' LEU . . . -125.93 135.73 52.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.99 0.424 . . . . 0.0 111.765 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -102.22 120.83 41.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -45.09 -59.87 2.39 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.868 0.73 . . . . 0.0 112.674 -171.537 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 8.7 p-10 -67.62 -50.0 60.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.129 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -56.36 -36.61 68.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.951 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.461 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 4.1 tp -58.5 -56.48 21.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.993 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -58.17 -33.26 69.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.473 0.178 . . . . 0.0 110.617 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 13.9 mmmm -65.0 -50.61 65.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.008 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.8 -42.39 88.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.563 0.697 . . . . 0.0 110.816 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' ILE . . . . . 0.75 HD13 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.42 -43.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.834 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -66.32 -35.55 80.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.5 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' GLU . . . . . 0.499 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 61.1 mm-40 -57.45 -51.19 70.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.223 0.535 . . . . 0.0 109.701 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' LEU . . . . . 0.709 HD22 ' HB ' ' B' ' 54' ' ' VAL . 30.5 mt -60.45 -35.32 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.018 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.9 -29.44 64.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.004 0.43 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.65 -34.79 15.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.087 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 49' ' ' LYS . . . . . 0.489 ' HB2' ' CG2' ' B' ' 54' ' ' VAL . 66.5 mttm -102.86 -151.9 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.935 0.398 . . . . 0.0 110.22 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.54 152.16 30.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 51' ' ' ILE . . . . . 0.654 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 1.5 mp -55.83 -55.06 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.029 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 52' ' ' GLU . . . . . 0.912 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.36 -34.67 74.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.909 0.385 . . . . 0.0 110.69 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 53' ' ' ASP . . . . . 0.404 ' O ' ' HG3' ' B' ' 57' ' ' GLN . 28.9 t70 -66.41 -53.66 33.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.697 179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 54' ' ' VAL . . . . . 0.709 ' HB ' HD22 ' B' ' 46' ' ' LEU . 69.8 t -61.16 -31.33 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.449 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 55' ' ' ILE . . . . . 0.608 HG23 HG23 ' A' ' 55' ' ' ILE . 2.9 mm -59.47 -61.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.386 0.612 . . . . 0.0 111.419 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 56' ' ' ALA . . . . . 0.895 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.69 -18.36 63.54 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.36 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 57' ' ' GLN . . . . . 0.404 ' HG3' ' O ' ' B' ' 53' ' ' ASP . 83.6 mt-30 -93.58 -27.48 16.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 172.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.99 -36.26 6.43 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.351 -0.452 . . . . 0.0 114.035 -171.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 59' ' ' ILE . . . . . 0.623 HG13 ' HG3' ' B' ' 1' ' ' MET . 1.7 mp -69.31 -46.22 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.041 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.15 -104.23 0.71 Allowed Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.083 -0.962 . . . . 0.0 114.396 167.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.36 -1.89 57.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 111.08 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' LEU . . . . . 0.435 ' CD1' ' HB3' ' B' ' 1' ' ' MET . 54.3 mt -88.65 -152.86 0.23 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.26 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' ALA . . . . . 0.667 ' HB3' ' HB ' ' A' ' 51' ' ' ILE . . . 64.7 30.35 12.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.35 0.595 . . . . 0.0 110.086 -174.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 74.59 5.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.993 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' VAL . . . . . 0.629 ' CG2' ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -73.53 146.59 86.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.622 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' PRO . . . . . 0.629 ' HD2' ' CG2' ' B' ' 65' ' ' VAL . 1.7 Cg_endo -43.3 -57.88 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.516 2.811 . . . . 0.0 112.658 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . 49.84 46.64 23.95 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.705 0.628 . . . . 0.0 111.34 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.89 -38.96 2.88 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.806 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.089 179.326 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.785 ' HA ' HD13 ' B' ' 12' ' ' LEU . 20.6 mmm180 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.681 0.277 . . . . 0.0 111.528 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 16.4 m-85 -91.04 -20.35 22.17 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.794 HG22 HD11 ' A' ' 46' ' ' LEU . 73.0 t -60.41 -37.24 73.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.087 0.47 . . . . 0.0 110.78 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.17 -54.61 44.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.392 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -35.83 67.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.975 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.673 ' CD2' HD13 ' A' ' 46' ' ' LEU . 47.9 t80 -54.79 -50.91 67.36 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.847 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.799 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.9 mp -57.86 -55.88 29.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.736 HD12 HD12 ' B' ' 9' ' ' LEU . 12.5 mt -47.55 -50.33 24.09 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.29 88.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.66 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.2 -41.08 99.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.278 0.561 . . . . 0.0 110.776 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.799 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.3 mt -75.65 -23.25 56.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.312 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.83 10.2 53.02 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.612 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.37 -11.51 39.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.877 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 62.6 t30 -103.86 81.2 1.85 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.999 0.428 . . . . 0.0 109.913 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 26.2 t -64.16 -28.77 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.49 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 t -111.51 81.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.61 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 4.5 Cg_exo -79.8 137.52 12.69 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.688 2.925 . . . . 0.0 113.353 -170.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 23' ' ' ILE . 45.3 t -79.52 147.13 32.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.66 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.48 68.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.27 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 mmtm -67.16 -42.29 84.56 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.12 0.486 . . . . 0.0 110.291 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.5 m-20 -58.37 -45.33 88.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.308 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 43' ' ' ILE . 41.4 mm -51.62 -50.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 59.0 mttm -53.86 -46.4 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.108 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -62.75 -41.85 99.4 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.285 0.564 . . . . 0.0 111.673 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 22' ' ' ASP . 13.0 mt -68.35 -36.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 110.081 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 34' ' ' ALA . 15.6 mt -65.87 -35.91 81.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.141 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.75 -33.98 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.474 0.178 . . . . 0.0 110.992 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.97 -42.91 86.04 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.201 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' B' ' 9' ' ' LEU . 15.9 m -104.22 -3.25 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.726 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 50.37 4.09 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.496 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 59.2 mt -116.0 147.36 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.083 0.468 . . . . 0.0 111.343 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.12 159.53 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.472 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -159.25 117.28 2.81 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.9 176.97 9.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.624 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.95 -48.0 4.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.999 -0.438 . . . . 0.0 110.644 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 13.5 t70 -64.45 -60.75 2.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 42' ' ' VAL . 8.7 tpp180 -54.89 -40.51 69.86 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 123.439 0.462 . . . . 0.0 110.731 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.555 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 4.2 tp -61.33 -53.97 49.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.995 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.73 -30.14 70.57 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.51 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 29.3 mmtp -66.14 -47.74 73.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.761 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 38' ' ' ARG . 92.7 t -61.2 -43.63 96.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.609 . . . . 0.0 110.378 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.32 -44.39 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.09 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 -35.72 80.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -57.77 -53.57 56.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.794 HD11 HG22 ' A' ' 4' ' ' VAL . 42.0 mt -61.77 -29.85 70.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -77.45 -39.51 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.94 -23.16 59.99 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.617 ' HD2' HG22 ' A' ' 54' ' ' VAL . 94.3 mttt -113.75 -164.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.96 0.409 . . . . 0.0 109.954 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB3' ' OE2' ' A' ' 52' ' ' GLU . 93.6 m-20 -93.21 146.84 23.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.546 HG13 HD22 ' A' ' 46' ' ' LEU . 1.5 mp -57.34 -47.46 84.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.215 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 1.053 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.9 OUTLIER -59.04 -40.97 86.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 -177.411 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 33.4 t70 -62.88 -56.56 16.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.711 ' HB ' HD23 ' A' ' 46' ' ' LEU . 53.0 t -58.23 -40.26 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.099 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.04 HD13 HD13 ' B' ' 55' ' ' ILE . 14.5 mt -60.44 -56.1 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.056 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.55 -14.13 62.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.575 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 96.4 mt-30 -88.97 -50.39 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.466 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.12 9.95 67.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.991 0.756 . . . . 0.0 114.991 -167.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.628 HD12 HG23 ' A' ' 55' ' ' ILE . 5.7 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 117.668 0.734 . . . . 0.0 110.696 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.77 ' HA ' HD13 ' A' ' 12' ' ' LEU . 20.5 mmm180 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.701 0.286 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.569 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 16.4 m-85 -90.91 -20.26 22.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.813 HG22 HD11 ' B' ' 46' ' ' LEU . 71.5 t -60.57 -37.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.92 -54.73 43.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.445 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.69 -35.72 67.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.957 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' B' ' 46' ' ' LEU . 46.6 t80 -55.03 -50.77 68.23 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.801 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.8 mp -57.84 -55.88 29.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.736 HD12 HD12 ' A' ' 9' ' ' LEU . 12.4 mt -47.6 -50.39 24.29 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.289 0.368 . . . . 0.0 111.918 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.611 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.51 -40.52 97.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.232 0.539 . . . . 0.0 110.869 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.801 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.2 mt -76.16 -22.6 55.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.409 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.47 10.88 53.83 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.719 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.71 -11.0 41.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.81 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 62.5 t30 -104.16 81.46 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.081 0.467 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 24.8 t -64.42 -28.65 69.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.387 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.9 t -111.67 82.01 3.63 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.61 ' HA ' ' ND2' ' B' ' 15' ' ' ASN . 4.3 Cg_exo -80.36 137.52 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.661 2.908 . . . . 0.0 113.374 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.429 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.5 t -79.53 147.23 32.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.633 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.414 ' HB1' ' CD2' ' B' ' 39' ' ' LEU . . . -62.75 -26.22 68.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.227 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 48.2 mmtm -67.15 -42.15 84.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.183 0.516 . . . . 0.0 110.23 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.647 ' O ' HG13 ' B' ' 26' ' ' ILE . 17.3 m-20 -58.3 -45.68 87.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.325 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.635 HG13 HD11 ' B' ' 43' ' ' ILE . 41.3 mm -51.47 -50.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.425 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 59.4 mttm -53.59 -46.48 70.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.137 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -62.85 -41.6 99.42 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 111.739 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.647 HG13 ' O ' ' B' ' 22' ' ' ASP . 12.6 mt -68.51 -36.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.18 0.514 . . . . 0.0 110.144 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' B' ' 34' ' ' ALA . 15.8 mt -65.87 -36.01 82.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.174 172.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.32 -34.4 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.496 0.189 . . . . 0.0 110.899 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.9 t -57.66 -43.06 84.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.278 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 9' ' ' LEU . 15.9 m -104.12 -3.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 0.0 111.678 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.64 51.32 3.9 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.307 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 58.7 mt -116.48 147.57 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 111.358 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.43 159.44 33.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.583 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -159.38 116.68 2.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 112.935 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.62 177.09 9.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.666 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.0 -47.99 4.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.168 -0.333 . . . . 0.0 110.679 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.708 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 13.0 t70 -64.43 -60.93 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.258 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.452 ' O ' HG23 ' B' ' 42' ' ' VAL . 8.6 tpp180 -54.76 -40.63 69.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.785 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.569 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 4.2 tp -61.24 -54.08 48.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.76 -30.15 70.6 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.442 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 29.4 mmtp -66.26 -47.47 73.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.729 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 38' ' ' ARG . 91.7 t -61.36 -43.63 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.317 0.58 . . . . 0.0 110.435 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.635 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.24 -44.54 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.1 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 10.3 t -66.38 -35.68 80.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.706 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -57.78 -53.43 58.3 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.071 0.462 . . . . 0.0 109.814 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.813 HD11 HG22 ' B' ' 4' ' ' VAL . 42.1 mt -61.93 -29.72 70.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.986 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -77.56 -39.56 45.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.161 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.32 -22.53 60.43 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.297 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.622 ' HD2' HG22 ' B' ' 54' ' ' VAL . 94.3 mttt -114.1 -165.06 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 50' ' ' ASN . . . . . 0.527 ' HB3' ' OE2' ' B' ' 52' ' ' GLU . 93.4 m-20 -92.85 146.99 23.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.189 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.56 HG13 HD22 ' B' ' 46' ' ' LEU . 1.5 mp -57.59 -47.44 85.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.293 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 1.056 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -59.08 -40.79 86.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 -177.482 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 53' ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' B' ' 57' ' ' GLN . 33.6 t70 -63.12 -56.6 15.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.08 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.695 ' HB ' HD23 ' B' ' 46' ' ' LEU . 54.6 t -57.85 -40.22 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.236 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 1.04 HD13 HD13 ' A' ' 55' ' ' ILE . 14.5 mt -60.63 -56.06 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 1.053 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.58 -13.94 62.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.623 -173.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' B' ' 53' ' ' ASP . 96.9 mt-30 -89.05 -50.67 6.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.88 9.76 68.26 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.656 HD12 HG23 ' B' ' 55' ' ' ILE . 5.7 mt . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 117.72 0.76 . . . . 0.0 110.584 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.75 ' HA ' HD13 ' B' ' 12' ' ' LEU . 42.6 ttm180 . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' HD1' HD11 ' A' ' 27' ' ' LEU . 39.2 m-85 -83.54 -16.56 44.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.307 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 46' ' ' LEU . 91.7 t -64.0 -36.12 75.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.536 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -56.7 -54.85 41.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.508 0.671 . . . . 0.0 111.282 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.408 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -71.72 -34.97 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.797 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 46' ' ' LEU . 65.5 t80 -55.45 -47.82 75.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.837 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.748 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.0 mp -60.11 -57.26 13.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.329 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.846 HD12 HD12 ' B' ' 9' ' ' LEU . 14.9 mt -47.48 -50.8 22.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.65 -37.87 79.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.53 -40.92 96.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.783 HD13 ' HA ' ' B' ' 2' ' ' ARG . 4.8 mt -74.41 -24.5 59.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.385 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.35 -19.34 74.23 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.372 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.54 -33.8 1.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.045 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.8 m-20 -92.47 88.07 6.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.604 0.24 . . . . 0.0 110.645 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.616 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 6.2 m -60.87 -27.79 68.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.349 0.595 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 p -108.79 82.52 1.79 Allowed Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.8 Cg_exo -80.33 152.92 20.97 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.811 3.008 . . . . 0.0 113.038 -172.136 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.447 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 14.2 t -89.42 146.33 24.73 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -65.23 -23.76 67.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.537 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.782 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 50.5 tptt -64.6 -44.72 89.71 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.337 0.589 . . . . 0.0 110.357 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.5 m-20 -58.63 -45.12 89.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.828 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.671 HG13 HD11 ' A' ' 43' ' ' ILE . 44.3 mm -50.91 -50.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.3 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HD2' ' HD2' ' A' ' 21' ' ' LYS . 60.7 mttm -52.27 -48.07 65.47 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.71 -40.38 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.12 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 22' ' ' ASP . 12.1 mt -67.95 -37.95 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 110.197 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.665 HD13 ' HB2' ' A' ' 34' ' ' ALA . 10.5 mt -63.9 -39.91 95.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.996 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.12 -32.28 71.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.322 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 t -66.7 -34.19 77.31 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.035 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 32' ' ' ILE . 15.5 m -103.04 -5.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.692 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.52 33.65 8.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.453 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 46.9 mt -102.91 129.69 54.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 122.631 -0.334 . . . . 0.0 110.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.5 144.83 51.24 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.182 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.665 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -131.13 156.97 44.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.467 0.651 . . . . 0.0 111.625 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 14.8 t70 -111.99 178.66 4.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.416 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -102.88 -53.01 2.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.221 0.534 . . . . 0.0 110.081 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.67 -49.27 41.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.043 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 12.6 tpp180 -63.44 -38.04 89.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.572 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.502 ' CD2' ' HB1' ' A' ' 20' ' ' ALA . 3.1 tp -65.84 -55.99 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.36 -30.05 69.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.2 tmtt? -62.49 -52.11 64.81 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 38' ' ' ARG . 78.7 t -60.83 -42.82 93.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 110.87 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.44 -41.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.398 175.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -68.26 -33.89 75.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.705 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 45.2 mt-10 -58.39 -53.4 58.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 4' ' ' VAL . 19.7 mt -57.17 -43.31 82.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.69 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.81 -29.01 65.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.263 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.72 -21.23 64.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.548 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 54' ' ' VAL . 34.5 mttm -117.06 -97.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.741 0.782 . . . . 0.0 110.432 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.98 154.51 1.47 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.5 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 1.7 mp -57.64 -54.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.967 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.6 OUTLIER -61.44 -38.39 87.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -172.972 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 15.6 t70 -64.75 -53.79 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.721 ' HB ' HD23 ' A' ' 46' ' ' LEU . 28.7 t -58.7 -37.13 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.495 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.611 HG21 HG21 ' B' ' 55' ' ' ILE . 2.2 mm -56.56 -60.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 111.776 172.613 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.933 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.84 -15.29 63.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.651 -170.421 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 85.4 mm-40 -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 173.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.81 -42.08 3.42 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.51 -171.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 55' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 117.253 0.526 . . . . 0.0 110.827 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.783 ' HA ' HD13 ' A' ' 12' ' ' LEU . 42.6 ttm180 . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.489 ' HD1' HD11 ' B' ' 27' ' ' LEU . 39.7 m-85 -83.97 -16.51 43.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.164 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.985 HG22 HD11 ' B' ' 46' ' ' LEU . 91.9 t -63.92 -35.95 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.82 -54.97 40.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.519 0.676 . . . . 0.0 111.177 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' B' ' 26' ' ' ILE . 0.3 OUTLIER -71.86 -34.98 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.684 179.197 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.594 ' CD2' HD13 ' B' ' 46' ' ' LEU . 64.9 t80 -55.23 -48.15 74.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.9 mp -59.99 -57.29 13.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.279 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.846 HD12 HD12 ' A' ' 9' ' ' LEU . 14.8 mt -47.43 -50.54 22.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.99 80.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.23 -41.36 97.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 2' ' ' ARG . 4.8 mt -74.07 -24.35 59.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.498 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.18 74.31 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.223 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.4 -33.26 2.0 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.22 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 85.9 m-20 -92.8 88.01 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.6 0.238 . . . . 0.0 110.647 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.609 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 6.1 m -60.79 -27.97 68.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.419 0.628 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 39.2 p -108.85 82.5 1.8 Allowed Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.215 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.6 Cg_exo -80.17 153.27 21.59 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.763 2.975 . . . . 0.0 112.814 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.457 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 15.4 t -89.59 146.71 24.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -65.49 -23.68 66.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.525 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.762 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 50.6 tptt -64.4 -44.8 90.13 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.255 0.55 . . . . 0.0 110.295 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.716 ' O ' HG13 ' B' ' 26' ' ' ILE . 2.6 m-20 -58.77 -44.72 90.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.91 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.652 HG13 HD11 ' B' ' 43' ' ' ILE . 44.5 mm -51.32 -50.39 27.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.266 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.762 ' HD2' ' HD2' ' B' ' 21' ' ' LYS . 60.9 mttm -51.97 -48.63 64.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.58 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.64 -40.28 95.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.061 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 22' ' ' ASP . 11.7 mt -67.86 -38.06 79.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' B' ' 34' ' ' ALA . 10.5 mt -63.71 -39.81 95.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.912 171.346 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.04 -32.86 72.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.234 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 12.9 t -66.12 -34.62 78.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.06 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.464 HG23 HG13 ' B' ' 32' ' ' ILE . 15.3 m -102.65 -5.69 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.706 0.289 . . . . 0.0 111.557 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.49 34.4 7.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.341 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 46.9 mt -103.41 129.72 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.969 0.385 . . . . 0.0 110.533 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.5 144.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.124 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -131.34 156.71 45.03 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.493 0.663 . . . . 0.0 111.746 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' B' ' 38' ' ' ARG . 14.7 t70 -111.62 178.9 4.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.614 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -103.12 -52.6 3.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.227 0.537 . . . . 0.0 110.278 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.98 -49.61 35.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.012 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.47 ' HB3' ' HB3' ' B' ' 35' ' ' ASP . 12.7 tpp180 -63.08 -38.31 90.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.497 ' CD2' ' HB1' ' B' ' 20' ' ' ALA . 3.1 tp -65.57 -56.16 13.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.25 -29.85 69.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 12.1 tmtt? -62.63 -52.14 64.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 38' ' ' ARG . 77.6 t -60.77 -43.04 94.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.564 0.697 . . . . 0.0 110.778 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.652 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.2 -41.31 83.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.382 175.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.679 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 46.0 mt-10 -58.42 -53.1 62.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.985 HD11 HG22 ' B' ' 4' ' ' VAL . 20.0 mt -57.35 -43.3 83.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.819 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.95 -29.22 65.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.71 -20.72 65.3 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.452 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' B' ' 54' ' ' VAL . 34.4 mttm -117.4 -97.96 0.46 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.66 0.743 . . . . 0.0 110.487 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.85 154.68 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.494 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.7 mp -57.64 -54.57 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.933 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -61.56 -38.16 86.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.734 0.302 . . . . 0.0 111.116 -172.897 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 53' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' B' ' 57' ' ' GLN . 15.7 t70 -64.69 -53.85 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.594 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.723 ' HB ' HD23 ' B' ' 46' ' ' LEU . 26.9 t -58.82 -37.1 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.538 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.611 HG21 HG21 ' A' ' 55' ' ' ILE . 2.2 mm -56.47 -60.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.346 0.593 . . . . 0.0 111.823 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.967 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.96 -15.19 63.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.5 -170.321 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 57' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 53' ' ' ASP . 85.9 mm-40 -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.66 -43.21 3.19 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.408 -171.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' B' ' 55' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 117.228 0.514 . . . . 0.0 110.867 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.017 0.436 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 49.6 m-85 -99.18 -11.13 21.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.972 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 46' ' ' LEU . 60.9 t -57.13 -39.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.662 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -55.72 -55.41 32.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.855 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -70.55 -36.22 73.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.616 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CD1' HD13 ' A' ' 46' ' ' LEU . 58.0 t80 -55.41 -49.62 71.9 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.936 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.782 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.7 mp -59.94 -55.96 27.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.558 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.845 HD12 HD12 ' B' ' 9' ' ' LEU . 15.1 mt -48.02 -49.99 29.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.175 0.297 . . . . 0.0 111.702 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.18 85.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.351 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 16' ' ' SER . . . -61.73 -38.53 88.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.349 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.6 mt -78.42 -25.9 46.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.721 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.74 10.7 50.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.574 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.07 -23.84 26.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.955 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.4 64.96 7.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.33 0.586 . . . . 0.0 109.575 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 15.7 m -64.48 -20.4 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.803 -175.433 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.89 78.21 4.0 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.0 Cg_exo -77.08 129.11 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.452 -167.679 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.5 t -72.09 142.24 49.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.69 -22.35 65.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 24.4 tptp -70.27 -41.01 73.99 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.157 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.1 t70 -63.37 -40.02 96.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 43' ' ' ILE . 47.6 mm -53.68 -49.76 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.327 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 75.5 mttt -55.2 -43.4 74.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 10.9 mmmm -58.07 -47.48 83.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.396 0.617 . . . . 0.0 111.698 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.7 mt -67.43 -39.31 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.732 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 34' ' ' ALA . 9.3 mt -62.87 -39.15 93.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.126 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -59.57 -39.46 84.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.251 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 t -59.91 -38.52 82.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.244 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 32' ' ' ILE . 16.8 m -96.4 -10.31 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.271 . . . . 0.0 111.682 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 32.2 6.74 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.514 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 29.6 mt -107.24 132.87 53.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.931 0.365 . . . . 0.0 110.104 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.24 151.38 23.2 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.67 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -128.85 128.5 43.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.179 0.514 . . . . 0.0 112.318 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -92.29 122.9 35.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.187 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.91 -54.58 14.81 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 30.6 t70 -66.33 -48.42 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.437 -171.917 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.8 tpp180 -64.88 -35.2 80.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.8 tp -63.73 -56.2 17.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.66 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -57.52 -32.57 67.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 4.2 tppt? -64.41 -54.59 30.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 38' ' ' ARG . 85.4 t -57.01 -43.92 81.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 110.635 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.02 -44.0 93.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.649 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 t -64.75 -35.28 80.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.814 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 42.1 mt-10 -59.12 -53.06 62.57 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.977 HD11 HG22 ' A' ' 4' ' ' VAL . 17.7 mt -64.99 -24.32 67.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.866 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.67 -33.41 58.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.991 0.424 . . . . 0.0 111.034 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.05 11.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.735 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.496 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 16.6 mtpp -115.28 176.06 5.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.46 141.66 55.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.718 HG13 HD22 ' A' ' 46' ' ' LEU . 1.6 mp -59.66 -45.84 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.277 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 1.014 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.07 -42.15 93.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 109.635 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.15 -53.59 47.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.542 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.638 ' HB ' HD23 ' A' ' 46' ' ' LEU . 42.2 t -59.88 -35.17 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.865 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.087 HD13 HD13 ' B' ' 55' ' ' ILE . 17.9 mt -65.41 -55.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.845 0.355 . . . . 0.0 111.887 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.009 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.63 -16.07 63.31 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.431 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -91.77 -28.83 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.712 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.47 -45.5 5.23 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.312 0.485 . . . . 0.0 114.312 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.84 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 117.565 0.683 . . . . 0.0 110.361 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttt85 . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.542 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 50.5 m-85 -99.01 -11.11 21.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.91 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 1.0 HG22 HD11 ' B' ' 46' ' ' LEU . 58.7 t -57.08 -39.56 67.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.369 . . . . 0.0 110.801 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.55 -55.72 28.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.655 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -70.43 -36.22 73.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.593 ' CD1' HD13 ' B' ' 46' ' ' LEU . 57.8 t80 -55.67 -49.11 73.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.952 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.787 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -60.5 -55.62 31.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.426 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.845 HD12 HD12 ' A' ' 9' ' ' LEU . 14.9 mt -48.37 -50.07 32.14 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.182 0.301 . . . . 0.0 111.641 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.14 83.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.498 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' B' ' 16' ' ' SER . . . -61.85 -38.64 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.26 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.787 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -78.44 -25.86 46.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.785 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.72 10.86 49.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.549 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.54 27.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.118 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.59 64.4 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' B' ' 11' ' ' ALA . 15.0 m -63.86 -20.27 65.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.971 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.99 78.06 4.06 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.4 Cg_exo -76.91 128.82 10.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.153 2.569 . . . . 0.0 113.631 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 31.4 t -71.49 141.79 50.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.48 -22.15 64.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.507 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 24.4 tptp -70.7 -40.73 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.105 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.672 ' O ' HG13 ' B' ' 26' ' ' ILE . 29.4 t70 -63.53 -39.98 95.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.636 HG13 HD11 ' B' ' 43' ' ' ILE . 47.0 mm -53.61 -49.91 53.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.348 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 75.5 mttt -55.19 -43.29 74.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.654 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -58.09 -47.78 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.728 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.672 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.7 mt -67.35 -39.18 82.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.697 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' B' ' 34' ' ' ALA . 9.4 mt -62.89 -38.96 92.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.043 172.72 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.03 -39.42 85.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 34.9 t -59.6 -38.54 81.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.257 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.571 HG23 HG13 ' B' ' 32' ' ' ILE . 16.6 m -96.54 -10.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 111.639 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 32.76 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.388 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 29.8 mt -107.63 132.63 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.974 0.387 . . . . 0.0 110.094 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -86.62 152.27 22.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -130.22 127.94 40.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 0.0 112.305 -174.46 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.08 122.64 34.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.258 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -48.85 -54.35 15.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' B' ' 41' ' ' LYS . 32.0 t70 -66.48 -48.09 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.638 -171.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.488 ' O ' HG23 ' B' ' 42' ' ' VAL . 21.7 tpp180 -65.18 -34.76 79.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.516 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.542 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.6 tp -63.96 -56.24 16.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.659 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -57.42 -32.67 67.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 4.4 tppt? -64.44 -54.49 31.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.801 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 38' ' ' ARG . 84.6 t -57.12 -43.68 81.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.527 0.679 . . . . 0.0 110.612 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.636 HD11 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.29 -43.98 94.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.717 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -64.06 -36.06 82.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.779 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 43.0 mt-10 -58.73 -53.03 62.98 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 1.0 HD11 HG22 ' B' ' 4' ' ' VAL . 17.4 mt -65.01 -24.52 67.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.936 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -76.85 -33.08 57.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 -29.12 11.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.718 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.501 ' HB2' ' CG2' ' B' ' 54' ' ' VAL . 16.8 mtpp -115.31 176.19 5.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.582 0.229 . . . . 0.0 110.403 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.59 141.81 55.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.717 HG13 HD22 ' B' ' 46' ' ' LEU . 1.6 mp -59.8 -45.65 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.273 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 1.009 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.34 -42.02 94.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.325 0.584 . . . . 0.0 109.59 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.93 -53.78 45.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.637 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.64 ' HB ' HD23 ' B' ' 46' ' ' LEU . 42.2 t -59.88 -35.23 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 1.087 HD13 HD13 ' A' ' 55' ' ' ILE . 18.8 mt -65.23 -55.9 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 1.014 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.82 -15.57 63.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.105 0.479 . . . . 0.0 111.48 -173.175 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -92.04 -28.21 17.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.2 -45.43 5.04 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.842 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.464 0.267 0 CA-C-N 117.444 0.622 . . . . 0.0 110.263 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.6 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 19.0 tpp180 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 43.7 m-85 -105.62 -7.23 18.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.959 HG22 HD11 ' A' ' 46' ' ' LEU . 97.8 t -69.34 -31.7 50.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.104 0.478 . . . . 0.0 109.999 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.647 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -58.55 -55.08 39.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.346 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' SER . . . . . 0.46 ' HA ' HD11 ' B' ' 9' ' ' LEU . 1.4 p -71.44 -36.32 71.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.56 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.606 ' CD1' HD13 ' A' ' 46' ' ' LEU . 70.3 t80 -55.14 -49.07 72.71 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.823 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.7 mp -59.18 -57.43 13.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 1.019 HD12 HD12 ' B' ' 9' ' ' LEU . 13.5 mt -48.79 -48.97 40.83 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.81 82.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.32 95.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.293 0.568 . . . . 0.0 110.808 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.2 mt -75.15 -15.63 60.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.3 1.24 81.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.189 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.23 -28.75 7.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.013 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -94.85 85.27 4.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.607 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 8.8 m -61.49 -25.85 67.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.57 81.68 3.35 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 16' ' ' SER . 9.1 Cg_exo -73.11 153.39 51.83 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.787 2.992 . . . . 0.0 113.041 -170.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 23' ' ' ILE . 2.4 p -104.84 147.46 27.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.783 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.26 -26.71 68.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.959 -168.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.43 -41.21 76.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 110.169 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.692 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.3 t70 -62.74 -42.31 99.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.673 HG13 HD11 ' A' ' 43' ' ' ILE . 41.8 mm -51.67 -51.2 28.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.562 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 89.9 mttt -56.39 -42.35 77.76 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.446 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.776 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.98 -43.74 98.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.311 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.5 mt -67.97 -39.78 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 34' ' ' ALA . 15.6 mt -60.41 -43.24 96.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.75 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 22.0 t70 -63.29 -28.69 70.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -70.0 -24.86 63.36 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.24 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.51 HG23 HG13 ' A' ' 32' ' ' ILE . 14.2 m -112.87 -3.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.29 34.89 7.26 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.587 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 52.4 mt -105.41 138.6 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.037 0.419 . . . . 0.0 111.124 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.36 144.16 26.9 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.229 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -131.22 132.5 44.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.919 0.39 . . . . 0.0 111.978 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.8 m-20 -98.02 124.51 42.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -46.73 -58.66 3.65 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.03 -49.71 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 35' ' ' ASP . 20.6 tpp180 -61.28 -39.27 89.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.138 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' CD1' HG21 ' A' ' 23' ' ' ILE . 3.7 tp -63.8 -56.16 17.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.016 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -60.3 -28.98 68.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -67.01 -49.85 63.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 71.9 t -61.54 -41.9 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.843 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.673 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.49 -40.21 85.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.844 0.83 . . . . 0.0 110.651 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -71.05 -35.84 72.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.365 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 13.5 pt-20 -69.55 -37.26 76.97 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.959 HD11 HG22 ' A' ' 4' ' ' VAL . 35.9 mt -62.54 -41.53 98.94 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.272 173.136 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.01 -30.92 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.2 -38.46 25.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.389 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HB2' HG23 ' A' ' 54' ' ' VAL . 73.3 mmtt -103.42 -156.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.072 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -100.63 159.95 14.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.5 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.3 mp -60.26 -50.76 79.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.82 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -57.55 -40.69 79.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.903 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.5 -55.51 26.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.844 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.65 ' HB ' HD23 ' A' ' 46' ' ' LEU . 24.6 t -58.79 -35.34 55.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.654 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.581 HG21 HG21 ' B' ' 55' ' ' ILE . 2.5 mm -59.16 -61.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.412 0.625 . . . . 0.0 111.782 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.819 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.41 -15.61 62.86 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.113 -169.929 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.51 -44.48 10.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.968 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -48.01 7.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.82 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD13 HG23 ' A' ' 55' ' ' ILE . 2.1 mp . . . . . 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.496 . . . . 0.0 110.039 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.603 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 19.2 tpp180 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 43.9 m-85 -105.34 -7.39 18.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.972 HG22 HD11 ' B' ' 46' ' ' LEU . 99.3 t -69.46 -31.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -58.84 -54.97 41.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.39 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 6' ' ' SER . . . . . 0.464 ' HA ' HD11 ' A' ' 9' ' ' LEU . 1.3 p -71.39 -36.34 71.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.506 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.597 ' CD1' HD13 ' B' ' 46' ' ' LEU . 70.8 t80 -55.28 -49.12 72.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.801 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.7 mp -58.97 -57.54 12.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.588 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 1.019 HD12 HD12 ' A' ' 9' ' ' LEU . 13.4 mt -48.87 -48.99 41.62 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.74 81.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.29 95.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -75.37 -15.62 60.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.541 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.74 0.71 81.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.319 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.66 -29.04 6.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.13 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -94.56 85.22 4.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.589 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 12.5 m -61.66 -25.59 67.48 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.52 81.41 3.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' B' ' 16' ' ' SER . 9.4 Cg_exo -73.28 153.3 50.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.674 2.916 . . . . 0.0 113.11 -170.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.425 ' O ' HG12 ' B' ' 23' ' ' ILE . 2.7 p -104.33 147.33 27.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.964 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.93 -27.29 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.951 -169.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -68.69 -40.98 79.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.057 0.456 . . . . 0.0 110.463 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.692 ' O ' HG13 ' B' ' 26' ' ' ILE . 5.4 t70 -63.34 -42.37 98.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.682 HG13 HD11 ' B' ' 43' ' ' ILE . 41.5 mm -51.5 -51.17 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.605 174.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 89.8 mttt -56.35 -42.13 77.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.696 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.784 ' HE3' ' HA ' ' B' ' 25' ' ' LYS . 0.1 OUTLIER -62.1 -44.02 97.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.692 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.5 mt -67.79 -40.14 83.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.041 0.448 . . . . 0.0 110.491 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.689 HD13 ' HB2' ' B' ' 34' ' ' ALA . 15.4 mt -60.05 -43.17 95.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.889 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.425 ' HB3' ' HE3' ' B' ' 25' ' ' LYS . 22.6 t70 -63.32 -28.29 69.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.053 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -70.7 -24.33 62.63 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.509 HG23 HG13 ' B' ' 32' ' ' ILE . 14.0 m -113.23 -3.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.295 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.56 6.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.469 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 51.8 mt -105.89 138.64 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.42 143.86 27.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.275 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.689 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -130.98 132.62 45.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.938 0.399 . . . . 0.0 111.894 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' B' ' 38' ' ' ARG . 7.7 m-20 -98.37 124.46 43.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.42 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -46.24 -59.2 3.05 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.65 -49.74 73.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.291 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.444 ' O ' HG23 ' B' ' 42' ' ' VAL . 20.7 tpp180 -61.37 -39.11 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.48 ' CD1' HG21 ' B' ' 23' ' ' ILE . 3.7 tp -63.83 -56.25 16.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -60.12 -28.81 68.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -67.27 -49.88 62.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.551 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 72.9 t -61.4 -42.01 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.828 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.682 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.53 -40.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.816 0.817 . . . . 0.0 110.585 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -70.49 -35.91 73.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.485 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' B' ' 42' ' ' VAL . 13.3 pt-20 -69.57 -37.39 76.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.972 HD11 HG22 ' B' ' 4' ' ' VAL . 36.1 mt -62.21 -41.66 98.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.359 172.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.87 -31.19 70.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.75 -38.95 26.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.306 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.525 ' HB2' HG23 ' B' ' 54' ' ' VAL . 73.4 mmtt -103.46 -156.12 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.163 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.96 159.38 15.26 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.502 ' HA ' HD22 ' B' ' 46' ' ' LEU . 1.3 mp -59.88 -50.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.819 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -57.72 -40.6 79.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.927 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.64 -55.59 25.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.902 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.663 ' HB ' HD23 ' B' ' 46' ' ' LEU . 24.8 t -58.63 -35.23 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.665 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.581 HG21 HG21 ' A' ' 55' ' ' ILE . 2.5 mm -59.36 -61.81 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.514 0.673 . . . . 0.0 111.675 173.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.82 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.36 -15.63 62.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.224 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -88.49 -44.44 10.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.72 -48.49 7.14 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.807 -171.955 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.539 HD13 HG23 ' B' ' 55' ' ' ILE . 2.0 mp . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.99 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' B' ' 12' ' ' LEU . 4.7 mtp85 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.549 ' HD1' HD11 ' A' ' 27' ' ' LEU . 27.8 m-85 -102.04 -10.89 19.32 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.916 HG22 HD11 ' A' ' 46' ' ' LEU . 99.1 t -70.05 -33.42 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.992 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -55.86 -54.57 42.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.47 0.652 . . . . 0.0 111.417 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -36.64 70.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.869 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' HD13 ' A' ' 46' ' ' LEU . 63.2 t80 -55.48 -48.76 74.05 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.758 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.6 mp -57.09 -58.96 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.516 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.97 HD12 HD12 ' B' ' 9' ' ' LEU . 15.5 mt -48.67 -50.24 34.01 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -59.45 -37.9 79.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.799 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.37 -39.67 94.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -78.57 -26.51 45.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.857 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.67 -19.27 64.83 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.723 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.57 -18.03 4.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 52.9 t30 -99.55 88.65 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.562 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 14.1 m -65.35 -17.86 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.726 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 t -112.39 78.52 2.62 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 16' ' ' SER . 15.9 Cg_exo -68.29 125.24 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.093 2.529 . . . . 0.0 112.975 -169.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.566 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 34.6 t -76.59 140.39 41.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.274 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.07 -21.09 63.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.194 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.631 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.2 mmmm -68.08 -45.26 74.26 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.732 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.1 m-20 -57.34 -46.53 83.19 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 43' ' ' ILE . 40.3 mm -50.73 -52.98 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.711 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 34.2 mttm -52.42 -45.88 66.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.817 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 16.1 tppt? -67.02 -42.68 84.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.335 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.2 mt -65.84 -38.37 82.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.118 0.485 . . . . 0.0 110.05 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 34' ' ' ALA . 14.1 mt -62.9 -38.76 92.25 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.967 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 19.9 t70 -63.73 -30.86 71.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -64.75 -39.39 93.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.893 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.507 HG23 HG13 ' A' ' 32' ' ' ILE . 15.6 m -102.2 -4.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.661 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.84 44.55 6.02 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.422 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 62.9 mt -108.81 136.75 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.92 139.77 41.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.82 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.642 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -127.91 132.78 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.359 0.6 . . . . 0.0 111.744 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.92 114.92 29.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.996 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -48.82 -50.0 36.49 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.5 0.5 . . . . 0.0 112.25 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 20.7 t70 -62.31 -58.23 8.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.621 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.6 tpp180 -61.97 -29.8 70.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.7 tp -60.87 -56.5 20.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -58.51 -34.01 70.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 34.0 mmtp -63.42 -51.11 67.12 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.286 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 74.8 t -59.78 -42.65 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.697 0.76 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.581 HD11 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.52 -40.15 83.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.308 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -68.51 -34.25 75.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.792 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 42' ' ' VAL . 44.4 mt-10 -58.38 -51.07 71.38 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.916 HD11 HG22 ' A' ' 4' ' ' VAL . 43.4 mt -64.36 -23.57 67.34 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.565 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.86 -25.92 56.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.011 0.434 . . . . 0.0 110.883 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.81 -41.83 18.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.537 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 54' ' ' VAL . 7.7 mtpt -116.6 -156.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.402 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 56.5 m-80 -94.64 173.57 7.54 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.444 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 1.3 mp -64.91 -52.13 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.438 -174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.6 -39.35 80.16 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 111.024 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.27 -57.47 12.76 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.985 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.709 ' HB ' HD23 ' A' ' 46' ' ' LEU . 42.6 t -63.47 -31.81 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.96 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.541 HG23 HD13 ' A' ' 59' ' ' ILE . 2.7 mm -58.7 -60.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.48 0.657 . . . . 0.0 111.211 170.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.878 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.72 -17.68 62.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.455 -169.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -94.23 -26.2 16.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.85 -50.59 3.05 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.808 -173.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.541 HD13 HG23 ' A' ' 55' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 117.395 0.598 . . . . 0.0 109.822 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.575 ' HA ' HD13 ' A' ' 12' ' ' LEU . 4.8 mtp85 . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.538 ' HD1' HD11 ' B' ' 27' ' ' LEU . 27.7 m-85 -102.01 -11.06 19.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.919 HG22 HD11 ' B' ' 46' ' ' LEU . 99.5 t -70.06 -33.39 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.033 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.9 -54.56 43.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.468 0.652 . . . . 0.0 111.479 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -36.61 69.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.868 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.67 ' CD2' HD13 ' B' ' 46' ' ' LEU . 63.0 t80 -55.42 -48.77 73.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.881 175.253 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.76 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.7 mp -57.12 -59.05 5.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.48 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.97 HD12 HD12 ' A' ' 9' ' ' LEU . 15.5 mt -48.33 -50.65 29.5 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' B' ' 18' ' ' PRO . . . -59.26 -37.9 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.893 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.28 -39.97 95.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.3 mt -78.04 -27.06 48.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.855 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.09 -19.69 64.01 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.74 -17.98 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 53.1 t30 -99.55 88.84 3.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 14.4 m -65.32 -17.95 64.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.563 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.7 t -112.67 78.57 2.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' B' ' 16' ' ' SER . 16.2 Cg_exo -68.09 125.66 13.35 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.142 2.561 . . . . 0.0 112.861 -169.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.551 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 33.3 t -76.83 140.84 40.78 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.319 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.96 -20.5 63.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.624 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.3 mmmm -68.22 -45.43 73.32 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.102 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.736 ' O ' HG13 ' B' ' 26' ' ' ILE . 13.3 m-20 -57.13 -46.76 82.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.572 HG13 HD11 ' B' ' 43' ' ' ILE . 40.4 mm -50.56 -53.14 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.677 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.624 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 33.9 mttm -52.24 -45.85 65.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.03 -42.56 84.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.736 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.3 mt -66.07 -38.28 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 109.947 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' B' ' 34' ' ' ALA . 14.1 mt -62.92 -38.98 93.18 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.967 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -31.28 72.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.35 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.8 t -64.29 -39.5 94.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.916 0.388 . . . . 0.0 110.812 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.504 HG23 HG13 ' B' ' 32' ' ' ILE . 15.7 m -102.1 -4.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.579 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.17 44.21 6.03 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.379 173.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 63.3 mt -108.57 136.75 43.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.909 0.355 . . . . 0.0 111.047 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.81 139.33 41.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.067 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.625 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -127.14 133.3 50.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -104.67 114.64 28.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.023 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -48.4 -50.33 31.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.676 0.61 . . . . 0.0 112.168 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.64 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 20.6 t70 -62.19 -58.28 8.36 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.569 0.543 . . . . 0.0 110.546 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.515 ' O ' HG23 ' B' ' 42' ' ' VAL . 20.6 tpp180 -62.13 -29.58 70.44 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.055 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.8 tp -60.83 -56.71 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.29 -33.73 69.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 34.0 mmtp -63.7 -51.12 66.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.29 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.515 HG23 ' O ' ' B' ' 38' ' ' ARG . 73.0 t -59.83 -42.43 89.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.73 0.776 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.572 HD11 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.64 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.3 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.2 t -68.78 -33.87 74.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.945 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' B' ' 42' ' ' VAL . 44.4 mt-10 -58.54 -51.06 71.5 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.919 HD11 HG22 ' B' ' 4' ' ' VAL . 43.5 mt -64.54 -23.83 67.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.63 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.8 -25.79 56.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.965 0.412 . . . . 0.0 110.741 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.71 -42.52 17.01 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.39 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.592 ' HB2' HG23 ' B' ' 54' ' ' VAL . 7.8 mtpt -115.67 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -94.35 174.07 7.32 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.53 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.3 mp -65.3 -52.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.228 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.878 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.18 -57.2 13.9 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.137 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.7 ' HB ' HD23 ' B' ' 46' ' ' LEU . 42.6 t -63.9 -31.6 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.975 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.541 HG23 HD13 ' B' ' 59' ' ' ILE . 2.7 mm -58.82 -60.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.495 0.664 . . . . 0.0 111.201 170.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.875 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.53 -18.08 62.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.388 -169.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -94.03 -25.92 17.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 173.552 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -50.71 3.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.864 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.541 HD13 HG23 ' B' ' 55' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 117.281 0.541 . . . . 0.0 109.664 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.613 ' HA ' HD13 ' B' ' 12' ' ' LEU . 35.0 ttm180 . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CZ ' ' HD2' ' A' ' 2' ' ' ARG . 28.1 m-85 -86.8 -24.45 25.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.115 -171.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.952 HG22 HD11 ' A' ' 46' ' ' LEU . 75.8 t -58.96 -36.25 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 0.0 110.557 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.643 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.89 -55.17 38.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.358 0.599 . . . . 0.0 111.744 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -72.3 -37.39 68.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.671 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CD1' HD13 ' A' ' 46' ' ' LEU . 54.7 t80 -54.12 -48.7 70.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.679 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.796 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.4 mp -58.59 -58.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.372 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.977 HD12 HD12 ' B' ' 9' ' ' LEU . 14.1 mt -48.59 -48.83 38.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' ' CD1' ' A' ' 26' ' ' ILE . . . -60.53 -37.41 81.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.31 -39.35 92.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.749 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -80.43 -17.52 51.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.13 -14.56 78.92 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.973 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.9 -27.14 3.51 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.252 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 44.9 t30 -93.42 98.02 10.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 0.0 110.693 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 18' ' ' PRO . 15.2 m -74.6 -3.64 32.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.51 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -123.3 71.65 46.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 16' ' ' SER . 14.9 Cg_exo -69.2 126.36 13.58 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.322 2.681 . . . . 0.0 112.542 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.579 ' O ' HG12 ' A' ' 23' ' ' ILE . 62.5 p -78.05 147.87 34.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.03 -26.78 69.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.37 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.94 -39.37 69.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.999 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 26' ' ' ILE . 15.6 t70 -62.03 -44.67 96.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.588 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 43' ' ' ILE . 41.1 mm -50.63 -50.46 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.517 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 94.0 mttt -55.88 -43.61 77.35 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.091 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 4.3 mmmp? -65.53 -38.99 91.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 22' ' ' ASP . 11.2 mt -68.16 -39.38 81.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.071 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.4 mt -61.91 -39.98 93.89 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 171.229 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 4.7 t70 -59.41 -35.44 73.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.722 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 t -64.8 -35.3 80.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.655 0.264 . . . . 0.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 32' ' ' ILE . 16.8 m -102.33 -8.78 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.17 44.13 4.18 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.374 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.9 mt -116.34 135.18 57.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.868 0.334 . . . . 0.0 110.214 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.89 155.5 21.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.628 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -134.77 130.97 36.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.256 0.551 . . . . 0.0 112.07 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -94.63 116.25 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.208 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -42.32 -64.12 0.65 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.45 -45.62 93.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.61 -173.479 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 42' ' ' VAL . 16.6 tpp180 -64.09 -36.83 85.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.026 0.441 . . . . 0.0 110.649 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.45 HD12 HG13 ' A' ' 43' ' ' ILE . 5.8 tp -65.04 -56.77 11.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.23 -32.85 68.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -60.85 -57.59 12.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.542 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 38' ' ' ARG . 93.2 t -56.03 -44.58 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.778 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.711 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.78 -47.61 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.399 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.1 p -69.0 -28.21 66.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.123 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.39 -37.16 60.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.322 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.952 HD11 HG22 ' A' ' 4' ' ' VAL . 43.1 mt -63.17 -33.93 76.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.068 0.461 . . . . 0.0 110.614 172.73 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.06 -42.51 63.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -37.3 67.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.254 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -103.47 -151.48 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.408 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 22.1 m120 -114.46 141.36 47.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.507 HG13 HD22 ' A' ' 46' ' ' LEU . 1.7 mp -46.9 -56.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.395 0.435 . . . . 0.0 111.368 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.761 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 27.8 mt-10 -55.07 -36.24 65.39 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.485 0.491 . . . . 0.0 111.864 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.41 -52.46 18.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.637 ' HB ' HD23 ' A' ' 46' ' ' LEU . 54.0 t -62.27 -29.32 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.435 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' B' ' 55' ' ' ILE . 2.1 mm -60.43 -61.13 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.097 0.475 . . . . 0.0 111.459 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -72.36 -9.54 58.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.432 -170.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -104.82 -19.89 13.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.757 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.09 -35.08 4.33 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.442 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 HG23 ' A' ' 55' ' ' ILE . 1.8 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 117.916 0.858 . . . . 0.0 109.088 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.637 ' HA ' HD13 ' A' ' 12' ' ' LEU . 34.8 ttm180 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.99 0.424 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.528 ' CZ ' ' HD2' ' B' ' 2' ' ' ARG . 28.4 m-85 -86.92 -24.42 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.178 -171.294 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.926 HG22 HD11 ' B' ' 46' ' ' LEU . 75.3 t -58.98 -36.07 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -58.0 -55.36 35.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.655 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -72.24 -37.3 69.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.502 ' CD1' HD13 ' B' ' 46' ' ' LEU . 54.9 t80 -54.3 -48.6 71.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.729 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.79 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.3 mp -58.74 -58.34 9.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.372 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 9' ' ' LEU . 14.2 mt -48.36 -48.7 36.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' CD1' ' B' ' 26' ' ' ILE . . . -60.9 -37.75 83.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.78 -39.34 93.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 0.0 110.777 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.0 mt -80.44 -17.49 51.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.619 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.09 -14.6 78.84 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.998 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.1 -27.53 3.43 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.126 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 45.2 t30 -92.95 98.44 11.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.417 ' C ' ' HD3' ' B' ' 18' ' ' PRO . 17.0 m -75.18 -3.17 31.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.515 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.9 t -123.51 71.69 48.29 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' B' ' 16' ' ' SER . 15.0 Cg_exo -69.44 126.01 13.01 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.237 2.625 . . . . 0.0 112.746 -171.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.583 ' O ' HG12 ' B' ' 23' ' ' ILE . 64.6 p -77.8 147.98 34.99 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.671 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -63.15 -27.01 69.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.275 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.88 -39.26 69.74 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.352 0.596 . . . . 0.0 110.002 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.674 ' O ' HG13 ' B' ' 26' ' ' ILE . 15.7 t70 -62.02 -44.86 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.699 HG13 HD11 ' B' ' 43' ' ' ILE . 41.2 mm -50.53 -50.38 22.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.591 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 93.9 mttt -55.98 -43.71 77.87 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' B' ' 28' ' ' ASP . 4.3 mmmp? -65.16 -39.27 92.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.674 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.1 -39.19 80.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 0.0 110.136 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.4 mt -62.09 -39.92 94.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.679 171.05 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' B' ' 25' ' ' LYS . 5.6 t70 -59.59 -35.24 73.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.928 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 10.0 t -64.76 -35.48 81.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.872 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.475 HG23 HG13 ' B' ' 32' ' ' ILE . 17.1 m -102.28 -8.62 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.277 . . . . 0.0 111.622 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.7 44.75 4.15 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.281 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 37.9 mt -116.98 135.49 57.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.82 0.31 . . . . 0.0 110.295 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.96 155.97 21.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.641 0.258 . . . . 0.0 110.576 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -135.43 130.51 34.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.313 0.578 . . . . 0.0 111.985 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.23 116.37 28.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.326 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -42.53 -64.04 0.67 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.2 -45.93 91.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.809 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.48 ' O ' HG23 ' B' ' 42' ' ' VAL . 16.4 tpp180 -64.11 -36.5 84.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 110.598 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.449 ' O ' HG13 ' B' ' 43' ' ' ILE . 5.7 tp -65.27 -56.72 11.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.86 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -58.41 -32.78 68.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -60.78 -57.73 11.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 38' ' ' ARG . 94.3 t -56.03 -44.59 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.129 0.49 . . . . 0.0 110.888 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.699 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.69 -47.6 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.444 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -68.86 -28.15 66.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.156 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.57 -37.1 60.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.33 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.926 HD11 HG22 ' B' ' 4' ' ' VAL . 43.7 mt -63.14 -34.1 76.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 110.635 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -72.96 -42.07 63.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.379 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.02 -37.29 64.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.128 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -103.67 -151.49 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -114.23 141.69 47.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.507 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.7 mp -47.06 -56.73 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.274 0.359 . . . . 0.0 111.338 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.758 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 27.8 mt-10 -55.16 -35.92 65.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.16 0.505 . . . . 0.0 111.989 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.51 -52.5 17.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.13 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' B' ' 46' ' ' LEU . 55.0 t -62.38 -29.22 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.529 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 55' ' ' ILE . 2.1 mm -60.45 -61.19 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.086 0.47 . . . . 0.0 111.53 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.761 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -72.26 -9.92 59.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.529 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -104.33 -20.35 13.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.652 170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.73 -35.65 4.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.285 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' HG2' ' A' ' 52' ' ' GLU . 1.8 mp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 117.91 0.855 . . . . 0.0 109.023 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 . . . . . 0 C--O 1.226 -0.148 0 CA-C-O 121.019 0.437 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 19.5 m-85 -90.99 -20.69 21.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -168.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.893 HG22 HD11 ' A' ' 46' ' ' LEU . 97.3 t -63.28 -33.78 63.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.043 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.57 -54.85 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.519 0.676 . . . . 0.0 111.075 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.37 -35.16 73.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.856 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.64 ' CD2' HD13 ' A' ' 46' ' ' LEU . 55.2 t80 -56.6 -47.51 79.44 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.762 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.4 mp -60.1 -57.64 11.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.514 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.926 HD12 HD12 ' B' ' 9' ' ' LEU . 14.3 mt -46.4 -49.83 17.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 26' ' ' ILE . . . -60.14 -38.83 84.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.15 -37.34 87.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.038 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.0 mt -81.46 -24.18 36.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.673 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.77 -21.27 74.9 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.9 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.63 -15.37 3.14 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.269 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 60.4 t30 -108.41 86.62 2.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 16.3 m -61.81 -27.75 68.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.736 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -108.63 82.62 1.76 Allowed Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.7 Cg_exo -78.73 147.8 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.348 2.699 . . . . 0.0 112.489 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.493 ' O ' HG12 ' A' ' 23' ' ' ILE . 89.7 p -94.14 156.96 16.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.582 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.45 -25.58 67.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.463 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -45.09 83.55 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.027 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.734 ' O ' HG13 ' A' ' 26' ' ' ILE . 55.5 m-20 -55.22 -50.9 68.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 43' ' ' ILE . 37.2 mm -50.39 -51.1 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.957 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 88.3 mttt -52.89 -49.65 65.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 123.754 0.659 . . . . 0.0 110.943 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -66.68 -35.99 81.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.397 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.6 mt -68.62 -38.25 78.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 0.0 110.02 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 13.3 mt -62.11 -41.15 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.067 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.22 -38.6 73.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.218 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -60.37 -35.78 76.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.743 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.552 HG23 HG13 ' A' ' 32' ' ' ILE . 14.6 m -103.33 -9.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.98 39.02 4.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.11 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 17.5 mt -117.69 149.42 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.56 167.76 9.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -139.57 133.54 30.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.354 0.597 . . . . 0.0 112.02 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -97.84 113.97 25.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -42.53 -58.61 2.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 12.6 m-20 -60.98 -54.71 41.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.477 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' VAL . 23.2 tpp180 -55.31 -43.33 74.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.145 0.498 . . . . 0.0 110.808 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 6.1 tp -58.44 -54.83 42.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.27 -34.23 70.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 73.5 mmtt -65.19 -53.09 50.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.086 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 38' ' ' ARG . 89.2 t -57.04 -44.18 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.407 0.623 . . . . 0.0 110.578 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.718 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -59.16 -45.99 92.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.292 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.0 t -65.57 -33.22 75.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.104 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 46.6 mt-10 -67.52 -44.25 78.85 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.893 HD11 HG22 ' A' ' 4' ' ' VAL . 45.6 mt -62.14 -41.72 98.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.377 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.26 -22.93 64.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.065 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 4.39 56.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.672 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.532 ' HD2' HG22 ' A' ' 54' ' ' VAL . 66.4 mttm -142.21 -163.62 1.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.27 144.99 25.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.371 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.55 HG13 HD22 ' A' ' 46' ' ' LEU . 1.2 mp -54.52 -50.04 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.334 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.795 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.38 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.426 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -65.75 -53.47 40.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.859 0.362 . . . . 0.0 110.284 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.69 ' HB ' HD23 ' A' ' 46' ' ' LEU . 70.7 t -62.01 -29.65 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.376 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.671 HD12 HD12 ' B' ' 55' ' ' ILE . 2.5 mm -61.6 -61.09 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.279 0.561 . . . . 0.0 111.564 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -71.04 -13.87 62.13 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.466 -170.476 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -97.65 -27.97 14.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.135 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.86 -33.16 7.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.943 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.484 HD13 HG23 ' A' ' 55' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 117.311 0.556 . . . . 0.0 109.559 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.414 ' HA ' HD13 ' A' ' 12' ' ' LEU . 79.5 mtp180 . . . . . 0 C--O 1.227 -0.116 0 CA-C-O 121.057 0.456 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 19.2 m-85 -90.96 -20.81 21.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.918 HG22 HD11 ' B' ' 46' ' ' LEU . 98.5 t -63.27 -33.64 62.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.119 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.71 -54.78 42.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.818 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.633 ' CD2' HD13 ' B' ' 46' ' ' LEU . 56.7 t80 -56.29 -47.75 78.01 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.759 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.4 mp -60.03 -57.48 12.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.557 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.926 HD12 HD12 ' A' ' 9' ' ' LEU . 14.4 mt -46.66 -50.01 18.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.286 0.366 . . . . 0.0 111.976 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' B' ' 26' ' ' ILE . . . -59.89 -38.93 83.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.891 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.32 -36.68 84.91 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.759 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.0 mt -81.71 -24.29 36.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.97 -21.04 75.16 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.861 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.84 -15.94 3.07 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.28 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 60.7 t30 -107.88 86.78 2.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.608 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 15.4 m -61.85 -27.98 69.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.656 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -108.32 82.32 1.56 Allowed Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.8 Cg_exo -78.37 147.82 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.37 2.713 . . . . 0.0 112.428 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.502 ' O ' HG12 ' B' ' 23' ' ' ILE . 94.3 p -93.77 157.47 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.585 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.82 -25.72 67.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.456 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.0 83.96 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.086 0.469 . . . . 0.0 110.147 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.722 ' O ' HG13 ' B' ' 26' ' ' ILE . 55.6 m-20 -55.14 -51.0 67.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.705 HG13 HD11 ' B' ' 43' ' ' ILE . 37.1 mm -50.43 -50.87 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.02 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 87.6 mttt -52.9 -49.55 65.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.869 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -66.86 -36.1 81.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.007 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.722 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.8 mt -68.65 -38.3 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 110.03 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 13.7 mt -62.03 -41.07 97.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.009 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -57.52 -38.36 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.22 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -60.39 -35.93 76.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.583 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.552 HG23 HG13 ' B' ' 32' ' ' ILE . 14.0 m -103.3 -9.14 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.75 39.56 4.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.075 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 17.9 mt -118.03 149.45 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -101.46 168.14 9.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -139.47 133.67 31.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.312 0.577 . . . . 0.0 112.14 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -97.97 113.76 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.69 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -42.27 -58.22 2.25 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 12.8 m-20 -61.5 -54.49 42.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.453 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 42' ' ' VAL . 23.2 tpp180 -55.33 -43.24 74.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.019 0.437 . . . . 0.0 110.822 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 6.3 tp -58.45 -54.94 41.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.099 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.07 -34.1 69.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.477 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 73.4 mmtt -65.32 -53.17 47.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.099 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 38' ' ' ARG . 86.2 t -56.83 -44.2 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 110.596 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.705 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.22 -46.07 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.236 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -65.37 -33.42 75.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.07 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 45.2 mt-10 -67.49 -44.45 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.918 HD11 HG22 ' B' ' 4' ' ' VAL . 44.9 mt -61.99 -41.67 98.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.397 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -68.34 -22.6 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.142 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.53 5.28 54.6 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' B' ' 54' ' ' VAL . 66.4 mttm -142.55 -163.12 1.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.89 145.05 25.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.541 HG13 HD22 ' B' ' 46' ' ' LEU . 1.2 mp -54.37 -50.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.364 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.784 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.49 69.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.509 -175.528 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -65.57 -53.69 38.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.874 0.368 . . . . 0.0 110.131 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' B' ' 46' ' ' LEU . 71.6 t -62.05 -29.6 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.495 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.671 HD12 HD12 ' A' ' 55' ' ' ILE . 2.5 mm -61.56 -61.16 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.37 0.605 . . . . 0.0 111.587 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.795 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.94 -13.92 62.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.632 -170.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -97.59 -28.38 13.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.053 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.28 -33.29 8.18 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.751 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.48 HD13 HG23 ' B' ' 55' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 117.506 0.653 . . . . 0.0 109.345 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.522 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 26.8 m-85 -111.01 -9.01 14.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.988 HG22 HD11 ' A' ' 46' ' ' LEU . 54.0 t -62.89 -36.5 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.162 0.506 . . . . 0.0 110.359 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.63 -54.98 40.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.69 -36.51 73.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 46' ' ' LEU . 68.6 t80 -55.49 -49.54 72.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.986 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.795 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.2 mp -59.84 -55.9 28.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.452 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.826 HD12 HD12 ' B' ' 9' ' ' LEU . 15.5 mt -48.54 -50.45 32.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.04 81.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.73 -38.37 90.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.081 0.467 . . . . 0.0 111.014 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.8 mt -79.93 -30.27 39.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.998 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.64 -23.94 73.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.437 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.67 -27.07 1.64 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.867 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 18' ' ' PRO . 2.4 t-20 -89.54 73.49 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.55 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m -60.47 -20.34 59.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.486 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.8 p -112.5 75.34 1.75 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.587 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 20.3 Cg_exo -66.17 139.68 56.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.168 2.579 . . . . 0.0 113.553 -166.38 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 23' ' ' ILE . 10.7 p -96.54 142.17 28.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.224 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.46 -24.47 67.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.21 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LYS . . . . . 0.614 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.4 mmmm -64.52 -46.18 84.02 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.392 0.615 . . . . 0.0 110.134 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.73 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.1 t70 -59.06 -46.25 88.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.76 HG13 HD11 ' A' ' 43' ' ' ILE . 43.9 mm -50.95 -51.55 20.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.049 176.237 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.614 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 43.6 mttm -52.98 -44.27 67.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.808 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 4.4 mmmp? -70.03 -35.28 74.2 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 22' ' ' ASP . 8.9 mt -69.93 -40.91 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.065 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 34' ' ' ALA . 12.8 mt -61.86 -38.05 86.82 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 11.8 t70 -61.81 -34.91 76.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.731 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.66 -36.12 81.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.584 HG23 HG13 ' A' ' 32' ' ' ILE . 16.2 m -98.94 -10.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.07 0.462 . . . . 0.0 111.152 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.77 44.01 5.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.24 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.584 HG13 HG23 ' A' ' 30' ' ' VAL . 87.6 mt -102.65 126.87 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.26 0.552 . . . . 0.0 111.642 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.9 127.75 33.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.944 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -126.64 124.47 39.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.968 0.413 . . . . 0.0 111.796 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -92.35 121.34 33.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.14 -57.68 8.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.18 -45.27 95.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 -172.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 42' ' ' VAL . 12.3 tpp180 -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.337 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 23' ' ' ILE . 5.3 tp -58.99 -56.81 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.668 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.66 -34.96 71.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.0 109.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.6 tmtt? -63.98 -55.38 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.448 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 38' ' ' ARG . 77.2 t -55.92 -44.38 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.883 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.76 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.01 -46.11 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.198 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -66.16 -34.27 77.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.756 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 16.8 mm-40 -61.03 -52.12 66.3 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 4' ' ' VAL . 22.7 mt -60.35 -37.56 81.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.762 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -72.96 -25.02 60.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.027 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.18 -30.24 12.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.289 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG23 ' A' ' 54' ' ' VAL . 74.0 mmtt -106.98 -157.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -98.69 149.37 22.89 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.644 HG13 HD22 ' A' ' 46' ' ' LEU . 1.3 mp -61.33 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.809 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 1.142 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.04 -44.63 87.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.849 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.46 -56.03 26.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.659 ' HB ' HD23 ' A' ' 46' ' ' LEU . 74.1 t -60.0 -29.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.741 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 1.084 HD13 HD13 ' B' ' 55' ' ' ILE . 18.0 mt -69.15 -56.23 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 173.518 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 1.105 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -68.69 -14.89 63.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.169 0.509 . . . . 0.0 111.044 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -94.24 -32.75 13.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.62 169.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.95 -34.86 13.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.755 0.662 . . . . 0.0 114.755 -170.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.897 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--O 1.233 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.701 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.519 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 26.9 m-85 -111.14 -8.89 14.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -168.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.982 HG22 HD11 ' B' ' 46' ' ' LEU . 54.2 t -63.06 -36.3 75.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.61 -55.26 37.13 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.639 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -70.36 -36.52 74.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.535 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.572 ' CD2' HD13 ' B' ' 46' ' ' LEU . 69.1 t80 -55.27 -49.74 71.3 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.796 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.3 mp -59.97 -55.73 30.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.826 HD12 HD12 ' A' ' 9' ' ' LEU . 15.5 mt -48.73 -50.37 33.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.757 0.313 . . . . 0.0 111.623 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.53 82.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.25 -38.58 91.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.8 mt -79.97 -30.01 39.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.005 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.83 73.94 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.404 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.55 -27.73 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.902 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.593 ' OD1' ' HA ' ' B' ' 18' ' ' PRO . 2.5 t-20 -89.02 73.91 8.19 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.557 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 13.5 m -60.79 -20.62 61.86 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.394 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -112.23 75.63 1.7 Allowed Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.593 ' HA ' ' OD1' ' B' ' 15' ' ' ASN . 19.4 Cg_exo -66.06 139.79 57.4 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.287 2.658 . . . . 0.0 113.386 -166.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.456 ' O ' HG12 ' B' ' 23' ' ' ILE . 11.6 p -97.05 141.97 29.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.277 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -62.25 -24.64 67.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.194 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' LYS . . . . . 0.619 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.4 mmmm -64.42 -46.17 84.4 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.384 0.611 . . . . 0.0 110.122 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.731 ' O ' HG13 ' B' ' 26' ' ' ILE . 4.9 t70 -59.25 -46.13 89.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.235 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.778 HG13 HD11 ' B' ' 43' ' ' ILE . 44.0 mm -51.05 -51.47 21.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.089 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 43.6 mttm -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' B' ' 28' ' ' ASP . 4.5 mmmp? -69.88 -35.38 74.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.731 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.0 mt -70.1 -40.76 78.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.025 0.44 . . . . 0.0 110.004 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.694 HD13 ' HB2' ' B' ' 34' ' ' ALA . 12.8 mt -62.01 -38.06 87.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.462 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' B' ' 25' ' ' LYS . 10.9 t70 -61.76 -34.65 76.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.747 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.98 -36.08 81.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.249 . . . . 0.0 111.042 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.57 HG23 HG13 ' B' ' 32' ' ' ILE . 16.2 m -98.84 -10.14 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 111.382 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 44.45 5.5 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.028 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 88.1 mt -103.03 126.27 57.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.668 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -65.07 127.98 33.86 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.953 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.694 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -127.13 124.08 38.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.0 111.775 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -92.35 121.5 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.742 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.88 -58.35 6.72 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -60.64 -45.09 95.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.418 ' O ' HG23 ' B' ' 42' ' ' VAL . 12.4 tpp180 -62.81 -38.88 92.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.405 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.562 ' CD1' HG21 ' B' ' 23' ' ' ILE . 5.3 tp -59.0 -57.01 14.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.635 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.5 -35.11 71.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.922 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 6.7 tmtt? -63.78 -55.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 38' ' ' ARG . 75.6 t -55.97 -44.22 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.362 0.601 . . . . 0.0 110.87 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.778 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.37 -45.68 89.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.202 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.4 t -66.48 -33.99 76.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.68 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 15.3 mm-40 -61.26 -52.14 65.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.176 0.512 . . . . 0.0 109.801 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.982 HD11 HG22 ' B' ' 4' ' ' VAL . 22.4 mt -60.46 -37.48 81.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.704 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -73.05 -24.63 60.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.7 -30.02 12.44 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.22 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.428 ' HB2' HG23 ' B' ' 54' ' ' VAL . 74.1 mmtt -106.86 -157.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -99.18 149.31 23.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.658 HG13 HD22 ' B' ' 46' ' ' LEU . 1.4 mp -61.47 -45.31 98.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.762 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 1.105 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.2 mp0 -58.22 -44.27 88.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -60.67 -56.07 25.74 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.27 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.68 ' HB ' HD23 ' B' ' 46' ' ' LEU . 75.5 t -59.92 -29.73 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.707 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 1.084 HD13 HD13 ' A' ' 55' ' ' ILE . 17.5 mt -69.33 -56.25 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 1.142 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -68.36 -15.61 63.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.49 -33.41 13.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.695 169.434 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.2 -35.34 15.16 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.929 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--O 1.234 0.268 0 CA-C-N 117.977 0.889 . . . . 0.0 109.471 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.734 ' HA ' ' CD1' ' B' ' 12' ' ' LEU . 9.6 ptp180 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 15.9 m-85 -79.26 -26.3 42.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.968 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.869 HG22 HD11 ' A' ' 46' ' ' LEU . 62.1 t -71.66 -32.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.186 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -56.8 -54.86 41.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.66 -35.33 67.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 46' ' ' LEU . 54.9 t80 -55.47 -48.19 74.93 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.783 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.6 mp -57.4 -61.08 2.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.221 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.906 HD12 HD12 ' B' ' 9' ' ' LEU . 16.5 mt -46.98 -49.08 21.4 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 26' ' ' ILE . . . -63.05 -35.63 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.397 . . . . 0.0 110.944 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.78 -37.95 87.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 3.4 mt -81.77 -18.42 44.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.922 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.63 12.92 42.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.574 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.14 -76.38 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.819 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 40.0 t30 -145.88 143.8 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.844 -0.209 . . . . 0.0 110.796 -170.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -77.22 44.3 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.7 t -165.84 65.64 1.01 Allowed Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.07 143.47 20.36 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.903 3.069 . . . . 0.0 112.691 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 46.7 t -77.51 143.23 38.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.965 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.4 66.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.287 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.62 -40.77 76.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.713 ' O ' HG13 ' A' ' 26' ' ' ILE . 18.6 m-20 -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.227 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.624 HG13 HD11 ' A' ' 43' ' ' ILE . 28.2 mm -52.08 -51.2 31.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -52.73 -48.82 66.42 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.764 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.15 -46.68 82.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.713 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.6 mt -68.11 -37.88 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.055 0.455 . . . . 0.0 110.574 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.786 HD13 ' HB2' ' A' ' 34' ' ' ALA . 11.2 mt -63.18 -41.48 99.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.012 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.46 -26.77 68.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.6 m -70.68 -25.26 62.9 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.644 0.259 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 HG13 ' A' ' 32' ' ' ILE . 16.5 m -112.17 -9.28 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.692 0.282 . . . . 0.0 111.453 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.4 5.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.497 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 39.2 mt -111.3 136.5 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.012 0.406 . . . . 0.0 110.873 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -76.78 158.4 30.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.55 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.786 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -150.22 138.82 20.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -85.68 -178.02 6.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.792 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.51 -52.93 2.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.198 0.523 . . . . 0.0 109.851 167.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.49 -58.19 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.837 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.5 tpp180 -60.6 -35.95 77.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.5 tp -63.57 -55.63 22.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -62.24 -28.54 69.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.687 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -64.87 -49.92 68.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.324 176.476 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' ARG . 88.8 t -62.15 -41.32 90.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.683 0.754 . . . . 0.0 110.725 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.624 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.45 -41.39 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.714 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t -70.42 -34.95 73.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.311 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 12.3 pt-20 -72.24 -37.12 69.2 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.107 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.869 HD11 HG22 ' A' ' 4' ' ' VAL . 17.8 mt -57.14 -46.3 82.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.158 169.707 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -71.28 -3.6 21.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.554 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.24 -14.86 40.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.727 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 54' ' ' VAL . 13.7 mmmm -133.72 -146.89 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASN . . . . . 0.432 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 25.1 m-80 -105.03 162.38 13.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 166.149 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.472 ' CG2' HD11 ' A' ' 8' ' ' LEU . 1.6 mp -58.91 -50.9 77.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.175 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.905 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.8 mp0 -59.25 -39.06 81.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.296 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.2 -54.32 48.27 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.246 0.546 . . . . 0.0 110.02 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.78 ' HB ' HD23 ' A' ' 46' ' ' LEU . 50.9 t -65.91 -32.14 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.778 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' B' ' 55' ' ' ILE . 2.5 mm -58.09 -60.65 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.489 0.661 . . . . 0.0 111.286 170.604 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.906 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.44 -14.84 62.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.382 -170.643 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -100.6 -18.1 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.743 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.08 -40.09 3.15 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.486 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.56 HD13 HG23 ' A' ' 55' ' ' ILE . 1.9 mp . . . . . 0 C--O 1.234 0.27 0 CA-C-N 117.689 0.744 . . . . 0.0 110.078 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.712 ' HA ' HD13 ' A' ' 12' ' ' LEU . 9.5 ptp180 . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 15.7 m-85 -78.91 -26.32 43.74 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.956 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.881 HG22 HD11 ' B' ' 46' ' ' LEU . 61.2 t -71.66 -32.42 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.283 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.03 -54.75 43.21 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.482 0.658 . . . . 0.0 110.847 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -35.46 68.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.613 ' CD2' HD13 ' B' ' 46' ' ' LEU . 54.4 t80 -55.21 -48.14 74.3 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.788 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -57.82 -60.69 3.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.906 HD12 HD12 ' A' ' 9' ' ' LEU . 16.2 mt -47.27 -48.8 24.6 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' B' ' 26' ' ' ILE . . . -63.1 -35.89 81.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -65.67 -37.93 87.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 110.849 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.788 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 3.4 mt -81.75 -18.37 44.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.943 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.87 12.97 41.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.738 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.93 -75.37 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.203 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 39.1 t30 -147.02 143.78 28.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.919 -0.165 . . . . 0.0 110.782 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -76.59 44.11 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.254 0.55 . . . . 0.0 111.118 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.9 t -165.93 66.06 1.02 Allowed Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.63 143.51 18.99 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.817 3.011 . . . . 0.0 112.632 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.478 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 46.3 t -77.61 143.81 37.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.822 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.2 -25.32 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.228 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -40.38 76.3 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.091 0.472 . . . . 0.0 110.016 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.699 ' O ' HG13 ' B' ' 26' ' ' ILE . 16.4 m-20 -60.91 -44.25 97.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.151 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.627 HG13 HD11 ' B' ' 43' ' ' ILE . 27.3 mm -52.01 -51.08 31.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.492 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -52.92 -48.27 67.38 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.912 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.58 -46.64 83.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.684 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.699 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.09 -38.11 79.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.441 . . . . 0.0 110.571 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' B' ' 34' ' ' ALA . 11.3 mt -62.97 -41.23 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.149 172.499 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.04 -26.03 68.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -71.34 -24.79 62.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.69 0.281 . . . . 0.0 111.234 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.536 HG23 HG13 ' B' ' 32' ' ' ILE . 17.0 m -112.71 -8.86 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 111.519 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 34.64 5.58 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.669 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.6 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 39.3 mt -110.69 136.73 45.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.076 0.438 . . . . 0.0 110.777 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.84 158.51 30.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.498 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.778 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -150.29 138.62 20.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -85.55 -177.73 6.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.582 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.71 -52.95 2.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.175 0.512 . . . . 0.0 109.828 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.24 -57.83 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.863 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.465 ' O ' HG23 ' B' ' 42' ' ' VAL . 18.5 tpp180 -61.27 -35.86 78.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.5 tp -63.52 -55.59 22.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.724 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.19 -28.49 69.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.664 ' HE3' ' HA ' ' B' ' 41' ' ' LYS . 0.1 OUTLIER -64.74 -50.38 67.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.408 176.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 42' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 38' ' ' ARG . 88.6 t -61.77 -41.53 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.686 0.755 . . . . 0.0 110.684 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.627 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.29 -41.4 89.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.76 175.356 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -70.7 -34.82 72.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.258 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' B' ' 42' ' ' VAL . 12.3 pt-20 -72.41 -36.87 68.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.163 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.881 HD11 HG22 ' B' ' 4' ' ' VAL . 17.9 mt -57.44 -45.97 84.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.967 0.413 . . . . 0.0 110.258 169.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.66 -3.15 20.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.5 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.71 -14.55 40.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.867 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.549 ' HB2' HG23 ' B' ' 54' ' ' VAL . 13.6 mmmm -133.8 -147.06 0.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 50' ' ' ASN . . . . . 0.434 ' H ' ' HB3' ' B' ' 49' ' ' LYS . 27.1 m-80 -104.91 162.2 13.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 165.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.474 ' CG2' HD11 ' B' ' 8' ' ' LEU . 1.6 mp -58.67 -50.9 77.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.108 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.906 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 mp0 -59.46 -38.79 81.69 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.127 0.267 . . . . 0.0 111.18 -174.767 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -59.14 -54.98 40.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.04 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.785 ' HB ' HD23 ' B' ' 46' ' ' LEU . 52.8 t -65.17 -32.34 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 55' ' ' ILE . 2.5 mm -58.18 -60.46 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.458 0.647 . . . . 0.0 111.337 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.905 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.2 -15.42 62.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.448 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -99.88 -18.72 16.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.618 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -39.66 3.29 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.98 -0.629 . . . . 0.0 114.454 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.57 HD13 HG23 ' B' ' 55' ' ' ILE . 1.9 mp . . . . . 0 C--O 1.235 0.315 0 CA-C-N 117.878 0.839 . . . . 0.0 110.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ARG . . . . . 0.64 ' HA ' HD13 ' B' ' 12' ' ' LEU . 96.3 mtt180 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.373 0.606 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 21.3 m-85 -78.37 -26.58 46.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.388 -168.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.851 HG22 HD11 ' A' ' 46' ' ' LEU . 60.0 t -64.2 -31.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.809 0.338 . . . . 0.0 110.827 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -59.67 -54.58 44.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.473 0.654 . . . . 0.0 111.064 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -72.38 -34.99 68.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.759 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' TYR . . . . . 0.694 ' CD1' HD13 ' A' ' 46' ' ' LEU . 48.7 t80 -55.34 -47.96 74.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.664 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.3 mp -58.19 -59.68 4.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.275 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.891 HD12 HD12 ' B' ' 9' ' ' LEU . 16.2 mt -46.34 -49.93 17.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.24 89.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.72 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -62.72 -37.82 88.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 110.773 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.7 mt -80.07 -28.64 39.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.354 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.78 -28.57 73.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.969 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.86 -33.17 0.48 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.848 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 3.7 p30 -96.99 107.41 19.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 11.6 m -69.88 -19.68 63.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.519 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p -117.14 78.6 10.18 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.426 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 16' ' ' SER . 10.7 Cg_exo -73.14 140.87 31.7 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.609 2.873 . . . . 0.0 112.607 -171.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' SER . . . . . 0.519 ' O ' HG12 ' A' ' 23' ' ' ILE . 54.2 p -87.92 151.37 22.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.5 -25.03 68.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.166 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -69.41 -40.56 77.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 110.273 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.699 ' O ' HG13 ' A' ' 26' ' ' ILE . 46.2 m-20 -58.49 -46.88 85.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.75 HG13 HD11 ' A' ' 43' ' ' ILE . 39.6 mm -52.31 -49.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.888 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 84.5 mttt -59.37 -41.71 89.92 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -58.03 -46.98 84.44 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 111.13 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.699 HG13 ' O ' ' A' ' 22' ' ' ASP . 7.3 mt -70.43 -42.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.765 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 34' ' ' ALA . 13.8 mt -61.25 -36.77 80.9 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.02 -39.99 96.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 98.6 p -62.65 -37.08 84.96 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.474 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' VAL . . . . . 0.493 HG23 HG13 ' A' ' 32' ' ' ILE . 19.5 m -94.68 -10.24 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.203 0.525 . . . . 0.0 110.8 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 46.69 5.43 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.982 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.583 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 81.2 mt -104.58 131.43 53.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.04 0.42 . . . . 0.0 111.756 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.4 127.52 33.31 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.997 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -125.87 136.05 52.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -102.61 120.9 41.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.3 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -45.38 -59.59 2.6 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.903 0.752 . . . . 0.0 112.64 -171.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 8.9 p-10 -67.6 -50.28 58.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.089 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -56.32 -36.51 68.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' CD1' HG21 ' A' ' 23' ' ' ILE . 4.1 tp -58.64 -56.27 24.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.958 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -58.07 -33.73 69.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.591 0.234 . . . . 0.0 110.767 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.0 mmmm -64.56 -50.47 67.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.96 -42.63 90.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.465 0.65 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.75 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.24 -43.26 89.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.859 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -66.98 -35.39 79.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.608 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 54.7 mm-40 -57.53 -50.9 71.58 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 4' ' ' VAL . 30.5 mt -60.58 -35.19 75.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.997 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.36 -29.42 63.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.113 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.74 -34.64 15.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.129 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.498 ' HD2' HG22 ' A' ' 54' ' ' VAL . 66.6 mttm -102.93 -152.24 0.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 0.0 110.288 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.23 152.04 30.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ILE . . . . . 0.533 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 1.5 mp -55.91 -54.98 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.08 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLU . . . . . 0.902 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.35 -34.55 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 110.715 -174.036 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 30.7 t70 -66.45 -53.58 33.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.863 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.656 ' HB ' HD23 ' A' ' 46' ' ' LEU . 70.7 t -61.28 -31.2 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.662 HG21 HG21 ' B' ' 55' ' ' ILE . 2.9 mm -59.6 -61.26 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.415 0.626 . . . . 0.0 111.427 171.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.36 -18.71 63.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.447 -169.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 83.2 mt-30 -93.51 -27.49 16.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 172.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.59 -36.5 6.47 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.278 -0.487 . . . . 0.0 114.134 -171.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ILE . . . . . 0.522 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' ARG . . . . . 0.661 ' HA ' HD13 ' A' ' 12' ' ' LEU . 96.2 mtt180 . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 121.333 0.587 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' TYR . . . . . 0.455 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 21.3 m-85 -78.44 -26.64 46.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.337 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' VAL . . . . . 0.887 HG22 HD11 ' B' ' 46' ' ' LEU . 61.1 t -64.19 -31.87 55.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 110.938 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -59.67 -54.52 45.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.419 0.628 . . . . 0.0 110.909 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -72.4 -35.31 68.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.584 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 7' ' ' TYR . . . . . 0.691 ' CD1' HD13 ' B' ' 46' ' ' LEU . 49.1 t80 -55.12 -47.91 74.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.704 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.3 mp -58.06 -59.82 4.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.2 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 9' ' ' LEU . . . . . 0.891 HD12 HD12 ' A' ' 9' ' ' LEU . 16.5 mt -46.44 -49.86 17.59 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.21 89.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.703 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 11' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -62.93 -37.81 88.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.694 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.6 mt -79.84 -28.92 40.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.326 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.03 -29.82 75.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.92 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.44 -32.99 0.45 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.994 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 15' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 3.6 p30 -97.25 107.33 19.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.228 0.537 . . . . 0.0 110.859 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 8.1 m -69.62 -19.72 63.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.269 0.557 . . . . 0.0 110.654 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 41.1 p -117.38 78.76 11.12 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.246 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 18' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' B' ' 16' ' ' SER . 11.2 Cg_exo -73.23 140.62 31.04 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.521 2.814 . . . . 0.0 112.657 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' SER . . . . . 0.51 ' O ' HG12 ' B' ' 23' ' ' ILE . 55.9 p -87.66 152.14 22.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -64.33 -24.43 67.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.133 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -69.6 -40.32 76.74 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.302 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 22' ' ' ASP . . . . . 0.698 ' O ' HG13 ' B' ' 26' ' ' ILE . 48.6 m-20 -58.65 -47.1 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ILE . . . . . 0.759 HG13 HD11 ' B' ' 43' ' ' ILE . 39.2 mm -51.97 -49.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.99 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 84.1 mttt -59.59 -41.59 90.63 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.11 -46.95 84.7 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.521 0.677 . . . . 0.0 111.099 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 26' ' ' ILE . . . . . 0.698 HG13 ' O ' ' B' ' 22' ' ' ASP . 7.2 mt -70.54 -42.26 78.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.807 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' B' ' 34' ' ' ALA . 13.6 mt -61.07 -36.92 80.91 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.15 -39.51 94.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.451 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 94.6 p -62.5 -37.62 86.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 30' ' ' VAL . . . . . 0.485 HG23 HG13 ' B' ' 32' ' ' ILE . 19.3 m -94.45 -10.32 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.3 46.91 5.4 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.91 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 81.6 mt -104.58 131.69 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.439 . . . . 0.0 111.615 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.78 127.64 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.146 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -125.93 135.73 52.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.99 0.424 . . . . 0.0 111.765 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -102.22 120.83 41.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -45.09 -59.87 2.39 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.868 0.73 . . . . 0.0 112.674 -171.537 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ASP . . . . . 0.674 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 8.7 p-10 -67.62 -50.0 60.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.129 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -56.36 -36.61 68.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.951 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 39' ' ' LEU . . . . . 0.489 ' CD1' HG21 ' B' ' 23' ' ' ILE . 4.1 tp -58.5 -56.48 21.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.993 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -58.17 -33.26 69.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.473 0.178 . . . . 0.0 110.617 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 41' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 13.9 mmmm -65.0 -50.61 65.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.008 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.8 -42.39 88.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.563 0.697 . . . . 0.0 110.816 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 43' ' ' ILE . . . . . 0.759 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.42 -43.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.834 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -66.32 -35.55 80.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.5 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 45' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 61.1 mm-40 -57.45 -51.19 70.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.223 0.535 . . . . 0.0 109.701 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 46' ' ' LEU . . . . . 0.887 HD11 HG22 ' B' ' 4' ' ' VAL . 30.5 mt -60.45 -35.32 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.018 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.9 -29.44 64.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.004 0.43 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.65 -34.79 15.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.087 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 49' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' B' ' 54' ' ' VAL . 66.5 mttm -102.86 -151.9 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.935 0.398 . . . . 0.0 110.22 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.54 152.16 30.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 51' ' ' ILE . . . . . 0.534 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.5 mp -55.83 -55.06 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.029 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 52' ' ' GLU . . . . . 0.917 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.36 -34.67 74.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.909 0.385 . . . . 0.0 110.69 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.41 -53.66 33.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.697 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 54' ' ' VAL . . . . . 0.656 ' HB ' HD23 ' B' ' 46' ' ' LEU . 69.8 t -61.16 -31.33 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.449 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 55' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 55' ' ' ILE . 2.9 mm -59.47 -61.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.386 0.612 . . . . 0.0 111.419 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 56' ' ' ALA . . . . . 0.902 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.69 -18.36 63.54 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.36 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.58 -27.48 16.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.99 -36.26 6.43 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.351 -0.452 . . . . 0.0 114.035 -171.676 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 59' ' ' ILE . . . . . 0.536 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.932 0.396 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.738 ' HB3' HG12 ' A' ' 59' ' ' ILE . 24.6 ptm -98.24 -5.27 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.293 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.785 ' HA ' HD13 ' B' ' 12' ' ' LEU . 20.6 mmm180 -57.37 -47.07 82.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.528 -175.269 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 16.4 m-85 -91.04 -20.35 22.17 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.794 HG22 HD11 ' A' ' 46' ' ' LEU . 73.0 t -60.41 -37.24 73.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.087 0.47 . . . . 0.0 110.78 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.17 -54.61 44.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.392 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -35.83 67.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.975 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.673 ' CD2' HD13 ' A' ' 46' ' ' LEU . 47.9 t80 -54.79 -50.91 67.36 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.847 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.799 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.9 mp -57.86 -55.88 29.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.736 HD12 HD12 ' B' ' 9' ' ' LEU . 12.5 mt -47.55 -50.33 24.09 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.29 88.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.66 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.2 -41.08 99.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.278 0.561 . . . . 0.0 110.776 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.799 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.3 mt -75.65 -23.25 56.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.312 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.83 10.2 53.02 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.612 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.37 -11.51 39.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.877 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 62.6 t30 -103.86 81.2 1.85 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.999 0.428 . . . . 0.0 109.913 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 26.2 t -64.16 -28.77 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.49 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 t -111.51 81.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.61 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 4.5 Cg_exo -79.8 137.52 12.69 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.688 2.925 . . . . 0.0 113.353 -170.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 23' ' ' ILE . 45.3 t -79.52 147.13 32.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.66 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.48 68.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.27 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 mmtm -67.16 -42.29 84.56 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.12 0.486 . . . . 0.0 110.291 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.5 m-20 -58.37 -45.33 88.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.308 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 43' ' ' ILE . 41.4 mm -51.62 -50.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 59.0 mttm -53.86 -46.4 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.108 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -62.75 -41.85 99.4 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.285 0.564 . . . . 0.0 111.673 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 22' ' ' ASP . 13.0 mt -68.35 -36.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 110.081 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 34' ' ' ALA . 15.6 mt -65.87 -35.91 81.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.141 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.75 -33.98 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.474 0.178 . . . . 0.0 110.992 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.97 -42.91 86.04 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.201 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' B' ' 9' ' ' LEU . 15.9 m -104.22 -3.25 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.726 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 50.37 4.09 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.496 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 59.2 mt -116.0 147.36 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.083 0.468 . . . . 0.0 111.343 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.12 159.53 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.472 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -159.25 117.28 2.81 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.9 176.97 9.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.624 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.95 -48.0 4.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.999 -0.438 . . . . 0.0 110.644 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 13.5 t70 -64.45 -60.75 2.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 42' ' ' VAL . 8.7 tpp180 -54.89 -40.51 69.86 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 123.439 0.462 . . . . 0.0 110.731 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.555 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 4.2 tp -61.33 -53.97 49.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.995 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.73 -30.14 70.57 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.51 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 29.3 mmtp -66.14 -47.74 73.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.761 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 38' ' ' ARG . 92.7 t -61.2 -43.63 96.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.609 . . . . 0.0 110.378 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.32 -44.39 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.09 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 -35.72 80.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -57.77 -53.57 56.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.794 HD11 HG22 ' A' ' 4' ' ' VAL . 42.0 mt -61.77 -29.85 70.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -77.45 -39.51 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.94 -23.16 59.99 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.617 ' HD2' HG22 ' A' ' 54' ' ' VAL . 94.3 mttt -113.75 -164.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.96 0.409 . . . . 0.0 109.954 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB3' ' OE2' ' A' ' 52' ' ' GLU . 93.6 m-20 -93.21 146.84 23.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.889 ' HB ' ' HB1' ' B' ' 63' ' ' ALA . 1.5 mp -57.34 -47.46 84.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.215 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 1.053 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.9 OUTLIER -59.04 -40.97 86.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 -177.411 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 33.4 t70 -62.88 -56.56 16.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.711 ' HB ' HD23 ' A' ' 46' ' ' LEU . 53.0 t -58.23 -40.26 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.099 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.04 HD13 HD13 ' B' ' 55' ' ' ILE . 14.5 mt -60.44 -56.1 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.056 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.55 -14.13 62.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.575 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 96.4 mt-30 -88.97 -50.39 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.466 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.12 9.95 67.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.991 0.756 . . . . 0.0 114.991 -167.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.738 HG12 ' HB3' ' A' ' 1' ' ' MET . 5.7 mt -103.39 -65.6 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.668 0.734 . . . . 0.0 110.696 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' B' ' 52' ' ' GLU . . . 71.37 -156.02 52.72 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.307 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -75.21 12.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.357 . . . . 0.0 111.816 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.24 -21.27 58.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.85 ' HB1' ' HB ' ' B' ' 51' ' ' ILE . . . -64.96 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.161 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.5 p -129.76 133.71 47.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.261 0.553 . . . . 0.0 111.42 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.684 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -89.24 145.49 34.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.684 ' HD2' HG22 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -60.19 88.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.19 2.593 . . . . 0.0 112.69 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.86 101.19 12.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.802 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.89 51.12 4.12 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.751 -1.027 . . . . 0.0 111.528 -177.261 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.935 0.398 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.731 ' HB3' HG12 ' B' ' 59' ' ' ILE . 24.4 ptm -97.8 -5.24 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 0.0 111.379 -174.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.77 ' HA ' HD13 ' A' ' 12' ' ' LEU . 20.5 mmm180 -57.46 -47.31 82.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.476 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.569 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 16.4 m-85 -90.91 -20.26 22.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.813 HG22 HD11 ' B' ' 46' ' ' LEU . 71.5 t -60.57 -37.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.92 -54.73 43.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.445 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.69 -35.72 67.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.957 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' B' ' 46' ' ' LEU . 46.6 t80 -55.03 -50.77 68.23 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.801 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.8 mp -57.84 -55.88 29.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.736 HD12 HD12 ' A' ' 9' ' ' LEU . 12.4 mt -47.6 -50.39 24.29 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.289 0.368 . . . . 0.0 111.918 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.611 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.51 -40.52 97.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.232 0.539 . . . . 0.0 110.869 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.801 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.2 mt -76.16 -22.6 55.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.409 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.47 10.88 53.83 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.719 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.71 -11.0 41.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.81 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 62.5 t30 -104.16 81.46 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.081 0.467 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 24.8 t -64.42 -28.65 69.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.387 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.9 t -111.67 82.01 3.63 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.61 ' HA ' ' ND2' ' B' ' 15' ' ' ASN . 4.3 Cg_exo -80.36 137.52 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.661 2.908 . . . . 0.0 113.374 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.429 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.5 t -79.53 147.23 32.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.633 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.414 ' HB1' ' CD2' ' B' ' 39' ' ' LEU . . . -62.75 -26.22 68.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.227 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 48.2 mmtm -67.15 -42.15 84.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.183 0.516 . . . . 0.0 110.23 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.647 ' O ' HG13 ' B' ' 26' ' ' ILE . 17.3 m-20 -58.3 -45.68 87.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.325 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.635 HG13 HD11 ' B' ' 43' ' ' ILE . 41.3 mm -51.47 -50.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.425 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 59.4 mttm -53.59 -46.48 70.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.137 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -62.85 -41.6 99.42 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 111.739 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.647 HG13 ' O ' ' B' ' 22' ' ' ASP . 12.6 mt -68.51 -36.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.18 0.514 . . . . 0.0 110.144 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' B' ' 34' ' ' ALA . 15.8 mt -65.87 -36.01 82.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.174 172.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.32 -34.4 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.496 0.189 . . . . 0.0 110.899 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.9 t -57.66 -43.06 84.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.278 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 9' ' ' LEU . 15.9 m -104.12 -3.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 0.0 111.678 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.64 51.32 3.9 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.307 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 58.7 mt -116.48 147.57 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 111.358 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.43 159.44 33.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.583 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -159.38 116.68 2.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 112.935 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.62 177.09 9.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.666 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.0 -47.99 4.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.168 -0.333 . . . . 0.0 110.679 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.708 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 13.0 t70 -64.43 -60.93 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.258 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.452 ' O ' HG23 ' B' ' 42' ' ' VAL . 8.6 tpp180 -54.76 -40.63 69.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.785 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.569 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 4.2 tp -61.24 -54.08 48.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.76 -30.15 70.6 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.442 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 29.4 mmtp -66.26 -47.47 73.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.729 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 38' ' ' ARG . 91.7 t -61.36 -43.63 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.317 0.58 . . . . 0.0 110.435 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.635 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.24 -44.54 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.1 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 10.3 t -66.38 -35.68 80.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.706 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -57.78 -53.43 58.3 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.071 0.462 . . . . 0.0 109.814 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.813 HD11 HG22 ' B' ' 4' ' ' VAL . 42.1 mt -61.93 -29.72 70.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.986 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 52.3 t30 -77.56 -39.56 45.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.161 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.32 -22.53 60.43 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.297 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.622 ' HD2' HG22 ' B' ' 54' ' ' VAL . 94.3 mttt -114.1 -165.06 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.527 ' HB3' ' OE2' ' B' ' 52' ' ' GLU . 93.4 m-20 -92.85 146.99 23.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.189 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.85 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 1.5 mp -57.59 -47.44 85.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.293 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 1.056 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -59.08 -40.79 86.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 -177.482 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' B' ' 57' ' ' GLN . 33.6 t70 -63.12 -56.6 15.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.08 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.695 ' HB ' HD23 ' B' ' 46' ' ' LEU . 54.6 t -57.85 -40.22 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.236 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 1.04 HD13 HD13 ' A' ' 55' ' ' ILE . 14.5 mt -60.63 -56.06 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 1.053 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.58 -13.94 62.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.623 -173.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' B' ' 53' ' ' ASP . 96.9 mt-30 -89.05 -50.67 6.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.88 9.76 68.26 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.731 HG12 ' HB3' ' B' ' 1' ' ' MET . 5.7 mt -103.17 -65.55 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.72 0.76 . . . . 0.0 110.584 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.45 ' H ' ' HG2' ' A' ' 52' ' ' GLU . . . 71.03 -156.3 53.14 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.452 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.96 12.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 111.778 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.07 -21.51 58.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.889 ' HB1' ' HB ' ' A' ' 51' ' ' ILE . . . -64.86 -78.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.084 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -129.87 133.5 46.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.119 0.485 . . . . 0.0 111.394 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.707 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -89.29 145.65 34.51 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.707 ' HD2' HG22 ' B' ' 65' ' ' VAL . 18.4 Cg_endo -60.35 89.2 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.102 2.535 . . . . 0.0 112.715 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.96 100.67 12.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.807 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.93 51.77 3.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.063 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.835 0 CA-C-O 119.002 -0.888 . . . . 0.0 111.506 -177.401 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.573 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.696 0.284 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.707 ' SD ' HG13 ' A' ' 59' ' ' ILE . 18.4 ttt -119.16 115.84 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.519 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.75 ' HA ' HD13 ' B' ' 12' ' ' LEU . 42.6 ttm180 175.36 -55.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.148 172.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' HD1' HD11 ' A' ' 27' ' ' LEU . 39.2 m-85 -83.54 -16.56 44.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.307 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 46' ' ' LEU . 91.7 t -64.0 -36.12 75.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.536 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -56.7 -54.85 41.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.508 0.671 . . . . 0.0 111.282 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.408 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -71.72 -34.97 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.797 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 46' ' ' LEU . 65.5 t80 -55.45 -47.82 75.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.837 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.748 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.0 mp -60.11 -57.26 13.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.329 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.846 HD12 HD12 ' B' ' 9' ' ' LEU . 14.9 mt -47.48 -50.8 22.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.65 -37.87 79.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.53 -40.92 96.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.783 HD13 ' HA ' ' B' ' 2' ' ' ARG . 4.8 mt -74.41 -24.5 59.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.385 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.35 -19.34 74.23 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.372 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.54 -33.8 1.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.045 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.8 m-20 -92.47 88.07 6.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.604 0.24 . . . . 0.0 110.645 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.616 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 6.2 m -60.87 -27.79 68.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.349 0.595 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 p -108.79 82.52 1.79 Allowed Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.8 Cg_exo -80.33 152.92 20.97 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.811 3.008 . . . . 0.0 113.038 -172.136 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.447 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 14.2 t -89.42 146.33 24.73 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -65.23 -23.76 67.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.537 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.782 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 50.5 tptt -64.6 -44.72 89.71 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.337 0.589 . . . . 0.0 110.357 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.5 m-20 -58.63 -45.12 89.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.828 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.671 HG13 HD11 ' A' ' 43' ' ' ILE . 44.3 mm -50.91 -50.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.3 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HD2' ' HD2' ' A' ' 21' ' ' LYS . 60.7 mttm -52.27 -48.07 65.47 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.71 -40.38 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.12 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 22' ' ' ASP . 12.1 mt -67.95 -37.95 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 110.197 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.665 HD13 ' HB2' ' A' ' 34' ' ' ALA . 10.5 mt -63.9 -39.91 95.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.996 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.12 -32.28 71.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.322 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 t -66.7 -34.19 77.31 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.035 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 32' ' ' ILE . 15.5 m -103.04 -5.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.692 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.52 33.65 8.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.453 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 46.9 mt -102.91 129.69 54.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 122.631 -0.334 . . . . 0.0 110.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.5 144.83 51.24 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.182 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.665 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -131.13 156.97 44.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.467 0.651 . . . . 0.0 111.625 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 14.8 t70 -111.99 178.66 4.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.416 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -102.88 -53.01 2.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.221 0.534 . . . . 0.0 110.081 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.67 -49.27 41.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.043 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 12.6 tpp180 -63.44 -38.04 89.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.572 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.502 ' CD2' ' HB1' ' A' ' 20' ' ' ALA . 3.1 tp -65.84 -55.99 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.36 -30.05 69.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.2 tmtt? -62.49 -52.11 64.81 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' HB3' ' A' ' -1' ' ' ALA . 78.7 t -60.83 -42.82 93.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 110.87 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.44 -41.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.398 175.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -68.26 -33.89 75.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.705 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 45.2 mt-10 -58.39 -53.4 58.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 4' ' ' VAL . 19.7 mt -57.17 -43.31 82.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.69 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.81 -29.01 65.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.263 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.72 -21.23 64.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.548 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 54' ' ' VAL . 34.5 mttm -117.06 -97.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.741 0.782 . . . . 0.0 110.432 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.98 154.51 1.47 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.757 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.7 mp -57.64 -54.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.967 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.6 OUTLIER -61.44 -38.39 87.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -172.972 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 15.6 t70 -64.75 -53.79 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.721 ' HB ' HD23 ' A' ' 46' ' ' LEU . 28.7 t -58.7 -37.13 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.495 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.611 HG21 HG21 ' B' ' 55' ' ' ILE . 2.2 mm -56.56 -60.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 111.776 172.613 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.933 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.84 -15.29 63.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.651 -170.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 85.4 mm-40 -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 173.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.81 -42.08 3.42 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.51 -171.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.707 HG13 ' SD ' ' A' ' 1' ' ' MET . 1.6 mp -62.06 -63.11 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.253 0.526 . . . . 0.0 110.827 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.7 -124.2 35.3 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.517 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -79.21 9.37 4.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -173.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.41 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 61.2 mt -89.04 -8.95 52.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 174.068 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.74 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -96.93 23.48 7.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.538 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.1 m -98.29 129.0 45.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.67 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -150.27 146.55 20.17 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 65' ' ' VAL . 18.1 Cg_endo -61.01 93.64 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.967 2.445 . . . . 0.0 111.855 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.57 104.93 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.615 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.72 128.67 12.75 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.964 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.839 -0.978 . . . . 0.0 111.283 179.548 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' -1' ' ' ALA . . . . . 0.574 ' HB3' HG22 ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.574 0.226 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.72 ' SD ' HG13 ' B' ' 59' ' ' ILE . 18.5 ttt -119.74 115.16 23.34 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.922 0.392 . . . . 0.0 111.566 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.783 ' HA ' HD13 ' A' ' 12' ' ' LEU . 42.6 ttm180 175.7 -55.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.168 172.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.489 ' HD1' HD11 ' B' ' 27' ' ' LEU . 39.7 m-85 -83.97 -16.51 43.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.164 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.985 HG22 HD11 ' B' ' 46' ' ' LEU . 91.9 t -63.92 -35.95 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.82 -54.97 40.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.519 0.676 . . . . 0.0 111.177 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' B' ' 26' ' ' ILE . 0.3 OUTLIER -71.86 -34.98 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.684 179.197 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.594 ' CD2' HD13 ' B' ' 46' ' ' LEU . 64.9 t80 -55.23 -48.15 74.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.9 mp -59.99 -57.29 13.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.279 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.846 HD12 HD12 ' A' ' 9' ' ' LEU . 14.8 mt -47.43 -50.54 22.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.99 80.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.23 -41.36 97.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 2' ' ' ARG . 4.8 mt -74.07 -24.35 59.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.498 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.18 74.31 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.223 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.4 -33.26 2.0 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.22 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 85.9 m-20 -92.8 88.01 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.6 0.238 . . . . 0.0 110.647 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.609 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 6.1 m -60.79 -27.97 68.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.419 0.628 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 39.2 p -108.85 82.5 1.8 Allowed Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.215 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.6 Cg_exo -80.17 153.27 21.59 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.763 2.975 . . . . 0.0 112.814 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.457 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 15.4 t -89.59 146.71 24.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -65.49 -23.68 66.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.525 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.762 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 50.6 tptt -64.4 -44.8 90.13 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.255 0.55 . . . . 0.0 110.295 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.716 ' O ' HG13 ' B' ' 26' ' ' ILE . 2.6 m-20 -58.77 -44.72 90.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.91 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.652 HG13 HD11 ' B' ' 43' ' ' ILE . 44.5 mm -51.32 -50.39 27.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.266 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.762 ' HD2' ' HD2' ' B' ' 21' ' ' LYS . 60.9 mttm -51.97 -48.63 64.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.58 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.64 -40.28 95.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.061 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 22' ' ' ASP . 11.7 mt -67.86 -38.06 79.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' B' ' 34' ' ' ALA . 10.5 mt -63.71 -39.81 95.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.912 171.346 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.04 -32.86 72.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.234 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 12.9 t -66.12 -34.62 78.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.06 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.464 HG23 HG13 ' B' ' 32' ' ' ILE . 15.3 m -102.65 -5.69 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.706 0.289 . . . . 0.0 111.557 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.49 34.4 7.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.341 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 46.9 mt -103.41 129.72 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.969 0.385 . . . . 0.0 110.533 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.5 144.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.124 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -131.34 156.71 45.03 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.493 0.663 . . . . 0.0 111.746 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' B' ' 38' ' ' ARG . 14.7 t70 -111.62 178.9 4.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.614 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -103.12 -52.6 3.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.227 0.537 . . . . 0.0 110.278 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.98 -49.61 35.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.012 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.47 ' HB3' ' HB3' ' B' ' 35' ' ' ASP . 12.7 tpp180 -63.08 -38.31 90.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.497 ' CD2' ' HB1' ' B' ' 20' ' ' ALA . 3.1 tp -65.57 -56.16 13.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.25 -29.85 69.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 12.1 tmtt? -62.63 -52.14 64.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' B' ' -1' ' ' ALA . 77.6 t -60.77 -43.04 94.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.564 0.697 . . . . 0.0 110.778 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.652 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.2 -41.31 83.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.382 175.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.679 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 46.0 mt-10 -58.42 -53.1 62.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.985 HD11 HG22 ' B' ' 4' ' ' VAL . 20.0 mt -57.35 -43.3 83.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.819 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.95 -29.22 65.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.71 -20.72 65.3 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.452 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' B' ' 54' ' ' VAL . 34.4 mttm -117.4 -97.96 0.46 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.66 0.743 . . . . 0.0 110.487 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.85 154.68 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.74 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.7 mp -57.64 -54.57 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.933 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -61.56 -38.16 86.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.734 0.302 . . . . 0.0 111.116 -172.897 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 53' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' B' ' 57' ' ' GLN . 15.7 t70 -64.69 -53.85 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.594 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.723 ' HB ' HD23 ' B' ' 46' ' ' LEU . 26.9 t -58.82 -37.1 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.538 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.611 HG21 HG21 ' A' ' 55' ' ' ILE . 2.2 mm -56.47 -60.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.346 0.593 . . . . 0.0 111.823 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.967 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.96 -15.19 63.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.5 -170.321 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 57' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 53' ' ' ASP . 85.9 mm-40 -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.66 -43.21 3.19 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.408 -171.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.72 HG13 ' SD ' ' B' ' 1' ' ' MET . 1.6 mp -61.35 -63.26 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.228 0.514 . . . . 0.0 110.867 -174.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.51 -124.09 34.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.491 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -79.26 8.85 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.408 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 62.1 mt -88.68 -8.77 53.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.432 0.634 . . . . 0.0 110.133 174.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.757 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -97.02 23.73 6.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.551 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 32.1 m -98.73 128.93 45.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.664 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -150.2 146.74 20.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' B' ' 65' ' ' VAL . 18.1 Cg_endo -60.96 93.67 0.11 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.025 2.483 . . . . 0.0 112.008 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.75 103.77 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.68 128.24 14.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.052 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.941 -0.921 . . . . 0.0 111.595 179.375 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.603 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.571 0.224 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.756 ' SD ' HG13 ' A' ' 59' ' ' ILE . 13.1 ttt -91.92 110.18 21.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.965 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 -179.44 -56.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.704 0.627 . . . . 0.0 109.961 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 49.6 m-85 -99.18 -11.13 21.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.972 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 46' ' ' LEU . 60.9 t -57.13 -39.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.662 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -55.72 -55.41 32.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.855 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -70.55 -36.22 73.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.616 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CD1' HD13 ' A' ' 46' ' ' LEU . 58.0 t80 -55.41 -49.62 71.9 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.936 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.782 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.7 mp -59.94 -55.96 27.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.558 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.845 HD12 HD12 ' B' ' 9' ' ' LEU . 15.1 mt -48.02 -49.99 29.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.175 0.297 . . . . 0.0 111.702 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.18 85.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.351 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 16' ' ' SER . . . -61.73 -38.53 88.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.349 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.6 mt -78.42 -25.9 46.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.721 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.74 10.7 50.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.574 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.07 -23.84 26.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.955 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.4 64.96 7.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.33 0.586 . . . . 0.0 109.575 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 15.7 m -64.48 -20.4 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.803 -175.433 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.89 78.21 4.0 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.0 Cg_exo -77.08 129.11 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.452 -167.679 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.5 t -72.09 142.24 49.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.69 -22.35 65.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 24.4 tptp -70.27 -41.01 73.99 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.157 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.1 t70 -63.37 -40.02 96.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 43' ' ' ILE . 47.6 mm -53.68 -49.76 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.327 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 75.5 mttt -55.2 -43.4 74.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 10.9 mmmm -58.07 -47.48 83.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.396 0.617 . . . . 0.0 111.698 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.7 mt -67.43 -39.31 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.732 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 34' ' ' ALA . 9.3 mt -62.87 -39.15 93.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.126 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -59.57 -39.46 84.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.251 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 t -59.91 -38.52 82.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.244 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 32' ' ' ILE . 16.8 m -96.4 -10.31 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.271 . . . . 0.0 111.682 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 32.2 6.74 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.514 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 29.6 mt -107.24 132.87 53.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.931 0.365 . . . . 0.0 110.104 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.24 151.38 23.2 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.67 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -128.85 128.5 43.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.179 0.514 . . . . 0.0 112.318 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -92.29 122.9 35.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.187 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.91 -54.58 14.81 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 30.6 t70 -66.33 -48.42 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.437 -171.917 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.8 tpp180 -64.88 -35.2 80.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.8 tp -63.73 -56.2 17.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.66 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 90.9 m-20 -57.52 -32.57 67.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 4.2 tppt? -64.41 -54.59 30.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG22 ' HB3' ' A' ' -1' ' ' ALA . 85.4 t -57.01 -43.92 81.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 110.635 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.02 -44.0 93.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.649 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 t -64.75 -35.28 80.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.814 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 42.1 mt-10 -59.12 -53.06 62.57 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.977 HD11 HG22 ' A' ' 4' ' ' VAL . 17.7 mt -64.99 -24.32 67.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.866 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.67 -33.41 58.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.991 0.424 . . . . 0.0 111.034 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.05 11.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.735 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.496 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 16.6 mtpp -115.28 176.06 5.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.46 141.66 55.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.718 HG13 HD22 ' A' ' 46' ' ' LEU . 1.6 mp -59.66 -45.84 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.277 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 1.014 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.07 -42.15 93.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 109.635 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.15 -53.59 47.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.542 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.638 ' HB ' HD23 ' A' ' 46' ' ' LEU . 42.2 t -59.88 -35.17 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.865 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.087 HD13 HD13 ' B' ' 55' ' ' ILE . 17.9 mt -65.41 -55.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.845 0.355 . . . . 0.0 111.887 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.009 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.63 -16.07 63.31 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.431 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 20.2 mm-40 -91.77 -28.83 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.712 170.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.47 -45.5 5.23 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.312 0.485 . . . . 0.0 114.312 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.84 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp -64.89 -61.98 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 117.565 0.683 . . . . 0.0 110.361 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' H ' ' HG2' ' B' ' 52' ' ' GLU . . . 60.39 -124.82 36.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -89.05 47.51 1.51 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.73 -176.832 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 6.0 mt -125.81 -6.43 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.113 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.725 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -86.8 -118.54 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.0 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -83.63 49.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.992 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.734 ' CB ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -71.34 -61.82 2.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.756 0.788 . . . . 0.0 111.146 177.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.734 ' HD3' ' CB ' ' A' ' 65' ' ' VAL . 9.1 Cg_endo -95.75 29.93 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 126.093 4.529 . . . . 0.0 111.932 -175.717 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.65 -8.0 45.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.68 -116.94 3.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.938 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.933 -0.926 . . . . 0.0 111.555 -179.527 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' -1' ' ' ALA . . . . . 0.611 ' HB3' HG22 ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.54 0.21 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.748 ' SD ' HG13 ' B' ' 59' ' ' ILE . 13.2 ttt -91.55 110.42 21.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.001 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' B' ' 1' ' ' MET . 34.3 ttt85 -179.87 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.734 0.646 . . . . 0.0 109.902 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.542 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 50.5 m-85 -99.01 -11.11 21.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.91 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 1.0 HG22 HD11 ' B' ' 46' ' ' LEU . 58.7 t -57.08 -39.56 67.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.369 . . . . 0.0 110.801 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.55 -55.72 28.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.655 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -70.43 -36.22 73.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.593 ' CD1' HD13 ' B' ' 46' ' ' LEU . 57.8 t80 -55.67 -49.11 73.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.952 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.787 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -60.5 -55.62 31.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.426 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.845 HD12 HD12 ' A' ' 9' ' ' LEU . 14.9 mt -48.37 -50.07 32.14 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.182 0.301 . . . . 0.0 111.641 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.14 83.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.498 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' B' ' 16' ' ' SER . . . -61.85 -38.64 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.26 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.787 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -78.44 -25.86 46.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.785 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.72 10.86 49.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.549 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.54 27.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.118 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.59 64.4 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' B' ' 11' ' ' ALA . 15.0 m -63.86 -20.27 65.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.971 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.99 78.06 4.06 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.4 Cg_exo -76.91 128.82 10.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.153 2.569 . . . . 0.0 113.631 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 31.4 t -71.49 141.79 50.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.48 -22.15 64.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.507 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 24.4 tptp -70.7 -40.73 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.105 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.672 ' O ' HG13 ' B' ' 26' ' ' ILE . 29.4 t70 -63.53 -39.98 95.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.636 HG13 HD11 ' B' ' 43' ' ' ILE . 47.0 mm -53.61 -49.91 53.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.348 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 75.5 mttt -55.19 -43.29 74.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.654 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -58.09 -47.78 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.728 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.672 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.7 mt -67.35 -39.18 82.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.697 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' B' ' 34' ' ' ALA . 9.4 mt -62.89 -38.96 92.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.043 172.72 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.03 -39.42 85.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 34.9 t -59.6 -38.54 81.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.257 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.571 HG23 HG13 ' B' ' 32' ' ' ILE . 16.6 m -96.54 -10.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 111.639 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 32.76 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.388 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 29.8 mt -107.63 132.63 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.974 0.387 . . . . 0.0 110.094 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -86.62 152.27 22.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -130.22 127.94 40.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 0.0 112.305 -174.46 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.08 122.64 34.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.258 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -48.85 -54.35 15.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' B' ' 41' ' ' LYS . 32.0 t70 -66.48 -48.09 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.638 -171.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.488 ' O ' HG23 ' B' ' 42' ' ' VAL . 21.7 tpp180 -65.18 -34.76 79.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.516 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.542 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.6 tp -63.96 -56.24 16.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.659 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 90.7 m-20 -57.42 -32.67 67.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 4.4 tppt? -64.44 -54.49 31.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.801 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.611 HG22 ' HB3' ' B' ' -1' ' ' ALA . 84.6 t -57.12 -43.68 81.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.527 0.679 . . . . 0.0 110.612 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.636 HD11 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.29 -43.98 94.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.717 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -64.06 -36.06 82.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.779 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 43.0 mt-10 -58.73 -53.03 62.98 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 1.0 HD11 HG22 ' B' ' 4' ' ' VAL . 17.4 mt -65.01 -24.52 67.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.936 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -76.85 -33.08 57.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 -29.12 11.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.718 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.501 ' HB2' ' CG2' ' B' ' 54' ' ' VAL . 16.8 mtpp -115.31 176.19 5.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.582 0.229 . . . . 0.0 110.403 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.59 141.81 55.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.725 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.6 mp -59.8 -45.65 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.273 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 1.009 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.34 -42.02 94.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.325 0.584 . . . . 0.0 109.59 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.93 -53.78 45.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.637 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.64 ' HB ' HD23 ' B' ' 46' ' ' LEU . 42.2 t -59.88 -35.23 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 1.087 HD13 HD13 ' A' ' 55' ' ' ILE . 18.8 mt -65.23 -55.9 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 175.126 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 1.014 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.82 -15.57 63.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.105 0.479 . . . . 0.0 111.48 -173.175 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 20.4 mm-40 -92.04 -28.21 17.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 170.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.2 -45.43 5.04 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.842 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp -64.85 -62.09 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.444 0.622 . . . . 0.0 110.263 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 60' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 52' ' ' GLU . . . 60.77 -124.89 36.88 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.472 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.19 47.71 1.53 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 110.627 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.426 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 6.0 mt -125.76 -6.66 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.093 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' B' ' 59' ' ' ILE . . . -86.58 -118.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.014 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -83.38 50.49 1.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.881 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.742 ' CB ' ' HD3' ' B' ' 66' ' ' PRO . 0.2 OUTLIER -72.19 -62.04 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.756 0.789 . . . . 0.0 111.071 177.238 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.742 ' HD3' ' CB ' ' B' ' 65' ' ' VAL . 8.8 Cg_endo -95.24 29.52 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 1 C-N-CA 126.21 4.607 . . . . 0.0 111.973 -175.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.57 -8.5 44.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.163 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.78 -116.86 3.32 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.979 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.75 -1.028 . . . . 0.0 111.671 -179.148 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' HG13 ' A' ' 59' ' ' ILE . 24.9 ptm -116.85 -14.7 10.7 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.6 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 19.0 tpp180 -52.09 -40.92 61.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 43.7 m-85 -105.62 -7.23 18.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.959 HG22 HD11 ' A' ' 46' ' ' LEU . 97.8 t -69.34 -31.7 50.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.104 0.478 . . . . 0.0 109.999 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.647 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -58.55 -55.08 39.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.346 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' SER . . . . . 0.46 ' HA ' HD11 ' B' ' 9' ' ' LEU . 1.4 p -71.44 -36.32 71.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.56 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.606 ' CD1' HD13 ' A' ' 46' ' ' LEU . 70.3 t80 -55.14 -49.07 72.71 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.823 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.7 mp -59.18 -57.43 13.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 1.019 HD12 HD12 ' B' ' 9' ' ' LEU . 13.5 mt -48.79 -48.97 40.83 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.81 82.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.32 95.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.293 0.568 . . . . 0.0 110.808 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.2 mt -75.15 -15.63 60.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.3 1.24 81.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.189 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.23 -28.75 7.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.013 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -94.85 85.27 4.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.607 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 8.8 m -61.49 -25.85 67.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.57 81.68 3.35 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 16' ' ' SER . 9.1 Cg_exo -73.11 153.39 51.83 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.787 2.992 . . . . 0.0 113.041 -170.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 23' ' ' ILE . 2.4 p -104.84 147.46 27.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.783 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.26 -26.71 68.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.959 -168.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.43 -41.21 76.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 110.169 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.692 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.3 t70 -62.74 -42.31 99.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.673 HG13 HD11 ' A' ' 43' ' ' ILE . 41.8 mm -51.67 -51.2 28.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.562 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 89.9 mttt -56.39 -42.35 77.76 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.446 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.776 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.98 -43.74 98.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.311 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.5 mt -67.97 -39.78 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 34' ' ' ALA . 15.6 mt -60.41 -43.24 96.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.75 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 22.0 t70 -63.29 -28.69 70.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -70.0 -24.86 63.36 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.24 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.51 HG23 HG13 ' A' ' 32' ' ' ILE . 14.2 m -112.87 -3.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.29 34.89 7.26 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.587 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 52.4 mt -105.41 138.6 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.037 0.419 . . . . 0.0 111.124 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.36 144.16 26.9 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.229 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -131.22 132.5 44.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.919 0.39 . . . . 0.0 111.978 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.8 m-20 -98.02 124.51 42.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -46.73 -58.66 3.65 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.03 -49.71 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 35' ' ' ASP . 20.6 tpp180 -61.28 -39.27 89.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.138 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' CD1' HG21 ' A' ' 23' ' ' ILE . 3.7 tp -63.8 -56.16 17.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.016 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -60.3 -28.98 68.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -67.01 -49.85 63.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 71.9 t -61.54 -41.9 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.843 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.673 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.49 -40.21 85.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.844 0.83 . . . . 0.0 110.651 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -71.05 -35.84 72.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.365 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 13.5 pt-20 -69.55 -37.26 76.97 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.959 HD11 HG22 ' A' ' 4' ' ' VAL . 35.9 mt -62.54 -41.53 98.94 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.272 173.136 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.01 -30.92 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.2 -38.46 25.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.389 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HB2' HG23 ' A' ' 54' ' ' VAL . 73.3 mmtt -103.42 -156.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.072 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -100.63 159.95 14.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.831 ' HB ' ' HB1' ' B' ' 63' ' ' ALA . 1.3 mp -60.26 -50.76 79.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.82 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -57.55 -40.69 79.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.903 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.5 -55.51 26.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.844 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.65 ' HB ' HD23 ' A' ' 46' ' ' LEU . 24.6 t -58.79 -35.34 55.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.654 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.581 HG21 HG21 ' B' ' 55' ' ' ILE . 2.5 mm -59.16 -61.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.412 0.625 . . . . 0.0 111.782 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.819 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.41 -15.61 62.86 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.113 -169.929 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -88.51 -44.48 10.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.968 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -48.01 7.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.82 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.804 HG21 ' HB2' ' A' ' 63' ' ' ALA . 2.1 mp -63.08 -41.15 91.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.496 . . . . 0.0 110.039 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.58 -96.83 0.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.771 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -146.59 27.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 110.56 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 62' ' ' LEU . 2.0 tt -81.11 -22.74 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.842 ' HB1' ' HB ' ' B' ' 51' ' ' ILE . . . -60.59 -75.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.889 -1.05 . . . . 0.0 113.732 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t -106.91 177.8 4.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 -168.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.72 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.7 p -169.48 146.61 2.92 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.72 ' HD2' HG22 ' A' ' 65' ' ' VAL . 40.7 Cg_endo -67.1 66.61 0.61 Allowed 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.39 2.726 . . . . 0.0 112.712 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.34 64.19 7.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.33 44.3 1.22 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.62 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.162 -1.355 . . . . 0.0 111.305 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' -1' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.542 ' SD ' HG13 ' B' ' 59' ' ' ILE . 24.8 ptm -117.12 -14.82 10.54 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.603 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 19.2 tpp180 -52.21 -40.87 62.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 43.9 m-85 -105.34 -7.39 18.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.972 HG22 HD11 ' B' ' 46' ' ' LEU . 99.3 t -69.46 -31.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -58.84 -54.97 41.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.39 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 6' ' ' SER . . . . . 0.464 ' HA ' HD11 ' A' ' 9' ' ' LEU . 1.3 p -71.39 -36.34 71.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.506 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.597 ' CD1' HD13 ' B' ' 46' ' ' LEU . 70.8 t80 -55.28 -49.12 72.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.801 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.7 mp -58.97 -57.54 12.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.588 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 1.019 HD12 HD12 ' A' ' 9' ' ' LEU . 13.4 mt -48.87 -48.99 41.62 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.74 81.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.29 95.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -75.37 -15.62 60.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.541 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.74 0.71 81.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.319 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.66 -29.04 6.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.13 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 15.7 t-20 -94.56 85.22 4.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.589 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 12.5 m -61.66 -25.59 67.48 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.52 81.41 3.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' B' ' 16' ' ' SER . 9.4 Cg_exo -73.28 153.3 50.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.674 2.916 . . . . 0.0 113.11 -170.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.425 ' O ' HG12 ' B' ' 23' ' ' ILE . 2.7 p -104.33 147.33 27.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.964 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.93 -27.29 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.951 -169.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -68.69 -40.98 79.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.057 0.456 . . . . 0.0 110.463 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.692 ' O ' HG13 ' B' ' 26' ' ' ILE . 5.4 t70 -63.34 -42.37 98.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.682 HG13 HD11 ' B' ' 43' ' ' ILE . 41.5 mm -51.5 -51.17 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.605 174.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 89.8 mttt -56.35 -42.13 77.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.696 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.784 ' HE3' ' HA ' ' B' ' 25' ' ' LYS . 0.1 OUTLIER -62.1 -44.02 97.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.692 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.5 mt -67.79 -40.14 83.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.041 0.448 . . . . 0.0 110.491 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.689 HD13 ' HB2' ' B' ' 34' ' ' ALA . 15.4 mt -60.05 -43.17 95.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.889 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.425 ' HB3' ' HE3' ' B' ' 25' ' ' LYS . 22.6 t70 -63.32 -28.29 69.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.053 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -70.7 -24.33 62.63 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.509 HG23 HG13 ' B' ' 32' ' ' ILE . 14.0 m -113.23 -3.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.295 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.56 6.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.469 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 51.8 mt -105.89 138.64 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.42 143.86 27.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.275 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.689 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -130.98 132.62 45.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.938 0.399 . . . . 0.0 111.894 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' B' ' 38' ' ' ARG . 7.7 m-20 -98.37 124.46 43.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.42 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -46.24 -59.2 3.05 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.65 -49.74 73.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.291 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.444 ' O ' HG23 ' B' ' 42' ' ' VAL . 20.7 tpp180 -61.37 -39.11 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.48 ' CD1' HG21 ' B' ' 23' ' ' ILE . 3.7 tp -63.83 -56.25 16.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -60.12 -28.81 68.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -67.27 -49.88 62.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.551 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 72.9 t -61.4 -42.01 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.828 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.682 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.53 -40.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.816 0.817 . . . . 0.0 110.585 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -70.49 -35.91 73.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.485 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' B' ' 42' ' ' VAL . 13.3 pt-20 -69.57 -37.39 76.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.972 HD11 HG22 ' B' ' 4' ' ' VAL . 36.1 mt -62.21 -41.66 98.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.359 172.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.87 -31.19 70.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.75 -38.95 26.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.306 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.525 ' HB2' HG23 ' B' ' 54' ' ' VAL . 73.4 mmtt -103.46 -156.12 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.163 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.96 159.38 15.26 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.842 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 1.3 mp -59.88 -50.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.819 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -57.72 -40.6 79.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.927 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.64 -55.59 25.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.902 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.663 ' HB ' HD23 ' B' ' 46' ' ' LEU . 24.8 t -58.63 -35.23 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.665 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.581 HG21 HG21 ' A' ' 55' ' ' ILE . 2.5 mm -59.36 -61.81 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.514 0.673 . . . . 0.0 111.675 173.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.82 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.36 -15.63 62.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.224 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 97.1 mt-30 -88.49 -44.44 10.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.72 -48.49 7.14 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.807 -171.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.803 HG21 ' HB2' ' B' ' 63' ' ' ALA . 2.0 mp -62.61 -41.41 92.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.99 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.66 -96.9 0.6 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.709 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' B' ' 61' ' ' LYS . 33.0 mmtm -146.51 27.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.159 0.504 . . . . 0.0 110.574 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.457 ' O ' HD23 ' B' ' 62' ' ' LEU . 2.0 tt -81.3 -22.55 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.578 0.704 . . . . 0.0 109.163 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.831 ' HB1' ' HB ' ' A' ' 51' ' ' ILE . . . -60.84 -76.11 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.646 -173.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.9 t -106.99 177.87 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.318 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.698 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.6 p -169.44 146.38 2.9 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.698 ' HD2' HG22 ' B' ' 65' ' ' VAL . 40.5 Cg_endo -67.03 66.72 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.335 2.69 . . . . 0.0 112.579 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.41 65.35 8.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.04 43.3 1.3 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.4 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' -1' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.526 0.679 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.599 ' CE ' ' HG ' ' B' ' 8' ' ' LEU . 0.8 OUTLIER -58.84 -41.53 87.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.126 -173.628 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' B' ' 12' ' ' LEU . 4.7 mtp85 -48.22 -45.92 34.68 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.549 ' HD1' HD11 ' A' ' 27' ' ' LEU . 27.8 m-85 -102.04 -10.89 19.32 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.916 HG22 HD11 ' A' ' 46' ' ' LEU . 99.1 t -70.05 -33.42 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.992 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -55.86 -54.57 42.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.47 0.652 . . . . 0.0 111.417 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -36.64 70.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.869 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' HD13 ' A' ' 46' ' ' LEU . 63.2 t80 -55.48 -48.76 74.05 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.758 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.6 mp -57.09 -58.96 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.516 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.97 HD12 HD12 ' B' ' 9' ' ' LEU . 15.5 mt -48.67 -50.24 34.01 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -59.45 -37.9 79.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.799 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.37 -39.67 94.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -78.57 -26.51 45.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.857 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.67 -19.27 64.83 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.723 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.57 -18.03 4.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 52.9 t30 -99.55 88.65 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.562 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 14.1 m -65.35 -17.86 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.726 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 t -112.39 78.52 2.62 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 16' ' ' SER . 15.9 Cg_exo -68.29 125.24 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.093 2.529 . . . . 0.0 112.975 -169.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.566 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 34.6 t -76.59 140.39 41.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.274 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.07 -21.09 63.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.194 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.631 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.2 mmmm -68.08 -45.26 74.26 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.732 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.1 m-20 -57.34 -46.53 83.19 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 43' ' ' ILE . 40.3 mm -50.73 -52.98 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.711 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 34.2 mttm -52.42 -45.88 66.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.817 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 16.1 tppt? -67.02 -42.68 84.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.335 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.2 mt -65.84 -38.37 82.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.118 0.485 . . . . 0.0 110.05 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 34' ' ' ALA . 14.1 mt -62.9 -38.76 92.25 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.967 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 19.9 t70 -63.73 -30.86 71.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -64.75 -39.39 93.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.893 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG23 HG13 ' A' ' 32' ' ' ILE . 15.6 m -102.2 -4.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.661 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.84 44.55 6.02 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.422 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 62.9 mt -108.81 136.75 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.92 139.77 41.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.82 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.642 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -127.91 132.78 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.359 0.6 . . . . 0.0 111.744 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.92 114.92 29.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.996 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -48.82 -50.0 36.49 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.5 0.5 . . . . 0.0 112.25 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 20.7 t70 -62.31 -58.23 8.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.621 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.6 tpp180 -61.97 -29.8 70.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.7 tp -60.87 -56.5 20.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -58.51 -34.01 70.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 34.0 mmtp -63.42 -51.11 67.12 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.286 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 74.8 t -59.78 -42.65 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.697 0.76 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.581 HD11 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.52 -40.15 83.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.308 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -68.51 -34.25 75.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.792 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 42' ' ' VAL . 44.4 mt-10 -58.38 -51.07 71.38 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.916 HD11 HG22 ' A' ' 4' ' ' VAL . 43.4 mt -64.36 -23.57 67.34 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.565 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.86 -25.92 56.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.011 0.434 . . . . 0.0 110.883 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.81 -41.83 18.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.537 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 54' ' ' VAL . 7.7 mtpt -116.6 -156.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.402 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 56.5 m-80 -94.64 173.57 7.54 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.637 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.3 mp -64.91 -52.13 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.438 -174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.6 -39.35 80.16 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 111.024 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.27 -57.47 12.76 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.985 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.709 ' HB ' HD23 ' A' ' 46' ' ' LEU . 42.6 t -63.47 -31.81 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.96 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.541 HG23 HD13 ' A' ' 59' ' ' ILE . 2.7 mm -58.7 -60.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.48 0.657 . . . . 0.0 111.211 170.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.878 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.72 -17.68 62.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.455 -169.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -94.23 -26.2 16.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.85 -50.59 3.05 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.808 -173.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.734 HG23 ' HB2' ' A' ' 62' ' ' LEU . 1.9 mp -57.82 -50.79 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 117.395 0.598 . . . . 0.0 109.822 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.48 -101.42 0.24 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.371 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 42.1 tptt -101.35 53.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.707 0.765 . . . . 0.0 110.308 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.734 ' HB2' HG23 ' A' ' 59' ' ' ILE . 49.2 mt -137.15 -151.46 0.4 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.58 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.634 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . 69.41 45.45 0.83 Allowed 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.37 0.419 . . . . 0.0 110.755 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 t 68.82 -175.54 0.2 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.033 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.583 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 3.1 m -127.78 161.78 53.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' HB ' ' A' ' 65' ' ' VAL . 6.7 Cg_endo -43.82 -57.9 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 124.049 3.166 . . . . 0.0 112.787 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.99 142.93 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.918 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.83 32.82 0.34 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.158 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.465 -178.81 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' -1' ' ' ALA . . . . . 0.495 ' HB3' ' CG2' ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 121.673 0.749 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.591 ' CE ' ' HG ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -58.26 -41.65 84.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.302 -173.721 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.575 ' HA ' HD13 ' A' ' 12' ' ' LEU . 4.8 mtp85 -48.27 -45.64 34.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -171.078 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.538 ' HD1' HD11 ' B' ' 27' ' ' LEU . 27.7 m-85 -102.01 -11.06 19.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.919 HG22 HD11 ' B' ' 46' ' ' LEU . 99.5 t -70.06 -33.39 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.033 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.9 -54.56 43.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.468 0.652 . . . . 0.0 111.479 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -36.61 69.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.868 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.67 ' CD2' HD13 ' B' ' 46' ' ' LEU . 63.0 t80 -55.42 -48.77 73.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.881 175.253 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.76 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.7 mp -57.12 -59.05 5.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.48 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.97 HD12 HD12 ' A' ' 9' ' ' LEU . 15.5 mt -48.33 -50.65 29.5 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' B' ' 18' ' ' PRO . . . -59.26 -37.9 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.893 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.28 -39.97 95.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.3 mt -78.04 -27.06 48.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.855 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.09 -19.69 64.01 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.74 -17.98 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 53.1 t30 -99.55 88.84 3.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 14.4 m -65.32 -17.95 64.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.563 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.7 t -112.67 78.57 2.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' B' ' 16' ' ' SER . 16.2 Cg_exo -68.09 125.66 13.35 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.142 2.561 . . . . 0.0 112.861 -169.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.551 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 33.3 t -76.83 140.84 40.78 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.319 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.96 -20.5 63.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.624 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.3 mmmm -68.22 -45.43 73.32 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.102 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.736 ' O ' HG13 ' B' ' 26' ' ' ILE . 13.3 m-20 -57.13 -46.76 82.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.572 HG13 HD11 ' B' ' 43' ' ' ILE . 40.4 mm -50.56 -53.14 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.677 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.624 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 33.9 mttm -52.24 -45.85 65.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.03 -42.56 84.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.736 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.3 mt -66.07 -38.28 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 109.947 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' B' ' 34' ' ' ALA . 14.1 mt -62.92 -38.98 93.18 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.967 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -31.28 72.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.35 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.8 t -64.29 -39.5 94.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.916 0.388 . . . . 0.0 110.812 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.504 HG23 HG13 ' B' ' 32' ' ' ILE . 15.7 m -102.1 -4.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.579 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.17 44.21 6.03 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.379 173.269 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 63.3 mt -108.57 136.75 43.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.909 0.355 . . . . 0.0 111.047 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.81 139.33 41.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.067 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.625 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -127.14 133.3 50.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -104.67 114.64 28.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.023 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -48.4 -50.33 31.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.676 0.61 . . . . 0.0 112.168 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.64 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 20.6 t70 -62.19 -58.28 8.36 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.569 0.543 . . . . 0.0 110.546 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.515 ' O ' HG23 ' B' ' 42' ' ' VAL . 20.6 tpp180 -62.13 -29.58 70.44 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.055 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.8 tp -60.83 -56.71 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.29 -33.73 69.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 34.0 mmtp -63.7 -51.12 66.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.29 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.515 HG23 ' O ' ' B' ' 38' ' ' ARG . 73.0 t -59.83 -42.43 89.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.73 0.776 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.572 HD11 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.64 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.3 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.2 t -68.78 -33.87 74.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.945 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' B' ' 42' ' ' VAL . 44.4 mt-10 -58.54 -51.06 71.5 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.919 HD11 HG22 ' B' ' 4' ' ' VAL . 43.5 mt -64.54 -23.83 67.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.63 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.8 -25.79 56.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.965 0.412 . . . . 0.0 110.741 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.71 -42.52 17.01 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.39 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.592 ' HB2' HG23 ' B' ' 54' ' ' VAL . 7.8 mtpt -115.67 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -94.35 174.07 7.32 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.634 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.3 mp -65.3 -52.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.228 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.878 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.18 -57.2 13.9 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.137 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.7 ' HB ' HD23 ' B' ' 46' ' ' LEU . 42.6 t -63.9 -31.6 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.975 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.541 HG23 HD13 ' B' ' 59' ' ' ILE . 2.7 mm -58.82 -60.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.495 0.664 . . . . 0.0 111.201 170.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.875 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.53 -18.08 62.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.388 -169.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -94.03 -25.92 17.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 173.552 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -50.71 3.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.864 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.721 HG23 ' HB2' ' B' ' 62' ' ' LEU . 1.8 mp -57.57 -50.61 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 117.281 0.541 . . . . 0.0 109.664 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.33 -100.76 0.2 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.658 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' B' ' 61' ' ' LYS . 42.2 tptt -101.98 53.53 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.769 0.795 . . . . 0.0 110.343 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.721 ' HB2' HG23 ' B' ' 59' ' ' ILE . 49.3 mt -136.86 -151.48 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.451 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.637 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . 69.16 45.83 0.85 Allowed 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.364 0.415 . . . . 0.0 110.643 176.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 22.1 t 68.85 -175.17 0.2 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.566 ' HB ' ' HD2' ' B' ' 66' ' ' PRO . 3.1 m -128.15 161.8 54.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' B' ' 65' ' ' VAL . 6.6 Cg_endo -43.92 -57.85 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.977 3.118 . . . . 0.0 112.749 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.14 142.82 17.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.92 33.1 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.035 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.858 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.481 -178.863 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.084 0.469 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.643 ' HG3' HG13 ' A' ' 59' ' ' ILE . 17.4 ttt -76.58 91.81 3.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.987 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.613 ' HA ' HD13 ' B' ' 12' ' ' LEU . 35.0 ttm180 -158.75 -59.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CZ ' ' HD2' ' A' ' 2' ' ' ARG . 28.1 m-85 -86.8 -24.45 25.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.115 -171.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.952 HG22 HD11 ' A' ' 46' ' ' LEU . 75.8 t -58.96 -36.25 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 0.0 110.557 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.643 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.89 -55.17 38.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.358 0.599 . . . . 0.0 111.744 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -72.3 -37.39 68.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.671 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CD1' HD13 ' A' ' 46' ' ' LEU . 54.7 t80 -54.12 -48.7 70.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.679 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.796 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.4 mp -58.59 -58.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.372 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.977 HD12 HD12 ' B' ' 9' ' ' LEU . 14.1 mt -48.59 -48.83 38.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' ' CD1' ' A' ' 26' ' ' ILE . . . -60.53 -37.41 81.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.31 -39.35 92.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.749 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -80.43 -17.52 51.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.13 -14.56 78.92 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.973 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.9 -27.14 3.51 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.252 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 44.9 t30 -93.42 98.02 10.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 0.0 110.693 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 18' ' ' PRO . 15.2 m -74.6 -3.64 32.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.51 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -123.3 71.65 46.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 16' ' ' SER . 14.9 Cg_exo -69.2 126.36 13.58 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.322 2.681 . . . . 0.0 112.542 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.579 ' O ' HG12 ' A' ' 23' ' ' ILE . 62.5 p -78.05 147.87 34.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.03 -26.78 69.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.37 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.94 -39.37 69.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.999 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 26' ' ' ILE . 15.6 t70 -62.03 -44.67 96.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.588 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 43' ' ' ILE . 41.1 mm -50.63 -50.46 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.517 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 94.0 mttt -55.88 -43.61 77.35 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.091 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 4.3 mmmp? -65.53 -38.99 91.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 22' ' ' ASP . 11.2 mt -68.16 -39.38 81.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.071 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.4 mt -61.91 -39.98 93.89 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 171.229 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 4.7 t70 -59.41 -35.44 73.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.722 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 t -64.8 -35.3 80.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.655 0.264 . . . . 0.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 32' ' ' ILE . 16.8 m -102.33 -8.78 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.17 44.13 4.18 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.374 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.9 mt -116.34 135.18 57.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.868 0.334 . . . . 0.0 110.214 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.89 155.5 21.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.628 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -134.77 130.97 36.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.256 0.551 . . . . 0.0 112.07 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -94.63 116.25 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.208 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -42.32 -64.12 0.65 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.45 -45.62 93.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.61 -173.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 42' ' ' VAL . 16.6 tpp180 -64.09 -36.83 85.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.026 0.441 . . . . 0.0 110.649 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.45 HD12 HG13 ' A' ' 43' ' ' ILE . 5.8 tp -65.04 -56.77 11.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.23 -32.85 68.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -60.85 -57.59 12.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.542 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 38' ' ' ARG . 93.2 t -56.03 -44.58 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.778 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.711 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.78 -47.61 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.399 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.1 p -69.0 -28.21 66.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.123 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.39 -37.16 60.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.322 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.952 HD11 HG22 ' A' ' 4' ' ' VAL . 43.1 mt -63.17 -33.93 76.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.068 0.461 . . . . 0.0 110.614 172.73 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.06 -42.51 63.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -37.3 67.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.254 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -103.47 -151.48 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.549 ' HA ' ' OG ' ' B' ' 64' ' ' SER . 22.1 m120 -114.46 141.36 47.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.889 ' HB ' ' HB1' ' B' ' 63' ' ' ALA . 1.7 mp -46.9 -56.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.395 0.435 . . . . 0.0 111.368 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.761 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 27.8 mt-10 -55.07 -36.24 65.39 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.485 0.491 . . . . 0.0 111.864 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.41 -52.46 18.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.637 ' HB ' HD23 ' A' ' 46' ' ' LEU . 54.0 t -62.27 -29.32 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.435 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' B' ' 55' ' ' ILE . 2.1 mm -60.43 -61.13 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.097 0.475 . . . . 0.0 111.459 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -72.36 -9.54 58.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.432 -170.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 96.4 mt-30 -104.82 -19.89 13.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.757 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.09 -35.08 4.33 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.442 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.762 HG21 ' HB2' ' A' ' 63' ' ' ALA . 1.8 mp -69.78 -48.39 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 117.916 0.858 . . . . 0.0 109.088 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.97 68.37 1.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.95 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.31 2.36 3.98 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.914 0.486 . . . . 0.0 112.047 172.707 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 6.9 mt -78.0 -10.18 59.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.951 0.881 . . . . 0.0 108.795 169.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.921 ' HB1' ' HB ' ' B' ' 51' ' ' ILE . . . -88.88 83.54 6.64 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.862 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.518 ' OG ' ' HA ' ' B' ' 50' ' ' ASN . 35.7 p 53.97 178.97 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.394 1.059 . . . . 0.0 113.044 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.625 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 10.4 m -135.47 175.27 3.73 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' A' ' 65' ' ' VAL . 9.2 Cg_endo -50.21 84.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.109 2.539 . . . . 0.0 112.418 168.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.17 76.32 10.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.153 0.501 . . . . 0.0 110.707 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.5 59.69 4.79 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.002 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.667 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.033 0.444 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.629 ' HG3' HG13 ' B' ' 59' ' ' ILE . 17.5 ttt -76.14 91.85 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.159 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.637 ' HA ' HD13 ' A' ' 12' ' ' LEU . 34.8 ttm180 -159.06 -59.72 0.07 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.667 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.528 ' CZ ' ' HD2' ' B' ' 2' ' ' ARG . 28.4 m-85 -86.92 -24.42 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.178 -171.294 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.926 HG22 HD11 ' B' ' 46' ' ' LEU . 75.3 t -58.98 -36.07 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -58.0 -55.36 35.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.655 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -72.24 -37.3 69.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.502 ' CD1' HD13 ' B' ' 46' ' ' LEU . 54.9 t80 -54.3 -48.6 71.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.729 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.79 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.3 mp -58.74 -58.34 9.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.372 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 9' ' ' LEU . 14.2 mt -48.36 -48.7 36.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' CD1' ' B' ' 26' ' ' ILE . . . -60.9 -37.75 83.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.78 -39.34 93.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 0.0 110.777 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.0 mt -80.44 -17.49 51.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.619 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.09 -14.6 78.84 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.998 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.1 -27.53 3.43 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.126 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 45.2 t30 -92.95 98.44 11.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.417 ' C ' ' HD3' ' B' ' 18' ' ' PRO . 17.0 m -75.18 -3.17 31.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.515 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.9 t -123.51 71.69 48.29 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' B' ' 16' ' ' SER . 15.0 Cg_exo -69.44 126.01 13.01 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.237 2.625 . . . . 0.0 112.746 -171.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.583 ' O ' HG12 ' B' ' 23' ' ' ILE . 64.6 p -77.8 147.98 34.99 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.671 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -63.15 -27.01 69.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.275 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.88 -39.26 69.74 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.352 0.596 . . . . 0.0 110.002 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.674 ' O ' HG13 ' B' ' 26' ' ' ILE . 15.7 t70 -62.02 -44.86 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.699 HG13 HD11 ' B' ' 43' ' ' ILE . 41.2 mm -50.53 -50.38 22.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.591 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 93.9 mttt -55.98 -43.71 77.87 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' B' ' 28' ' ' ASP . 4.3 mmmp? -65.16 -39.27 92.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.674 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.1 -39.19 80.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 0.0 110.136 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.4 mt -62.09 -39.92 94.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.679 171.05 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' B' ' 25' ' ' LYS . 5.6 t70 -59.59 -35.24 73.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.928 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 10.0 t -64.76 -35.48 81.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.872 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.475 HG23 HG13 ' B' ' 32' ' ' ILE . 17.1 m -102.28 -8.62 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.277 . . . . 0.0 111.622 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.7 44.75 4.15 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.281 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 37.9 mt -116.98 135.49 57.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.82 0.31 . . . . 0.0 110.295 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.96 155.97 21.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.641 0.258 . . . . 0.0 110.576 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -135.43 130.51 34.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.313 0.578 . . . . 0.0 111.985 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.23 116.37 28.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.326 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -42.53 -64.04 0.67 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.2 -45.93 91.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.809 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.48 ' O ' HG23 ' B' ' 42' ' ' VAL . 16.4 tpp180 -64.11 -36.5 84.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 110.598 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.449 ' O ' HG13 ' B' ' 43' ' ' ILE . 5.7 tp -65.27 -56.72 11.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.86 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -58.41 -32.78 68.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -60.78 -57.73 11.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 38' ' ' ARG . 94.3 t -56.03 -44.59 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.129 0.49 . . . . 0.0 110.888 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.699 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.69 -47.6 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.444 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -68.86 -28.15 66.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.156 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.57 -37.1 60.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.33 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.926 HD11 HG22 ' B' ' 4' ' ' VAL . 43.7 mt -63.14 -34.1 76.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 110.635 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -72.96 -42.07 63.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.379 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.02 -37.29 64.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.128 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -103.67 -151.49 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' OG ' ' A' ' 64' ' ' SER . 23.0 m120 -114.23 141.69 47.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.921 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 1.7 mp -47.06 -56.73 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.274 0.359 . . . . 0.0 111.338 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.758 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 27.8 mt-10 -55.16 -35.92 65.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.16 0.505 . . . . 0.0 111.989 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.51 -52.5 17.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.13 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' B' ' 46' ' ' LEU . 55.0 t -62.38 -29.22 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.529 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 55' ' ' ILE . 2.1 mm -60.45 -61.19 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.086 0.47 . . . . 0.0 111.53 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.761 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -72.26 -9.92 59.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.529 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 96.2 mt-30 -104.33 -20.35 13.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.652 170.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.73 -35.65 4.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.285 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.766 HG21 ' HB2' ' B' ' 63' ' ' ALA . 1.8 mp -69.06 -49.03 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.91 0.855 . . . . 0.0 109.023 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.39 68.14 1.79 Allowed Glycine 0 C--O 1.236 0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.774 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.65 2.08 3.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.932 0.493 . . . . 0.0 112.069 172.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.401 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 6.7 mt -77.99 -10.12 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.015 0.912 . . . . 0.0 108.7 169.482 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.889 ' HB1' ' HB ' ' A' ' 51' ' ' ILE . . . -89.04 83.49 6.57 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.85 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 64' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' A' ' 50' ' ' ASN . 35.0 p 54.09 179.18 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.591 1.182 . . . . 0.0 113.079 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.63 ' HB ' ' HD2' ' B' ' 66' ' ' PRO . 10.5 m -135.87 175.17 3.77 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.63 ' HD2' ' HB ' ' B' ' 65' ' ' VAL . 9.2 Cg_endo -50.46 84.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.155 2.57 . . . . 0.0 112.459 169.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.06 76.61 10.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.128 0.49 . . . . 0.0 110.642 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.04 59.9 4.84 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.01 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.916 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.551 179.145 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB2' ' HA ' ' A' ' 59' ' ' ILE . 21.9 ttt -89.66 76.35 7.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.972 0.415 . . . . 0.0 111.111 -175.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -141.97 -58.54 0.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.477 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 19.5 m-85 -90.99 -20.69 21.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -168.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.893 HG22 HD11 ' A' ' 46' ' ' LEU . 97.3 t -63.28 -33.78 63.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.043 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.57 -54.85 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.519 0.676 . . . . 0.0 111.075 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.37 -35.16 73.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.856 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.64 ' CD2' HD13 ' A' ' 46' ' ' LEU . 55.2 t80 -56.6 -47.51 79.44 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.762 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.4 mp -60.1 -57.64 11.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.514 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.926 HD12 HD12 ' B' ' 9' ' ' LEU . 14.3 mt -46.4 -49.83 17.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 26' ' ' ILE . . . -60.14 -38.83 84.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.15 -37.34 87.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.038 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.0 mt -81.46 -24.18 36.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.673 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.77 -21.27 74.9 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.9 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.63 -15.37 3.14 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.269 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 60.4 t30 -108.41 86.62 2.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 16.3 m -61.81 -27.75 68.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.736 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -108.63 82.62 1.76 Allowed Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.7 Cg_exo -78.73 147.8 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.348 2.699 . . . . 0.0 112.489 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.493 ' O ' HG12 ' A' ' 23' ' ' ILE . 89.7 p -94.14 156.96 16.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.582 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.45 -25.58 67.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.463 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -45.09 83.55 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.027 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.734 ' O ' HG13 ' A' ' 26' ' ' ILE . 55.5 m-20 -55.22 -50.9 68.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 43' ' ' ILE . 37.2 mm -50.39 -51.1 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.957 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 88.3 mttt -52.89 -49.65 65.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 123.754 0.659 . . . . 0.0 110.943 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -66.68 -35.99 81.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.397 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.6 mt -68.62 -38.25 78.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 0.0 110.02 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 13.3 mt -62.11 -41.15 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.067 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.22 -38.6 73.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.218 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -60.37 -35.78 76.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.743 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG23 HG13 ' A' ' 32' ' ' ILE . 14.6 m -103.33 -9.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.98 39.02 4.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.11 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 17.5 mt -117.69 149.42 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.56 167.76 9.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -139.57 133.54 30.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.354 0.597 . . . . 0.0 112.02 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -97.84 113.97 25.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -42.53 -58.61 2.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 12.6 m-20 -60.98 -54.71 41.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.477 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' VAL . 23.2 tpp180 -55.31 -43.33 74.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.145 0.498 . . . . 0.0 110.808 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 6.1 tp -58.44 -54.83 42.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.27 -34.23 70.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 73.5 mmtt -65.19 -53.09 50.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.086 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 38' ' ' ARG . 89.2 t -57.04 -44.18 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.407 0.623 . . . . 0.0 110.578 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.718 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -59.16 -45.99 92.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.292 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.0 t -65.57 -33.22 75.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.104 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 46.6 mt-10 -67.52 -44.25 78.85 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.893 HD11 HG22 ' A' ' 4' ' ' VAL . 45.6 mt -62.14 -41.72 98.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.377 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.26 -22.93 64.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.065 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 4.39 56.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.672 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.532 ' HD2' HG22 ' A' ' 54' ' ' VAL . 66.4 mttm -142.21 -163.62 1.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.27 144.99 25.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.371 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.72 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.2 mp -54.52 -50.04 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.334 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.795 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.38 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.426 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -65.75 -53.47 40.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.859 0.362 . . . . 0.0 110.284 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.69 ' HB ' HD23 ' A' ' 46' ' ' LEU . 70.7 t -62.01 -29.65 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.376 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.671 HD12 HD12 ' B' ' 55' ' ' ILE . 2.5 mm -61.6 -61.09 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.279 0.561 . . . . 0.0 111.564 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -71.04 -13.87 62.13 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.466 -170.476 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -97.65 -27.97 14.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.135 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.86 -33.16 7.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.943 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.642 HG21 ' HB2' ' A' ' 63' ' ' ALA . 1.9 mp -76.41 -58.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 117.311 0.556 . . . . 0.0 109.559 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.26 64.53 4.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.618 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm 66.44 10.21 7.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.411 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -81.74 -7.14 59.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.078 0.942 . . . . 0.0 108.596 171.705 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.709 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -67.02 -74.91 0.1 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.679 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 p -159.82 179.86 8.45 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.082 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.701 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.5 p -143.6 145.03 29.73 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 65' ' ' VAL . 18.9 Cg_endo -59.62 89.91 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.175 2.583 . . . . 0.0 112.443 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.61 64.44 4.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 110.868 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.96 -167.37 16.94 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.404 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.479 -178.497 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.616 0.246 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.553 ' HB2' ' HA ' ' B' ' 59' ' ' ILE . 21.9 ttt -88.58 76.42 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.078 0.466 . . . . 0.0 111.321 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.414 ' HA ' HD13 ' A' ' 12' ' ' LEU . 79.5 mtp180 -142.17 -58.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.309 174.945 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 19.2 m-85 -90.96 -20.81 21.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.918 HG22 HD11 ' B' ' 46' ' ' LEU . 98.5 t -63.27 -33.64 62.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.119 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.71 -54.78 42.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.818 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.633 ' CD2' HD13 ' B' ' 46' ' ' LEU . 56.7 t80 -56.29 -47.75 78.01 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.759 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.4 mp -60.03 -57.48 12.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.557 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.926 HD12 HD12 ' A' ' 9' ' ' LEU . 14.4 mt -46.66 -50.01 18.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.286 0.366 . . . . 0.0 111.976 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' B' ' 26' ' ' ILE . . . -59.89 -38.93 83.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.891 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.32 -36.68 84.91 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.759 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.0 mt -81.71 -24.29 36.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.97 -21.04 75.16 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.861 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.84 -15.94 3.07 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.28 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 60.7 t30 -107.88 86.78 2.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.608 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 15.4 m -61.85 -27.98 69.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.656 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -108.32 82.32 1.56 Allowed Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.8 Cg_exo -78.37 147.82 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.37 2.713 . . . . 0.0 112.428 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.502 ' O ' HG12 ' B' ' 23' ' ' ILE . 94.3 p -93.77 157.47 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.585 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.82 -25.72 67.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.456 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.0 83.96 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.086 0.469 . . . . 0.0 110.147 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.722 ' O ' HG13 ' B' ' 26' ' ' ILE . 55.6 m-20 -55.14 -51.0 67.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.705 HG13 HD11 ' B' ' 43' ' ' ILE . 37.1 mm -50.43 -50.87 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.02 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 87.6 mttt -52.9 -49.55 65.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.869 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -66.86 -36.1 81.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.007 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.722 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.8 mt -68.65 -38.3 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 110.03 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 13.7 mt -62.03 -41.07 97.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.009 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -57.52 -38.36 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.22 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -60.39 -35.93 76.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.583 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.552 HG23 HG13 ' B' ' 32' ' ' ILE . 14.0 m -103.3 -9.14 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.75 39.56 4.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.075 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 17.9 mt -118.03 149.45 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -101.46 168.14 9.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -139.47 133.67 31.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.312 0.577 . . . . 0.0 112.14 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -97.97 113.76 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.69 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -42.27 -58.22 2.25 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 12.8 m-20 -61.5 -54.49 42.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.453 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 42' ' ' VAL . 23.2 tpp180 -55.33 -43.24 74.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.019 0.437 . . . . 0.0 110.822 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 6.3 tp -58.45 -54.94 41.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.099 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.07 -34.1 69.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.477 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 73.4 mmtt -65.32 -53.17 47.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.099 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 38' ' ' ARG . 86.2 t -56.83 -44.2 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 110.596 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.705 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.22 -46.07 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.236 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -65.37 -33.42 75.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.07 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 45.2 mt-10 -67.49 -44.45 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.918 HD11 HG22 ' B' ' 4' ' ' VAL . 44.9 mt -61.99 -41.67 98.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.397 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -68.34 -22.6 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.142 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.53 5.28 54.6 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' B' ' 54' ' ' VAL . 66.4 mttm -142.55 -163.12 1.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.89 145.05 25.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.709 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.2 mp -54.37 -50.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.364 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.784 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.49 69.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.509 -175.528 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -65.57 -53.69 38.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.874 0.368 . . . . 0.0 110.131 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' B' ' 46' ' ' LEU . 71.6 t -62.05 -29.6 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.495 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.671 HD12 HD12 ' A' ' 55' ' ' ILE . 2.5 mm -61.56 -61.16 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.37 0.605 . . . . 0.0 111.587 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.795 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.94 -13.92 62.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.632 -170.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 90.0 mm-40 -97.59 -28.38 13.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.053 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.28 -33.29 8.18 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.751 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.634 HG21 ' HB2' ' B' ' 63' ' ' ALA . 1.9 mp -76.43 -58.42 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.506 0.653 . . . . 0.0 109.345 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.72 64.09 4.68 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.735 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm 66.36 10.64 7.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.408 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 0.6 OUTLIER -82.02 -7.26 59.6 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.738 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.72 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -66.93 -74.83 0.1 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.666 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.3 p -159.65 -179.67 8.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.693 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.5 p -144.19 144.81 27.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.693 ' HD2' HG22 ' B' ' 65' ' ' VAL . 19.3 Cg_endo -59.3 90.25 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.321 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 64.79 4.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 110.783 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.54 -167.96 16.64 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.357 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.819 -0.989 . . . . 0.0 111.665 -178.411 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.63 ' SD ' HG13 ' A' ' 59' ' ' ILE . 20.5 ttt -77.8 -29.49 50.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -49.06 -43.93 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.522 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 26.8 m-85 -111.01 -9.01 14.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.988 HG22 HD11 ' A' ' 46' ' ' LEU . 54.0 t -62.89 -36.5 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.162 0.506 . . . . 0.0 110.359 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.63 -54.98 40.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.69 -36.51 73.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 46' ' ' LEU . 68.6 t80 -55.49 -49.54 72.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.986 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.795 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.2 mp -59.84 -55.9 28.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.452 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.826 HD12 HD12 ' B' ' 9' ' ' LEU . 15.5 mt -48.54 -50.45 32.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.04 81.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.73 -38.37 90.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.081 0.467 . . . . 0.0 111.014 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.8 mt -79.93 -30.27 39.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.998 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.64 -23.94 73.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.437 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.67 -27.07 1.64 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.867 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 18' ' ' PRO . 2.4 t-20 -89.54 73.49 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.55 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m -60.47 -20.34 59.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.486 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.8 p -112.5 75.34 1.75 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.587 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 20.3 Cg_exo -66.17 139.68 56.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.168 2.579 . . . . 0.0 113.553 -166.38 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 23' ' ' ILE . 10.7 p -96.54 142.17 28.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.224 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.46 -24.47 67.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.21 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LYS . . . . . 0.614 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.4 mmmm -64.52 -46.18 84.02 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.392 0.615 . . . . 0.0 110.134 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.73 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.1 t70 -59.06 -46.25 88.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.76 HG13 HD11 ' A' ' 43' ' ' ILE . 43.9 mm -50.95 -51.55 20.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.049 176.237 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.614 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 43.6 mttm -52.98 -44.27 67.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.808 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 4.4 mmmp? -70.03 -35.28 74.2 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 22' ' ' ASP . 8.9 mt -69.93 -40.91 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.065 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 34' ' ' ALA . 12.8 mt -61.86 -38.05 86.82 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 11.8 t70 -61.81 -34.91 76.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.731 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.66 -36.12 81.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG23 HG13 ' A' ' 32' ' ' ILE . 16.2 m -98.94 -10.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.07 0.462 . . . . 0.0 111.152 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.77 44.01 5.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.24 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.584 HG13 HG23 ' A' ' 30' ' ' VAL . 87.6 mt -102.65 126.87 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.26 0.552 . . . . 0.0 111.642 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.9 127.75 33.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.944 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -126.64 124.47 39.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.968 0.413 . . . . 0.0 111.796 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -92.35 121.34 33.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.14 -57.68 8.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.18 -45.27 95.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 -172.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 42' ' ' VAL . 12.3 tpp180 -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.337 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 23' ' ' ILE . 5.3 tp -58.99 -56.81 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.668 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.66 -34.96 71.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.0 109.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.6 tmtt? -63.98 -55.38 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.448 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 38' ' ' ARG . 77.2 t -55.92 -44.38 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.883 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.76 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.01 -46.11 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.198 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -66.16 -34.27 77.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.756 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 16.8 mm-40 -61.03 -52.12 66.3 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 4' ' ' VAL . 22.7 mt -60.35 -37.56 81.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.762 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -72.96 -25.02 60.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.027 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.18 -30.24 12.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.289 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG23 ' A' ' 54' ' ' VAL . 74.0 mmtt -106.98 -157.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -98.69 149.37 22.89 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.644 HG13 HD22 ' A' ' 46' ' ' LEU . 1.3 mp -61.33 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.809 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 1.142 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.04 -44.63 87.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.849 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.46 -56.03 26.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.659 ' HB ' HD23 ' A' ' 46' ' ' LEU . 74.1 t -60.0 -29.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.741 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 1.084 HD13 HD13 ' B' ' 55' ' ' ILE . 18.0 mt -69.15 -56.23 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 173.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 1.105 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -68.69 -14.89 63.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.169 0.509 . . . . 0.0 111.044 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -94.24 -32.75 13.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.62 169.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.95 -34.86 13.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.755 0.662 . . . . 0.0 114.755 -170.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.897 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp -71.71 -50.37 39.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.701 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.75 -91.86 0.43 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.482 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' LYS . 31.6 mmtp -134.64 22.96 3.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.317 0.58 . . . . 0.0 110.456 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 mt -91.18 -8.06 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.73 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.656 ' HB1' HD13 ' B' ' 51' ' ' ILE . . . -69.71 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.019 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -176.75 -172.5 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.65 HG22 ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -144.9 141.31 17.23 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 65' ' ' VAL . 12.0 Cg_endo -56.4 -30.93 83.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.955 3.103 . . . . 0.0 113.134 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.51 57.07 6.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.686 0.617 . . . . 0.0 111.514 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.46 122.78 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.163 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.592 -1.116 . . . . 0.0 111.867 179.392 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.603 0.24 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.624 ' SD ' HG13 ' B' ' 59' ' ' ILE . 20.5 ttt -77.09 -29.28 54.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -49.57 -43.69 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.519 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 26.9 m-85 -111.14 -8.89 14.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -168.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.982 HG22 HD11 ' B' ' 46' ' ' LEU . 54.2 t -63.06 -36.3 75.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.61 -55.26 37.13 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.639 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -70.36 -36.52 74.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.535 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.572 ' CD2' HD13 ' B' ' 46' ' ' LEU . 69.1 t80 -55.27 -49.74 71.3 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.796 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.3 mp -59.97 -55.73 30.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.826 HD12 HD12 ' A' ' 9' ' ' LEU . 15.5 mt -48.73 -50.37 33.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.757 0.313 . . . . 0.0 111.623 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.53 82.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.25 -38.58 91.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.8 mt -79.97 -30.01 39.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.005 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.83 73.94 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.404 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.55 -27.73 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.902 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.593 ' OD1' ' HA ' ' B' ' 18' ' ' PRO . 2.5 t-20 -89.02 73.91 8.19 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.557 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 13.5 m -60.79 -20.62 61.86 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.394 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -112.23 75.63 1.7 Allowed Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.593 ' HA ' ' OD1' ' B' ' 15' ' ' ASN . 19.4 Cg_exo -66.06 139.79 57.4 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.287 2.658 . . . . 0.0 113.386 -166.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.456 ' O ' HG12 ' B' ' 23' ' ' ILE . 11.6 p -97.05 141.97 29.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.277 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -62.25 -24.64 67.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.194 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' LYS . . . . . 0.619 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.4 mmmm -64.42 -46.17 84.4 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.384 0.611 . . . . 0.0 110.122 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.731 ' O ' HG13 ' B' ' 26' ' ' ILE . 4.9 t70 -59.25 -46.13 89.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.235 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.778 HG13 HD11 ' B' ' 43' ' ' ILE . 44.0 mm -51.05 -51.47 21.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.089 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 43.6 mttm -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' B' ' 28' ' ' ASP . 4.5 mmmp? -69.88 -35.38 74.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.731 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.0 mt -70.1 -40.76 78.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.025 0.44 . . . . 0.0 110.004 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.694 HD13 ' HB2' ' B' ' 34' ' ' ALA . 12.8 mt -62.01 -38.06 87.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.462 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' B' ' 25' ' ' LYS . 10.9 t70 -61.76 -34.65 76.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.747 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.98 -36.08 81.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.249 . . . . 0.0 111.042 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.57 HG23 HG13 ' B' ' 32' ' ' ILE . 16.2 m -98.84 -10.14 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 111.382 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 44.45 5.5 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.028 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 88.1 mt -103.03 126.27 57.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.668 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -65.07 127.98 33.86 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.953 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.694 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -127.13 124.08 38.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.0 111.775 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -92.35 121.5 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.742 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.88 -58.35 6.72 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -168.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -60.64 -45.09 95.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.418 ' O ' HG23 ' B' ' 42' ' ' VAL . 12.4 tpp180 -62.81 -38.88 92.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.405 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.562 ' CD1' HG21 ' B' ' 23' ' ' ILE . 5.3 tp -59.0 -57.01 14.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.635 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.5 -35.11 71.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.922 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 6.7 tmtt? -63.78 -55.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 38' ' ' ARG . 75.6 t -55.97 -44.22 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.362 0.601 . . . . 0.0 110.87 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.778 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.37 -45.68 89.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.202 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.4 t -66.48 -33.99 76.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.68 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 15.3 mm-40 -61.26 -52.14 65.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.176 0.512 . . . . 0.0 109.801 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.982 HD11 HG22 ' B' ' 4' ' ' VAL . 22.4 mt -60.46 -37.48 81.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.704 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -73.05 -24.63 60.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.7 -30.02 12.44 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.22 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.428 ' HB2' HG23 ' B' ' 54' ' ' VAL . 74.1 mmtt -106.86 -157.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -99.18 149.31 23.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.658 HG13 HD22 ' B' ' 46' ' ' LEU . 1.4 mp -61.47 -45.31 98.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.762 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 1.105 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.2 mp0 -58.22 -44.27 88.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -60.67 -56.07 25.74 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.27 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.68 ' HB ' HD23 ' B' ' 46' ' ' LEU . 75.5 t -59.92 -29.73 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.707 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 1.084 HD13 HD13 ' A' ' 55' ' ' ILE . 17.5 mt -69.33 -56.25 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 1.142 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -68.36 -15.61 63.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.49 -33.41 13.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.695 169.434 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.2 -35.34 15.16 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.929 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp -71.19 -50.98 37.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.977 0.889 . . . . 0.0 109.471 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.05 -92.43 0.47 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.288 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -134.13 22.38 3.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.295 0.569 . . . . 0.0 110.415 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.92 -7.68 51.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.606 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.625 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -69.76 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.924 -176.257 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 16.6 p -176.61 -172.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.654 HG22 ' HD2' ' B' ' 66' ' ' PRO . 0.9 OUTLIER -145.29 141.18 16.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.543 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.654 ' HD2' HG22 ' B' ' 65' ' ' VAL . 12.0 Cg_endo -56.34 -30.93 83.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.904 3.069 . . . . 0.0 113.156 -176.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.38 56.81 6.94 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.748 0.655 . . . . 0.0 111.764 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.26 123.15 6.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.12 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.484 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.819 0.343 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.721 ' HE2' ' HG ' ' B' ' 8' ' ' LEU . 22.8 ttt -135.08 -45.2 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.734 ' HA ' ' CD1' ' B' ' 12' ' ' LEU . 9.6 ptp180 -55.51 -41.38 73.01 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -170.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 15.9 m-85 -79.26 -26.3 42.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.968 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.869 HG22 HD11 ' A' ' 46' ' ' LEU . 62.1 t -71.66 -32.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.186 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -56.8 -54.86 41.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.66 -35.33 67.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 46' ' ' LEU . 54.9 t80 -55.47 -48.19 74.93 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.783 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.6 mp -57.4 -61.08 2.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.221 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.906 HD12 HD12 ' B' ' 9' ' ' LEU . 16.5 mt -46.98 -49.08 21.4 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 26' ' ' ILE . . . -63.05 -35.63 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.397 . . . . 0.0 110.944 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.78 -37.95 87.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 3.4 mt -81.77 -18.42 44.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.922 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.63 12.92 42.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.574 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.14 -76.38 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.819 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 40.0 t30 -145.88 143.8 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.844 -0.209 . . . . 0.0 110.796 -170.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -77.22 44.3 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.7 t -165.84 65.64 1.01 Allowed Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.07 143.47 20.36 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.903 3.069 . . . . 0.0 112.691 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 46.7 t -77.51 143.23 38.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.965 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.4 66.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.287 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.62 -40.77 76.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.713 ' O ' HG13 ' A' ' 26' ' ' ILE . 18.6 m-20 -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.227 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.624 HG13 HD11 ' A' ' 43' ' ' ILE . 28.2 mm -52.08 -51.2 31.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -52.73 -48.82 66.42 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.764 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.15 -46.68 82.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.713 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.6 mt -68.11 -37.88 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.055 0.455 . . . . 0.0 110.574 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.786 HD13 ' HB2' ' A' ' 34' ' ' ALA . 11.2 mt -63.18 -41.48 99.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.012 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.46 -26.77 68.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.6 m -70.68 -25.26 62.9 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.644 0.259 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 HG13 ' A' ' 32' ' ' ILE . 16.5 m -112.17 -9.28 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.692 0.282 . . . . 0.0 111.453 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.4 5.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.497 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 39.2 mt -111.3 136.5 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.012 0.406 . . . . 0.0 110.873 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -76.78 158.4 30.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.55 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.786 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -150.22 138.82 20.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -85.68 -178.02 6.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.792 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.51 -52.93 2.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.198 0.523 . . . . 0.0 109.851 167.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.49 -58.19 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.837 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.5 tpp180 -60.6 -35.95 77.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.5 tp -63.57 -55.63 22.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -62.24 -28.54 69.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.687 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -64.87 -49.92 68.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.324 176.476 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' ARG . 88.8 t -62.15 -41.32 90.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.683 0.754 . . . . 0.0 110.725 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.624 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.45 -41.39 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.714 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t -70.42 -34.95 73.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.311 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 12.3 pt-20 -72.24 -37.12 69.2 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.107 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.869 HD11 HG22 ' A' ' 4' ' ' VAL . 17.8 mt -57.14 -46.3 82.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.158 169.707 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -71.28 -3.6 21.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.554 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.24 -14.86 40.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.727 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 54' ' ' VAL . 13.7 mmmm -133.72 -146.89 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASN . . . . . 0.432 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 25.1 m-80 -105.03 162.38 13.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 166.149 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.549 HD13 ' HB1' ' B' ' 63' ' ' ALA . 1.6 mp -58.91 -50.9 77.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.175 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.905 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.8 mp0 -59.25 -39.06 81.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.296 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.2 -54.32 48.27 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.246 0.546 . . . . 0.0 110.02 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.78 ' HB ' HD23 ' A' ' 46' ' ' LEU . 50.9 t -65.91 -32.14 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.778 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' B' ' 55' ' ' ILE . 2.5 mm -58.09 -60.65 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.489 0.661 . . . . 0.0 111.286 170.604 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.906 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.44 -14.84 62.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.382 -170.643 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -100.6 -18.1 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.743 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.08 -40.09 3.15 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.486 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.63 HG21 ' HB2' ' A' ' 63' ' ' ALA . 1.9 mp -69.12 -63.67 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 117.689 0.744 . . . . 0.0 110.078 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.6 -67.24 2.61 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 114.046 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -129.86 -23.16 2.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.902 0.382 . . . . 0.0 111.541 -173.099 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.616 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -67.33 -28.33 67.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -172.857 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 59' ' ' ILE . . . -47.68 -59.11 3.52 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 123.32 0.388 . . . . 0.0 111.433 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 m 62.84 -168.67 0.2 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.573 0.546 . . . . 0.0 111.201 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.674 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.3 p -172.51 142.27 1.14 Allowed Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 65' ' ' VAL . 19.2 Cg_endo -59.08 113.06 1.42 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.31 2.673 . . . . 0.0 112.428 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.15 81.85 5.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.3 0.571 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.13 -125.73 1.59 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.591 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.542 -1.143 . . . . 0.0 111.519 179.496 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.719 0.295 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.701 ' HE2' ' HG ' ' A' ' 8' ' ' LEU . 22.6 ttt -135.11 -45.24 0.71 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.712 ' HA ' HD13 ' A' ' 12' ' ' LEU . 9.5 ptp180 -55.51 -41.55 73.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -170.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 15.7 m-85 -78.91 -26.32 43.74 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.956 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.881 HG22 HD11 ' B' ' 46' ' ' LEU . 61.2 t -71.66 -32.42 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.283 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.03 -54.75 43.21 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.482 0.658 . . . . 0.0 110.847 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -35.46 68.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.613 ' CD2' HD13 ' B' ' 46' ' ' LEU . 54.4 t80 -55.21 -48.14 74.3 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.788 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -57.82 -60.69 3.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.906 HD12 HD12 ' A' ' 9' ' ' LEU . 16.2 mt -47.27 -48.8 24.6 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' B' ' 26' ' ' ILE . . . -63.1 -35.89 81.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -65.67 -37.93 87.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 110.849 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.788 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 3.4 mt -81.75 -18.37 44.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.943 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.87 12.97 41.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.738 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.93 -75.37 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.203 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 39.1 t30 -147.02 143.78 28.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.919 -0.165 . . . . 0.0 110.782 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -76.59 44.11 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.254 0.55 . . . . 0.0 111.118 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.9 t -165.93 66.06 1.02 Allowed Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.63 143.51 18.99 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.817 3.011 . . . . 0.0 112.632 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.478 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 46.3 t -77.61 143.81 37.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.822 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.2 -25.32 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.228 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -40.38 76.3 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.091 0.472 . . . . 0.0 110.016 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.699 ' O ' HG13 ' B' ' 26' ' ' ILE . 16.4 m-20 -60.91 -44.25 97.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.151 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.627 HG13 HD11 ' B' ' 43' ' ' ILE . 27.3 mm -52.01 -51.08 31.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.492 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -52.92 -48.27 67.38 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.912 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.58 -46.64 83.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.684 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.699 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.09 -38.11 79.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.441 . . . . 0.0 110.571 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' B' ' 34' ' ' ALA . 11.3 mt -62.97 -41.23 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.149 172.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.04 -26.03 68.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -71.34 -24.79 62.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.69 0.281 . . . . 0.0 111.234 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.536 HG23 HG13 ' B' ' 32' ' ' ILE . 17.0 m -112.71 -8.86 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 111.519 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 34.64 5.58 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.669 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.6 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 39.3 mt -110.69 136.73 45.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.076 0.438 . . . . 0.0 110.777 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.84 158.51 30.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.498 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.778 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -150.29 138.62 20.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -85.55 -177.73 6.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.582 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.71 -52.95 2.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.175 0.512 . . . . 0.0 109.828 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.24 -57.83 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.863 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.465 ' O ' HG23 ' B' ' 42' ' ' VAL . 18.5 tpp180 -61.27 -35.86 78.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.5 tp -63.52 -55.59 22.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.724 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.19 -28.49 69.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.664 ' HE3' ' HA ' ' B' ' 41' ' ' LYS . 0.1 OUTLIER -64.74 -50.38 67.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.408 176.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 42' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 38' ' ' ARG . 88.6 t -61.77 -41.53 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.686 0.755 . . . . 0.0 110.684 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.627 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.29 -41.4 89.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.76 175.356 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -70.7 -34.82 72.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.258 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' B' ' 42' ' ' VAL . 12.3 pt-20 -72.41 -36.87 68.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.163 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.881 HD11 HG22 ' B' ' 4' ' ' VAL . 17.9 mt -57.44 -45.97 84.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.967 0.413 . . . . 0.0 110.258 169.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.66 -3.15 20.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.5 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.71 -14.55 40.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.867 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.549 ' HB2' HG23 ' B' ' 54' ' ' VAL . 13.6 mmmm -133.8 -147.06 0.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 50' ' ' ASN . . . . . 0.434 ' H ' ' HB3' ' B' ' 49' ' ' LYS . 27.1 m-80 -104.91 162.2 13.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 165.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.561 HD13 ' HB1' ' A' ' 63' ' ' ALA . 1.6 mp -58.67 -50.9 77.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.108 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.906 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 mp0 -59.46 -38.79 81.69 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.127 0.267 . . . . 0.0 111.18 -174.767 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -59.14 -54.98 40.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.04 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.785 ' HB ' HD23 ' B' ' 46' ' ' LEU . 52.8 t -65.17 -32.34 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 55' ' ' ILE . 2.5 mm -58.18 -60.46 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.458 0.647 . . . . 0.0 111.337 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.905 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.2 -15.42 62.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.448 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -99.88 -18.72 16.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.618 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -39.66 3.29 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.98 -0.629 . . . . 0.0 114.454 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.637 HG21 ' HB2' ' B' ' 63' ' ' ALA . 1.9 mp -69.36 -63.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 117.878 0.839 . . . . 0.0 110.137 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.75 -67.12 2.67 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.358 -0.449 . . . . 0.0 114.032 170.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -129.76 -23.15 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.678 0.275 . . . . 0.0 111.46 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.611 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 0.5 OUTLIER -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -172.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.637 ' HB2' HG21 ' B' ' 59' ' ' ILE . . . -47.31 -58.93 3.58 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.407 0.442 . . . . 0.0 111.457 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m 62.44 -168.63 0.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.501 0.501 . . . . 0.0 111.213 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.674 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.2 p -172.43 142.45 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' B' ' 65' ' ' VAL . 18.4 Cg_endo -59.45 112.76 1.35 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.406 2.738 . . . . 0.0 112.385 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.1 82.66 5.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.284 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.47 -125.11 1.51 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.472 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.562 179.33 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.128 0.489 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.627 ' HG3' HG13 ' A' ' 59' ' ' ILE . 19.2 ttt -78.45 79.82 4.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.194 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ARG . . . . . 0.64 ' HA ' HD13 ' B' ' 12' ' ' LEU . 96.3 mtt180 -144.48 -62.72 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.373 0.606 . . . . 0.0 110.271 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 21.3 m-85 -78.37 -26.58 46.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.388 -168.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.851 HG22 HD11 ' A' ' 46' ' ' LEU . 60.0 t -64.2 -31.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.809 0.338 . . . . 0.0 110.827 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -59.67 -54.58 44.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.473 0.654 . . . . 0.0 111.064 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -72.38 -34.99 68.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.759 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' TYR . . . . . 0.694 ' CD1' HD13 ' A' ' 46' ' ' LEU . 48.7 t80 -55.34 -47.96 74.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.664 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.3 mp -58.19 -59.68 4.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.275 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.891 HD12 HD12 ' B' ' 9' ' ' LEU . 16.2 mt -46.34 -49.93 17.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.24 89.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.72 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -62.72 -37.82 88.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 110.773 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.7 mt -80.07 -28.64 39.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.354 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.78 -28.57 73.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.969 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.86 -33.17 0.48 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.848 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 3.7 p30 -96.99 107.41 19.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 11.6 m -69.88 -19.68 63.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.519 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p -117.14 78.6 10.18 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.426 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 16' ' ' SER . 10.7 Cg_exo -73.14 140.87 31.7 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.609 2.873 . . . . 0.0 112.607 -171.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' SER . . . . . 0.519 ' O ' HG12 ' A' ' 23' ' ' ILE . 54.2 p -87.92 151.37 22.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.5 -25.03 68.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.166 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -69.41 -40.56 77.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 110.273 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.699 ' O ' HG13 ' A' ' 26' ' ' ILE . 46.2 m-20 -58.49 -46.88 85.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.75 HG13 HD11 ' A' ' 43' ' ' ILE . 39.6 mm -52.31 -49.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.888 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 84.5 mttt -59.37 -41.71 89.92 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -58.03 -46.98 84.44 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 111.13 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.699 HG13 ' O ' ' A' ' 22' ' ' ASP . 7.3 mt -70.43 -42.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.765 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 34' ' ' ALA . 13.8 mt -61.25 -36.77 80.9 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.02 -39.99 96.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 98.6 p -62.65 -37.08 84.96 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.474 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' VAL . . . . . 0.493 HG23 HG13 ' A' ' 32' ' ' ILE . 19.5 m -94.68 -10.24 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.203 0.525 . . . . 0.0 110.8 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 46.69 5.43 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.982 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.583 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 81.2 mt -104.58 131.43 53.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.04 0.42 . . . . 0.0 111.756 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.4 127.52 33.31 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.997 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -125.87 136.05 52.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -102.61 120.9 41.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.3 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -45.38 -59.59 2.6 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.903 0.752 . . . . 0.0 112.64 -171.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 8.9 p-10 -67.6 -50.28 58.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.089 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -56.32 -36.51 68.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' CD1' HG21 ' A' ' 23' ' ' ILE . 4.1 tp -58.64 -56.27 24.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.958 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -58.07 -33.73 69.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.591 0.234 . . . . 0.0 110.767 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.0 mmmm -64.56 -50.47 67.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.96 -42.63 90.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.465 0.65 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.75 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.24 -43.26 89.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.859 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -66.98 -35.39 79.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.608 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 54.7 mm-40 -57.53 -50.9 71.58 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 4' ' ' VAL . 30.5 mt -60.58 -35.19 75.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.997 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.36 -29.42 63.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.113 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.74 -34.64 15.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.129 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.498 ' HD2' HG22 ' A' ' 54' ' ' VAL . 66.6 mttm -102.93 -152.24 0.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 0.0 110.288 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.23 152.04 30.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ILE . . . . . 0.679 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.5 mp -55.91 -54.98 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.08 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLU . . . . . 0.902 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.35 -34.55 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 110.715 -174.036 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 30.7 t70 -66.45 -53.58 33.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.863 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.656 ' HB ' HD23 ' A' ' 46' ' ' LEU . 70.7 t -61.28 -31.2 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.662 HG21 HG21 ' B' ' 55' ' ' ILE . 2.9 mm -59.6 -61.26 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.415 0.626 . . . . 0.0 111.427 171.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.36 -18.71 63.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.447 -169.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 83.2 mt-30 -93.51 -27.49 16.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 172.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.59 -36.5 6.47 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.278 -0.487 . . . . 0.0 114.134 -171.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ILE . . . . . 0.627 HG13 ' HG3' ' A' ' 1' ' ' MET . 1.7 mp -69.29 -46.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 -104.63 0.74 Allowed Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.003 -0.998 . . . . 0.0 114.321 168.003 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -89.86 -1.94 58.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.939 0.4 . . . . 0.0 111.289 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 1' ' ' MET . 53.7 mt -88.44 -152.88 0.23 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.218 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.68 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . 64.91 30.3 12.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.529 0.681 . . . . 0.0 110.165 -174.892 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -78.29 74.54 4.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.186 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -73.72 146.54 85.79 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -43.13 -57.89 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.548 2.832 . . . . 0.0 112.737 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 49.54 46.78 23.29 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.613 0.57 . . . . 0.0 111.29 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.9 -38.97 2.88 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.855 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.633 -1.093 . . . . 0.0 112.024 179.417 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.163 0.506 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' MET . . . . . 0.62 ' HB2' ' HA ' ' B' ' 59' ' ' ILE . 19.2 ttt -78.29 79.77 4.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -176.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 2' ' ' ARG . . . . . 0.661 ' HA ' HD13 ' A' ' 12' ' ' LEU . 96.2 mtt180 -144.55 -62.73 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 0.0 110.25 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 3' ' ' TYR . . . . . 0.455 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 21.3 m-85 -78.44 -26.64 46.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.337 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' VAL . . . . . 0.887 HG22 HD11 ' B' ' 46' ' ' LEU . 61.1 t -64.19 -31.87 55.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 110.938 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -59.67 -54.52 45.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.419 0.628 . . . . 0.0 110.909 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -72.4 -35.31 68.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.584 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 7' ' ' TYR . . . . . 0.691 ' CD1' HD13 ' B' ' 46' ' ' LEU . 49.1 t80 -55.12 -47.91 74.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.704 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.3 mp -58.06 -59.82 4.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.2 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 9' ' ' LEU . . . . . 0.891 HD12 HD12 ' A' ' 9' ' ' LEU . 16.5 mt -46.44 -49.86 17.59 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.21 89.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.703 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 11' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -62.93 -37.81 88.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.694 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.6 mt -79.84 -28.92 40.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.326 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.03 -29.82 75.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.92 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.44 -32.99 0.45 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.994 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 15' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 3.6 p30 -97.25 107.33 19.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.228 0.537 . . . . 0.0 110.859 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 8.1 m -69.62 -19.72 63.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.269 0.557 . . . . 0.0 110.654 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 41.1 p -117.38 78.76 11.12 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.246 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 18' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' B' ' 16' ' ' SER . 11.2 Cg_exo -73.23 140.62 31.04 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.521 2.814 . . . . 0.0 112.657 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' SER . . . . . 0.51 ' O ' HG12 ' B' ' 23' ' ' ILE . 55.9 p -87.66 152.14 22.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -64.33 -24.43 67.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.133 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -69.6 -40.32 76.74 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.302 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 22' ' ' ASP . . . . . 0.698 ' O ' HG13 ' B' ' 26' ' ' ILE . 48.6 m-20 -58.65 -47.1 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ILE . . . . . 0.759 HG13 HD11 ' B' ' 43' ' ' ILE . 39.2 mm -51.97 -49.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.99 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 84.1 mttt -59.59 -41.59 90.63 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.11 -46.95 84.7 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.521 0.677 . . . . 0.0 111.099 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 26' ' ' ILE . . . . . 0.698 HG13 ' O ' ' B' ' 22' ' ' ASP . 7.2 mt -70.54 -42.26 78.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.807 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' B' ' 34' ' ' ALA . 13.6 mt -61.07 -36.92 80.91 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.15 -39.51 94.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.451 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 94.6 p -62.5 -37.62 86.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 30' ' ' VAL . . . . . 0.485 HG23 HG13 ' B' ' 32' ' ' ILE . 19.3 m -94.45 -10.32 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.3 46.91 5.4 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.91 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 81.6 mt -104.58 131.69 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.439 . . . . 0.0 111.615 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.78 127.64 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.146 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -125.93 135.73 52.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.99 0.424 . . . . 0.0 111.765 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -102.22 120.83 41.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -45.09 -59.87 2.39 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.868 0.73 . . . . 0.0 112.674 -171.537 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ASP . . . . . 0.674 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 8.7 p-10 -67.62 -50.0 60.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.129 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -56.36 -36.61 68.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.951 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.489 ' CD1' HG21 ' B' ' 23' ' ' ILE . 4.1 tp -58.5 -56.48 21.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.993 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -58.17 -33.26 69.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.473 0.178 . . . . 0.0 110.617 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 41' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 13.9 mmmm -65.0 -50.61 65.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.008 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.8 -42.39 88.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.563 0.697 . . . . 0.0 110.816 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' ILE . . . . . 0.759 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.42 -43.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.834 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -66.32 -35.55 80.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.5 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 61.1 mm-40 -57.45 -51.19 70.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.223 0.535 . . . . 0.0 109.701 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 46' ' ' LEU . . . . . 0.887 HD11 HG22 ' B' ' 4' ' ' VAL . 30.5 mt -60.45 -35.32 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.018 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.9 -29.44 64.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.004 0.43 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.65 -34.79 15.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.087 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 49' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' B' ' 54' ' ' VAL . 66.5 mttm -102.86 -151.9 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.935 0.398 . . . . 0.0 110.22 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.54 152.16 30.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 51' ' ' ILE . . . . . 0.68 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.5 mp -55.83 -55.06 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.029 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 52' ' ' GLU . . . . . 0.917 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.36 -34.67 74.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.909 0.385 . . . . 0.0 110.69 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.41 -53.66 33.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.697 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 54' ' ' VAL . . . . . 0.656 ' HB ' HD23 ' B' ' 46' ' ' LEU . 69.8 t -61.16 -31.33 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.449 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 55' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 55' ' ' ILE . 2.9 mm -59.47 -61.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.386 0.612 . . . . 0.0 111.419 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 56' ' ' ALA . . . . . 0.902 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.69 -18.36 63.54 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.36 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.58 -27.48 16.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.99 -36.26 6.43 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.351 -0.452 . . . . 0.0 114.035 -171.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 59' ' ' ILE . . . . . 0.62 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 1.7 mp -69.31 -46.22 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.15 -104.23 0.71 Allowed Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.083 -0.962 . . . . 0.0 114.396 167.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.36 -1.89 57.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 111.08 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 62' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' B' ' 1' ' ' MET . 54.3 mt -88.65 -152.86 0.23 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.26 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 63' ' ' ALA . . . . . 0.679 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . 64.7 30.35 12.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.35 0.595 . . . . 0.0 110.086 -174.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 74.59 5.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.993 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' VAL . . . . . 0.645 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -73.53 146.59 86.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.622 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' PRO . . . . . 0.645 ' HD2' HG22 ' B' ' 65' ' ' VAL . 1.7 Cg_endo -43.3 -57.88 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.516 2.811 . . . . 0.0 112.658 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . 49.84 46.64 23.95 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.705 0.628 . . . . 0.0 111.34 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.89 -38.96 2.88 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.806 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.089 179.326 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.785 ' HA ' HD13 ' B' ' 12' ' ' LEU . 20.6 mmm180 . . . . . 0 CA--C 1.529 0.145 0 CA-C-O 120.681 0.277 . . . . 0.0 111.528 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 16.4 m-85 -91.04 -20.35 22.17 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.794 HG22 HD11 ' A' ' 46' ' ' LEU . 73.0 t -60.41 -37.24 73.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.087 0.47 . . . . 0.0 110.78 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.17 -54.61 44.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.392 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -35.83 67.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.975 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.673 ' CD2' HD13 ' A' ' 46' ' ' LEU . 47.9 t80 -54.79 -50.91 67.36 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.847 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.799 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.9 mp -57.86 -55.88 29.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.736 HD12 HD12 ' B' ' 9' ' ' LEU . 12.5 mt -47.55 -50.33 24.09 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.29 88.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.66 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.2 -41.08 99.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.278 0.561 . . . . 0.0 110.776 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.799 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.3 mt -75.65 -23.25 56.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.312 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.83 10.2 53.02 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.612 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.37 -11.51 39.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.877 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 62.6 t30 -103.86 81.2 1.85 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.999 0.428 . . . . 0.0 109.913 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 26.2 t -64.16 -28.77 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.49 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 t -111.51 81.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.61 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 4.5 Cg_exo -79.8 137.52 12.69 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.688 2.925 . . . . 0.0 113.353 -170.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 23' ' ' ILE . 45.3 t -79.52 147.13 32.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.66 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.48 68.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.27 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 mmtm -67.16 -42.29 84.56 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.12 0.486 . . . . 0.0 110.291 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.5 m-20 -58.37 -45.33 88.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.308 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 43' ' ' ILE . 41.4 mm -51.62 -50.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 59.0 mttm -53.86 -46.4 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.108 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -62.75 -41.85 99.4 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.285 0.564 . . . . 0.0 111.673 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 22' ' ' ASP . 13.0 mt -68.35 -36.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 110.081 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 34' ' ' ALA . 15.6 mt -65.87 -35.91 81.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.141 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.75 -33.98 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.474 0.178 . . . . 0.0 110.992 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.97 -42.91 86.04 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.201 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' B' ' 9' ' ' LEU . 15.9 m -104.22 -3.25 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.726 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 50.37 4.09 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.496 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 59.2 mt -116.0 147.36 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.083 0.468 . . . . 0.0 111.343 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.12 159.53 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.472 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -159.25 117.28 2.81 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.9 176.97 9.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.624 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.95 -48.0 4.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.999 -0.438 . . . . 0.0 110.644 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 13.5 t70 -64.45 -60.75 2.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 42' ' ' VAL . 8.7 tpp180 -54.89 -40.51 69.86 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 123.439 0.462 . . . . 0.0 110.731 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.555 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 4.2 tp -61.33 -53.97 49.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.995 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.73 -30.14 70.57 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.51 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 29.3 mmtp -66.14 -47.74 73.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.761 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 38' ' ' ARG . 92.7 t -61.2 -43.63 96.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.609 . . . . 0.0 110.378 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.32 -44.39 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.09 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 -35.72 80.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -57.77 -53.57 56.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.794 HD11 HG22 ' A' ' 4' ' ' VAL . 42.0 mt -61.77 -29.85 70.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.45 -39.51 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.94 -23.16 59.99 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.617 ' HD2' HG22 ' A' ' 54' ' ' VAL . 94.3 mttt -113.75 -164.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.96 0.409 . . . . 0.0 109.954 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB3' ' OE2' ' A' ' 52' ' ' GLU . 93.6 m-20 -93.21 146.84 23.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.546 HG13 HD22 ' A' ' 46' ' ' LEU . 1.5 mp -57.34 -47.46 84.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.215 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 1.053 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.9 OUTLIER -59.04 -40.97 86.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 -177.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 33.4 t70 -62.88 -56.56 16.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.711 ' HB ' HD23 ' A' ' 46' ' ' LEU . 53.0 t -58.23 -40.26 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.099 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.04 HD13 HD13 ' B' ' 55' ' ' ILE . 14.5 mt -60.44 -56.1 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.056 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.55 -14.13 62.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.575 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 96.4 mt-30 -88.97 -50.39 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.466 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.12 9.95 67.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.991 0.756 . . . . 0.0 114.991 -167.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.628 HD12 HG23 ' A' ' 55' ' ' ILE . 5.7 mt . . . . . 0 C--N 1.324 -0.531 0 CA-C-N 117.668 0.734 . . . . 0.0 110.696 174.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.77 ' HA ' HD13 ' A' ' 12' ' ' LEU . 20.5 mmm180 . . . . . 0 CA--C 1.529 0.143 0 CA-C-O 120.701 0.286 . . . . 0.0 111.476 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.569 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 16.4 m-85 -90.91 -20.26 22.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.813 HG22 HD11 ' B' ' 46' ' ' LEU . 71.5 t -60.57 -37.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.92 -54.73 43.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.445 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.69 -35.72 67.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.957 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' B' ' 46' ' ' LEU . 46.6 t80 -55.03 -50.77 68.23 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.801 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.8 mp -57.84 -55.88 29.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.736 HD12 HD12 ' A' ' 9' ' ' LEU . 12.4 mt -47.6 -50.39 24.29 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.289 0.368 . . . . 0.0 111.918 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.611 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.51 -40.52 97.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.232 0.539 . . . . 0.0 110.869 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.801 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.2 mt -76.16 -22.6 55.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.409 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.47 10.88 53.83 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.719 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.71 -11.0 41.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.81 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 62.5 t30 -104.16 81.46 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.081 0.467 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 24.8 t -64.42 -28.65 69.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.387 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.9 t -111.67 82.01 3.63 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.61 ' HA ' ' ND2' ' B' ' 15' ' ' ASN . 4.3 Cg_exo -80.36 137.52 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.661 2.908 . . . . 0.0 113.374 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.429 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.5 t -79.53 147.23 32.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.633 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.414 ' HB1' ' CD2' ' B' ' 39' ' ' LEU . . . -62.75 -26.22 68.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.227 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 48.2 mmtm -67.15 -42.15 84.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.183 0.516 . . . . 0.0 110.23 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.647 ' O ' HG13 ' B' ' 26' ' ' ILE . 17.3 m-20 -58.3 -45.68 87.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.325 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.635 HG13 HD11 ' B' ' 43' ' ' ILE . 41.3 mm -51.47 -50.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.425 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 59.4 mttm -53.59 -46.48 70.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.137 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -62.85 -41.6 99.42 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 111.739 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.647 HG13 ' O ' ' B' ' 22' ' ' ASP . 12.6 mt -68.51 -36.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.18 0.514 . . . . 0.0 110.144 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' B' ' 34' ' ' ALA . 15.8 mt -65.87 -36.01 82.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.174 172.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.32 -34.4 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.496 0.189 . . . . 0.0 110.899 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.9 t -57.66 -43.06 84.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.278 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 9' ' ' LEU . 15.9 m -104.12 -3.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 0.0 111.678 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.64 51.32 3.9 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.307 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 58.7 mt -116.48 147.57 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 111.358 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.43 159.44 33.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.583 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -159.38 116.68 2.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 112.935 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.62 177.09 9.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.666 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.0 -47.99 4.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.168 -0.333 . . . . 0.0 110.679 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.708 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 13.0 t70 -64.43 -60.93 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.258 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.452 ' O ' HG23 ' B' ' 42' ' ' VAL . 8.6 tpp180 -54.76 -40.63 69.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.785 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.569 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 4.2 tp -61.24 -54.08 48.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.76 -30.15 70.6 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.442 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 29.4 mmtp -66.26 -47.47 73.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.729 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 38' ' ' ARG . 91.7 t -61.36 -43.63 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.317 0.58 . . . . 0.0 110.435 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.635 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.24 -44.54 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.1 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 10.3 t -66.38 -35.68 80.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.706 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -57.78 -53.43 58.3 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.071 0.462 . . . . 0.0 109.814 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.813 HD11 HG22 ' B' ' 4' ' ' VAL . 42.1 mt -61.93 -29.72 70.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.986 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -77.56 -39.56 45.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.161 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.32 -22.53 60.43 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.297 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.622 ' HD2' HG22 ' B' ' 54' ' ' VAL . 94.3 mttt -114.1 -165.06 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . 0.527 ' HB3' ' OE2' ' B' ' 52' ' ' GLU . 93.4 m-20 -92.85 146.99 23.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.56 HG13 HD22 ' B' ' 46' ' ' LEU . 1.5 mp -57.59 -47.44 85.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.293 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 1.056 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -59.08 -40.79 86.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 -177.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' B' ' 57' ' ' GLN . 33.6 t70 -63.12 -56.6 15.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.08 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.695 ' HB ' HD23 ' B' ' 46' ' ' LEU . 54.6 t -57.85 -40.22 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.236 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 1.04 HD13 HD13 ' A' ' 55' ' ' ILE . 14.5 mt -60.63 -56.06 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 1.053 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.58 -13.94 62.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.623 -173.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' B' ' 53' ' ' ASP . 96.9 mt-30 -89.05 -50.67 6.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.88 9.76 68.26 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.656 HD12 HG23 ' B' ' 55' ' ' ILE . 5.7 mt . . . . . 0 C--N 1.324 -0.523 0 CA-C-N 117.72 0.76 . . . . 0.0 110.584 174.18 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.75 ' HA ' HD13 ' B' ' 12' ' ' LEU . 42.6 ttm180 . . . . . 0 CA--C 1.516 -0.359 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.489 ' HD1' HD11 ' A' ' 27' ' ' LEU . 39.2 m-85 -83.54 -16.56 44.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.307 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 46' ' ' LEU . 91.7 t -64.0 -36.12 75.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.536 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -56.7 -54.85 41.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.508 0.671 . . . . 0.0 111.282 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.408 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -71.72 -34.97 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.797 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 46' ' ' LEU . 65.5 t80 -55.45 -47.82 75.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.837 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.748 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.0 mp -60.11 -57.26 13.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.329 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.846 HD12 HD12 ' B' ' 9' ' ' LEU . 14.9 mt -47.48 -50.8 22.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.65 -37.87 79.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.53 -40.92 96.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.783 HD13 ' HA ' ' B' ' 2' ' ' ARG . 4.8 mt -74.41 -24.5 59.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.385 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.35 -19.34 74.23 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.372 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.54 -33.8 1.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.045 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.8 m-20 -92.47 88.07 6.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.604 0.24 . . . . 0.0 110.645 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.616 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 6.2 m -60.87 -27.79 68.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.349 0.595 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 p -108.79 82.52 1.79 Allowed Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.8 Cg_exo -80.33 152.92 20.97 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.811 3.008 . . . . 0.0 113.038 -172.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.447 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 14.2 t -89.42 146.33 24.73 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -65.23 -23.76 67.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.537 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.782 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 50.5 tptt -64.6 -44.72 89.71 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.337 0.589 . . . . 0.0 110.357 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.5 m-20 -58.63 -45.12 89.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.828 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.671 HG13 HD11 ' A' ' 43' ' ' ILE . 44.3 mm -50.91 -50.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.3 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HD2' ' HD2' ' A' ' 21' ' ' LYS . 60.7 mttm -52.27 -48.07 65.47 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.71 -40.38 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.12 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 22' ' ' ASP . 12.1 mt -67.95 -37.95 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 110.197 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.665 HD13 ' HB2' ' A' ' 34' ' ' ALA . 10.5 mt -63.9 -39.91 95.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.996 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.12 -32.28 71.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.322 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 t -66.7 -34.19 77.31 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.035 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 32' ' ' ILE . 15.5 m -103.04 -5.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.692 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.52 33.65 8.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.453 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 46.9 mt -102.91 129.69 54.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 122.631 -0.334 . . . . 0.0 110.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.5 144.83 51.24 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.182 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.665 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -131.13 156.97 44.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.467 0.651 . . . . 0.0 111.625 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 14.8 t70 -111.99 178.66 4.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.416 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -102.88 -53.01 2.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.221 0.534 . . . . 0.0 110.081 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.67 -49.27 41.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.043 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 12.6 tpp180 -63.44 -38.04 89.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.572 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.502 ' CD2' ' HB1' ' A' ' 20' ' ' ALA . 3.1 tp -65.84 -55.99 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.36 -30.05 69.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.2 tmtt? -62.49 -52.11 64.81 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 38' ' ' ARG . 78.7 t -60.83 -42.82 93.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 110.87 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.44 -41.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.398 175.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -68.26 -33.89 75.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.705 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 45.2 mt-10 -58.39 -53.4 58.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 4' ' ' VAL . 19.7 mt -57.17 -43.31 82.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.69 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.81 -29.01 65.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.263 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.72 -21.23 64.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.548 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 54' ' ' VAL . 34.5 mttm -117.06 -97.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.741 0.782 . . . . 0.0 110.432 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.98 154.51 1.47 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.5 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 1.7 mp -57.64 -54.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.967 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.6 OUTLIER -61.44 -38.39 87.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -172.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 15.6 t70 -64.75 -53.79 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.721 ' HB ' HD23 ' A' ' 46' ' ' LEU . 28.7 t -58.7 -37.13 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.495 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.611 HG21 HG21 ' B' ' 55' ' ' ILE . 2.2 mm -56.56 -60.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 111.776 172.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.933 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.84 -15.29 63.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.651 -170.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.2 mm100 -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 173.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.81 -42.08 3.42 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.51 -171.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.598 HD13 ' HA ' ' A' ' 55' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.466 0.351 0 CA-C-N 117.253 0.526 . . . . 0.0 110.827 -175.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.783 ' HA ' HD13 ' A' ' 12' ' ' LEU . 42.6 ttm180 . . . . . 0 CA--C 1.515 -0.386 0 N-CA-C 109.168 -0.678 . . . . 0.0 109.168 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.489 ' HD1' HD11 ' B' ' 27' ' ' LEU . 39.7 m-85 -83.97 -16.51 43.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.164 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.985 HG22 HD11 ' B' ' 46' ' ' LEU . 91.9 t -63.92 -35.95 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.82 -54.97 40.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.519 0.676 . . . . 0.0 111.177 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' B' ' 26' ' ' ILE . 0.3 OUTLIER -71.86 -34.98 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.684 179.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.594 ' CD2' HD13 ' B' ' 46' ' ' LEU . 64.9 t80 -55.23 -48.15 74.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.9 mp -59.99 -57.29 13.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.279 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.846 HD12 HD12 ' A' ' 9' ' ' LEU . 14.8 mt -47.43 -50.54 22.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.99 80.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.23 -41.36 97.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 2' ' ' ARG . 4.8 mt -74.07 -24.35 59.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.498 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.18 74.31 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.223 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.4 -33.26 2.0 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.22 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 85.9 m-20 -92.8 88.01 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.6 0.238 . . . . 0.0 110.647 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.609 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 6.1 m -60.79 -27.97 68.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.419 0.628 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 39.2 p -108.85 82.5 1.8 Allowed Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.215 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.6 Cg_exo -80.17 153.27 21.59 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.763 2.975 . . . . 0.0 112.814 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.457 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 15.4 t -89.59 146.71 24.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -65.49 -23.68 66.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.525 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.762 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 50.6 tptt -64.4 -44.8 90.13 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.255 0.55 . . . . 0.0 110.295 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.716 ' O ' HG13 ' B' ' 26' ' ' ILE . 2.6 m-20 -58.77 -44.72 90.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.91 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.652 HG13 HD11 ' B' ' 43' ' ' ILE . 44.5 mm -51.32 -50.39 27.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.266 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.762 ' HD2' ' HD2' ' B' ' 21' ' ' LYS . 60.9 mttm -51.97 -48.63 64.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.58 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.64 -40.28 95.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.061 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 22' ' ' ASP . 11.7 mt -67.86 -38.06 79.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' B' ' 34' ' ' ALA . 10.5 mt -63.71 -39.81 95.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.912 171.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.04 -32.86 72.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.234 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 12.9 t -66.12 -34.62 78.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.06 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.464 HG23 HG13 ' B' ' 32' ' ' ILE . 15.3 m -102.65 -5.69 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.706 0.289 . . . . 0.0 111.557 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.49 34.4 7.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.341 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 46.9 mt -103.41 129.72 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.969 0.385 . . . . 0.0 110.533 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.5 144.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.124 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -131.34 156.71 45.03 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.493 0.663 . . . . 0.0 111.746 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' B' ' 38' ' ' ARG . 14.7 t70 -111.62 178.9 4.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.614 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -103.12 -52.6 3.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.227 0.537 . . . . 0.0 110.278 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.98 -49.61 35.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.012 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.47 ' HB3' ' HB3' ' B' ' 35' ' ' ASP . 12.7 tpp180 -63.08 -38.31 90.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.497 ' CD2' ' HB1' ' B' ' 20' ' ' ALA . 3.1 tp -65.57 -56.16 13.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.25 -29.85 69.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 12.1 tmtt? -62.63 -52.14 64.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.441 HG23 ' O ' ' B' ' 38' ' ' ARG . 77.6 t -60.77 -43.04 94.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.564 0.697 . . . . 0.0 110.778 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.652 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.2 -41.31 83.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.382 175.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.679 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 46.0 mt-10 -58.42 -53.1 62.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.985 HD11 HG22 ' B' ' 4' ' ' VAL . 20.0 mt -57.35 -43.3 83.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.819 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.95 -29.22 65.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.71 -20.72 65.3 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.452 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' B' ' 54' ' ' VAL . 34.4 mttm -117.4 -97.96 0.46 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.66 0.743 . . . . 0.0 110.487 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.85 154.68 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.494 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.7 mp -57.64 -54.57 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.933 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -61.56 -38.16 86.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.734 0.302 . . . . 0.0 111.116 -172.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' B' ' 57' ' ' GLN . 15.7 t70 -64.69 -53.85 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.594 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.723 ' HB ' HD23 ' B' ' 46' ' ' LEU . 26.9 t -58.82 -37.1 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.538 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.611 HG21 HG21 ' A' ' 55' ' ' ILE . 2.2 mm -56.47 -60.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.346 0.593 . . . . 0.0 111.823 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.967 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.96 -15.19 63.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.5 -170.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 53' ' ' ASP . 16.9 mm100 -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.66 -43.21 3.19 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.408 -171.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.61 HD13 ' HA ' ' B' ' 55' ' ' ILE . 1.6 mp . . . . . 0 N--CA 1.468 0.439 0 CA-C-N 117.228 0.514 . . . . 0.0 110.867 -174.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 . . . . . 0 CA--C 1.521 -0.155 0 CA-C-O 121.017 0.436 . . . . 0.0 109.961 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 49.6 m-85 -99.18 -11.13 21.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.972 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 46' ' ' LEU . 60.9 t -57.13 -39.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.662 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -55.72 -55.41 32.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.855 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -70.55 -36.22 73.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.616 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CD1' HD13 ' A' ' 46' ' ' LEU . 58.0 t80 -55.41 -49.62 71.9 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.936 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.782 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.7 mp -59.94 -55.96 27.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.558 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.845 HD12 HD12 ' B' ' 9' ' ' LEU . 15.1 mt -48.02 -49.99 29.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.175 0.297 . . . . 0.0 111.702 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.18 85.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.351 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 16' ' ' SER . . . -61.73 -38.53 88.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.349 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.6 mt -78.42 -25.9 46.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.721 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.74 10.7 50.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.574 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.07 -23.84 26.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.955 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.4 64.96 7.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.33 0.586 . . . . 0.0 109.575 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 15.7 m -64.48 -20.4 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.803 -175.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.89 78.21 4.0 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.0 Cg_exo -77.08 129.11 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.452 -167.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.5 t -72.09 142.24 49.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.69 -22.35 65.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 24.4 tptp -70.27 -41.01 73.99 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.157 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.1 t70 -63.37 -40.02 96.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 43' ' ' ILE . 47.6 mm -53.68 -49.76 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.327 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 75.5 mttt -55.2 -43.4 74.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 10.9 mmmm -58.07 -47.48 83.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.396 0.617 . . . . 0.0 111.698 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.7 mt -67.43 -39.31 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.732 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 34' ' ' ALA . 9.3 mt -62.87 -39.15 93.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.126 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -59.57 -39.46 84.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.251 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 t -59.91 -38.52 82.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.244 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 32' ' ' ILE . 16.8 m -96.4 -10.31 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.271 . . . . 0.0 111.682 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 32.2 6.74 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.514 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 29.6 mt -107.24 132.87 53.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.931 0.365 . . . . 0.0 110.104 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.24 151.38 23.2 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.67 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -128.85 128.5 43.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.179 0.514 . . . . 0.0 112.318 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -92.29 122.9 35.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.187 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.91 -54.58 14.81 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 30.6 t70 -66.33 -48.42 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.437 -171.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.8 tpp180 -64.88 -35.2 80.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.8 tp -63.73 -56.2 17.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.66 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -57.52 -32.57 67.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 4.2 tppt? -64.41 -54.59 30.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.474 HG23 ' O ' ' A' ' 38' ' ' ARG . 85.4 t -57.01 -43.92 81.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 110.635 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.02 -44.0 93.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.649 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 t -64.75 -35.28 80.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.814 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 42.1 mt-10 -59.12 -53.06 62.57 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.977 HD11 HG22 ' A' ' 4' ' ' VAL . 17.7 mt -64.99 -24.32 67.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.866 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.67 -33.41 58.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.991 0.424 . . . . 0.0 111.034 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.05 11.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.735 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.496 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 16.6 mtpp -115.28 176.06 5.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.46 141.66 55.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.718 HG13 HD22 ' A' ' 46' ' ' LEU . 1.6 mp -59.66 -45.84 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.277 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 1.014 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.07 -42.15 93.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 109.635 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.15 -53.59 47.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.542 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.638 ' HB ' HD23 ' A' ' 46' ' ' LEU . 42.2 t -59.88 -35.17 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.865 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.087 HD13 HD13 ' B' ' 55' ' ' ILE . 17.9 mt -65.41 -55.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.845 0.355 . . . . 0.0 111.887 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.009 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.63 -16.07 63.31 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.431 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.816 ' HA ' HE21 ' A' ' 57' ' ' GLN . 0.0 OUTLIER -91.77 -28.83 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.712 170.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.47 -45.5 5.23 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.312 0.485 . . . . 0.0 114.312 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.84 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.465 0.29 0 CA-C-N 117.565 0.683 . . . . 0.0 110.361 -178.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 34.3 ttt85 . . . . . 0 C--O 1.226 -0.171 0 CA-C-O 121.001 0.429 . . . . 0.0 109.902 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.542 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 50.5 m-85 -99.01 -11.11 21.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.91 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 1.0 HG22 HD11 ' B' ' 46' ' ' LEU . 58.7 t -57.08 -39.56 67.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.369 . . . . 0.0 110.801 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.55 -55.72 28.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.655 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -70.43 -36.22 73.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.593 ' CD1' HD13 ' B' ' 46' ' ' LEU . 57.8 t80 -55.67 -49.11 73.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.952 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.787 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -60.5 -55.62 31.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.426 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.845 HD12 HD12 ' A' ' 9' ' ' LEU . 14.9 mt -48.37 -50.07 32.14 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.182 0.301 . . . . 0.0 111.641 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.14 83.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.498 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' B' ' 16' ' ' SER . . . -61.85 -38.64 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.26 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.787 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -78.44 -25.86 46.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.785 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.72 10.86 49.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.549 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.54 27.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.118 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.59 64.4 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' B' ' 11' ' ' ALA . 15.0 m -63.86 -20.27 65.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.971 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.99 78.06 4.06 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.4 Cg_exo -76.91 128.82 10.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.153 2.569 . . . . 0.0 113.631 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 31.4 t -71.49 141.79 50.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.48 -22.15 64.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.507 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 24.4 tptp -70.7 -40.73 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.105 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.672 ' O ' HG13 ' B' ' 26' ' ' ILE . 29.4 t70 -63.53 -39.98 95.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.636 HG13 HD11 ' B' ' 43' ' ' ILE . 47.0 mm -53.61 -49.91 53.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.348 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 75.5 mttt -55.19 -43.29 74.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.654 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -58.09 -47.78 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.728 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.672 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.7 mt -67.35 -39.18 82.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.697 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' B' ' 34' ' ' ALA . 9.4 mt -62.89 -38.96 92.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.043 172.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.03 -39.42 85.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 34.9 t -59.6 -38.54 81.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.257 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.571 HG23 HG13 ' B' ' 32' ' ' ILE . 16.6 m -96.54 -10.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 111.639 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 32.76 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.388 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 29.8 mt -107.63 132.63 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.974 0.387 . . . . 0.0 110.094 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -86.62 152.27 22.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -130.22 127.94 40.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 0.0 112.305 -174.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.08 122.64 34.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.258 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -48.85 -54.35 15.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' B' ' 41' ' ' LYS . 32.0 t70 -66.48 -48.09 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.638 -171.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.488 ' O ' HG23 ' B' ' 42' ' ' VAL . 21.7 tpp180 -65.18 -34.76 79.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.516 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.542 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.6 tp -63.96 -56.24 16.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.659 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -57.42 -32.67 67.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 4.4 tppt? -64.44 -54.49 31.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.801 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.488 HG23 ' O ' ' B' ' 38' ' ' ARG . 84.6 t -57.12 -43.68 81.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.527 0.679 . . . . 0.0 110.612 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.636 HD11 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.29 -43.98 94.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.717 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -64.06 -36.06 82.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.779 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 43.0 mt-10 -58.73 -53.03 62.98 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 1.0 HD11 HG22 ' B' ' 4' ' ' VAL . 17.4 mt -65.01 -24.52 67.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.936 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -76.85 -33.08 57.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 -29.12 11.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.718 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.501 ' HB2' ' CG2' ' B' ' 54' ' ' VAL . 16.8 mtpp -115.31 176.19 5.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.582 0.229 . . . . 0.0 110.403 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.59 141.81 55.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.717 HG13 HD22 ' B' ' 46' ' ' LEU . 1.6 mp -59.8 -45.65 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.273 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 1.009 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.34 -42.02 94.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.325 0.584 . . . . 0.0 109.59 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.93 -53.78 45.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.637 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.64 ' HB ' HD23 ' B' ' 46' ' ' LEU . 42.2 t -59.88 -35.23 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 1.087 HD13 HD13 ' A' ' 55' ' ' ILE . 18.8 mt -65.23 -55.9 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 1.014 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.82 -15.57 63.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.105 0.479 . . . . 0.0 111.48 -173.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . 0.808 HE21 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -92.04 -28.21 17.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 170.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.2 -45.43 5.04 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.842 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp . . . . . 0 N--CA 1.464 0.267 0 CA-C-N 117.444 0.622 . . . . 0.0 110.263 -178.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.6 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 19.0 tpp180 . . . . . 0 CA--C 1.533 0.304 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 43.7 m-85 -105.62 -7.23 18.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.959 HG22 HD11 ' A' ' 46' ' ' LEU . 97.8 t -69.34 -31.7 50.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.104 0.478 . . . . 0.0 109.999 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.647 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -58.55 -55.08 39.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.346 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . 0.46 ' HA ' HD11 ' B' ' 9' ' ' LEU . 1.4 p -71.44 -36.32 71.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.56 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.606 ' CD1' HD13 ' A' ' 46' ' ' LEU . 70.3 t80 -55.14 -49.07 72.71 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.823 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.7 mp -59.18 -57.43 13.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 1.019 HD12 HD12 ' B' ' 9' ' ' LEU . 13.5 mt -48.79 -48.97 40.83 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.81 82.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.32 95.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.293 0.568 . . . . 0.0 110.808 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.2 mt -75.15 -15.63 60.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.3 1.24 81.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.189 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.23 -28.75 7.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.013 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 7.0 t30 -94.85 85.27 4.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.607 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 8.8 m -61.49 -25.85 67.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.57 81.68 3.35 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 16' ' ' SER . 9.1 Cg_exo -73.11 153.39 51.83 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.787 2.992 . . . . 0.0 113.041 -170.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 23' ' ' ILE . 2.4 p -104.84 147.46 27.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.783 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.26 -26.71 68.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.959 -168.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.43 -41.21 76.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 110.169 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.692 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.3 t70 -62.74 -42.31 99.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.673 HG13 HD11 ' A' ' 43' ' ' ILE . 41.8 mm -51.67 -51.2 28.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.562 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 89.9 mttt -56.39 -42.35 77.76 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.446 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.776 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.98 -43.74 98.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.311 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.5 mt -67.97 -39.78 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 34' ' ' ALA . 15.6 mt -60.41 -43.24 96.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.75 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.422 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 22.0 t70 -63.29 -28.69 70.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -70.0 -24.86 63.36 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.24 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.51 HG23 HG13 ' A' ' 32' ' ' ILE . 14.2 m -112.87 -3.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.29 34.89 7.26 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.587 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 52.4 mt -105.41 138.6 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.037 0.419 . . . . 0.0 111.124 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.36 144.16 26.9 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.229 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -131.22 132.5 44.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.919 0.39 . . . . 0.0 111.978 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.8 m-20 -98.02 124.51 42.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -46.73 -58.66 3.65 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.03 -49.71 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 35' ' ' ASP . 20.6 tpp180 -61.28 -39.27 89.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.138 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.479 ' CD1' HG21 ' A' ' 23' ' ' ILE . 3.7 tp -63.8 -56.16 17.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.016 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -60.3 -28.98 68.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -67.01 -49.85 63.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 71.9 t -61.54 -41.9 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.843 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.673 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.49 -40.21 85.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.844 0.83 . . . . 0.0 110.651 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -71.05 -35.84 72.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.365 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 13.5 pt-20 -69.55 -37.26 76.97 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.959 HD11 HG22 ' A' ' 4' ' ' VAL . 35.9 mt -62.54 -41.53 98.94 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.272 173.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.01 -30.92 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.2 -38.46 25.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.389 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HB2' HG23 ' A' ' 54' ' ' VAL . 73.3 mmtt -103.42 -156.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.072 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -100.63 159.95 14.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.5 ' HA ' HD22 ' A' ' 46' ' ' LEU . 1.3 mp -60.26 -50.76 79.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.82 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -57.55 -40.69 79.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.903 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.5 -55.51 26.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.844 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.65 ' HB ' HD23 ' A' ' 46' ' ' LEU . 24.6 t -58.79 -35.34 55.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.654 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.581 HG21 HG21 ' B' ' 55' ' ' ILE . 2.5 mm -59.16 -61.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.412 0.625 . . . . 0.0 111.782 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.819 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.41 -15.61 62.86 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.113 -169.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.51 -44.48 10.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.968 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -48.01 7.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.82 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.533 HD13 HG23 ' A' ' 55' ' ' ILE . 2.1 mp . . . . . 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.496 . . . . 0.0 110.039 -177.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.603 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 19.2 tpp180 . . . . . 0 CA--C 1.531 0.229 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 43.9 m-85 -105.34 -7.39 18.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.972 HG22 HD11 ' B' ' 46' ' ' LEU . 99.3 t -69.46 -31.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -58.84 -54.97 41.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.39 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . 0.464 ' HA ' HD11 ' A' ' 9' ' ' LEU . 1.3 p -71.39 -36.34 71.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.506 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.597 ' CD1' HD13 ' B' ' 46' ' ' LEU . 70.8 t80 -55.28 -49.12 72.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.801 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.7 mp -58.97 -57.54 12.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.588 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 1.019 HD12 HD12 ' A' ' 9' ' ' LEU . 13.4 mt -48.87 -48.99 41.62 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.74 81.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.29 95.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -75.37 -15.62 60.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.541 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.74 0.71 81.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.319 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.66 -29.04 6.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.13 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 7.2 t30 -94.56 85.22 4.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.589 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 12.5 m -61.66 -25.59 67.48 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.52 81.41 3.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' B' ' 16' ' ' SER . 9.4 Cg_exo -73.28 153.3 50.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.674 2.916 . . . . 0.0 113.11 -170.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.425 ' O ' HG12 ' B' ' 23' ' ' ILE . 2.7 p -104.33 147.33 27.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.964 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.93 -27.29 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.951 -169.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -68.69 -40.98 79.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.057 0.456 . . . . 0.0 110.463 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.692 ' O ' HG13 ' B' ' 26' ' ' ILE . 5.4 t70 -63.34 -42.37 98.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.682 HG13 HD11 ' B' ' 43' ' ' ILE . 41.5 mm -51.5 -51.17 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.605 174.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 89.8 mttt -56.35 -42.13 77.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.696 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.784 ' HE3' ' HA ' ' B' ' 25' ' ' LYS . 0.1 OUTLIER -62.1 -44.02 97.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.692 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.5 mt -67.79 -40.14 83.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.041 0.448 . . . . 0.0 110.491 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.689 HD13 ' HB2' ' B' ' 34' ' ' ALA . 15.4 mt -60.05 -43.17 95.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.889 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.425 ' HB3' ' HE3' ' B' ' 25' ' ' LYS . 22.6 t70 -63.32 -28.29 69.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.053 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -70.7 -24.33 62.63 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.509 HG23 HG13 ' B' ' 32' ' ' ILE . 14.0 m -113.23 -3.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.295 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.56 6.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.469 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 51.8 mt -105.89 138.64 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.42 143.86 27.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.275 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.689 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -130.98 132.62 45.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.938 0.399 . . . . 0.0 111.894 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' B' ' 38' ' ' ARG . 7.7 m-20 -98.37 124.46 43.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.42 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -46.24 -59.2 3.05 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.65 -49.74 73.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.291 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.444 ' O ' HG23 ' B' ' 42' ' ' VAL . 20.7 tpp180 -61.37 -39.11 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.48 ' CD1' HG21 ' B' ' 23' ' ' ILE . 3.7 tp -63.83 -56.25 16.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -60.12 -28.81 68.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -67.27 -49.88 62.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.551 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 72.9 t -61.4 -42.01 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.828 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.682 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.53 -40.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.816 0.817 . . . . 0.0 110.585 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -70.49 -35.91 73.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.485 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' B' ' 42' ' ' VAL . 13.3 pt-20 -69.57 -37.39 76.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.972 HD11 HG22 ' B' ' 4' ' ' VAL . 36.1 mt -62.21 -41.66 98.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.359 172.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.87 -31.19 70.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.75 -38.95 26.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.306 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.525 ' HB2' HG23 ' B' ' 54' ' ' VAL . 73.4 mmtt -103.46 -156.12 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.163 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.96 159.38 15.26 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.502 ' HA ' HD22 ' B' ' 46' ' ' LEU . 1.3 mp -59.88 -50.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.819 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -57.72 -40.6 79.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.927 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.64 -55.59 25.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.902 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.663 ' HB ' HD23 ' B' ' 46' ' ' LEU . 24.8 t -58.63 -35.23 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.665 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.581 HG21 HG21 ' A' ' 55' ' ' ILE . 2.5 mm -59.36 -61.81 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.514 0.673 . . . . 0.0 111.675 173.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.82 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.36 -15.63 62.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.224 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.49 -44.44 10.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.72 -48.49 7.14 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.807 -171.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.539 HD13 HG23 ' B' ' 55' ' ' ILE . 2.0 mp . . . . . 0 C--O 1.235 0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.99 -177.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' B' ' 12' ' ' LEU . 4.7 mtp85 . . . . . 0 N--CA 1.467 0.397 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.549 ' HD1' HD11 ' A' ' 27' ' ' LEU . 27.8 m-85 -102.04 -10.89 19.32 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.916 HG22 HD11 ' A' ' 46' ' ' LEU . 99.1 t -70.05 -33.42 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.992 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -55.86 -54.57 42.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.47 0.652 . . . . 0.0 111.417 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -36.64 70.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.869 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' HD13 ' A' ' 46' ' ' LEU . 63.2 t80 -55.48 -48.76 74.05 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.758 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.6 mp -57.09 -58.96 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.516 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.97 HD12 HD12 ' B' ' 9' ' ' LEU . 15.5 mt -48.67 -50.24 34.01 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -59.45 -37.9 79.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.799 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.37 -39.67 94.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -78.57 -26.51 45.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.857 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.67 -19.27 64.83 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.723 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.57 -18.03 4.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 52.9 t30 -99.55 88.65 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.562 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 14.1 m -65.35 -17.86 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.726 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 t -112.39 78.52 2.62 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 16' ' ' SER . 15.9 Cg_exo -68.29 125.24 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.093 2.529 . . . . 0.0 112.975 -169.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.566 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 34.6 t -76.59 140.39 41.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.274 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.07 -21.09 63.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.194 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.631 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.2 mmmm -68.08 -45.26 74.26 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.732 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.1 m-20 -57.34 -46.53 83.19 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 43' ' ' ILE . 40.3 mm -50.73 -52.98 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.711 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 34.2 mttm -52.42 -45.88 66.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.817 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 16.1 tppt? -67.02 -42.68 84.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.335 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.2 mt -65.84 -38.37 82.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.118 0.485 . . . . 0.0 110.05 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 34' ' ' ALA . 14.1 mt -62.9 -38.76 92.25 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.967 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 19.9 t70 -63.73 -30.86 71.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -64.75 -39.39 93.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.893 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.507 HG23 HG13 ' A' ' 32' ' ' ILE . 15.6 m -102.2 -4.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.661 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.84 44.55 6.02 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.422 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 62.9 mt -108.81 136.75 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.92 139.77 41.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.82 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.642 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -127.91 132.78 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.359 0.6 . . . . 0.0 111.744 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.92 114.92 29.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.996 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -48.82 -50.0 36.49 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.5 0.5 . . . . 0.0 112.25 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 20.7 t70 -62.31 -58.23 8.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.621 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.6 tpp180 -61.97 -29.8 70.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.7 tp -60.87 -56.5 20.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -58.51 -34.01 70.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 34.0 mmtp -63.42 -51.11 67.12 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.286 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 74.8 t -59.78 -42.65 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.697 0.76 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.581 HD11 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.52 -40.15 83.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.308 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -68.51 -34.25 75.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.792 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 42' ' ' VAL . 44.4 mt-10 -58.38 -51.07 71.38 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.916 HD11 HG22 ' A' ' 4' ' ' VAL . 43.4 mt -64.36 -23.57 67.34 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.565 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.86 -25.92 56.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.011 0.434 . . . . 0.0 110.883 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.81 -41.83 18.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.537 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 54' ' ' VAL . 7.7 mtpt -116.6 -156.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.402 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 56.5 m-80 -94.64 173.57 7.54 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.534 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 1.3 mp -64.91 -52.13 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.438 -174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.6 -39.35 80.16 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 111.024 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.27 -57.47 12.76 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.985 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.709 ' HB ' HD23 ' A' ' 46' ' ' LEU . 42.6 t -63.47 -31.81 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.96 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.541 HG23 HD13 ' A' ' 59' ' ' ILE . 2.7 mm -58.7 -60.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.48 0.657 . . . . 0.0 111.211 170.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.878 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.72 -17.68 62.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.455 -169.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -94.23 -26.2 16.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.85 -50.59 3.05 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.808 -173.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.541 HD13 HG23 ' A' ' 55' ' ' ILE . 1.9 mp . . . . . 0 N--CA 1.463 0.192 0 CA-C-N 117.395 0.598 . . . . 0.0 109.822 -178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.575 ' HA ' HD13 ' A' ' 12' ' ' LEU . 4.8 mtp85 . . . . . 0 N--CA 1.468 0.452 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.538 ' HD1' HD11 ' B' ' 27' ' ' LEU . 27.7 m-85 -102.01 -11.06 19.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.919 HG22 HD11 ' B' ' 46' ' ' LEU . 99.5 t -70.06 -33.39 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.033 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.9 -54.56 43.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.468 0.652 . . . . 0.0 111.479 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -36.61 69.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.868 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.67 ' CD2' HD13 ' B' ' 46' ' ' LEU . 63.0 t80 -55.42 -48.77 73.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.881 175.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.76 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.7 mp -57.12 -59.05 5.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.48 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.97 HD12 HD12 ' A' ' 9' ' ' LEU . 15.5 mt -48.33 -50.65 29.5 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' B' ' 18' ' ' PRO . . . -59.26 -37.9 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.893 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.28 -39.97 95.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.3 mt -78.04 -27.06 48.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.855 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.09 -19.69 64.01 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.74 -17.98 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 53.1 t30 -99.55 88.84 3.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 14.4 m -65.32 -17.95 64.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.563 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.7 t -112.67 78.57 2.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' B' ' 16' ' ' SER . 16.2 Cg_exo -68.09 125.66 13.35 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.142 2.561 . . . . 0.0 112.861 -169.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.551 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 33.3 t -76.83 140.84 40.78 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.319 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.96 -20.5 63.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.624 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.3 mmmm -68.22 -45.43 73.32 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.102 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.736 ' O ' HG13 ' B' ' 26' ' ' ILE . 13.3 m-20 -57.13 -46.76 82.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.572 HG13 HD11 ' B' ' 43' ' ' ILE . 40.4 mm -50.56 -53.14 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.677 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.624 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 33.9 mttm -52.24 -45.85 65.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.03 -42.56 84.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.736 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.3 mt -66.07 -38.28 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 109.947 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' B' ' 34' ' ' ALA . 14.1 mt -62.92 -38.98 93.18 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.967 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -31.28 72.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.35 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.8 t -64.29 -39.5 94.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.916 0.388 . . . . 0.0 110.812 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.504 HG23 HG13 ' B' ' 32' ' ' ILE . 15.7 m -102.1 -4.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.579 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.17 44.21 6.03 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.379 173.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 63.3 mt -108.57 136.75 43.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.909 0.355 . . . . 0.0 111.047 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.81 139.33 41.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.067 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.625 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -127.14 133.3 50.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -104.67 114.64 28.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.023 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -48.4 -50.33 31.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.676 0.61 . . . . 0.0 112.168 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.64 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 20.6 t70 -62.19 -58.28 8.36 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.569 0.543 . . . . 0.0 110.546 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.515 ' O ' HG23 ' B' ' 42' ' ' VAL . 20.6 tpp180 -62.13 -29.58 70.44 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.055 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.8 tp -60.83 -56.71 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.29 -33.73 69.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 34.0 mmtp -63.7 -51.12 66.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.29 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.515 HG23 ' O ' ' B' ' 38' ' ' ARG . 73.0 t -59.83 -42.43 89.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.73 0.776 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.572 HD11 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.64 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.3 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.2 t -68.78 -33.87 74.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.945 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' B' ' 42' ' ' VAL . 44.4 mt-10 -58.54 -51.06 71.5 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.919 HD11 HG22 ' B' ' 4' ' ' VAL . 43.5 mt -64.54 -23.83 67.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.63 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.8 -25.79 56.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.965 0.412 . . . . 0.0 110.741 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.71 -42.52 17.01 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.39 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.592 ' HB2' HG23 ' B' ' 54' ' ' VAL . 7.8 mtpt -115.67 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -94.35 174.07 7.32 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.53 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.3 mp -65.3 -52.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.228 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.878 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.18 -57.2 13.9 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.137 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.7 ' HB ' HD23 ' B' ' 46' ' ' LEU . 42.6 t -63.9 -31.6 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.975 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.541 HG23 HD13 ' B' ' 59' ' ' ILE . 2.7 mm -58.82 -60.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.495 0.664 . . . . 0.0 111.201 170.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.875 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.53 -18.08 62.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.388 -169.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -94.03 -25.92 17.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 173.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -50.71 3.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.864 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.541 HD13 HG23 ' B' ' 55' ' ' ILE . 1.8 mp . . . . . 0 N--CA 1.462 0.126 0 CA-C-N 117.281 0.541 . . . . 0.0 109.664 -178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.613 ' HA ' HD13 ' B' ' 12' ' ' LEU . 35.0 ttm180 . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 121.016 0.436 . . . . 0.0 110.679 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CZ ' ' HD2' ' A' ' 2' ' ' ARG . 28.1 m-85 -86.8 -24.45 25.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.115 -171.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.952 HG22 HD11 ' A' ' 46' ' ' LEU . 75.8 t -58.96 -36.25 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 0.0 110.557 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.643 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.89 -55.17 38.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.358 0.599 . . . . 0.0 111.744 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -72.3 -37.39 68.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.671 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CD1' HD13 ' A' ' 46' ' ' LEU . 54.7 t80 -54.12 -48.7 70.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.679 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.796 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.4 mp -58.59 -58.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.372 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.977 HD12 HD12 ' B' ' 9' ' ' LEU . 14.1 mt -48.59 -48.83 38.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' ' CD1' ' A' ' 26' ' ' ILE . . . -60.53 -37.41 81.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.31 -39.35 92.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.749 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -80.43 -17.52 51.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.13 -14.56 78.92 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.973 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.9 -27.14 3.51 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.252 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 44.9 t30 -93.42 98.02 10.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 0.0 110.693 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 18' ' ' PRO . 15.2 m -74.6 -3.64 32.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.51 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -123.3 71.65 46.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 16' ' ' SER . 14.9 Cg_exo -69.2 126.36 13.58 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.322 2.681 . . . . 0.0 112.542 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.579 ' O ' HG12 ' A' ' 23' ' ' ILE . 62.5 p -78.05 147.87 34.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.03 -26.78 69.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.37 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.94 -39.37 69.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.999 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 26' ' ' ILE . 15.6 t70 -62.03 -44.67 96.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.588 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 43' ' ' ILE . 41.1 mm -50.63 -50.46 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.517 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 94.0 mttt -55.88 -43.61 77.35 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.091 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 4.3 mmmp? -65.53 -38.99 91.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 22' ' ' ASP . 11.2 mt -68.16 -39.38 81.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.071 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.4 mt -61.91 -39.98 93.89 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 171.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 4.7 t70 -59.41 -35.44 73.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.722 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 t -64.8 -35.3 80.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.655 0.264 . . . . 0.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 32' ' ' ILE . 16.8 m -102.33 -8.78 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.17 44.13 4.18 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.374 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.9 mt -116.34 135.18 57.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.868 0.334 . . . . 0.0 110.214 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.89 155.5 21.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.628 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -134.77 130.97 36.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.256 0.551 . . . . 0.0 112.07 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -94.63 116.25 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.208 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -42.32 -64.12 0.65 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.45 -45.62 93.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.61 -173.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 42' ' ' VAL . 16.6 tpp180 -64.09 -36.83 85.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.026 0.441 . . . . 0.0 110.649 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.45 HD12 HG13 ' A' ' 43' ' ' ILE . 5.8 tp -65.04 -56.77 11.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.23 -32.85 68.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -60.85 -57.59 12.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.542 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 38' ' ' ARG . 93.2 t -56.03 -44.58 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.778 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.711 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.78 -47.61 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.399 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.1 p -69.0 -28.21 66.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.123 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.39 -37.16 60.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.322 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.952 HD11 HG22 ' A' ' 4' ' ' VAL . 43.1 mt -63.17 -33.93 76.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.068 0.461 . . . . 0.0 110.614 172.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.06 -42.51 63.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -37.3 67.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.254 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -103.47 -151.48 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.408 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 22.1 m120 -114.46 141.36 47.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.507 HG13 HD22 ' A' ' 46' ' ' LEU . 1.7 mp -46.9 -56.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.395 0.435 . . . . 0.0 111.368 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.761 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 27.8 mt-10 -55.07 -36.24 65.39 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.485 0.491 . . . . 0.0 111.864 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.41 -52.46 18.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.637 ' HB ' HD23 ' A' ' 46' ' ' LEU . 54.0 t -62.27 -29.32 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.435 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' B' ' 55' ' ' ILE . 2.1 mm -60.43 -61.13 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.097 0.475 . . . . 0.0 111.459 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -72.36 -9.54 58.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.432 -170.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.82 -19.89 13.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.757 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.09 -35.08 4.33 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.442 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.546 HD13 HG23 ' A' ' 55' ' ' ILE . 1.8 mp . . . . . 0 C--N 1.328 -0.344 0 CA-C-N 117.916 0.858 . . . . 0.0 109.088 178.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.637 ' HA ' HD13 ' A' ' 12' ' ' LEU . 34.8 ttm180 . . . . . 0 N--CA 1.451 -0.42 0 CA-C-O 120.99 0.424 . . . . 0.0 110.667 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.528 ' CZ ' ' HD2' ' B' ' 2' ' ' ARG . 28.4 m-85 -86.92 -24.42 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.178 -171.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.926 HG22 HD11 ' B' ' 46' ' ' LEU . 75.3 t -58.98 -36.07 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -58.0 -55.36 35.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.655 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -72.24 -37.3 69.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.502 ' CD1' HD13 ' B' ' 46' ' ' LEU . 54.9 t80 -54.3 -48.6 71.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.729 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.79 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.3 mp -58.74 -58.34 9.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.372 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 9' ' ' LEU . 14.2 mt -48.36 -48.7 36.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' CD1' ' B' ' 26' ' ' ILE . . . -60.9 -37.75 83.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.78 -39.34 93.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 0.0 110.777 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.0 mt -80.44 -17.49 51.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.619 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.09 -14.6 78.84 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.998 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.1 -27.53 3.43 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.126 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 45.2 t30 -92.95 98.44 11.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.417 ' C ' ' HD3' ' B' ' 18' ' ' PRO . 17.0 m -75.18 -3.17 31.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.515 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.9 t -123.51 71.69 48.29 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' B' ' 16' ' ' SER . 15.0 Cg_exo -69.44 126.01 13.01 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.237 2.625 . . . . 0.0 112.746 -171.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.583 ' O ' HG12 ' B' ' 23' ' ' ILE . 64.6 p -77.8 147.98 34.99 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.671 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -63.15 -27.01 69.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.275 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.88 -39.26 69.74 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.352 0.596 . . . . 0.0 110.002 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.674 ' O ' HG13 ' B' ' 26' ' ' ILE . 15.7 t70 -62.02 -44.86 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.699 HG13 HD11 ' B' ' 43' ' ' ILE . 41.2 mm -50.53 -50.38 22.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.591 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 93.9 mttt -55.98 -43.71 77.87 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' B' ' 28' ' ' ASP . 4.3 mmmp? -65.16 -39.27 92.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.674 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.1 -39.19 80.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 0.0 110.136 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.4 mt -62.09 -39.92 94.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.679 171.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' B' ' 25' ' ' LYS . 5.6 t70 -59.59 -35.24 73.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.928 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 10.0 t -64.76 -35.48 81.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.872 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.475 HG23 HG13 ' B' ' 32' ' ' ILE . 17.1 m -102.28 -8.62 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.277 . . . . 0.0 111.622 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.7 44.75 4.15 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.281 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 37.9 mt -116.98 135.49 57.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.82 0.31 . . . . 0.0 110.295 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.96 155.97 21.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.641 0.258 . . . . 0.0 110.576 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -135.43 130.51 34.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.313 0.578 . . . . 0.0 111.985 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.23 116.37 28.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.326 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -42.53 -64.04 0.67 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.2 -45.93 91.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.809 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.48 ' O ' HG23 ' B' ' 42' ' ' VAL . 16.4 tpp180 -64.11 -36.5 84.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 110.598 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.449 ' O ' HG13 ' B' ' 43' ' ' ILE . 5.7 tp -65.27 -56.72 11.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.86 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -58.41 -32.78 68.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -60.78 -57.73 11.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 38' ' ' ARG . 94.3 t -56.03 -44.59 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.129 0.49 . . . . 0.0 110.888 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.699 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.69 -47.6 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.444 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -68.86 -28.15 66.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.156 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.57 -37.1 60.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.33 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.926 HD11 HG22 ' B' ' 4' ' ' VAL . 43.7 mt -63.14 -34.1 76.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 110.635 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -72.96 -42.07 63.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.379 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.02 -37.29 64.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.128 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -103.67 -151.49 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 23.0 m120 -114.23 141.69 47.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.507 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.7 mp -47.06 -56.73 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.274 0.359 . . . . 0.0 111.338 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.758 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 27.8 mt-10 -55.16 -35.92 65.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.16 0.505 . . . . 0.0 111.989 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.51 -52.5 17.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.13 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' B' ' 46' ' ' LEU . 55.0 t -62.38 -29.22 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.529 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 55' ' ' ILE . 2.1 mm -60.45 -61.19 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.086 0.47 . . . . 0.0 111.53 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.761 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -72.26 -9.92 59.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.529 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -104.33 -20.35 13.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.652 170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.73 -35.65 4.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.285 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.551 ' HB ' ' HG2' ' A' ' 52' ' ' GLU . 1.8 mp . . . . . 0 C--N 1.329 -0.303 0 CA-C-N 117.91 0.855 . . . . 0.0 109.023 178.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 . . . . . 0 C--O 1.226 -0.148 0 CA-C-O 121.019 0.437 . . . . 0.0 110.477 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 19.5 m-85 -90.99 -20.69 21.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -168.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.893 HG22 HD11 ' A' ' 46' ' ' LEU . 97.3 t -63.28 -33.78 63.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.043 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.57 -54.85 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.519 0.676 . . . . 0.0 111.075 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.37 -35.16 73.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.856 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.64 ' CD2' HD13 ' A' ' 46' ' ' LEU . 55.2 t80 -56.6 -47.51 79.44 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.762 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.4 mp -60.1 -57.64 11.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.514 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.926 HD12 HD12 ' B' ' 9' ' ' LEU . 14.3 mt -46.4 -49.83 17.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 26' ' ' ILE . . . -60.14 -38.83 84.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.15 -37.34 87.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.038 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.0 mt -81.46 -24.18 36.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.673 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.77 -21.27 74.9 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.9 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.63 -15.37 3.14 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.269 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 60.4 t30 -108.41 86.62 2.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 16.3 m -61.81 -27.75 68.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.736 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -108.63 82.62 1.76 Allowed Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.7 Cg_exo -78.73 147.8 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.348 2.699 . . . . 0.0 112.489 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.493 ' O ' HG12 ' A' ' 23' ' ' ILE . 89.7 p -94.14 156.96 16.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.582 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.45 -25.58 67.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.463 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -45.09 83.55 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.027 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.734 ' O ' HG13 ' A' ' 26' ' ' ILE . 55.5 m-20 -55.22 -50.9 68.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 43' ' ' ILE . 37.2 mm -50.39 -51.1 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.957 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 88.3 mttt -52.89 -49.65 65.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 123.754 0.659 . . . . 0.0 110.943 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -66.68 -35.99 81.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.6 mt -68.62 -38.25 78.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 0.0 110.02 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 13.3 mt -62.11 -41.15 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.067 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.22 -38.6 73.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.218 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -60.37 -35.78 76.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.743 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.552 HG23 HG13 ' A' ' 32' ' ' ILE . 14.6 m -103.33 -9.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.98 39.02 4.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.11 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 17.5 mt -117.69 149.42 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.56 167.76 9.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -139.57 133.54 30.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.354 0.597 . . . . 0.0 112.02 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -97.84 113.97 25.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -42.53 -58.61 2.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 12.6 m-20 -60.98 -54.71 41.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.477 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' VAL . 23.2 tpp180 -55.31 -43.33 74.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.145 0.498 . . . . 0.0 110.808 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 6.1 tp -58.44 -54.83 42.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.27 -34.23 70.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 73.5 mmtt -65.19 -53.09 50.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.086 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 38' ' ' ARG . 89.2 t -57.04 -44.18 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.407 0.623 . . . . 0.0 110.578 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.718 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -59.16 -45.99 92.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.292 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.0 t -65.57 -33.22 75.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.104 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 46.6 mt-10 -67.52 -44.25 78.85 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.893 HD11 HG22 ' A' ' 4' ' ' VAL . 45.6 mt -62.14 -41.72 98.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.377 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.26 -22.93 64.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.065 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 4.39 56.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.672 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.532 ' HD2' HG22 ' A' ' 54' ' ' VAL . 66.4 mttm -142.21 -163.62 1.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.27 144.99 25.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.55 HG13 HD22 ' A' ' 46' ' ' LEU . 1.2 mp -54.52 -50.04 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.334 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.795 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.38 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.426 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -65.75 -53.47 40.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.859 0.362 . . . . 0.0 110.284 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.69 ' HB ' HD23 ' A' ' 46' ' ' LEU . 70.7 t -62.01 -29.65 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.376 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.671 HD12 HD12 ' B' ' 55' ' ' ILE . 2.5 mm -61.6 -61.09 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.279 0.561 . . . . 0.0 111.564 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -71.04 -13.87 62.13 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.466 -170.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -97.65 -27.97 14.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.135 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.86 -33.16 7.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.943 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.484 HD13 HG23 ' A' ' 55' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.327 -0.373 0 CA-C-N 117.311 0.556 . . . . 0.0 109.559 177.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.414 ' HA ' HD13 ' A' ' 12' ' ' LEU . 79.5 mtp180 . . . . . 0 C--O 1.227 -0.116 0 CA-C-O 121.057 0.456 . . . . 0.0 110.309 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 19.2 m-85 -90.96 -20.81 21.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.918 HG22 HD11 ' B' ' 46' ' ' LEU . 98.5 t -63.27 -33.64 62.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.119 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.71 -54.78 42.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.818 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.633 ' CD2' HD13 ' B' ' 46' ' ' LEU . 56.7 t80 -56.29 -47.75 78.01 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.759 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.4 mp -60.03 -57.48 12.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.557 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.926 HD12 HD12 ' A' ' 9' ' ' LEU . 14.4 mt -46.66 -50.01 18.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.286 0.366 . . . . 0.0 111.976 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' B' ' 26' ' ' ILE . . . -59.89 -38.93 83.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.891 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.32 -36.68 84.91 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.759 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.0 mt -81.71 -24.29 36.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.97 -21.04 75.16 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.861 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.84 -15.94 3.07 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.28 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 60.7 t30 -107.88 86.78 2.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.608 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 15.4 m -61.85 -27.98 69.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.656 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -108.32 82.32 1.56 Allowed Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.8 Cg_exo -78.37 147.82 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.37 2.713 . . . . 0.0 112.428 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.502 ' O ' HG12 ' B' ' 23' ' ' ILE . 94.3 p -93.77 157.47 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.585 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.82 -25.72 67.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.456 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.0 83.96 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.086 0.469 . . . . 0.0 110.147 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.722 ' O ' HG13 ' B' ' 26' ' ' ILE . 55.6 m-20 -55.14 -51.0 67.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.705 HG13 HD11 ' B' ' 43' ' ' ILE . 37.1 mm -50.43 -50.87 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.02 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 87.6 mttt -52.9 -49.55 65.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.869 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -66.86 -36.1 81.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.007 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.722 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.8 mt -68.65 -38.3 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 110.03 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 13.7 mt -62.03 -41.07 97.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.009 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -57.52 -38.36 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.22 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -60.39 -35.93 76.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.583 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.552 HG23 HG13 ' B' ' 32' ' ' ILE . 14.0 m -103.3 -9.14 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.75 39.56 4.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.075 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 17.9 mt -118.03 149.45 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -101.46 168.14 9.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -139.47 133.67 31.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.312 0.577 . . . . 0.0 112.14 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -97.97 113.76 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.69 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -42.27 -58.22 2.25 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 12.8 m-20 -61.5 -54.49 42.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.453 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 42' ' ' VAL . 23.2 tpp180 -55.33 -43.24 74.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.019 0.437 . . . . 0.0 110.822 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 6.3 tp -58.45 -54.94 41.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.099 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.07 -34.1 69.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.477 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 73.4 mmtt -65.32 -53.17 47.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.099 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 38' ' ' ARG . 86.2 t -56.83 -44.2 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 110.596 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.705 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.22 -46.07 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.236 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -65.37 -33.42 75.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.07 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 45.2 mt-10 -67.49 -44.45 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.918 HD11 HG22 ' B' ' 4' ' ' VAL . 44.9 mt -61.99 -41.67 98.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.397 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -68.34 -22.6 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.142 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.53 5.28 54.6 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' B' ' 54' ' ' VAL . 66.4 mttm -142.55 -163.12 1.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.89 145.05 25.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.541 HG13 HD22 ' B' ' 46' ' ' LEU . 1.2 mp -54.37 -50.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.364 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.784 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.49 69.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.509 -175.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -65.57 -53.69 38.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.874 0.368 . . . . 0.0 110.131 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' B' ' 46' ' ' LEU . 71.6 t -62.05 -29.6 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.495 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.671 HD12 HD12 ' A' ' 55' ' ' ILE . 2.5 mm -61.56 -61.16 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.37 0.605 . . . . 0.0 111.587 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.795 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.94 -13.92 62.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.632 -170.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -97.59 -28.38 13.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.053 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.28 -33.29 8.18 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.751 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.48 HD13 HG23 ' B' ' 55' ' ' ILE . 1.9 mp . . . . . 0 C--N 1.325 -0.469 0 CA-C-N 117.506 0.653 . . . . 0.0 109.345 177.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.522 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 26.8 m-85 -111.01 -9.01 14.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.988 HG22 HD11 ' A' ' 46' ' ' LEU . 54.0 t -62.89 -36.5 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.162 0.506 . . . . 0.0 110.359 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.63 -54.98 40.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.69 -36.51 73.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 46' ' ' LEU . 68.6 t80 -55.49 -49.54 72.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.986 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.795 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.2 mp -59.84 -55.9 28.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.452 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.826 HD12 HD12 ' B' ' 9' ' ' LEU . 15.5 mt -48.54 -50.45 32.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.04 81.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.73 -38.37 90.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.081 0.467 . . . . 0.0 111.014 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.8 mt -79.93 -30.27 39.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.998 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.64 -23.94 73.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.437 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.67 -27.07 1.64 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.867 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 18' ' ' PRO . 2.4 t-20 -89.54 73.49 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.55 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m -60.47 -20.34 59.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.486 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.8 p -112.5 75.34 1.75 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.587 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 20.3 Cg_exo -66.17 139.68 56.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.168 2.579 . . . . 0.0 113.553 -166.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 23' ' ' ILE . 10.7 p -96.54 142.17 28.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.224 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.46 -24.47 67.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.21 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . 0.614 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.4 mmmm -64.52 -46.18 84.02 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.392 0.615 . . . . 0.0 110.134 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.73 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.1 t70 -59.06 -46.25 88.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.76 HG13 HD11 ' A' ' 43' ' ' ILE . 43.9 mm -50.95 -51.55 20.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.049 176.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.614 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 43.6 mttm -52.98 -44.27 67.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.808 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 4.4 mmmp? -70.03 -35.28 74.2 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 22' ' ' ASP . 8.9 mt -69.93 -40.91 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.065 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 34' ' ' ALA . 12.8 mt -61.86 -38.05 86.82 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 11.8 t70 -61.81 -34.91 76.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.731 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.66 -36.12 81.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.584 HG23 HG13 ' A' ' 32' ' ' ILE . 16.2 m -98.94 -10.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.07 0.462 . . . . 0.0 111.152 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.77 44.01 5.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.24 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.584 HG13 HG23 ' A' ' 30' ' ' VAL . 87.6 mt -102.65 126.87 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.26 0.552 . . . . 0.0 111.642 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.9 127.75 33.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.944 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -126.64 124.47 39.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.968 0.413 . . . . 0.0 111.796 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -92.35 121.34 33.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.14 -57.68 8.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.18 -45.27 95.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 -172.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 42' ' ' VAL . 12.3 tpp180 -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.337 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 23' ' ' ILE . 5.3 tp -58.99 -56.81 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.668 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.66 -34.96 71.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.0 109.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.6 tmtt? -63.98 -55.38 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.448 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 38' ' ' ARG . 77.2 t -55.92 -44.38 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.883 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.76 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.01 -46.11 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.198 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -66.16 -34.27 77.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.756 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 16.8 mm-40 -61.03 -52.12 66.3 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 4' ' ' VAL . 22.7 mt -60.35 -37.56 81.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.762 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.96 -25.02 60.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.027 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.18 -30.24 12.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.289 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG23 ' A' ' 54' ' ' VAL . 74.0 mmtt -106.98 -157.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -98.69 149.37 22.89 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.644 HG13 HD22 ' A' ' 46' ' ' LEU . 1.3 mp -61.33 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.809 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 1.142 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.04 -44.63 87.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.849 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.46 -56.03 26.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.659 ' HB ' HD23 ' A' ' 46' ' ' LEU . 74.1 t -60.0 -29.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.741 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 1.084 HD13 HD13 ' B' ' 55' ' ' ILE . 18.0 mt -69.15 -56.23 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 173.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 1.105 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -68.69 -14.89 63.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.169 0.509 . . . . 0.0 111.044 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -94.24 -32.75 13.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.62 169.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.95 -34.86 13.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.755 0.662 . . . . 0.0 114.755 -170.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.897 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--O 1.233 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.701 177.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 . . . . . 0 N--CA 1.465 0.299 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.519 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 26.9 m-85 -111.14 -8.89 14.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -168.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.982 HG22 HD11 ' B' ' 46' ' ' LEU . 54.2 t -63.06 -36.3 75.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.61 -55.26 37.13 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.639 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -70.36 -36.52 74.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.535 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.572 ' CD2' HD13 ' B' ' 46' ' ' LEU . 69.1 t80 -55.27 -49.74 71.3 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.796 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.3 mp -59.97 -55.73 30.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.826 HD12 HD12 ' A' ' 9' ' ' LEU . 15.5 mt -48.73 -50.37 33.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.757 0.313 . . . . 0.0 111.623 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.53 82.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.25 -38.58 91.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.8 mt -79.97 -30.01 39.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.005 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.83 73.94 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.404 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.55 -27.73 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.902 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.593 ' OD1' ' HA ' ' B' ' 18' ' ' PRO . 2.5 t-20 -89.02 73.91 8.19 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.557 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 13.5 m -60.79 -20.62 61.86 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.394 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -112.23 75.63 1.7 Allowed Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.593 ' HA ' ' OD1' ' B' ' 15' ' ' ASN . 19.4 Cg_exo -66.06 139.79 57.4 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.287 2.658 . . . . 0.0 113.386 -166.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.456 ' O ' HG12 ' B' ' 23' ' ' ILE . 11.6 p -97.05 141.97 29.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.277 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -62.25 -24.64 67.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.194 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . 0.619 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.4 mmmm -64.42 -46.17 84.4 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.384 0.611 . . . . 0.0 110.122 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.731 ' O ' HG13 ' B' ' 26' ' ' ILE . 4.9 t70 -59.25 -46.13 89.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.235 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.778 HG13 HD11 ' B' ' 43' ' ' ILE . 44.0 mm -51.05 -51.47 21.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.089 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 43.6 mttm -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' B' ' 28' ' ' ASP . 4.5 mmmp? -69.88 -35.38 74.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.731 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.0 mt -70.1 -40.76 78.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.025 0.44 . . . . 0.0 110.004 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.694 HD13 ' HB2' ' B' ' 34' ' ' ALA . 12.8 mt -62.01 -38.06 87.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.462 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' B' ' 25' ' ' LYS . 10.9 t70 -61.76 -34.65 76.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.747 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.98 -36.08 81.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.249 . . . . 0.0 111.042 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.57 HG23 HG13 ' B' ' 32' ' ' ILE . 16.2 m -98.84 -10.14 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 111.382 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 44.45 5.5 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.028 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 88.1 mt -103.03 126.27 57.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.668 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -65.07 127.98 33.86 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.953 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.694 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -127.13 124.08 38.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.0 111.775 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -92.35 121.5 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.742 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.88 -58.35 6.72 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -60.64 -45.09 95.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.418 ' O ' HG23 ' B' ' 42' ' ' VAL . 12.4 tpp180 -62.81 -38.88 92.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.405 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.562 ' CD1' HG21 ' B' ' 23' ' ' ILE . 5.3 tp -59.0 -57.01 14.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.635 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.5 -35.11 71.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.922 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 6.7 tmtt? -63.78 -55.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 38' ' ' ARG . 75.6 t -55.97 -44.22 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.362 0.601 . . . . 0.0 110.87 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.778 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.37 -45.68 89.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.202 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.4 t -66.48 -33.99 76.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.68 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 15.3 mm-40 -61.26 -52.14 65.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.176 0.512 . . . . 0.0 109.801 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.982 HD11 HG22 ' B' ' 4' ' ' VAL . 22.4 mt -60.46 -37.48 81.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.704 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.05 -24.63 60.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.7 -30.02 12.44 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.22 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.428 ' HB2' HG23 ' B' ' 54' ' ' VAL . 74.1 mmtt -106.86 -157.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -99.18 149.31 23.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.658 HG13 HD22 ' B' ' 46' ' ' LEU . 1.4 mp -61.47 -45.31 98.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.762 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 1.105 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.2 mp0 -58.22 -44.27 88.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -60.67 -56.07 25.74 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.27 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.68 ' HB ' HD23 ' B' ' 46' ' ' LEU . 75.5 t -59.92 -29.73 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.707 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 1.084 HD13 HD13 ' A' ' 55' ' ' ILE . 17.5 mt -69.33 -56.25 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 1.142 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -68.36 -15.61 63.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.49 -33.41 13.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.695 169.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.2 -35.34 15.16 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.929 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--O 1.234 0.268 0 CA-C-N 117.977 0.889 . . . . 0.0 109.471 177.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.734 ' HA ' ' CD1' ' B' ' 12' ' ' LEU . 9.6 ptp180 . . . . . 0 N--CA 1.464 0.242 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 15.9 m-85 -79.26 -26.3 42.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.968 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.869 HG22 HD11 ' A' ' 46' ' ' LEU . 62.1 t -71.66 -32.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.186 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -56.8 -54.86 41.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.66 -35.33 67.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 46' ' ' LEU . 54.9 t80 -55.47 -48.19 74.93 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.783 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.6 mp -57.4 -61.08 2.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.221 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.906 HD12 HD12 ' B' ' 9' ' ' LEU . 16.5 mt -46.98 -49.08 21.4 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 26' ' ' ILE . . . -63.05 -35.63 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.397 . . . . 0.0 110.944 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.78 -37.95 87.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 3.4 mt -81.77 -18.42 44.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.922 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.63 12.92 42.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.574 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.14 -76.38 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.819 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 40.0 t30 -145.88 143.8 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.844 -0.209 . . . . 0.0 110.796 -170.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -77.22 44.3 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.7 t -165.84 65.64 1.01 Allowed Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.07 143.47 20.36 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.903 3.069 . . . . 0.0 112.691 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 46.7 t -77.51 143.23 38.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.965 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.4 66.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.287 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.62 -40.77 76.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.713 ' O ' HG13 ' A' ' 26' ' ' ILE . 18.6 m-20 -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.227 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.624 HG13 HD11 ' A' ' 43' ' ' ILE . 28.2 mm -52.08 -51.2 31.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -52.73 -48.82 66.42 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.764 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.15 -46.68 82.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.713 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.6 mt -68.11 -37.88 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.055 0.455 . . . . 0.0 110.574 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.786 HD13 ' HB2' ' A' ' 34' ' ' ALA . 11.2 mt -63.18 -41.48 99.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.012 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.46 -26.77 68.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.6 m -70.68 -25.26 62.9 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.644 0.259 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 HG13 ' A' ' 32' ' ' ILE . 16.5 m -112.17 -9.28 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.692 0.282 . . . . 0.0 111.453 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.4 5.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.497 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 39.2 mt -111.3 136.5 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.012 0.406 . . . . 0.0 110.873 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -76.78 158.4 30.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.55 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.786 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -150.22 138.82 20.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -85.68 -178.02 6.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.792 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.51 -52.93 2.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.198 0.523 . . . . 0.0 109.851 167.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.49 -58.19 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.837 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.5 tpp180 -60.6 -35.95 77.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.5 tp -63.57 -55.63 22.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -62.24 -28.54 69.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.687 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -64.87 -49.92 68.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.324 176.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' ARG . 88.8 t -62.15 -41.32 90.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.683 0.754 . . . . 0.0 110.725 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.624 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.45 -41.39 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.714 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t -70.42 -34.95 73.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.311 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 12.3 pt-20 -72.24 -37.12 69.2 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.107 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.869 HD11 HG22 ' A' ' 4' ' ' VAL . 17.8 mt -57.14 -46.3 82.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.158 169.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -71.28 -3.6 21.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.554 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.24 -14.86 40.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.727 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 54' ' ' VAL . 13.7 mmmm -133.72 -146.89 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . 0.432 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 25.1 m-80 -105.03 162.38 13.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 166.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.472 ' CG2' HD11 ' A' ' 8' ' ' LEU . 1.6 mp -58.91 -50.9 77.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.175 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.905 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.8 mp0 -59.25 -39.06 81.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.296 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.2 -54.32 48.27 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.246 0.546 . . . . 0.0 110.02 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.78 ' HB ' HD23 ' A' ' 46' ' ' LEU . 50.9 t -65.91 -32.14 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.778 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' B' ' 55' ' ' ILE . 2.5 mm -58.09 -60.65 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.489 0.661 . . . . 0.0 111.286 170.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.906 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.44 -14.84 62.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.382 -170.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -100.6 -18.1 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.743 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.08 -40.09 3.15 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.486 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.56 HD13 HG23 ' A' ' 55' ' ' ILE . 1.9 mp . . . . . 0 C--O 1.234 0.27 0 CA-C-N 117.689 0.744 . . . . 0.0 110.078 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.712 ' HA ' HD13 ' A' ' 12' ' ' LEU . 9.5 ptp180 . . . . . 0 N--CA 1.465 0.321 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 15.7 m-85 -78.91 -26.32 43.74 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.956 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.881 HG22 HD11 ' B' ' 46' ' ' LEU . 61.2 t -71.66 -32.42 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.283 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.03 -54.75 43.21 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.482 0.658 . . . . 0.0 110.847 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -35.46 68.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.613 ' CD2' HD13 ' B' ' 46' ' ' LEU . 54.4 t80 -55.21 -48.14 74.3 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.788 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -57.82 -60.69 3.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.906 HD12 HD12 ' A' ' 9' ' ' LEU . 16.2 mt -47.27 -48.8 24.6 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' B' ' 26' ' ' ILE . . . -63.1 -35.89 81.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -65.67 -37.93 87.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 110.849 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.788 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 3.4 mt -81.75 -18.37 44.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.943 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.87 12.97 41.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.738 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.93 -75.37 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.203 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 39.1 t30 -147.02 143.78 28.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.919 -0.165 . . . . 0.0 110.782 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -76.59 44.11 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.254 0.55 . . . . 0.0 111.118 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.9 t -165.93 66.06 1.02 Allowed Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.63 143.51 18.99 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.817 3.011 . . . . 0.0 112.632 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.478 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 46.3 t -77.61 143.81 37.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.822 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.2 -25.32 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.228 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -40.38 76.3 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.091 0.472 . . . . 0.0 110.016 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.699 ' O ' HG13 ' B' ' 26' ' ' ILE . 16.4 m-20 -60.91 -44.25 97.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.151 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.627 HG13 HD11 ' B' ' 43' ' ' ILE . 27.3 mm -52.01 -51.08 31.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.492 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -52.92 -48.27 67.38 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.912 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.58 -46.64 83.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.684 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.699 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.09 -38.11 79.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.441 . . . . 0.0 110.571 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' B' ' 34' ' ' ALA . 11.3 mt -62.97 -41.23 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.149 172.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.04 -26.03 68.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -71.34 -24.79 62.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.69 0.281 . . . . 0.0 111.234 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.536 HG23 HG13 ' B' ' 32' ' ' ILE . 17.0 m -112.71 -8.86 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 111.519 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 34.64 5.58 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.669 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.6 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 39.3 mt -110.69 136.73 45.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.076 0.438 . . . . 0.0 110.777 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.84 158.51 30.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.498 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.778 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -150.29 138.62 20.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -85.55 -177.73 6.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.582 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.71 -52.95 2.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.175 0.512 . . . . 0.0 109.828 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.24 -57.83 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.863 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.465 ' O ' HG23 ' B' ' 42' ' ' VAL . 18.5 tpp180 -61.27 -35.86 78.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.5 tp -63.52 -55.59 22.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.724 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.19 -28.49 69.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.664 ' HE3' ' HA ' ' B' ' 41' ' ' LYS . 0.1 OUTLIER -64.74 -50.38 67.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.408 176.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 38' ' ' ARG . 88.6 t -61.77 -41.53 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.686 0.755 . . . . 0.0 110.684 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.627 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.29 -41.4 89.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.76 175.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -70.7 -34.82 72.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.258 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' B' ' 42' ' ' VAL . 12.3 pt-20 -72.41 -36.87 68.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.163 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.881 HD11 HG22 ' B' ' 4' ' ' VAL . 17.9 mt -57.44 -45.97 84.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.967 0.413 . . . . 0.0 110.258 169.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.66 -3.15 20.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.5 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.71 -14.55 40.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.867 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.549 ' HB2' HG23 ' B' ' 54' ' ' VAL . 13.6 mmmm -133.8 -147.06 0.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . 0.434 ' H ' ' HB3' ' B' ' 49' ' ' LYS . 27.1 m-80 -104.91 162.2 13.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 165.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.474 ' CG2' HD11 ' B' ' 8' ' ' LEU . 1.6 mp -58.67 -50.9 77.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.108 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.906 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 mp0 -59.46 -38.79 81.69 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.127 0.267 . . . . 0.0 111.18 -174.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -59.14 -54.98 40.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.04 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.785 ' HB ' HD23 ' B' ' 46' ' ' LEU . 52.8 t -65.17 -32.34 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 55' ' ' ILE . 2.5 mm -58.18 -60.46 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.458 0.647 . . . . 0.0 111.337 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.905 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.2 -15.42 62.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.448 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -99.88 -18.72 16.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.618 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -39.66 3.29 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.98 -0.629 . . . . 0.0 114.454 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.57 HD13 HG23 ' B' ' 55' ' ' ILE . 1.9 mp . . . . . 0 C--O 1.235 0.315 0 CA-C-N 117.878 0.839 . . . . 0.0 110.137 -179.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ARG . . . . . 0.64 ' HA ' HD13 ' B' ' 12' ' ' LEU . 96.3 mtt180 . . . . . 0 CA--C 1.521 -0.14 0 CA-C-O 121.373 0.606 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 21.3 m-85 -78.37 -26.58 46.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.388 -168.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.851 HG22 HD11 ' A' ' 46' ' ' LEU . 60.0 t -64.2 -31.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.809 0.338 . . . . 0.0 110.827 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -59.67 -54.58 44.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.473 0.654 . . . . 0.0 111.064 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -72.38 -34.99 68.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.759 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' TYR . . . . . 0.694 ' CD1' HD13 ' A' ' 46' ' ' LEU . 48.7 t80 -55.34 -47.96 74.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.664 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.3 mp -58.19 -59.68 4.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.275 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.891 HD12 HD12 ' B' ' 9' ' ' LEU . 16.2 mt -46.34 -49.93 17.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.24 89.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.72 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -62.72 -37.82 88.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 110.773 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.7 mt -80.07 -28.64 39.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.354 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.78 -28.57 73.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.969 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.86 -33.17 0.48 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.848 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 3.7 p30 -96.99 107.41 19.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 11.6 m -69.88 -19.68 63.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.519 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p -117.14 78.6 10.18 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.426 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 16' ' ' SER . 10.7 Cg_exo -73.14 140.87 31.7 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.609 2.873 . . . . 0.0 112.607 -171.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' SER . . . . . 0.519 ' O ' HG12 ' A' ' 23' ' ' ILE . 54.2 p -87.92 151.37 22.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.5 -25.03 68.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.166 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -69.41 -40.56 77.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 110.273 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.699 ' O ' HG13 ' A' ' 26' ' ' ILE . 46.2 m-20 -58.49 -46.88 85.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.75 HG13 HD11 ' A' ' 43' ' ' ILE . 39.6 mm -52.31 -49.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.888 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 84.5 mttt -59.37 -41.71 89.92 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -58.03 -46.98 84.44 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 111.13 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.699 HG13 ' O ' ' A' ' 22' ' ' ASP . 7.3 mt -70.43 -42.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.765 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 34' ' ' ALA . 13.8 mt -61.25 -36.77 80.9 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.02 -39.99 96.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 98.6 p -62.65 -37.08 84.96 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.474 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' VAL . . . . . 0.493 HG23 HG13 ' A' ' 32' ' ' ILE . 19.5 m -94.68 -10.24 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.203 0.525 . . . . 0.0 110.8 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 46.69 5.43 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.982 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.583 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 81.2 mt -104.58 131.43 53.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.04 0.42 . . . . 0.0 111.756 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.4 127.52 33.31 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.997 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -125.87 136.05 52.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -102.61 120.9 41.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.3 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -45.38 -59.59 2.6 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.903 0.752 . . . . 0.0 112.64 -171.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 8.9 p-10 -67.6 -50.28 58.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.089 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -56.32 -36.51 68.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.506 ' CD1' HG21 ' A' ' 23' ' ' ILE . 4.1 tp -58.64 -56.27 24.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.958 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -58.07 -33.73 69.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.591 0.234 . . . . 0.0 110.767 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.0 mmmm -64.56 -50.47 67.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.96 -42.63 90.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.465 0.65 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.75 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.24 -43.26 89.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.859 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -66.98 -35.39 79.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.608 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 54.7 mm-40 -57.53 -50.9 71.58 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 4' ' ' VAL . 30.5 mt -60.58 -35.19 75.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.997 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.36 -29.42 63.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.113 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.74 -34.64 15.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.129 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.498 ' HD2' HG22 ' A' ' 54' ' ' VAL . 66.6 mttm -102.93 -152.24 0.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 0.0 110.288 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.23 152.04 30.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ILE . . . . . 0.533 ' HA ' ' CD2' ' A' ' 46' ' ' LEU . 1.5 mp -55.91 -54.98 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLU . . . . . 0.902 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.35 -34.55 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 110.715 -174.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 30.7 t70 -66.45 -53.58 33.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.863 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.656 ' HB ' HD23 ' A' ' 46' ' ' LEU . 70.7 t -61.28 -31.2 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.662 HG21 HG21 ' B' ' 55' ' ' ILE . 2.9 mm -59.6 -61.26 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.415 0.626 . . . . 0.0 111.427 171.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.36 -18.71 63.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.447 -169.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 83.2 mt-30 -93.51 -27.49 16.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 172.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.59 -36.5 6.47 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.278 -0.487 . . . . 0.0 114.134 -171.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ILE . . . . . 0.522 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' ARG . . . . . 0.661 ' HA ' HD13 ' A' ' 12' ' ' LEU . 96.2 mtt180 . . . . . 0 C--O 1.226 -0.157 0 CA-C-O 121.333 0.587 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' TYR . . . . . 0.455 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 21.3 m-85 -78.44 -26.64 46.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.337 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' VAL . . . . . 0.887 HG22 HD11 ' B' ' 46' ' ' LEU . 61.1 t -64.19 -31.87 55.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 110.938 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -59.67 -54.52 45.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.419 0.628 . . . . 0.0 110.909 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -72.4 -35.31 68.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.584 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' TYR . . . . . 0.691 ' CD1' HD13 ' B' ' 46' ' ' LEU . 49.1 t80 -55.12 -47.91 74.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.704 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.3 mp -58.06 -59.82 4.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.2 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' LEU . . . . . 0.891 HD12 HD12 ' A' ' 9' ' ' LEU . 16.5 mt -46.44 -49.86 17.59 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.21 89.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.703 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -62.93 -37.81 88.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.694 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.6 mt -79.84 -28.92 40.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.326 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.03 -29.82 75.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.92 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.44 -32.99 0.45 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.994 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 3.6 p30 -97.25 107.33 19.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.228 0.537 . . . . 0.0 110.859 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 8.1 m -69.62 -19.72 63.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.269 0.557 . . . . 0.0 110.654 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 41.1 p -117.38 78.76 11.12 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.246 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' B' ' 16' ' ' SER . 11.2 Cg_exo -73.23 140.62 31.04 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.521 2.814 . . . . 0.0 112.657 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' SER . . . . . 0.51 ' O ' HG12 ' B' ' 23' ' ' ILE . 55.9 p -87.66 152.14 22.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -64.33 -24.43 67.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.133 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -69.6 -40.32 76.74 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.302 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' ASP . . . . . 0.698 ' O ' HG13 ' B' ' 26' ' ' ILE . 48.6 m-20 -58.65 -47.1 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ILE . . . . . 0.759 HG13 HD11 ' B' ' 43' ' ' ILE . 39.2 mm -51.97 -49.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.99 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 84.1 mttt -59.59 -41.59 90.63 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.11 -46.95 84.7 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.521 0.677 . . . . 0.0 111.099 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' ILE . . . . . 0.698 HG13 ' O ' ' B' ' 22' ' ' ASP . 7.2 mt -70.54 -42.26 78.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.807 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' B' ' 34' ' ' ALA . 13.6 mt -61.07 -36.92 80.91 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.15 -39.51 94.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.451 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 94.6 p -62.5 -37.62 86.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' VAL . . . . . 0.485 HG23 HG13 ' B' ' 32' ' ' ILE . 19.3 m -94.45 -10.32 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.3 46.91 5.4 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.91 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 81.6 mt -104.58 131.69 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.439 . . . . 0.0 111.615 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.78 127.64 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.146 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -125.93 135.73 52.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.99 0.424 . . . . 0.0 111.765 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -102.22 120.83 41.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -45.09 -59.87 2.39 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.868 0.73 . . . . 0.0 112.674 -171.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ASP . . . . . 0.674 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 8.7 p-10 -67.62 -50.0 60.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.129 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -56.36 -36.61 68.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.951 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 39' ' ' LEU . . . . . 0.489 ' CD1' HG21 ' B' ' 23' ' ' ILE . 4.1 tp -58.5 -56.48 21.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.993 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -58.17 -33.26 69.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.473 0.178 . . . . 0.0 110.617 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 41' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 13.9 mmmm -65.0 -50.61 65.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.008 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.8 -42.39 88.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.563 0.697 . . . . 0.0 110.816 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 43' ' ' ILE . . . . . 0.759 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.42 -43.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.834 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -66.32 -35.55 80.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.5 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 45' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 61.1 mm-40 -57.45 -51.19 70.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.223 0.535 . . . . 0.0 109.701 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 46' ' ' LEU . . . . . 0.887 HD11 HG22 ' B' ' 4' ' ' VAL . 30.5 mt -60.45 -35.32 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.018 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.9 -29.44 64.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.004 0.43 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.65 -34.79 15.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.087 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 49' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' B' ' 54' ' ' VAL . 66.5 mttm -102.86 -151.9 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.935 0.398 . . . . 0.0 110.22 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.54 152.16 30.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 51' ' ' ILE . . . . . 0.534 ' HA ' ' CD2' ' B' ' 46' ' ' LEU . 1.5 mp -55.83 -55.06 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 52' ' ' GLU . . . . . 0.917 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.36 -34.67 74.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.909 0.385 . . . . 0.0 110.69 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.41 -53.66 33.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.697 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 54' ' ' VAL . . . . . 0.656 ' HB ' HD23 ' B' ' 46' ' ' LEU . 69.8 t -61.16 -31.33 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.449 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 55' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 55' ' ' ILE . 2.9 mm -59.47 -61.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.386 0.612 . . . . 0.0 111.419 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 56' ' ' ALA . . . . . 0.902 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.69 -18.36 63.54 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.36 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.58 -27.48 16.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.99 -36.26 6.43 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.351 -0.452 . . . . 0.0 114.035 -171.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 59' ' ' ILE . . . . . 0.536 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp . . . . . 0 C--N 1.329 -0.291 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.154 0 CA-C-O 120.932 0.396 . . . . 0.0 110.706 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.738 ' HB3' HG12 ' A' ' 59' ' ' ILE . 24.6 ptm -98.24 -5.27 33.57 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.671 -0.241 . . . . 0.0 111.293 -175.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.785 ' HA ' HD13 ' B' ' 12' ' ' LEU . 20.6 mmm180 -57.37 -47.07 82.61 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.528 -175.269 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.555 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 16.4 m-85 -91.04 -20.35 22.17 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 112.396 0.517 . . . . 0.0 112.396 -174.525 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.794 HG22 HD11 ' A' ' 46' ' ' LEU . 73.0 t -60.41 -37.24 73.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.087 0.47 . . . . 0.0 110.78 -178.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.679 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.17 -54.61 44.88 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.392 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.66 -35.83 67.83 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.975 -179.324 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.673 ' CD2' HD13 ' A' ' 46' ' ' LEU . 47.9 t80 -54.79 -50.91 67.36 Favored 'General case' 0 C--O 1.238 0.464 0 CA-C-N 116.081 -0.509 . . . . 0.0 109.847 174.423 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.799 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.9 mp -57.86 -55.88 29.15 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.205 178.095 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.736 HD12 HD12 ' B' ' 9' ' ' LEU . 12.5 mt -47.55 -50.33 24.09 Favored 'General case' 0 N--CA 1.469 0.502 0 N-CA-C 111.957 0.354 . . . . 0.0 111.957 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.71 -39.29 88.02 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.66 -178.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.2 -41.08 99.11 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-O 121.278 0.561 . . . . 0.0 110.776 179.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.799 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.3 mt -75.65 -23.25 56.28 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.517 -0.765 . . . . 0.0 110.312 -176.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.83 10.2 53.02 Favored Glycine 0 N--CA 1.449 -0.44 0 CA-C-N 115.646 -0.706 . . . . 0.0 112.612 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.37 -11.51 39.68 Favored Glycine 0 N--CA 1.447 -0.572 0 C-N-CA 120.527 -0.844 . . . . 0.0 112.877 175.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 62.6 t30 -103.86 81.2 1.85 Allowed 'General case' 0 C--N 1.32 -0.701 0 CA-C-O 120.999 0.428 . . . . 0.0 109.913 -178.439 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.549 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 26.2 t -64.16 -28.77 69.99 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.687 -0.688 . . . . 0.0 111.49 -175.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.9 t -111.51 81.0 2.93 Favored Pre-proline 0 C--N 1.324 -0.512 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 175.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.61 ' HA ' ' ND2' ' A' ' 15' ' ' ASN . 4.5 Cg_exo -79.8 137.52 12.69 Favored 'Trans proline' 0 N--CA 1.462 -0.379 0 C-N-CA 123.688 2.925 . . . . 0.0 113.353 -170.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.442 ' O ' HG12 ' A' ' 23' ' ' ILE . 45.3 t -79.52 147.13 32.31 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.66 175.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.53 -26.48 68.58 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.27 -178.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.48 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 48.1 mmtm -67.16 -42.29 84.56 Favored 'General case' 0 C--O 1.237 0.435 0 CA-C-O 121.12 0.486 . . . . 0.0 110.291 177.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.669 ' O ' HG13 ' A' ' 26' ' ' ILE . 20.5 m-20 -58.37 -45.33 88.45 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.522 -0.763 . . . . 0.0 109.308 175.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 43' ' ' ILE . 41.4 mm -51.62 -50.12 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 176.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.48 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 59.0 mttm -53.86 -46.4 71.27 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.108 177.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 8.4 mmpt? -62.75 -41.85 99.4 Favored 'General case' 0 C--O 1.24 0.591 0 CA-C-O 121.285 0.564 . . . . 0.0 111.673 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.669 HG13 ' O ' ' A' ' 22' ' ' ASP . 13.0 mt -68.35 -36.45 75.02 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-O 121.305 0.574 . . . . 0.0 110.081 -179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.644 HD13 ' HB2' ' A' ' 34' ' ' ALA . 15.6 mt -65.87 -35.91 81.95 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.595 -0.729 . . . . 0.0 110.141 172.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -60.75 -33.98 73.75 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.474 0.178 . . . . 0.0 110.992 175.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 22.7 t -57.97 -42.91 86.04 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.201 179.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG21 ' HB3' ' B' ' 9' ' ' LEU . 15.9 m -104.22 -3.25 9.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.062 0.458 . . . . 0.0 111.726 -176.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.29 50.37 4.09 Favored Glycine 0 CA--C 1.518 0.252 0 CA-C-N 116.026 -0.534 . . . . 0.0 113.496 174.595 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.631 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 59.2 mt -116.0 147.36 19.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-O 121.083 0.468 . . . . 0.0 111.343 179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.12 159.53 33.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.411 -0.813 . . . . 0.0 110.472 178.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.644 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -159.25 117.28 2.81 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 112.911 0.708 . . . . 0.0 112.911 175.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 32.2 t70 -79.9 176.97 9.26 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 114.668 -1.151 . . . . 0.0 108.624 170.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -101.95 -48.0 4.39 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.999 -0.438 . . . . 0.0 110.644 176.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.713 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 13.5 t70 -64.45 -60.75 2.79 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.229 -177.255 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 42' ' ' VAL . 8.7 tpp180 -54.89 -40.51 69.86 Favored 'General case' 0 C--O 1.231 0.128 0 O-C-N 123.439 0.462 . . . . 0.0 110.731 -179.285 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.555 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 4.2 tp -61.33 -53.97 49.84 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.621 -0.718 . . . . 0.0 110.995 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.8 t-20 -61.73 -30.14 70.57 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 121.013 -0.275 . . . . 0.0 110.51 179.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.713 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 29.3 mmtp -66.14 -47.74 73.08 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.777 -0.192 . . . . 0.0 110.761 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 38' ' ' ARG . 92.7 t -61.2 -43.63 96.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.262 0 CA-C-O 121.378 0.609 . . . . 0.0 110.378 176.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.32 -44.39 92.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.561 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.09 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 10.8 t -66.6 -35.72 80.88 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.174 -0.921 . . . . 0.0 110.652 -179.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 29.5 mm-40 -57.77 -53.57 56.67 Favored 'General case' 0 CA--C 1.522 -0.125 0 N-CA-C 109.731 -0.47 . . . . 0.0 109.731 173.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.794 HD11 HG22 ' A' ' 4' ' ' VAL . 42.0 mt -61.77 -29.85 70.4 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.54 -0.754 . . . . 0.0 111.91 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -77.45 -39.51 46.47 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.239 -179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.94 -23.16 59.99 Favored Glycine 0 N--CA 1.453 -0.211 0 C-N-CA 120.758 -0.734 . . . . 0.0 112.454 -179.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.617 ' HD2' HG22 ' A' ' 54' ' ' VAL . 94.3 mttt -113.75 -164.79 0.95 Allowed 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.96 0.409 . . . . 0.0 109.954 179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.531 ' HB3' ' OE2' ' A' ' 52' ' ' GLU . 93.6 m-20 -93.21 146.84 23.39 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 170.166 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.889 ' HB ' ' HB1' ' B' ' 63' ' ' ALA . 1.5 mp -57.34 -47.46 84.49 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 C-N-CA 120.582 -0.447 . . . . 0.0 110.215 -178.552 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 1.053 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.9 OUTLIER -59.04 -40.97 86.69 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.173 -177.411 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.498 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 33.4 t70 -62.88 -56.56 16.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.284 -0.871 . . . . 0.0 109.988 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.711 ' HB ' HD23 ' A' ' 46' ' ' LEU . 53.0 t -58.23 -40.26 76.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.099 179.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.04 HD13 HD13 ' B' ' 55' ' ' ILE . 14.5 mt -60.44 -56.1 19.93 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.446 0 CA-C-O 121.169 0.509 . . . . 0.0 111.75 175.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.056 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.55 -14.13 62.69 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 115.778 -0.646 . . . . 0.0 111.575 -173.116 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.498 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 96.4 mt-30 -88.97 -50.39 6.21 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.466 170.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.12 9.95 67.71 Favored Glycine 0 CA--C 1.52 0.391 0 N-CA-C 114.991 0.756 . . . . 0.0 114.991 -167.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.738 HG12 ' HB3' ' A' ' 1' ' ' MET . 5.7 mt -103.39 -65.6 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 117.668 0.734 . . . . 0.0 110.696 174.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.458 ' H ' ' HG2' ' B' ' 52' ' ' GLU . . . 71.37 -156.02 52.72 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.858 -0.687 . . . . 0.0 112.307 178.626 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.0 mmmt -75.21 12.52 0.9 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.851 0.357 . . . . 0.0 111.816 -176.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.24 -21.27 58.72 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.85 ' HB1' ' HB ' ' B' ' 51' ' ' ILE . . . -64.96 -79.09 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.775 -1.102 . . . . 0.0 112.161 -178.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.5 p -129.76 133.71 47.16 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.261 0.553 . . . . 0.0 111.42 -175.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.684 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -89.24 145.49 34.26 Favored Pre-proline 0 C--N 1.324 -0.523 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 173.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.684 ' HD2' HG22 ' A' ' 65' ' ' VAL . 17.9 Cg_endo -60.19 88.17 0.08 OUTLIER 'Trans proline' 0 CA--C 1.528 0.211 0 C-N-CA 123.19 2.593 . . . . 0.0 112.69 -179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.86 101.19 12.62 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.802 176.257 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.89 51.12 4.12 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 111.04 -0.824 . . . . 0.0 111.04 -173.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.751 -1.027 . . . . 0.0 111.528 -177.261 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.935 0.398 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.731 ' HB3' HG12 ' B' ' 59' ' ' ILE . 24.4 ptm -97.8 -5.24 35.26 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.761 0.315 . . . . 0.0 111.379 -174.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.77 ' HA ' HD13 ' A' ' 12' ' ' LEU . 20.5 mmm180 -57.46 -47.31 82.18 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.915 -0.584 . . . . 0.0 111.476 -175.403 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.569 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 16.4 m-85 -90.91 -20.26 22.41 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 112.46 0.541 . . . . 0.0 112.46 -174.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.813 HG22 HD11 ' B' ' 46' ' ' LEU . 71.5 t -60.57 -37.15 74.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.014 0.435 . . . . 0.0 110.787 -178.384 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.689 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.92 -54.73 43.24 Favored 'General case' 0 C--N 1.318 -0.794 0 CA-C-N 115.671 -0.695 . . . . 0.0 111.445 179.201 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.69 -35.72 67.71 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.957 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.665 ' CD2' HD13 ' B' ' 46' ' ' LEU . 46.6 t80 -55.03 -50.77 68.23 Favored 'General case' 0 C--O 1.238 0.5 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 174.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.801 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.8 mp -57.84 -55.88 29.2 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.298 178.049 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.736 HD12 HD12 ' A' ' 9' ' ' LEU . 12.4 mt -47.6 -50.39 24.29 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 123.289 0.368 . . . . 0.0 111.918 179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.8 -39.08 87.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.611 -178.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.51 -40.52 97.29 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.232 0.539 . . . . 0.0 110.869 178.961 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.801 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.2 mt -76.16 -22.6 55.21 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.673 -0.694 . . . . 0.0 110.409 -176.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -82.47 10.88 53.83 Favored Glycine 0 N--CA 1.451 -0.327 0 CA-C-N 115.664 -0.698 . . . . 0.0 112.719 -179.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.71 -11.0 41.92 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.653 -0.784 . . . . 0.0 112.81 175.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.61 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 62.5 t30 -104.16 81.46 1.84 Allowed 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.081 0.467 . . . . 0.0 110.017 -178.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.543 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 24.8 t -64.42 -28.65 69.83 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.657 -0.701 . . . . 0.0 111.387 -175.228 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 11.9 t -111.67 82.01 3.63 Favored Pre-proline 0 C--N 1.322 -0.607 0 N-CA-C 108.863 -0.791 . . . . 0.0 108.863 175.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.61 ' HA ' ' ND2' ' B' ' 15' ' ' ASN . 4.3 Cg_exo -80.36 137.52 11.88 Favored 'Trans proline' 0 N--CA 1.459 -0.553 0 C-N-CA 123.661 2.908 . . . . 0.0 113.374 -170.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.429 ' O ' HG12 ' B' ' 23' ' ' ILE . 47.5 t -79.53 147.23 32.26 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.633 175.455 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.414 ' HB1' ' CD2' ' B' ' 39' ' ' LEU . . . -62.75 -26.22 68.59 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.681 -0.69 . . . . 0.0 111.227 -178.548 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.477 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 48.2 mmtm -67.15 -42.15 84.85 Favored 'General case' 0 C--O 1.238 0.454 0 CA-C-O 121.183 0.516 . . . . 0.0 110.23 177.699 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.647 ' O ' HG13 ' B' ' 26' ' ' ILE . 17.3 m-20 -58.3 -45.68 87.51 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.383 -0.826 . . . . 0.0 109.325 175.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.635 HG13 HD11 ' B' ' 43' ' ' ILE . 41.3 mm -51.47 -50.29 29.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 115.305 -0.862 . . . . 0.0 110.425 177.068 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.477 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 59.4 mttm -53.59 -46.48 70.35 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.714 -0.675 . . . . 0.0 111.137 178.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 8.2 mmpt? -62.85 -41.6 99.42 Favored 'General case' 0 C--O 1.24 0.553 0 CA-C-O 121.235 0.541 . . . . 0.0 111.739 -178.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.647 HG13 ' O ' ' B' ' 22' ' ' ASP . 12.6 mt -68.51 -36.44 74.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-O 121.18 0.514 . . . . 0.0 110.144 179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.655 HD13 ' HB2' ' B' ' 34' ' ' ALA . 15.8 mt -65.87 -36.01 82.23 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.794 -0.639 . . . . 0.0 110.174 172.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -60.32 -34.4 73.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.496 0.189 . . . . 0.0 110.899 175.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 25.9 t -57.66 -43.06 84.71 Favored 'General case' 0 CA--C 1.533 0.294 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.278 179.649 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.509 HG21 ' HB3' ' A' ' 9' ' ' LEU . 15.9 m -104.12 -3.06 9.64 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 120.973 0.416 . . . . 0.0 111.678 -176.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 84.64 51.32 3.9 Favored Glycine 0 N--CA 1.452 -0.284 0 CA-C-N 116.106 -0.497 . . . . 0.0 113.307 174.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 58.7 mt -116.48 147.57 19.77 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 CA-C-O 121.155 0.503 . . . . 0.0 111.358 178.668 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 8.6 mt-10 -72.43 159.44 33.97 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.583 177.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.655 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -159.38 116.68 2.69 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-O 121.62 0.724 . . . . 0.0 112.935 176.157 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -79.62 177.09 9.13 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.651 -1.159 . . . . 0.0 108.666 170.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -102.0 -47.99 4.39 Favored 'General case' 0 C--N 1.321 -0.646 0 O-C-N 122.168 -0.333 . . . . 0.0 110.679 176.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.708 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 13.0 t70 -64.43 -60.93 2.58 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.258 -177.236 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.452 ' O ' HG23 ' B' ' 42' ' ' VAL . 8.6 tpp180 -54.76 -40.63 69.57 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.785 -179.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.569 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 4.2 tp -61.24 -54.08 48.66 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.896 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.9 t-20 -61.76 -30.15 70.6 Favored 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 121.071 -0.252 . . . . 0.0 110.442 179.479 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.708 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 29.4 mmtp -66.26 -47.47 73.59 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.749 -0.205 . . . . 0.0 110.729 176.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.452 HG23 ' O ' ' B' ' 38' ' ' ARG . 91.7 t -61.36 -43.63 97.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.263 0 CA-C-O 121.317 0.58 . . . . 0.0 110.435 176.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.635 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.24 -44.54 92.27 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 CA-C-N 115.456 -0.793 . . . . 0.0 111.1 176.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 10.3 t -66.38 -35.68 80.96 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.161 -0.927 . . . . 0.0 110.706 -179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 27.6 mm-40 -57.78 -53.43 58.3 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-O 121.071 0.462 . . . . 0.0 109.814 173.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.813 HD11 HG22 ' B' ' 4' ' ' VAL . 42.1 mt -61.93 -29.72 70.42 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.47 -0.786 . . . . 0.0 111.986 179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -77.56 -39.56 45.38 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.161 -178.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.32 -22.53 60.43 Favored Glycine 0 C--N 1.331 0.276 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.297 -179.275 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.622 ' HD2' HG22 ' B' ' 54' ' ' VAL . 94.3 mttt -114.1 -165.06 0.97 Allowed 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.882 -0.414 . . . . 0.0 109.882 178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.527 ' HB3' ' OE2' ' B' ' 52' ' ' GLU . 93.4 m-20 -92.85 146.99 23.22 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.687 -0.857 . . . . 0.0 108.687 170.189 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.85 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 1.5 mp -57.59 -47.44 85.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.293 -178.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 1.056 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.9 OUTLIER -59.08 -40.79 86.3 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.686 -0.688 . . . . 0.0 110.187 -177.482 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.503 ' O ' ' HG3' ' B' ' 57' ' ' GLN . 33.6 t70 -63.12 -56.6 15.45 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.08 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.695 ' HB ' HD23 ' B' ' 46' ' ' LEU . 54.6 t -57.85 -40.22 75.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.236 179.066 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 1.04 HD13 HD13 ' A' ' 55' ' ' ILE . 14.5 mt -60.63 -56.06 20.29 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.48 0 CA-C-O 121.097 0.475 . . . . 0.0 111.597 175.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 1.053 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.58 -13.94 62.58 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.923 -0.581 . . . . 0.0 111.623 -173.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.503 ' HG3' ' O ' ' B' ' 53' ' ' ASP . 96.9 mt-30 -89.05 -50.67 6.03 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.338 171.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -95.88 9.76 68.26 Favored Glycine 0 CA--C 1.522 0.495 0 N-CA-C 115.01 0.764 . . . . 0.0 115.01 -167.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.731 HG12 ' HB3' ' B' ' 1' ' ' MET . 5.7 mt -103.17 -65.55 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-N 117.72 0.76 . . . . 0.0 110.584 174.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.45 ' H ' ' HG2' ' A' ' 52' ' ' GLU . . . 71.03 -156.3 53.14 Favored Glycine 0 N--CA 1.45 -0.375 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.452 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 32.1 mmmt -74.96 12.45 0.86 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.049 0.452 . . . . 0.0 111.778 -176.164 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 1.5 tt -75.07 -21.51 58.93 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 171.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.889 ' HB1' ' HB ' ' A' ' 51' ' ' ILE . . . -64.86 -78.99 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 114.824 -1.08 . . . . 0.0 112.084 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 p -129.87 133.5 46.93 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.119 0.485 . . . . 0.0 111.394 -175.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.707 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -89.29 145.65 34.51 Favored Pre-proline 0 C--N 1.322 -0.629 0 N-CA-C 108.496 -0.927 . . . . 0.0 108.496 173.683 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.707 ' HD2' HG22 ' B' ' 65' ' ' VAL . 18.4 Cg_endo -60.35 89.2 0.08 OUTLIER 'Trans proline' 0 C--O 1.235 0.328 0 C-N-CA 123.102 2.535 . . . . 0.0 112.715 -179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -86.96 100.67 12.77 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.807 176.657 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 83.93 51.77 3.89 Favored Glycine 0 N--CA 1.448 -0.565 0 C-N-CA 120.506 -0.854 . . . . 0.0 111.063 -173.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.835 0 CA-C-O 119.002 -0.888 . . . . 0.0 111.506 -177.401 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.573 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.207 0 CA-C-O 120.696 0.284 . . . . 0.0 110.934 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.707 ' SD ' HG13 ' A' ' 59' ' ' ILE . 18.4 ttt -119.16 115.84 25.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.689 0.28 . . . . 0.0 111.519 -178.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.75 ' HA ' HD13 ' B' ' 12' ' ' LEU . 42.6 ttm180 175.36 -55.87 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.148 172.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.489 ' HD1' HD11 ' A' ' 27' ' ' LEU . 39.2 m-85 -83.54 -16.56 44.97 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.111 -0.95 . . . . 0.0 111.307 -174.461 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.951 HG22 HD11 ' A' ' 46' ' ' LEU . 91.7 t -64.0 -36.12 75.76 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.38 0 CA-C-N 116.494 -0.321 . . . . 0.0 110.536 177.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.592 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -56.7 -54.85 41.43 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.508 0.671 . . . . 0.0 111.282 179.339 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.408 ' HB3' ' HB ' ' A' ' 26' ' ' ILE . 0.3 OUTLIER -71.72 -34.97 70.02 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.349 -0.842 . . . . 0.0 110.797 178.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.582 ' CD2' HD13 ' A' ' 46' ' ' LEU . 65.5 t80 -55.45 -47.82 75.43 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-N 116.053 -0.521 . . . . 0.0 109.837 174.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.748 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.0 mp -60.11 -57.26 13.58 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.329 177.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.846 HD12 HD12 ' B' ' 9' ' ' LEU . 14.9 mt -47.48 -50.8 22.34 Favored 'General case' 0 N--CA 1.47 0.574 0 N-CA-C 112.094 0.405 . . . . 0.0 112.094 178.5 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.65 -37.87 79.9 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.636 -178.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.53 -40.92 96.49 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.028 -0.533 . . . . 0.0 111.131 179.452 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.783 HD13 ' HA ' ' B' ' 2' ' ' ARG . 4.8 mt -74.41 -24.5 59.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.385 -176.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -69.35 -19.34 74.23 Favored Glycine 0 N--CA 1.45 -0.394 0 CA-C-N 115.671 -0.695 . . . . 0.0 112.372 178.676 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 142.54 -33.8 1.85 Allowed Glycine 0 N--CA 1.448 -0.527 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.045 178.692 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.574 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 84.8 m-20 -92.47 88.07 6.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 120.604 0.24 . . . . 0.0 110.645 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.616 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 6.2 m -60.87 -27.79 68.39 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.349 0.595 . . . . 0.0 110.342 178.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 48.7 p -108.79 82.52 1.79 Allowed Pre-proline 0 N--CA 1.445 -0.715 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.345 174.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.616 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.8 Cg_exo -80.33 152.92 20.97 Favored 'Trans proline' 0 C--O 1.234 0.313 0 C-N-CA 123.811 3.008 . . . . 0.0 113.038 -172.136 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.447 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 14.2 t -89.42 146.33 24.73 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 174.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.555 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -65.23 -23.76 67.16 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.537 -174.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.782 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 50.5 tptt -64.6 -44.72 89.71 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-O 121.337 0.589 . . . . 0.0 110.357 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.701 ' O ' HG13 ' A' ' 26' ' ' ILE . 2.5 m-20 -58.63 -45.12 89.93 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.186 -0.916 . . . . 0.0 108.828 176.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.671 HG13 HD11 ' A' ' 43' ' ' ILE . 44.3 mm -50.91 -50.49 23.67 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.3 176.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.782 ' HD2' ' HD2' ' A' ' 21' ' ' LYS . 60.7 mttm -52.27 -48.07 65.47 Favored 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 115.514 -0.766 . . . . 0.0 110.665 177.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.71 -40.38 95.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.582 -0.736 . . . . 0.0 112.12 -177.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.701 HG13 ' O ' ' A' ' 22' ' ' ASP . 12.1 mt -67.95 -37.95 79.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-O 121.136 0.493 . . . . 0.0 110.197 179.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.665 HD13 ' HB2' ' A' ' 34' ' ' ALA . 10.5 mt -63.9 -39.91 95.26 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.996 171.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -61.12 -32.28 71.97 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.322 178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.5 t -66.7 -34.19 77.31 Favored 'General case' 0 CA--C 1.534 0.353 0 CA-C-N 116.514 -0.312 . . . . 0.0 111.035 179.505 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.461 HG23 HG13 ' A' ' 32' ' ' ILE . 15.5 m -103.04 -5.29 9.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.866 0.365 . . . . 0.0 111.692 -179.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.52 33.65 8.44 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.97 -0.633 . . . . 0.0 113.453 173.222 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 46.9 mt -102.91 129.69 54.19 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 O-C-N 122.631 -0.334 . . . . 0.0 110.619 178.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -70.5 144.83 51.24 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.182 175.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.665 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -131.13 156.97 44.36 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-O 121.467 0.651 . . . . 0.0 111.625 -178.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.466 ' HB3' ' HB3' ' A' ' 38' ' ' ARG . 14.8 t70 -111.99 178.66 4.24 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 114.885 -1.052 . . . . 0.0 108.416 178.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -102.88 -53.01 2.94 Favored 'General case' 0 C--N 1.317 -0.807 0 CA-C-O 121.221 0.534 . . . . 0.0 110.081 173.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -71.67 -49.27 41.32 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.197 -0.91 . . . . 0.0 110.043 -174.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.466 ' HB3' ' HB3' ' A' ' 35' ' ' ASP . 12.6 tpp180 -63.44 -38.04 89.6 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.572 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.502 ' CD2' ' HB1' ' A' ' 20' ' ' ALA . 3.1 tp -65.84 -55.99 14.2 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.933 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.36 -30.05 69.3 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.574 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 12.2 tmtt? -62.49 -52.11 64.81 Favored 'General case' 0 C--O 1.225 -0.215 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.508 176.03 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.573 HG22 ' HB3' ' A' ' -1' ' ' ALA . 78.7 t -60.83 -42.82 93.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.587 0 CA-C-O 121.54 0.686 . . . . 0.0 110.87 178.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.671 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.44 -41.01 83.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.55 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.398 175.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.5 t -68.26 -33.89 75.19 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 114.503 -1.226 . . . . 0.0 110.705 179.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.574 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 45.2 mt-10 -58.39 -53.4 58.73 Favored 'General case' 0 CA--C 1.517 -0.297 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 174.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.951 HD11 HG22 ' A' ' 4' ' ' VAL . 19.7 mt -57.17 -43.31 82.48 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.14 -0.936 . . . . 0.0 111.69 179.279 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.81 -29.01 65.06 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.263 -177.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.72 -21.23 64.21 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.548 -179.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' HB2' HG23 ' A' ' 54' ' ' VAL . 34.5 mttm -117.06 -97.85 0.46 Allowed 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.741 0.782 . . . . 0.0 110.432 177.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.98 154.51 1.47 Allowed 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 105.899 -1.889 . . . . 0.0 105.899 177.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.757 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.7 mp -57.64 -54.45 31.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 112.403 0.52 . . . . 0.0 112.403 -167.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.967 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.6 OUTLIER -61.44 -38.39 87.01 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.774 0.321 . . . . 0.0 111.146 -172.972 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 57' ' ' GLN . 15.6 t70 -64.75 -53.79 41.63 Favored 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.55 -0.537 . . . . 0.0 109.55 -179.116 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.721 ' HB ' HD23 ' A' ' 46' ' ' LEU . 28.7 t -58.7 -37.13 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.377 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.495 177.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.611 HG21 HG21 ' B' ' 55' ' ' ILE . 2.2 mm -56.56 -60.94 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.46 0 CA-C-O 121.316 0.579 . . . . 0.0 111.776 172.613 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.933 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.84 -15.29 63.07 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.402 -0.817 . . . . 0.0 111.651 -170.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 53' ' ' ASP . 16.2 mm100 -92.1 -31.83 15.38 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.511 173.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.81 -42.08 3.42 Favored Glycine 0 CA--C 1.521 0.426 0 C-N-CA 120.8 -0.714 . . . . 0.0 114.51 -171.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.707 HG13 ' SD ' ' A' ' 1' ' ' MET . 1.6 mp -62.06 -63.11 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.351 0 CA-C-N 117.253 0.526 . . . . 0.0 110.827 -175.24 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.7 -124.2 35.3 Favored Glycine 0 CA--C 1.52 0.403 0 C-N-CA 121.181 -0.533 . . . . 0.0 113.517 177.585 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 46.8 mmtm -79.21 9.37 4.62 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 112.752 0.649 . . . . 0.0 112.752 -173.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.41 ' HB2' ' SD ' ' A' ' 1' ' ' MET . 61.2 mt -89.04 -8.95 52.98 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-O 121.22 0.533 . . . . 0.0 110.095 174.068 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.74 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -96.93 23.48 7.14 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.538 177.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.1 m -98.29 129.0 45.0 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.098 -176.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.67 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -150.27 146.55 20.17 Favored Pre-proline 0 C--N 1.325 -0.499 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.67 ' HD2' HG22 ' A' ' 65' ' ' VAL . 18.1 Cg_endo -61.01 93.64 0.11 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.967 2.445 . . . . 0.0 111.855 177.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.57 104.93 7.33 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.615 -179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -72.72 128.67 12.75 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 120.866 -0.683 . . . . 0.0 111.964 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.839 -0.978 . . . . 0.0 111.283 179.548 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . 0.574 ' HB3' HG22 ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.208 0 CA-C-O 120.574 0.226 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.72 ' SD ' HG13 ' B' ' 59' ' ' ILE . 18.5 ttt -119.74 115.16 23.34 Favored 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 120.922 0.392 . . . . 0.0 111.566 -178.603 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.783 ' HA ' HD13 ' A' ' 12' ' ' LEU . 42.6 ttm180 175.7 -55.44 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.076 -0.965 . . . . 0.0 109.168 172.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.489 ' HD1' HD11 ' B' ' 27' ' ' LEU . 39.7 m-85 -83.97 -16.51 43.83 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.174 -0.921 . . . . 0.0 111.164 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.985 HG22 HD11 ' B' ' 46' ' ' LEU . 91.9 t -63.92 -35.95 75.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.401 0 CA-C-O 120.862 0.363 . . . . 0.0 110.554 177.181 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.606 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -56.82 -54.97 40.35 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.519 0.676 . . . . 0.0 111.177 179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.413 ' HB3' ' HB ' ' B' ' 26' ' ' ILE . 0.3 OUTLIER -71.86 -34.98 69.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.684 179.197 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.594 ' CD2' HD13 ' B' ' 46' ' ' LEU . 64.9 t80 -55.23 -48.15 74.32 Favored 'General case' 0 C--O 1.236 0.372 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.661 174.843 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.74 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.9 mp -59.99 -57.29 13.5 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.666 -0.697 . . . . 0.0 110.279 178.003 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.846 HD12 HD12 ' A' ' 9' ' ' LEU . 14.8 mt -47.43 -50.54 22.49 Favored 'General case' 0 N--CA 1.472 0.639 0 N-CA-C 112.075 0.398 . . . . 0.0 112.075 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.86 -37.99 80.87 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.585 -178.403 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.583 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.23 -41.36 97.04 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.105 179.538 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.75 HD13 ' HA ' ' A' ' 2' ' ' ARG . 4.8 mt -74.07 -24.35 59.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.692 -0.686 . . . . 0.0 110.498 -176.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -70.0 -18.18 74.31 Favored Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.695 -0.684 . . . . 0.0 112.223 178.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 141.4 -33.26 2.0 Favored Glycine 0 N--CA 1.448 -0.517 0 C-N-CA 120.944 -0.645 . . . . 0.0 112.22 178.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.583 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 85.9 m-20 -92.8 88.01 6.06 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.6 0.238 . . . . 0.0 110.647 -179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.609 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 6.1 m -60.79 -27.97 68.41 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.419 0.628 . . . . 0.0 110.314 178.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 39.2 p -108.85 82.5 1.8 Allowed Pre-proline 0 N--CA 1.444 -0.729 0 CA-C-N 115.081 -0.963 . . . . 0.0 109.215 175.233 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.6 Cg_exo -80.17 153.27 21.59 Favored 'Trans proline' 0 C--O 1.233 0.267 0 C-N-CA 123.763 2.975 . . . . 0.0 112.814 -172.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.457 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 15.4 t -89.59 146.71 24.38 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 174.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.549 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -65.49 -23.68 66.96 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.525 -174.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.762 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 50.6 tptt -64.4 -44.8 90.13 Favored 'General case' 0 CA--C 1.517 -0.296 0 CA-C-O 121.255 0.55 . . . . 0.0 110.295 176.211 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.716 ' O ' HG13 ' B' ' 26' ' ' ILE . 2.6 m-20 -58.77 -44.72 90.7 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.224 -0.898 . . . . 0.0 108.91 177.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.652 HG13 HD11 ' B' ' 43' ' ' ILE . 44.5 mm -51.32 -50.39 27.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.175 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.266 176.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.762 ' HD2' ' HD2' ' B' ' 21' ' ' LYS . 60.9 mttm -51.97 -48.63 64.28 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 115.416 -0.811 . . . . 0.0 110.58 177.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 15.8 tppt? -64.64 -40.28 95.18 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.746 -0.661 . . . . 0.0 112.061 -177.437 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.716 HG13 ' O ' ' B' ' 22' ' ' ASP . 11.7 mt -67.86 -38.06 79.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.075 0.464 . . . . 0.0 110.284 179.415 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.666 HD13 ' HB2' ' B' ' 34' ' ' ALA . 10.5 mt -63.71 -39.81 95.23 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.887 -0.597 . . . . 0.0 109.912 171.346 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 27.7 t70 -61.04 -32.86 72.46 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.463 -0.789 . . . . 0.0 111.234 178.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 12.9 t -66.12 -34.62 78.48 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.06 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.464 HG23 HG13 ' B' ' 32' ' ' ILE . 15.3 m -102.65 -5.69 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-O 120.706 0.289 . . . . 0.0 111.557 -178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 90.49 34.4 7.98 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.912 -0.661 . . . . 0.0 113.341 173.37 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.615 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 46.9 mt -103.41 129.72 54.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.969 0.385 . . . . 0.0 110.533 178.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -70.5 144.8 51.26 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.124 175.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.666 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -131.34 156.71 45.03 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.493 0.663 . . . . 0.0 111.746 -178.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.47 ' HB3' ' HB3' ' B' ' 38' ' ' ARG . 14.7 t70 -111.62 178.9 4.18 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 114.772 -1.104 . . . . 0.0 108.614 178.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 15.2 m-20 -103.12 -52.6 3.0 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-O 121.227 0.537 . . . . 0.0 110.278 173.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -71.98 -49.61 35.8 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.2 -0.909 . . . . 0.0 110.012 -175.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.47 ' HB3' ' HB3' ' B' ' 35' ' ' ASP . 12.7 tpp180 -63.08 -38.31 90.67 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.76 -0.654 . . . . 0.0 110.643 179.681 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.497 ' CD2' ' HB1' ' B' ' 20' ' ' ALA . 3.1 tp -65.57 -56.16 13.78 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.999 -179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 27.4 t-20 -60.25 -29.85 69.05 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.959 -0.385 . . . . 0.0 109.959 178.61 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 12.1 tmtt? -62.63 -52.14 64.52 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 176.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.574 HG22 ' HB3' ' B' ' -1' ' ' ALA . 77.6 t -60.77 -43.04 94.46 Favored 'Isoleucine or valine' 0 C--O 1.239 0.549 0 CA-C-O 121.564 0.697 . . . . 0.0 110.778 178.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.652 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.2 -41.31 83.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-N 115.269 -0.878 . . . . 0.0 110.382 175.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.9 t -67.97 -33.8 75.34 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.568 -1.196 . . . . 0.0 110.679 179.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 46.0 mt-10 -58.42 -53.1 62.16 Favored 'General case' 0 CA--C 1.516 -0.361 0 N-CA-C 109.376 -0.601 . . . . 0.0 109.376 174.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.985 HD11 HG22 ' B' ' 4' ' ' VAL . 20.0 mt -57.35 -43.3 83.35 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.819 179.101 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -70.95 -29.22 65.18 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.129 -177.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -80.71 -20.72 65.3 Favored Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.93 -0.652 . . . . 0.0 112.452 -179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.458 ' HB2' HG23 ' B' ' 54' ' ' VAL . 34.4 mttm -117.4 -97.96 0.46 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.66 0.743 . . . . 0.0 110.487 177.789 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 4.9 p-10 -175.85 154.68 1.55 Allowed 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 105.965 -1.865 . . . . 0.0 105.965 176.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.74 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.7 mp -57.64 -54.57 29.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 112.479 0.548 . . . . 0.0 112.479 -167.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.933 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.6 OUTLIER -61.56 -38.16 86.46 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.734 0.302 . . . . 0.0 111.116 -172.897 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . 0.45 ' O ' ' HG2' ' B' ' 57' ' ' GLN . 15.7 t70 -64.69 -53.85 40.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.594 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.723 ' HB ' HD23 ' B' ' 46' ' ' LEU . 26.9 t -58.82 -37.1 64.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.432 -0.803 . . . . 0.0 110.538 177.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.611 HG21 HG21 ' A' ' 55' ' ' ILE . 2.2 mm -56.47 -60.91 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.346 0.593 . . . . 0.0 111.823 172.567 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.967 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.96 -15.19 63.0 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.471 -0.786 . . . . 0.0 111.5 -170.321 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.45 ' HG2' ' O ' ' B' ' 53' ' ' ASP . 16.9 mm100 -92.5 -31.3 15.29 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.515 173.504 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -96.66 -43.21 3.19 Favored Glycine 0 CA--C 1.52 0.383 0 C-N-CA 120.792 -0.718 . . . . 0.0 114.408 -171.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.72 HG13 ' SD ' ' B' ' 1' ' ' MET . 1.6 mp -61.35 -63.26 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 CA-C-N 117.228 0.514 . . . . 0.0 110.867 -174.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.51 -124.09 34.87 Favored Glycine 0 CA--C 1.52 0.396 0 C-N-CA 121.222 -0.513 . . . . 0.0 113.491 177.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 46.4 mmtm -79.26 8.85 5.29 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.522 0.564 . . . . 0.0 112.522 -172.859 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.408 ' HB2' ' SD ' ' B' ' 1' ' ' MET . 62.1 mt -88.68 -8.77 53.99 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-O 121.432 0.634 . . . . 0.0 110.133 174.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.757 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -97.02 23.73 6.96 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.551 177.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 32.1 m -98.73 128.93 45.14 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.075 -176.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.664 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -150.2 146.74 20.52 Favored Pre-proline 0 C--N 1.324 -0.505 0 N-CA-C 108.723 -0.844 . . . . 0.0 108.723 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.664 ' HD2' HG22 ' B' ' 65' ' ' VAL . 18.1 Cg_endo -60.96 93.67 0.11 Allowed 'Trans proline' 0 C--O 1.233 0.254 0 C-N-CA 123.025 2.483 . . . . 0.0 112.008 177.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -76.75 103.77 6.89 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.729 -179.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -71.68 128.24 14.77 Favored Glycine 0 N--CA 1.448 -0.544 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.052 179.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.819 0 CA-C-O 118.941 -0.921 . . . . 0.0 111.595 179.375 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.603 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.192 0 CA-C-O 120.571 0.224 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.756 ' SD ' HG13 ' A' ' 59' ' ' ILE . 13.1 ttt -91.92 110.18 21.54 Favored 'General case' 0 CA--C 1.516 -0.329 0 CA-C-N 116.699 -0.228 . . . . 0.0 110.965 -179.005 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 34.2 ttt85 -179.44 -56.54 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.406 0 O-C-N 123.704 0.627 . . . . 0.0 109.961 176.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.527 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 49.6 m-85 -99.18 -11.13 21.64 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.972 -176.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.977 HG22 HD11 ' A' ' 46' ' ' LEU . 60.9 t -57.13 -39.56 67.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-O 120.923 0.392 . . . . 0.0 110.849 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.662 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -55.72 -55.41 32.61 Favored 'General case' 0 C--N 1.32 -0.701 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.855 -178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -70.55 -36.22 73.53 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.629 -0.714 . . . . 0.0 110.616 179.724 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.599 ' CD1' HD13 ' A' ' 46' ' ' LEU . 58.0 t80 -55.41 -49.62 71.9 Favored 'General case' 0 C--O 1.237 0.406 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.936 175.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.782 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.7 mp -59.94 -55.96 27.58 Favored 'General case' 0 N--CA 1.453 -0.318 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.558 178.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.845 HD12 HD12 ' B' ' 9' ' ' LEU . 15.1 mt -48.02 -49.99 29.2 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 123.175 0.297 . . . . 0.0 111.702 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.88 -43.18 85.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.351 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.568 ' HA ' ' HA ' ' A' ' 16' ' ' SER . . . -61.73 -38.53 88.24 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.349 -179.157 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.782 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.6 mt -78.42 -25.9 46.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.721 -175.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.74 10.7 50.38 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 121.015 -0.612 . . . . 0.0 112.574 -179.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 107.07 -23.84 26.4 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.078 -0.582 . . . . 0.0 111.955 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.4 64.96 7.77 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-O 121.33 0.586 . . . . 0.0 109.575 -177.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.568 ' HA ' ' HA ' ' A' ' 11' ' ' ALA . 15.7 m -64.48 -20.4 66.16 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.319 -0.855 . . . . 0.0 111.803 -175.433 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.89 78.21 4.0 Favored Pre-proline 0 C--N 1.321 -0.67 0 N-CA-C 108.063 -1.088 . . . . 0.0 108.063 173.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.0 Cg_exo -77.08 129.11 10.3 Favored 'Trans proline' 0 N--CA 1.458 -0.591 0 C-N-CA 123.131 2.554 . . . . 0.0 113.452 -167.679 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . . . . . . . . . 36.5 t -72.09 142.24 49.21 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.645 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.69 -22.35 65.25 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.783 -178.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.502 ' HD2' ' HD2' ' A' ' 24' ' ' LYS . 24.4 tptp -70.27 -41.01 73.99 Favored 'General case' 0 C--O 1.237 0.418 0 CA-C-O 121.244 0.545 . . . . 0.0 110.157 178.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.666 ' O ' HG13 ' A' ' 26' ' ' ILE . 29.1 t70 -63.37 -40.02 96.13 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 175.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.637 HG13 HD11 ' A' ' 43' ' ' ILE . 47.6 mm -53.68 -49.76 54.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.327 174.036 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.645 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 75.5 mttt -55.2 -43.4 74.37 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.64 178.756 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.402 ' HE2' ' HB3' ' A' ' 25' ' ' LYS . 10.9 mmmm -58.07 -47.48 83.05 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-O 121.396 0.617 . . . . 0.0 111.698 177.763 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.666 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.7 mt -67.43 -39.31 82.36 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.732 -176.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.67 HD13 ' HB2' ' A' ' 34' ' ' ALA . 9.3 mt -62.87 -39.15 93.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.126 172.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -59.57 -39.46 84.17 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.251 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 36.4 t -59.91 -38.52 82.56 Favored 'General case' 0 CA--C 1.533 0.299 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.244 -179.453 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.574 HG23 HG13 ' A' ' 32' ' ' ILE . 16.8 m -96.4 -10.31 8.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 120.67 0.271 . . . . 0.0 111.682 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.51 32.2 6.74 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.855 -0.688 . . . . 0.0 113.514 174.112 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.624 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 29.6 mt -107.24 132.87 53.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.931 0.365 . . . . 0.0 110.104 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -87.24 151.38 23.2 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 110.229 -0.286 . . . . 0.0 110.229 176.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.67 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -128.85 128.5 43.99 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.179 0.514 . . . . 0.0 112.318 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -92.29 122.9 35.2 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.187 173.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -48.91 -54.58 14.81 Favored 'General case' 0 C--O 1.238 0.466 0 N-CA-C 112.786 0.662 . . . . 0.0 112.786 -172.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.421 ' O ' ' HB2' ' A' ' 41' ' ' LYS . 30.6 t70 -66.33 -48.42 70.34 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 111.437 -171.917 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.474 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.8 tpp180 -64.88 -35.2 80.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.84 0.352 . . . . 0.0 110.362 179.634 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.527 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.8 tp -63.73 -56.2 17.45 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.66 177.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 17.1 m120 -57.52 -32.57 67.18 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 177.246 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.496 ' O ' ' HG3' ' A' ' 45' ' ' GLU . 4.2 tppt? -64.41 -54.59 30.43 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.949 179.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG22 ' HB3' ' A' ' -1' ' ' ALA . 85.4 t -57.01 -43.92 81.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.326 0 CA-C-O 121.495 0.664 . . . . 0.0 110.635 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.637 HD11 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.02 -44.0 93.81 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.649 176.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 21.7 t -64.75 -35.28 80.55 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 114.795 -1.093 . . . . 0.0 110.814 179.347 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 42.1 mt-10 -59.12 -53.06 62.57 Favored 'General case' 0 CA--C 1.522 -0.129 0 N-CA-C 109.379 -0.6 . . . . 0.0 109.379 174.274 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.977 HD11 HG22 ' A' ' 4' ' ' VAL . 17.7 mt -64.99 -24.32 67.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.283 -0.871 . . . . 0.0 111.866 -179.592 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.1 t30 -76.67 -33.41 58.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.991 0.424 . . . . 0.0 111.034 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.35 -29.05 11.67 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.735 -177.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.496 ' HB2' ' CG2' ' A' ' 54' ' ' VAL . 16.6 mtpp -115.28 176.06 5.23 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 110.308 -0.256 . . . . 0.0 110.308 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 3.2 m120 -68.46 141.66 55.56 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 173.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.718 HG13 HD22 ' A' ' 46' ' ' LEU . 1.6 mp -59.66 -45.84 93.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 C-N-CA 120.752 -0.379 . . . . 0.0 110.277 178.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 1.014 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.07 -42.15 93.96 Favored 'General case' 0 CA--C 1.518 -0.276 0 CA-C-O 121.233 0.54 . . . . 0.0 109.635 -178.885 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.2 t70 -64.15 -53.59 47.03 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.068 -0.969 . . . . 0.0 110.542 179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.638 ' HB ' HD23 ' A' ' 46' ' ' LEU . 42.2 t -59.88 -35.17 58.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.865 178.237 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.087 HD13 HD13 ' B' ' 55' ' ' ILE . 17.9 mt -65.41 -55.73 18.7 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.576 0 CA-C-O 120.845 0.355 . . . . 0.0 111.887 175.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.009 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.63 -16.07 63.31 Favored 'General case' 0 C--N 1.315 -0.893 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.431 -173.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.816 ' HA ' HE21 ' A' ' 57' ' ' GLN . 0.0 OUTLIER -91.77 -28.83 17.14 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.712 170.826 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.47 -45.5 5.23 Favored Glycine 0 CA--C 1.519 0.339 0 N-CA-C 114.312 0.485 . . . . 0.0 114.312 -173.251 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.84 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp -64.89 -61.98 1.44 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-N 117.565 0.683 . . . . 0.0 110.361 -178.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.437 ' H ' ' HG2' ' B' ' 52' ' ' GLU . . . 60.39 -124.82 36.97 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.91 -0.662 . . . . 0.0 112.614 -179.402 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.402 ' HD2' ' N ' ' A' ' 61' ' ' LYS . 0.4 OUTLIER -89.05 47.51 1.51 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.104 0.478 . . . . 0.0 110.73 -176.832 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.436 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 6.0 mt -125.81 -6.43 6.8 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.858 -0.61 . . . . 0.0 111.113 178.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.725 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -86.8 -118.54 0.04 OUTLIER 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.967 -0.561 . . . . 0.0 112.0 -175.361 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 2.7 p -83.63 49.55 1.62 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.122 0.487 . . . . 0.0 111.992 -174.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.734 ' CB ' ' HD3' ' A' ' 66' ' ' PRO . 0.2 OUTLIER -71.34 -61.82 2.04 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.756 0.788 . . . . 0.0 111.146 177.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.734 ' HD3' ' CB ' ' A' ' 65' ' ' VAL . 9.1 Cg_endo -95.75 29.93 0.2 Allowed 'Trans proline' 0 N--CA 1.445 -1.371 1 C-N-CA 126.093 4.529 . . . . 0.0 111.932 -175.717 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.65 -8.0 45.31 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.344 -177.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.68 -116.94 3.35 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 120.976 -0.631 . . . . 0.0 111.938 -178.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.92 0 CA-C-O 118.933 -0.926 . . . . 0.0 111.555 -179.527 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . 0.611 ' HB3' HG22 ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.18 0 CA-C-O 120.54 0.21 . . . . 0.0 110.685 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.748 ' SD ' HG13 ' B' ' 59' ' ' ILE . 13.2 ttt -91.55 110.42 21.74 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.723 -0.217 . . . . 0.0 111.001 -179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.401 ' HB2' ' O ' ' B' ' 1' ' ' MET . 34.3 ttt85 -179.87 -56.88 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.414 0 O-C-N 123.734 0.646 . . . . 0.0 109.902 176.333 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.542 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 50.5 m-85 -99.01 -11.11 21.81 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.91 -176.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 1.0 HG22 HD11 ' B' ' 46' ' ' LEU . 58.7 t -57.08 -39.56 67.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.876 0.369 . . . . 0.0 110.801 178.131 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.649 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.55 -55.72 28.71 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.655 -178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 2.1 p -70.43 -36.22 73.86 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.53 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.593 ' CD1' HD13 ' B' ' 46' ' ' LEU . 57.8 t80 -55.67 -49.11 73.81 Favored 'General case' 0 C--O 1.238 0.458 0 CA-C-N 115.658 -0.701 . . . . 0.0 109.952 176.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.787 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -60.5 -55.62 31.25 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.426 178.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.845 HD12 HD12 ' A' ' 9' ' ' LEU . 14.9 mt -48.37 -50.07 32.14 Favored 'General case' 0 N--CA 1.469 0.516 0 O-C-N 123.182 0.301 . . . . 0.0 111.641 179.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.49 -43.14 83.9 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.498 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.57 ' HA ' ' HA ' ' B' ' 16' ' ' SER . . . -61.85 -38.64 88.98 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.26 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.787 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -78.44 -25.86 46.08 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.785 -175.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -81.72 10.86 49.56 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 121.032 -0.604 . . . . 0.0 112.549 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 106.82 -23.54 27.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.118 178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . . . . . . . . . 63.1 t30 -88.59 64.4 7.39 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 109.5 -0.556 . . . . 0.0 109.5 -178.071 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.57 ' HA ' ' HA ' ' B' ' 11' ' ' ALA . 15.0 m -63.86 -20.27 65.69 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.406 -0.816 . . . . 0.0 111.971 -175.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 5.0 t -113.99 78.06 4.06 Favored Pre-proline 0 C--N 1.32 -0.676 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 173.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.49 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.4 Cg_exo -76.91 128.82 10.24 Favored 'Trans proline' 0 N--CA 1.457 -0.62 0 C-N-CA 123.153 2.569 . . . . 0.0 113.631 -167.523 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . . . . . . . . . 31.4 t -71.49 141.79 50.17 Favored 'General case' 0 N--CA 1.446 -0.65 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 169.489 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.642 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.48 -22.15 64.83 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.808 -179.097 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.507 ' HD2' ' HD2' ' B' ' 24' ' ' LYS . 24.4 tptp -70.7 -40.73 72.7 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 121.184 0.516 . . . . 0.0 110.105 178.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.672 ' O ' HG13 ' B' ' 26' ' ' ILE . 29.4 t70 -63.53 -39.98 95.83 Favored 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 175.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.636 HG13 HD11 ' B' ' 43' ' ' ILE . 47.0 mm -53.61 -49.91 53.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.21 0 CA-C-N 115.179 -0.919 . . . . 0.0 110.348 174.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.642 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 75.5 mttt -55.19 -43.29 74.26 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.654 178.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 11.0 mmmm -58.09 -47.78 82.18 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.728 177.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.672 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.7 mt -67.35 -39.18 82.24 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.697 -176.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.671 HD13 ' HB2' ' B' ' 34' ' ' ALA . 9.4 mt -62.89 -38.96 92.97 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.043 172.72 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -60.03 -39.42 85.82 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.032 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 34.9 t -59.6 -38.54 81.53 Favored 'General case' 0 CA--C 1.532 0.281 0 CA-C-N 116.533 -0.303 . . . . 0.0 111.257 -179.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.571 HG23 HG13 ' B' ' 32' ' ' ILE . 16.6 m -96.54 -10.11 8.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-O 120.783 0.325 . . . . 0.0 111.639 -178.187 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 96.16 32.76 6.57 Favored Glycine 0 N--CA 1.45 -0.432 0 C-N-CA 120.903 -0.665 . . . . 0.0 113.388 174.07 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.623 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 29.8 mt -107.63 132.63 54.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.974 0.387 . . . . 0.0 110.094 178.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -86.62 152.27 22.73 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 176.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.671 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -130.22 127.94 40.66 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.265 0.555 . . . . 0.0 112.305 -174.46 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -92.08 122.64 34.77 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.258 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -48.85 -54.35 15.62 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -172.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.422 ' O ' ' HB2' ' B' ' 41' ' ' LYS . 32.0 t70 -66.48 -48.09 70.97 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.53 -0.305 . . . . 0.0 111.638 -171.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.488 ' O ' HG23 ' B' ' 42' ' ' VAL . 21.7 tpp180 -65.18 -34.76 79.15 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.945 0.403 . . . . 0.0 110.516 179.577 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.542 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.6 tp -63.96 -56.24 16.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.659 177.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 17.5 m120 -57.42 -32.67 67.12 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 177.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.498 ' O ' ' HG3' ' B' ' 45' ' ' GLU . 4.4 tppt? -64.44 -54.49 31.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.801 179.491 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.611 HG22 ' HB3' ' B' ' -1' ' ' ALA . 84.6 t -57.12 -43.68 81.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.279 0 CA-C-O 121.527 0.679 . . . . 0.0 110.612 178.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.636 HD11 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.29 -43.98 94.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.127 -0.942 . . . . 0.0 110.717 176.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -64.06 -36.06 82.76 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.924 -1.035 . . . . 0.0 110.779 179.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 43.0 mt-10 -58.73 -53.03 62.98 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 174.411 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 1.0 HD11 HG22 ' B' ' 4' ' ' VAL . 17.4 mt -65.01 -24.52 67.52 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.226 -0.897 . . . . 0.0 111.936 -179.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -76.85 -33.08 57.92 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.973 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -92.31 -29.12 11.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.717 -0.754 . . . . 0.0 112.718 -177.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.501 ' HB2' ' CG2' ' B' ' 54' ' ' VAL . 16.8 mtpp -115.31 176.19 5.18 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 120.582 0.229 . . . . 0.0 110.403 -179.63 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.59 141.81 55.34 Favored 'General case' 0 C--N 1.323 -0.586 0 N-CA-C 109.669 -0.493 . . . . 0.0 109.669 173.354 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.725 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.6 mp -59.8 -45.65 94.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 120.827 -0.349 . . . . 0.0 110.273 178.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 1.009 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.34 -42.02 94.81 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.325 0.584 . . . . 0.0 109.59 -178.734 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -63.93 -53.78 45.01 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.637 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.64 ' HB ' HD23 ' B' ' 46' ' ' LEU . 42.2 t -59.88 -35.23 59.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.824 178.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 1.087 HD13 HD13 ' A' ' 55' ' ' ILE . 18.8 mt -65.23 -55.9 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 111.849 0.315 . . . . 0.0 111.849 175.126 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 1.014 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.82 -15.57 63.13 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.105 0.479 . . . . 0.0 111.48 -173.175 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . 0.808 HE21 ' HA ' ' B' ' 57' ' ' GLN . 0.0 OUTLIER -92.04 -28.21 17.31 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.98 -0.554 . . . . 0.0 110.904 170.599 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -88.2 -45.43 5.04 Favored Glycine 0 CA--C 1.519 0.332 0 N-CA-C 114.363 0.505 . . . . 0.0 114.363 -173.403 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.842 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp -64.85 -62.09 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 117.444 0.622 . . . . 0.0 110.263 -178.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . 0.404 ' H ' ' HG2' ' A' ' 52' ' ' GLU . . . 60.77 -124.89 36.88 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.947 -0.644 . . . . 0.0 112.472 -179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -89.19 47.71 1.53 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.051 0.453 . . . . 0.0 110.627 -176.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.426 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 6.0 mt -125.76 -6.66 6.8 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.093 178.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.733 ' HB2' HG21 ' B' ' 59' ' ' ILE . . . -86.58 -118.61 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.876 -0.602 . . . . 0.0 112.014 -175.387 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 2.8 p -83.38 50.49 1.78 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.052 0.453 . . . . 0.0 111.881 -174.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.742 ' CB ' ' HD3' ' B' ' 66' ' ' PRO . 0.2 OUTLIER -72.19 -62.04 1.66 Allowed Pre-proline 0 C--N 1.326 -0.415 0 CA-C-O 121.756 0.789 . . . . 0.0 111.071 177.238 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.742 ' HD3' ' CB ' ' B' ' 65' ' ' VAL . 8.8 Cg_endo -95.24 29.52 0.22 Allowed 'Trans proline' 0 N--CA 1.446 -1.301 1 C-N-CA 126.21 4.607 . . . . 0.0 111.973 -175.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -92.57 -8.5 44.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.163 -176.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 120.78 -116.86 3.32 Favored Glycine 0 N--CA 1.447 -0.57 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.979 -178.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.956 0 CA-C-O 118.75 -1.028 . . . . 0.0 111.671 -179.148 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.526 ' HB3' HG22 ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.484 1.264 0 N-CA-C 110.218 -0.29 . . . . 0.0 110.218 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.545 ' SD ' HG13 ' A' ' 59' ' ' ILE . 24.9 ptm -116.85 -14.7 10.7 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 111.843 0.312 . . . . 0.0 111.843 -176.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.6 ' HD2' ' CG2' ' A' ' 32' ' ' ILE . 19.0 tpp180 -52.09 -40.92 61.95 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 112.252 0.464 . . . . 0.0 112.252 -174.605 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 43.7 m-85 -105.62 -7.23 18.65 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 112.411 0.523 . . . . 0.0 112.411 -175.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.959 HG22 HD11 ' A' ' 46' ' ' LEU . 97.8 t -69.34 -31.7 50.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.104 0.478 . . . . 0.0 109.999 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.647 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -58.55 -55.08 39.63 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.346 178.296 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . 0.46 ' HA ' HD11 ' B' ' 9' ' ' LEU . 1.4 p -71.44 -36.32 71.23 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.56 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.606 ' CD1' HD13 ' A' ' 46' ' ' LEU . 70.3 t80 -55.14 -49.07 72.71 Favored 'General case' 0 C--O 1.236 0.361 0 CA-C-N 115.879 -0.6 . . . . 0.0 109.823 175.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.7 mp -59.18 -57.43 13.08 Favored 'General case' 0 N--CA 1.455 -0.221 0 CA-C-N 115.599 -0.728 . . . . 0.0 110.629 178.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 1.019 HD12 HD12 ' B' ' 9' ' ' LEU . 13.5 mt -48.79 -48.97 40.83 Favored 'General case' 0 N--CA 1.47 0.526 0 N-CA-C 111.994 0.368 . . . . 0.0 111.994 179.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.45 -37.81 82.15 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.75 -178.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.67 -40.32 95.21 Favored 'General case' 0 C--O 1.232 0.161 0 CA-C-O 121.293 0.568 . . . . 0.0 110.808 178.023 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.2 mt -75.15 -15.63 60.57 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.571 -176.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -80.3 1.24 81.97 Favored Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 121.016 -0.611 . . . . 0.0 112.189 179.207 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.23 -28.75 7.08 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.013 177.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.419 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 7.0 t30 -94.85 85.27 4.36 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 -178.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.607 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 8.8 m -61.49 -25.85 67.53 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.881 0.697 . . . . 0.0 112.881 -172.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.57 81.68 3.35 Favored Pre-proline 0 C--N 1.327 -0.401 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 177.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.607 ' HD3' ' O ' ' A' ' 16' ' ' SER . 9.1 Cg_exo -73.11 153.39 51.83 Favored 'Trans proline' 0 N--CA 1.464 -0.25 0 C-N-CA 123.787 2.992 . . . . 0.0 113.041 -170.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.417 ' O ' HG12 ' A' ' 23' ' ' ILE . 2.4 p -104.84 147.46 27.72 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.783 177.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.551 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.26 -26.71 68.54 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.302 -0.863 . . . . 0.0 112.959 -168.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -69.43 -41.21 76.64 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-O 121.088 0.471 . . . . 0.0 110.169 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.692 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.3 t70 -62.74 -42.31 99.61 Favored 'General case' 0 C--N 1.325 -0.459 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 175.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.673 HG13 HD11 ' A' ' 43' ' ' ILE . 41.8 mm -51.67 -51.2 28.03 Favored 'Isoleucine or valine' 0 C--O 1.233 0.213 0 CA-C-N 115.204 -0.907 . . . . 0.0 110.562 174.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.551 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 89.9 mttt -56.39 -42.35 77.76 Favored 'General case' 0 C--O 1.225 -0.235 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.446 179.506 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.776 ' HA ' ' HE3' ' A' ' 25' ' ' LYS . 0.1 OUTLIER -61.98 -43.74 98.2 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.311 179.308 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.692 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.5 mt -67.97 -39.78 82.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.088 0.47 . . . . 0.0 110.588 -179.499 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 34' ' ' ALA . 15.6 mt -60.41 -43.24 96.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.91 -0.586 . . . . 0.0 109.75 172.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.422 ' HB3' ' HE3' ' A' ' 25' ' ' LYS . 22.0 t70 -63.29 -28.69 70.19 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.008 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 21.1 m -70.0 -24.86 63.36 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.599 -0.273 . . . . 0.0 111.24 179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.51 HG23 HG13 ' A' ' 32' ' ' ILE . 14.2 m -112.87 -3.27 10.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.82 0.343 . . . . 0.0 111.249 179.034 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.29 34.89 7.26 Favored Glycine 0 CA--C 1.517 0.208 0 C-N-CA 121.157 -0.544 . . . . 0.0 113.587 173.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.616 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 52.4 mt -105.41 138.6 29.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.536 0 CA-C-N 117.037 0.419 . . . . 0.0 111.124 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 40.9 mt-10 -87.36 144.16 26.9 Favored 'General case' 0 N--CA 1.446 -0.668 0 CA-C-N 115.681 -0.691 . . . . 0.0 110.229 177.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -131.22 132.5 44.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 120.919 0.39 . . . . 0.0 111.978 -176.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . 0.476 ' HB2' ' HB3' ' A' ' 38' ' ' ARG . 9.8 m-20 -98.02 124.51 42.55 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.801 -0.636 . . . . 0.0 109.666 175.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -46.73 -58.66 3.65 Favored 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 112.654 0.613 . . . . 0.0 112.654 -173.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -63.03 -49.71 73.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.302 -174.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.476 ' HB3' ' HB2' ' A' ' 35' ' ' ASP . 20.6 tpp180 -61.28 -39.27 89.8 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.138 -179.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.479 ' CD1' HG21 ' A' ' 23' ' ' ILE . 3.7 tp -63.8 -56.16 17.58 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.016 179.094 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 38.0 m-80 -60.3 -28.98 68.54 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 178.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 46.1 tptt -67.01 -49.85 63.99 Favored 'General case' 0 N--CA 1.452 -0.342 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.582 178.591 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.589 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 71.9 t -61.54 -41.9 91.94 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-O 121.558 0.694 . . . . 0.0 110.843 178.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.673 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.49 -40.21 85.61 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.874 0 CA-C-O 121.844 0.83 . . . . 0.0 110.651 175.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 22.9 t -71.05 -35.84 72.1 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.365 -178.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.589 ' HG2' ' O ' ' A' ' 42' ' ' VAL . 13.5 pt-20 -69.55 -37.26 76.97 Favored 'General case' 0 C--O 1.236 0.342 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 178.567 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.959 HD11 HG22 ' A' ' 4' ' ' VAL . 35.9 mt -62.54 -41.53 98.94 Favored 'General case' 0 N--CA 1.462 0.129 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.272 173.136 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 66.0 t30 -68.01 -30.92 70.28 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.959 -177.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -78.2 -38.46 25.8 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.76 -0.734 . . . . 0.0 112.389 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.516 ' HB2' HG23 ' A' ' 54' ' ' VAL . 73.3 mmtt -103.42 -156.21 0.56 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.879 0.371 . . . . 0.0 110.072 178.389 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -100.63 159.95 14.75 Favored 'General case' 0 C--N 1.321 -0.655 0 N-CA-C 108.347 -0.983 . . . . 0.0 108.347 168.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.831 ' HB ' ' HB1' ' B' ' 63' ' ' ALA . 1.3 mp -60.26 -50.76 79.01 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 N-CA-C 109.91 -0.404 . . . . 0.0 109.91 -178.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.82 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -57.55 -40.69 79.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.903 -176.597 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.1 m-20 -62.5 -55.51 26.77 Favored 'General case' 0 CA--C 1.514 -0.433 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.844 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.65 ' HB ' HD23 ' A' ' 46' ' ' LEU . 24.6 t -58.79 -35.34 55.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.654 178.637 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.581 HG21 HG21 ' B' ' 55' ' ' ILE . 2.5 mm -59.16 -61.82 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 121.412 0.625 . . . . 0.0 111.782 173.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.819 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.41 -15.61 62.86 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 115.341 -0.845 . . . . 0.0 111.113 -169.929 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 26.5 mt-30 -88.51 -44.48 10.65 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.968 171.384 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.93 -48.01 7.31 Favored Glycine 0 N--CA 1.453 -0.192 0 C-N-CA 121.248 -0.501 . . . . 0.0 113.82 -171.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.804 HG21 ' HB2' ' A' ' 63' ' ' ALA . 2.1 mp -63.08 -41.15 91.75 Favored 'Isoleucine or valine' 0 C--O 1.235 0.335 0 CA-C-O 121.143 0.496 . . . . 0.0 110.039 -177.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.58 -96.83 0.59 Allowed Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.688 -0.767 . . . . 0.0 111.771 178.532 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -146.59 27.57 1.1 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.233 0.54 . . . . 0.0 110.56 176.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.434 ' O ' HD23 ' A' ' 62' ' ' LEU . 2.0 tt -81.11 -22.74 38.9 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 109.087 -0.709 . . . . 0.0 109.087 177.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.842 ' HB1' ' HB ' ' B' ' 51' ' ' ILE . . . -60.59 -75.91 0.06 Allowed 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 114.889 -1.05 . . . . 0.0 113.732 -172.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 t -106.91 177.8 4.75 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 115.75 -0.659 . . . . 0.0 111.309 -168.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.72 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.7 p -169.48 146.61 2.92 Favored Pre-proline 0 N--CA 1.447 -0.624 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.72 ' HD2' HG22 ' A' ' 65' ' ' VAL . 40.7 Cg_endo -67.1 66.61 0.61 Allowed 'Trans proline' 0 C--O 1.236 0.396 0 C-N-CA 123.39 2.726 . . . . 0.0 112.712 178.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.34 64.19 7.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.243 0.544 . . . . 0.0 110.924 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -131.33 44.3 1.22 Allowed Glycine 0 N--CA 1.447 -0.592 0 CA-C-N 115.564 -0.744 . . . . 0.0 111.62 178.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.162 -1.355 . . . . 0.0 111.305 179.762 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . 0.515 ' HB3' HG22 ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.218 0 N-CA-C 110.199 -0.297 . . . . 0.0 110.199 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.542 ' SD ' HG13 ' B' ' 59' ' ' ILE . 24.8 ptm -117.12 -14.82 10.54 Favored 'General case' 0 N--CA 1.463 0.201 0 N-CA-C 111.907 0.336 . . . . 0.0 111.907 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.603 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 19.2 tpp180 -52.21 -40.87 62.16 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 112.289 0.477 . . . . 0.0 112.289 -174.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.471 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 43.9 m-85 -105.34 -7.39 18.88 Favored 'General case' 0 C--N 1.325 -0.491 0 N-CA-C 112.427 0.528 . . . . 0.0 112.427 -175.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.972 HG22 HD11 ' B' ' 46' ' ' LEU . 99.3 t -69.46 -31.44 49.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.065 0.46 . . . . 0.0 110.025 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.655 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -58.84 -54.97 41.11 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.39 178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . 0.464 ' HA ' HD11 ' A' ' 9' ' ' LEU . 1.3 p -71.39 -36.34 71.36 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.506 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.597 ' CD1' HD13 ' B' ' 46' ' ' LEU . 70.8 t80 -55.28 -49.12 72.9 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 115.751 -0.659 . . . . 0.0 109.801 175.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.742 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.7 mp -58.97 -57.54 12.64 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.588 178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 1.019 HD12 HD12 ' A' ' 9' ' ' LEU . 13.4 mt -48.87 -48.99 41.62 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 111.94 0.348 . . . . 0.0 111.94 179.777 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.35 -37.74 81.61 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.803 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . . . . . . . . . . . -64.66 -40.29 95.18 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.837 177.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.742 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.4 mt -75.37 -15.62 60.45 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.541 -176.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -79.74 0.71 81.18 Favored Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.319 178.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 117.66 -29.04 6.8 Favored Glycine 0 N--CA 1.447 -0.626 0 C-N-CA 120.984 -0.626 . . . . 0.0 112.13 177.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.426 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 7.2 t30 -94.56 85.22 4.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -178.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.589 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 12.5 m -61.66 -25.59 67.48 Favored 'General case' 0 N--CA 1.464 0.243 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 -173.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.5 t -111.52 81.41 3.16 Favored Pre-proline 0 C--N 1.326 -0.436 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 177.109 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.589 ' HD3' ' O ' ' B' ' 16' ' ' SER . 9.4 Cg_exo -73.28 153.3 50.87 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 123.674 2.916 . . . . 0.0 113.11 -170.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.425 ' O ' HG12 ' B' ' 23' ' ' ILE . 2.7 p -104.33 147.33 27.63 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.964 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.545 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.93 -27.29 68.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.351 -0.84 . . . . 0.0 112.951 -169.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 34.3 mmtp -68.69 -40.98 79.79 Favored 'General case' 0 C--O 1.238 0.478 0 CA-C-O 121.057 0.456 . . . . 0.0 110.463 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.692 ' O ' HG13 ' B' ' 26' ' ' ILE . 5.4 t70 -63.34 -42.37 98.94 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.556 -0.905 . . . . 0.0 108.556 175.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.682 HG13 HD11 ' B' ' 43' ' ' ILE . 41.5 mm -51.5 -51.17 26.6 Favored 'Isoleucine or valine' 0 C--O 1.234 0.243 0 CA-C-N 115.078 -0.964 . . . . 0.0 110.605 174.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.545 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 89.8 mttt -56.35 -42.13 77.26 Favored 'General case' 0 CA--C 1.517 -0.299 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.696 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.784 ' HE3' ' HA ' ' B' ' 25' ' ' LYS . 0.1 OUTLIER -62.1 -44.02 97.57 Favored 'General case' 0 N--CA 1.45 -0.459 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.258 179.114 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.692 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.5 mt -67.79 -40.14 83.2 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 CA-C-O 121.041 0.448 . . . . 0.0 110.491 -179.642 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.689 HD13 ' HB2' ' B' ' 34' ' ' ALA . 15.4 mt -60.05 -43.17 95.55 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.082 -0.508 . . . . 0.0 109.889 171.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.425 ' HB3' ' HE3' ' B' ' 25' ' ' LYS . 22.6 t70 -63.32 -28.29 69.9 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.053 179.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 21.6 m -70.7 -24.33 62.63 Favored 'General case' 0 CA--C 1.532 0.256 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.393 179.834 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.509 HG23 HG13 ' B' ' 32' ' ' ILE . 14.0 m -113.23 -3.58 10.92 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 CA-C-O 120.965 0.412 . . . . 0.0 111.295 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.52 35.56 6.88 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 121.004 -0.617 . . . . 0.0 113.469 173.084 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.635 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 51.8 mt -105.89 138.64 30.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.047 0.451 . . . . 0.0 111.28 179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 40.7 mt-10 -87.42 143.86 27.03 Favored 'General case' 0 N--CA 1.445 -0.704 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.275 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.689 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -130.98 132.62 45.14 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.938 0.399 . . . . 0.0 111.894 -176.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' B' ' 38' ' ' ARG . 7.7 m-20 -98.37 124.46 43.05 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.42 175.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -46.24 -59.2 3.05 Favored 'General case' 0 N--CA 1.473 0.689 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -173.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -62.65 -49.74 73.95 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.291 -174.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.444 ' O ' HG23 ' B' ' 42' ' ' VAL . 20.7 tpp180 -61.37 -39.11 89.43 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.097 0.475 . . . . 0.0 111.1 -179.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.48 ' CD1' HG21 ' B' ' 23' ' ' ILE . 3.7 tp -63.83 -56.25 16.8 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.952 -0.567 . . . . 0.0 111.132 179.106 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 38.1 m-80 -60.12 -28.81 68.18 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 178.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 46.3 tptt -67.27 -49.88 62.62 Favored 'General case' 0 N--CA 1.452 -0.356 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.551 178.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.586 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 72.9 t -61.4 -42.01 92.12 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-O 121.552 0.691 . . . . 0.0 110.828 177.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.682 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.53 -40.53 86.81 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.888 0 CA-C-O 121.816 0.817 . . . . 0.0 110.585 175.655 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 22.7 t -70.49 -35.91 73.53 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 114.855 -1.066 . . . . 0.0 111.485 -179.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.586 ' HG2' ' O ' ' B' ' 42' ' ' VAL . 13.3 pt-20 -69.57 -37.39 76.97 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 178.516 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.972 HD11 HG22 ' B' ' 4' ' ' VAL . 36.1 mt -62.21 -41.66 98.58 Favored 'General case' 0 C--N 1.333 -0.143 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.359 172.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 65.8 t30 -67.87 -31.19 70.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.015 -177.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.75 -38.95 26.22 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.972 -0.632 . . . . 0.0 112.306 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.525 ' HB2' HG23 ' B' ' 54' ' ' VAL . 73.4 mmtt -103.46 -156.12 0.55 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 120.875 0.369 . . . . 0.0 110.163 178.479 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -100.96 159.38 15.26 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.245 -1.02 . . . . 0.0 108.245 168.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.842 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 1.3 mp -59.88 -50.49 79.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 N-CA-C 109.981 -0.377 . . . . 0.0 109.981 -178.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.819 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -57.72 -40.6 79.95 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.927 -176.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 79.5 m-20 -62.64 -55.59 25.55 Favored 'General case' 0 CA--C 1.514 -0.434 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.902 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.663 ' HB ' HD23 ' B' ' 46' ' ' LEU . 24.8 t -58.63 -35.23 54.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 115.652 -0.704 . . . . 0.0 110.665 178.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.581 HG21 HG21 ' A' ' 55' ' ' ILE . 2.5 mm -59.36 -61.81 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-O 121.514 0.673 . . . . 0.0 111.675 173.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.82 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.36 -15.63 62.88 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 115.376 -0.829 . . . . 0.0 111.224 -169.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 26.6 mt-30 -88.49 -44.44 10.69 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 171.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -78.72 -48.49 7.14 Favored Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.961 -0.563 . . . . 0.0 113.807 -171.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.803 HG21 ' HB2' ' B' ' 63' ' ' ALA . 2.0 mp -62.61 -41.41 92.03 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 CA-C-O 121.132 0.492 . . . . 0.0 109.99 -177.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.66 -96.9 0.6 Allowed Glycine 0 N--CA 1.445 -0.715 0 CA-C-N 115.482 -0.781 . . . . 0.0 111.709 178.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.406 ' HD3' ' HA ' ' B' ' 61' ' ' LYS . 33.0 mmtm -146.51 27.69 1.1 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.159 0.504 . . . . 0.0 110.574 176.167 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.457 ' O ' HD23 ' B' ' 62' ' ' LEU . 2.0 tt -81.3 -22.55 38.48 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.578 0.704 . . . . 0.0 109.163 177.31 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.831 ' HB1' ' HB ' ' A' ' 51' ' ' ILE . . . -60.84 -76.11 0.06 Allowed 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 114.634 -1.166 . . . . 0.0 113.646 -173.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 15.9 t -106.99 177.87 4.73 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.318 -168.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.698 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.6 p -169.44 146.38 2.9 Favored Pre-proline 0 C--N 1.321 -0.671 0 N-CA-C 108.083 -1.08 . . . . 0.0 108.083 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.698 ' HD2' HG22 ' B' ' 65' ' ' VAL . 40.5 Cg_endo -67.03 66.72 0.58 Allowed 'Trans proline' 0 CA--C 1.53 0.304 0 C-N-CA 123.335 2.69 . . . . 0.0 112.579 178.293 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -83.41 65.35 8.31 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.194 0.521 . . . . 0.0 110.646 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -132.04 43.3 1.3 Allowed Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.707 -0.679 . . . . 0.0 111.449 179.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.049 0 CA-C-O 118.19 -1.339 . . . . 0.0 111.4 -179.968 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . 0.489 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.526 0.679 . . . . 0.0 110.9 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.599 ' CE ' ' HG ' ' B' ' 8' ' ' LEU . 0.8 OUTLIER -58.84 -41.53 87.16 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 114.315 -1.311 . . . . 0.0 113.126 -173.628 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.559 ' HA ' HD13 ' B' ' 12' ' ' LEU . 4.7 mtp85 -48.22 -45.92 34.68 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.307 1.225 . . . . 0.0 114.307 -171.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.549 ' HD1' HD11 ' A' ' 27' ' ' LEU . 27.8 m-85 -102.04 -10.89 19.32 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.017 0.747 . . . . 0.0 113.017 -171.449 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.916 HG22 HD11 ' A' ' 46' ' ' LEU . 99.1 t -70.05 -33.42 55.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.992 179.055 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.616 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -55.86 -54.57 42.95 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.47 0.652 . . . . 0.0 111.417 176.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.92 -36.64 70.01 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.869 -179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.677 ' CD2' HD13 ' A' ' 46' ' ' LEU . 63.2 t80 -55.48 -48.76 74.05 Favored 'General case' 0 C--O 1.236 0.358 0 CA-C-N 116.155 -0.475 . . . . 0.0 109.758 175.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.756 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.6 mp -57.09 -58.96 5.9 Favored 'General case' 0 N--CA 1.454 -0.231 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.516 177.313 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.97 HD12 HD12 ' B' ' 9' ' ' LEU . 15.5 mt -48.67 -50.24 34.01 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.187 0.44 . . . . 0.0 112.187 179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.47 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . . . -59.45 -37.9 79.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.369 -0.378 . . . . 0.0 110.799 -178.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.421 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.37 -39.67 94.33 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.845 178.762 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.756 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -78.57 -26.51 45.59 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.857 -176.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.67 -19.27 64.83 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.723 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.57 -18.03 4.16 Favored Glycine 0 N--CA 1.448 -0.555 0 C-N-CA 120.694 -0.765 . . . . 0.0 111.968 179.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.421 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 52.9 t30 -99.55 88.65 3.91 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 -179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.562 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 14.1 m -65.35 -17.86 64.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.726 -176.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 21.3 t -112.39 78.52 2.62 Favored Pre-proline 0 C--N 1.322 -0.61 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 174.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.562 ' HD3' ' O ' ' A' ' 16' ' ' SER . 15.9 Cg_exo -68.29 125.24 12.66 Favored 'Trans proline' 0 N--CA 1.462 -0.338 0 C-N-CA 123.093 2.529 . . . . 0.0 112.975 -169.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.566 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 34.6 t -76.59 140.39 41.02 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.274 176.285 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.422 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.07 -21.09 63.33 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.793 -0.639 . . . . 0.0 111.194 -179.984 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.631 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.2 mmmm -68.08 -45.26 74.26 Favored 'General case' 0 C--O 1.237 0.423 0 CA-C-O 121.024 0.44 . . . . 0.0 110.204 175.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.732 ' O ' HG13 ' A' ' 26' ' ' ILE . 14.1 m-20 -57.34 -46.53 83.19 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 108.475 -0.935 . . . . 0.0 108.475 175.674 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.581 HG13 HD11 ' A' ' 43' ' ' ILE . 40.3 mm -50.73 -52.98 14.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.168 -0.924 . . . . 0.0 110.711 178.236 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.631 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 34.2 mttm -52.42 -45.88 66.14 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.817 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.401 ' O ' ' HB3' ' A' ' 28' ' ' ASP . 16.1 tppt? -67.02 -42.68 84.48 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 116.032 -0.531 . . . . 0.0 112.335 -179.12 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.732 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.2 mt -65.84 -38.37 82.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.118 0.485 . . . . 0.0 110.05 -179.849 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.642 HD13 ' HB2' ' A' ' 34' ' ' ALA . 14.1 mt -62.9 -38.76 92.25 Favored 'General case' 0 C--O 1.221 -0.441 0 CA-C-N 115.72 -0.673 . . . . 0.0 109.967 171.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.401 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 19.9 t70 -63.73 -30.86 71.91 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.31 179.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 33.4 t -64.75 -39.39 93.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.799 0.333 . . . . 0.0 110.893 178.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.507 HG23 HG13 ' A' ' 32' ' ' ILE . 15.6 m -102.2 -4.2 9.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.308 -0.405 . . . . 0.0 111.661 -177.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.84 44.55 6.02 Favored Glycine 0 CA--C 1.518 0.243 0 C-N-CA 121.198 -0.525 . . . . 0.0 113.422 173.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.598 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 62.9 mt -108.81 136.75 43.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-O 120.839 0.352 . . . . 0.0 111.03 179.185 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -75.92 139.77 41.79 Favored 'General case' 0 N--CA 1.45 -0.451 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.82 177.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.642 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -127.91 132.78 49.26 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-O 121.359 0.6 . . . . 0.0 111.744 179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -103.92 114.92 29.52 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 114.923 -1.035 . . . . 0.0 108.996 175.895 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -48.82 -50.0 36.49 Favored 'General case' 0 N--CA 1.469 0.483 0 O-C-N 123.5 0.5 . . . . 0.0 112.25 -168.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.645 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 20.7 t70 -62.31 -58.23 8.48 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.621 -174.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.514 ' O ' HG23 ' A' ' 42' ' ' VAL . 20.6 tpp180 -61.97 -29.8 70.49 Favored 'General case' 0 N--CA 1.454 -0.24 0 CA-C-N 116.519 -0.309 . . . . 0.0 111.045 -179.556 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.513 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.7 tp -60.87 -56.5 20.48 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 110.118 -0.327 . . . . 0.0 110.118 174.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -58.51 -34.01 70.48 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.692 -0.484 . . . . 0.0 109.692 178.254 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 34.0 mmtp -63.42 -51.11 67.12 Favored 'General case' 0 C--O 1.221 -0.436 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.286 177.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.529 ' HA ' ' OE1' ' A' ' 45' ' ' GLU . 74.8 t -59.78 -42.65 89.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-O 121.697 0.76 . . . . 0.0 110.859 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.581 HD11 HG13 ' A' ' 23' ' ' ILE . 1.4 mt -60.52 -40.15 83.48 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.909 0 CA-C-N 114.837 -1.074 . . . . 0.0 110.308 175.458 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 34.2 t -68.51 -34.25 75.55 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 114.573 -1.194 . . . . 0.0 110.792 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.529 ' OE1' ' HA ' ' A' ' 42' ' ' VAL . 44.4 mt-10 -58.38 -51.07 71.38 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.916 HD11 HG22 ' A' ' 4' ' ' VAL . 43.4 mt -64.36 -23.57 67.34 Favored 'General case' 0 C--O 1.223 -0.317 0 CA-C-N 115.094 -0.957 . . . . 0.0 111.565 177.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -75.86 -25.92 56.63 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.011 0.434 . . . . 0.0 110.883 174.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.81 -41.83 18.24 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.993 -0.622 . . . . 0.0 112.537 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.59 ' HB2' HG23 ' A' ' 54' ' ' VAL . 7.7 mtpt -116.6 -156.19 0.61 Allowed 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 178.324 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.402 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 56.5 m-80 -94.64 173.57 7.54 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.49 -0.93 . . . . 0.0 108.49 168.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.637 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.3 mp -64.91 -52.13 57.92 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.753 0 C-N-CA 120.647 -0.421 . . . . 0.0 111.438 -174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.6 -39.35 80.16 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-O 120.739 0.304 . . . . 0.0 111.024 -174.268 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.27 -57.47 12.76 Favored 'General case' 0 CA--C 1.513 -0.463 0 CA-C-N 115.881 -0.599 . . . . 0.0 109.985 177.819 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.709 ' HB ' HD23 ' A' ' 46' ' ' LEU . 42.6 t -63.47 -31.81 54.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-N 115.254 -0.884 . . . . 0.0 110.96 -178.678 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.541 HG23 HD13 ' A' ' 59' ' ' ILE . 2.7 mm -58.7 -60.89 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.48 0.657 . . . . 0.0 111.211 170.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.878 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.72 -17.68 62.81 Favored 'General case' 0 C--N 1.317 -0.821 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.455 -169.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 84.8 mm-40 -94.23 -26.2 16.74 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.928 173.494 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.85 -50.59 3.05 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 121.18 -0.533 . . . . 0.0 113.808 -173.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.734 HG23 ' HB2' ' A' ' 62' ' ' LEU . 1.9 mp -57.82 -50.79 76.52 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 CA-C-N 117.395 0.598 . . . . 0.0 109.822 -178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.48 -101.42 0.24 Allowed Glycine 0 C--O 1.227 -0.322 0 CA-C-N 115.683 -0.689 . . . . 0.0 113.371 171.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HD2' ' HA ' ' A' ' 61' ' ' LYS . 42.1 tptt -101.35 53.98 0.83 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 121.707 0.765 . . . . 0.0 110.308 -179.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.734 ' HB2' HG23 ' A' ' 59' ' ' ILE . 49.2 mt -137.15 -151.46 0.4 Allowed 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.58 177.216 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.634 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . 69.41 45.45 0.83 Allowed 'General case' 0 C--O 1.232 0.168 0 O-C-N 123.37 0.419 . . . . 0.0 110.755 176.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 20.7 t 68.82 -175.54 0.2 Allowed 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 115.315 -0.857 . . . . 0.0 110.033 -177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.583 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 3.1 m -127.78 161.78 53.38 Favored Pre-proline 0 C--N 1.323 -0.564 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 178.012 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.583 ' HD2' ' HB ' ' A' ' 65' ' ' VAL . 6.7 Cg_endo -43.82 -57.9 1.67 Allowed 'Trans proline' 0 C--O 1.233 0.252 0 C-N-CA 124.049 3.166 . . . . 0.0 112.787 177.506 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.99 142.93 17.83 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.918 179.66 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.83 32.82 0.34 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.701 -0.761 . . . . 0.0 112.158 -179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.913 -0.937 . . . . 0.0 111.465 -178.81 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . 0.495 ' HB3' ' CG2' ' B' ' 42' ' ' VAL . . . . . . . . 0 N--CA 1.483 1.218 0 CA-C-O 121.673 0.749 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.591 ' CE ' ' HG ' ' A' ' 8' ' ' LEU . 0.8 OUTLIER -58.26 -41.65 84.74 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 114.175 -1.375 . . . . 0.0 113.302 -173.721 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.575 ' HA ' HD13 ' A' ' 12' ' ' LEU . 4.8 mtp85 -48.27 -45.64 34.8 Favored 'General case' 0 N--CA 1.468 0.452 0 N-CA-C 114.399 1.259 . . . . 0.0 114.399 -171.078 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.538 ' HD1' HD11 ' B' ' 27' ' ' LEU . 27.7 m-85 -102.01 -11.06 19.2 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 113.053 0.76 . . . . 0.0 113.053 -171.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.919 HG22 HD11 ' B' ' 46' ' ' LEU . 99.5 t -70.06 -33.39 54.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 C-N-CA 120.228 -0.589 . . . . 0.0 110.033 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.614 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -55.9 -54.56 43.14 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.468 0.652 . . . . 0.0 111.479 176.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.95 -36.61 69.92 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.513 -0.767 . . . . 0.0 110.868 -179.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.67 ' CD2' HD13 ' B' ' 46' ' ' LEU . 63.0 t80 -55.42 -48.77 73.9 Favored 'General case' 0 C--O 1.237 0.436 0 CA-C-N 116.112 -0.495 . . . . 0.0 109.881 175.253 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.76 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.7 mp -57.12 -59.05 5.66 Favored 'General case' 0 N--CA 1.455 -0.193 0 CA-C-N 115.562 -0.744 . . . . 0.0 110.48 177.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.97 HD12 HD12 ' A' ' 9' ' ' LEU . 15.5 mt -48.33 -50.65 29.5 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.173 0.435 . . . . 0.0 112.173 179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.451 ' HB3' ' HB3' ' B' ' 18' ' ' PRO . . . -59.26 -37.9 78.75 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.343 -0.389 . . . . 0.0 110.893 -177.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.427 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.28 -39.97 95.0 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.714 178.738 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.76 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.3 mt -78.04 -27.06 48.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.855 -176.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.09 -19.69 64.01 Favored Glycine 0 N--CA 1.452 -0.259 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.629 -179.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 134.74 -17.98 4.12 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.562 -0.828 . . . . 0.0 112.081 179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.427 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 53.1 t30 -99.55 88.84 3.96 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 109.766 -0.457 . . . . 0.0 109.766 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.565 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 14.4 m -65.32 -17.95 64.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.625 -0.716 . . . . 0.0 111.563 -176.068 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 21.7 t -112.67 78.57 2.83 Favored Pre-proline 0 C--N 1.321 -0.647 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 175.24 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.565 ' HD3' ' O ' ' B' ' 16' ' ' SER . 16.2 Cg_exo -68.09 125.66 13.35 Favored 'Trans proline' 0 N--CA 1.462 -0.346 0 C-N-CA 123.142 2.561 . . . . 0.0 112.861 -169.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.551 ' HB3' ' OD2' ' B' ' 22' ' ' ASP . 33.3 t -76.83 140.84 40.78 Favored 'General case' 0 N--CA 1.447 -0.601 0 CA-C-N 115.642 -0.708 . . . . 0.0 109.319 176.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.419 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.96 -20.5 63.9 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.838 -0.619 . . . . 0.0 111.105 -179.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.624 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.3 mmmm -68.22 -45.43 73.32 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.014 0.435 . . . . 0.0 110.102 175.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.736 ' O ' HG13 ' B' ' 26' ' ' ILE . 13.3 m-20 -57.13 -46.76 82.39 Favored 'General case' 0 CA--C 1.511 -0.541 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 175.7 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.572 HG13 HD11 ' B' ' 43' ' ' ILE . 40.4 mm -50.56 -53.14 13.78 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.131 -0.941 . . . . 0.0 110.677 178.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.624 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 33.9 mttm -52.24 -45.85 65.52 Favored 'General case' 0 C--N 1.333 -0.129 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.798 178.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -67.03 -42.56 84.66 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 112.513 0.56 . . . . 0.0 112.513 -179.178 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.736 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.3 mt -66.07 -38.28 81.67 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-O 121.268 0.556 . . . . 0.0 109.947 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.625 HD13 ' HB2' ' B' ' 34' ' ' ALA . 14.1 mt -62.92 -38.98 93.18 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.967 171.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -63.4 -31.28 72.4 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.35 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 33.8 t -64.29 -39.5 94.04 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-O 120.916 0.388 . . . . 0.0 110.812 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.504 HG23 HG13 ' B' ' 32' ' ' ILE . 15.7 m -102.1 -4.28 9.34 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.885 0.374 . . . . 0.0 111.579 -177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 86.17 44.21 6.03 Favored Glycine 0 C--N 1.33 0.226 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.379 173.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.604 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 63.3 mt -108.57 136.75 43.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.909 0.355 . . . . 0.0 111.047 179.309 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -75.81 139.33 41.71 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.067 176.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.625 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -127.14 133.3 50.38 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-O 121.553 0.692 . . . . 0.0 111.91 178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -104.67 114.64 28.98 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 114.966 -1.016 . . . . 0.0 109.023 175.631 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -48.4 -50.33 31.36 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 123.676 0.61 . . . . 0.0 112.168 -168.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.64 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 20.6 t70 -62.19 -58.28 8.36 Favored 'General case' 0 C--N 1.328 -0.358 0 O-C-N 123.569 0.543 . . . . 0.0 110.546 -174.768 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.515 ' O ' HG23 ' B' ' 42' ' ' VAL . 20.6 tpp180 -62.13 -29.58 70.44 Favored 'General case' 0 N--CA 1.453 -0.297 0 CA-C-N 116.662 -0.244 . . . . 0.0 111.055 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.515 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.8 tp -60.83 -56.71 17.99 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 110.182 -0.303 . . . . 0.0 110.182 174.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -58.29 -33.73 69.77 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.777 -0.453 . . . . 0.0 109.777 178.127 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.64 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 34.0 mmtp -63.7 -51.12 66.43 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.29 177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.515 HG23 ' O ' ' B' ' 38' ' ' ARG . 73.0 t -59.83 -42.43 89.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.73 0.776 . . . . 0.0 110.911 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.572 HD11 HG13 ' B' ' 23' ' ' ILE . 1.4 mt -60.64 -40.01 83.31 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.937 0 CA-C-N 114.799 -1.091 . . . . 0.0 110.3 175.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 32.2 t -68.78 -33.87 74.59 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 114.579 -1.191 . . . . 0.0 110.945 177.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.511 ' OE1' ' HA ' ' B' ' 42' ' ' VAL . 44.4 mt-10 -58.54 -51.06 71.5 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 109.214 -0.662 . . . . 0.0 109.214 173.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.919 HD11 HG22 ' B' ' 4' ' ' VAL . 43.5 mt -64.54 -23.83 67.4 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.126 -0.943 . . . . 0.0 111.63 177.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -75.8 -25.79 56.69 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.965 0.412 . . . . 0.0 110.741 174.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -77.71 -42.52 17.01 Favored Glycine 0 CA--C 1.518 0.273 0 C-N-CA 120.9 -0.667 . . . . 0.0 112.39 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.592 ' HB2' HG23 ' B' ' 54' ' ' VAL . 7.8 mtpt -115.67 -155.89 0.59 Allowed 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 178.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 58.0 m-80 -94.35 174.07 7.32 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 167.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.634 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.3 mp -65.3 -52.21 55.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.714 0 C-N-CA 120.766 -0.374 . . . . 0.0 111.228 -174.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.878 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.1 mp0 -58.64 -39.35 80.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.734 0.302 . . . . 0.0 110.894 -174.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -58.18 -57.2 13.9 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.137 177.758 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.7 ' HB ' HD23 ' B' ' 46' ' ' LEU . 42.6 t -63.9 -31.6 53.84 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.68 0 CA-C-N 115.218 -0.901 . . . . 0.0 110.975 -178.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.541 HG23 HD13 ' B' ' 59' ' ' ILE . 2.7 mm -58.82 -60.98 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 121.495 0.664 . . . . 0.0 111.201 170.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.875 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.53 -18.08 62.94 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 114.93 -1.032 . . . . 0.0 111.388 -169.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 85.6 mm-40 -94.03 -25.92 17.01 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.896 173.552 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -89.96 -50.71 3.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.923 -0.656 . . . . 0.0 113.864 -173.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.721 HG23 ' HB2' ' B' ' 62' ' ' LEU . 1.8 mp -57.57 -50.61 76.67 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.126 0 CA-C-N 117.281 0.541 . . . . 0.0 109.664 -178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 59.33 -100.76 0.2 Allowed Glycine 0 N--CA 1.452 -0.249 0 CA-C-N 115.712 -0.676 . . . . 0.0 113.658 171.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . 0.466 ' HD2' ' HA ' ' B' ' 61' ' ' LYS . 42.2 tptt -101.98 53.53 0.81 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.769 0.795 . . . . 0.0 110.343 -179.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.721 ' HB2' HG23 ' B' ' 59' ' ' ILE . 49.3 mt -136.86 -151.48 0.4 Allowed 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 114.7 -1.136 . . . . 0.0 108.451 177.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.637 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . 69.16 45.83 0.85 Allowed 'General case' 0 N--CA 1.462 0.131 0 O-C-N 123.364 0.415 . . . . 0.0 110.643 176.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 22.1 t 68.85 -175.17 0.2 Allowed 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 115.381 -0.827 . . . . 0.0 109.883 -177.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.566 ' HB ' ' HD2' ' B' ' 66' ' ' PRO . 3.1 m -128.15 161.8 54.08 Favored Pre-proline 0 C--N 1.324 -0.538 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 177.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.566 ' HD2' ' HB ' ' B' ' 65' ' ' VAL . 6.6 Cg_endo -43.92 -57.85 1.71 Allowed 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 123.977 3.118 . . . . 0.0 112.749 177.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.14 142.82 17.56 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.084 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -161.92 33.1 0.34 Allowed Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.035 -179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.858 0 CA-C-O 118.777 -1.013 . . . . 0.0 111.481 -178.863 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.04 0 CA-C-O 121.084 0.469 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.643 ' HG3' HG13 ' A' ' 59' ' ' ILE . 17.4 ttt -76.58 91.81 3.42 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.913 0.387 . . . . 0.0 109.987 177.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.613 ' HA ' HD13 ' B' ' 12' ' ' LEU . 35.0 ttm180 -158.75 -59.85 0.07 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.535 ' CZ ' ' HD2' ' A' ' 2' ' ' ARG . 28.1 m-85 -86.8 -24.45 25.02 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 116.088 -0.505 . . . . 0.0 112.115 -171.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.952 HG22 HD11 ' A' ' 46' ' ' LEU . 75.8 t -58.96 -36.25 60.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.963 0.411 . . . . 0.0 110.557 179.771 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.643 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.89 -55.17 38.33 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 121.358 0.599 . . . . 0.0 111.744 179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -72.3 -37.39 68.97 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.671 -179.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.501 ' CD1' HD13 ' A' ' 46' ' ' LEU . 54.7 t80 -54.12 -48.7 70.5 Favored 'General case' 0 C--O 1.237 0.4 0 CA-C-N 115.919 -0.582 . . . . 0.0 109.679 175.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.796 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 4.4 mp -58.59 -58.4 8.74 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 115.372 -0.831 . . . . 0.0 110.372 177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.977 HD12 HD12 ' B' ' 9' ' ' LEU . 14.1 mt -48.59 -48.83 38.77 Favored 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 112.025 0.38 . . . . 0.0 112.025 179.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' ' CD1' ' A' ' 26' ' ' ILE . . . -60.53 -37.41 81.09 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.882 -178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.564 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.31 -39.35 92.35 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.749 178.203 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.3 mt -80.43 -17.52 51.51 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.587 -175.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.13 -14.56 78.92 Favored Glycine 0 N--CA 1.449 -0.449 0 CA-C-N 115.806 -0.633 . . . . 0.0 111.973 177.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 132.9 -27.14 3.51 Favored Glycine 0 N--CA 1.446 -0.65 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.252 178.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.564 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 44.9 t30 -93.42 98.02 10.94 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.973 0.416 . . . . 0.0 110.693 -178.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.429 ' C ' ' HD3' ' A' ' 18' ' ' PRO . 15.2 m -74.6 -3.64 32.31 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.51 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 9.3 t -123.3 71.65 46.17 Favored Pre-proline 0 C--N 1.321 -0.673 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 176.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.429 ' HD3' ' C ' ' A' ' 16' ' ' SER . 14.9 Cg_exo -69.2 126.36 13.58 Favored 'Trans proline' 0 N--CA 1.463 -0.272 0 C-N-CA 123.322 2.681 . . . . 0.0 112.542 -171.717 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.579 ' O ' HG12 ' A' ' 23' ' ' ILE . 62.5 p -78.05 147.87 34.55 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 177.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.572 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.03 -26.78 69.01 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.37 -176.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.94 -39.37 69.47 Favored 'General case' 0 C--O 1.239 0.517 0 CA-C-O 121.349 0.595 . . . . 0.0 109.999 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.672 ' O ' HG13 ' A' ' 26' ' ' ILE . 15.6 t70 -62.03 -44.67 96.2 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.204 -0.907 . . . . 0.0 108.588 175.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.711 HG13 HD11 ' A' ' 43' ' ' ILE . 41.1 mm -50.63 -50.46 22.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.193 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.517 174.291 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.572 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 94.0 mttt -55.88 -43.61 77.35 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.091 -179.676 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.452 ' HA ' ' HD2' ' A' ' 25' ' ' LYS . 4.3 mmmp? -65.53 -38.99 91.24 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 112.059 0.392 . . . . 0.0 112.059 179.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.672 HG13 ' O ' ' A' ' 22' ' ' ASP . 11.2 mt -68.16 -39.38 81.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-O 121.053 0.454 . . . . 0.0 110.071 179.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.627 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 15.4 mt -61.91 -39.98 93.89 Favored 'General case' 0 C--O 1.221 -0.414 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.684 171.229 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.418 ' HB3' ' O ' ' A' ' 25' ' ' LYS . 4.7 t70 -59.41 -35.44 73.97 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.722 177.464 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 10.6 t -64.8 -35.3 80.67 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.655 0.264 . . . . 0.0 110.894 -178.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.478 HG23 HG13 ' A' ' 32' ' ' ILE . 16.8 m -102.33 -8.78 9.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-O 120.778 0.323 . . . . 0.0 111.482 -178.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 92.17 44.13 4.18 Favored Glycine 0 CA--C 1.521 0.418 0 C-N-CA 121.047 -0.597 . . . . 0.0 113.374 174.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.627 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 38.9 mt -116.34 135.18 57.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.868 0.334 . . . . 0.0 110.214 177.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 44.5 mt-10 -84.89 155.5 21.67 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.737 -0.211 . . . . 0.0 110.628 176.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.594 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -134.77 130.97 36.99 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 121.256 0.551 . . . . 0.0 112.07 -178.393 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -94.63 116.25 28.53 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.387 -0.824 . . . . 0.0 109.208 175.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -42.32 -64.12 0.65 Allowed 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 113.28 0.845 . . . . 0.0 113.28 -172.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -60.45 -45.62 93.01 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.61 -173.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.461 ' O ' HG23 ' A' ' 42' ' ' VAL . 16.6 tpp180 -64.09 -36.83 85.3 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.026 0.441 . . . . 0.0 110.649 179.493 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.45 HD12 HG13 ' A' ' 43' ' ' ILE . 5.8 tp -65.04 -56.77 11.12 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.981 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -58.23 -32.85 68.71 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.037 -0.357 . . . . 0.0 110.037 177.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . . . . . . . . . 26.3 tptp -60.85 -57.59 12.04 Favored 'General case' 0 N--CA 1.452 -0.352 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.542 177.109 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 38' ' ' ARG . 93.2 t -56.03 -44.58 78.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.15 0.5 . . . . 0.0 110.778 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.711 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.78 -47.61 88.64 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.399 178.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 87.1 p -69.0 -28.21 66.4 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.309 -0.86 . . . . 0.0 111.123 -176.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -75.39 -37.16 60.68 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 120.879 -0.328 . . . . 0.0 110.322 176.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.952 HD11 HG22 ' A' ' 4' ' ' VAL . 43.1 mt -63.17 -33.93 76.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 121.068 0.461 . . . . 0.0 110.614 172.73 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.06 -42.51 63.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.138 178.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -70.71 -37.3 67.01 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.254 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.439 ' HD2' ' N ' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -103.47 -151.48 0.43 Allowed 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 177.915 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.549 ' HA ' ' OG ' ' B' ' 64' ' ' SER . 22.1 m120 -114.46 141.36 47.78 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.499 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.889 ' HB ' ' HB1' ' B' ' 63' ' ' ALA . 1.7 mp -46.9 -56.72 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.381 0 O-C-N 123.395 0.435 . . . . 0.0 111.368 -177.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.761 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 27.8 mt-10 -55.07 -36.24 65.39 Favored 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.485 0.491 . . . . 0.0 111.864 -174.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.3 t70 -71.41 -52.46 18.45 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.254 0.549 . . . . 0.0 109.967 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.637 ' HB ' HD23 ' A' ' 46' ' ' LEU . 54.0 t -62.27 -29.32 46.39 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 115.449 -0.796 . . . . 0.0 110.435 177.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' B' ' 55' ' ' ILE . 2.1 mm -60.43 -61.13 1.66 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.37 0 CA-C-O 121.097 0.475 . . . . 0.0 111.459 170.25 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.758 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -72.36 -9.54 58.63 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.411 -0.813 . . . . 0.0 111.432 -170.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -104.82 -19.89 13.76 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.757 170.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -101.09 -35.08 4.33 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 121.008 -0.615 . . . . 0.0 114.442 -171.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.762 HG21 ' HB2' ' A' ' 63' ' ' ALA . 1.8 mp -69.78 -48.39 64.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 117.916 0.858 . . . . 0.0 109.088 178.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.97 68.37 1.7 Allowed Glycine 0 N--CA 1.452 -0.246 0 CA-C-N 115.928 -0.578 . . . . 0.0 113.95 168.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.31 2.36 3.98 Favored 'General case' 0 N--CA 1.467 0.389 0 C-N-CA 122.914 0.486 . . . . 0.0 112.047 172.707 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.404 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 6.9 mt -78.0 -10.18 59.47 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.951 0.881 . . . . 0.0 108.795 169.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.921 ' HB1' ' HB ' ' B' ' 51' ' ' ILE . . . -88.88 83.54 6.64 Favored 'General case' 0 N--CA 1.444 -0.725 0 CA-C-N 114.438 -1.255 . . . . 0.0 110.862 -178.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.518 ' OG ' ' HA ' ' B' ' 50' ' ' ASN . 35.7 p 53.97 178.97 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.428 0 O-C-N 124.394 1.059 . . . . 0.0 113.044 176.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.625 ' HB ' ' HD2' ' A' ' 66' ' ' PRO . 10.4 m -135.47 175.27 3.73 Favored Pre-proline 0 C--N 1.323 -0.549 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.625 ' HD2' ' HB ' ' A' ' 65' ' ' VAL . 9.2 Cg_endo -50.21 84.15 0.02 OUTLIER 'Trans proline' 0 CA--C 1.534 0.525 0 C-N-CA 123.109 2.539 . . . . 0.0 112.418 168.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.17 76.32 10.21 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.153 0.501 . . . . 0.0 110.707 -179.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.5 59.69 4.79 Favored Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.758 -0.655 . . . . 0.0 112.002 179.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.93 0 CA-C-O 118.595 -1.114 . . . . 0.0 111.667 179.804 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.014 0 CA-C-O 121.033 0.444 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.629 ' HG3' HG13 ' B' ' 59' ' ' ILE . 17.5 ttt -76.14 91.85 3.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.159 177.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.637 ' HA ' HD13 ' A' ' 12' ' ' LEU . 34.8 ttm180 -159.06 -59.72 0.07 Allowed 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.667 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.528 ' CZ ' ' HD2' ' B' ' 2' ' ' ARG . 28.4 m-85 -86.92 -24.42 24.81 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 116.165 -0.47 . . . . 0.0 112.178 -171.294 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.926 HG22 HD11 ' B' ' 46' ' ' LEU . 75.3 t -58.98 -36.07 60.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.902 0.382 . . . . 0.0 110.602 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.651 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -58.0 -55.36 35.91 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.976 -0.556 . . . . 0.0 111.655 179.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -72.24 -37.3 69.17 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.618 -179.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.502 ' CD1' HD13 ' B' ' 46' ' ' LEU . 54.9 t80 -54.3 -48.6 71.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.729 174.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.79 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 4.3 mp -58.74 -58.34 9.03 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.372 177.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.977 HD12 HD12 ' A' ' 9' ' ' LEU . 14.2 mt -48.36 -48.7 36.44 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 111.974 0.361 . . . . 0.0 111.974 179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.436 ' HB2' ' CD1' ' B' ' 26' ' ' ILE . . . -60.9 -37.75 83.32 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.632 -178.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.581 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.78 -39.34 93.44 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.23 0.538 . . . . 0.0 110.777 178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.79 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.0 mt -80.44 -17.49 51.6 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.705 -0.68 . . . . 0.0 110.619 -176.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -73.09 -14.6 78.84 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 121.008 -0.615 . . . . 0.0 111.998 177.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 133.1 -27.53 3.43 Favored Glycine 0 N--CA 1.446 -0.636 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.126 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.581 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 45.2 t30 -92.95 98.44 11.36 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.954 0.407 . . . . 0.0 110.587 -178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.417 ' C ' ' HD3' ' B' ' 18' ' ' PRO . 17.0 m -75.18 -3.17 31.43 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.515 -179.237 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 8.9 t -123.51 71.69 48.29 Favored Pre-proline 0 C--N 1.321 -0.637 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 176.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.417 ' HD3' ' C ' ' B' ' 16' ' ' SER . 15.0 Cg_exo -69.44 126.01 13.01 Favored 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 123.237 2.625 . . . . 0.0 112.746 -171.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.583 ' O ' HG12 ' B' ' 23' ' ' ILE . 64.6 p -77.8 147.98 34.99 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.947 -0.569 . . . . 0.0 109.671 177.385 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.568 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -63.15 -27.01 69.08 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.275 -176.062 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 29.8 mmtp -71.88 -39.26 69.74 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 121.352 0.596 . . . . 0.0 110.002 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.674 ' O ' HG13 ' B' ' 26' ' ' ILE . 15.7 t70 -62.02 -44.86 95.82 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.582 -0.895 . . . . 0.0 108.582 175.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.699 HG13 HD11 ' B' ' 43' ' ' ILE . 41.2 mm -50.53 -50.38 22.13 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 CA-C-N 115.096 -0.957 . . . . 0.0 110.591 174.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.568 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 93.9 mttt -55.98 -43.71 77.87 Favored 'General case' 0 C--O 1.225 -0.219 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.046 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.428 ' O ' ' HB3' ' B' ' 28' ' ' ASP . 4.3 mmmp? -65.16 -39.27 92.72 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 112.132 0.419 . . . . 0.0 112.132 179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.674 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.1 -39.19 80.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.152 0.501 . . . . 0.0 110.136 179.382 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.622 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 15.4 mt -62.09 -39.92 94.09 Favored 'General case' 0 C--O 1.221 -0.417 0 CA-C-N 115.737 -0.665 . . . . 0.0 109.679 171.05 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.428 ' HB3' ' O ' ' B' ' 25' ' ' LYS . 5.6 t70 -59.59 -35.24 73.92 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.928 177.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 10.0 t -64.76 -35.48 81.21 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-O 120.808 0.337 . . . . 0.0 110.872 -179.2 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.475 HG23 HG13 ' B' ' 32' ' ' ILE . 17.1 m -102.28 -8.62 9.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-O 120.683 0.277 . . . . 0.0 111.622 -178.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 91.7 44.75 4.15 Favored Glycine 0 CA--C 1.519 0.334 0 C-N-CA 120.968 -0.634 . . . . 0.0 113.281 174.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.622 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 37.9 mt -116.98 135.49 57.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 116.82 0.31 . . . . 0.0 110.295 177.486 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -84.96 155.97 21.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 120.641 0.258 . . . . 0.0 110.576 176.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.593 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -135.43 130.51 34.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 121.313 0.578 . . . . 0.0 111.985 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -94.23 116.37 28.76 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.34 -0.845 . . . . 0.0 109.326 175.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -42.53 -64.04 0.67 Allowed 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 113.3 0.852 . . . . 0.0 113.3 -172.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 25.5 m-20 -60.2 -45.93 91.47 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.809 -173.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.48 ' O ' HG23 ' B' ' 42' ' ' VAL . 16.4 tpp180 -64.11 -36.5 84.24 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.073 0.463 . . . . 0.0 110.598 179.57 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.449 ' O ' HG13 ' B' ' 43' ' ' ILE . 5.7 tp -65.27 -56.72 11.14 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.86 179.596 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -58.41 -32.78 68.96 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . . . . . . . . . 26.2 tptp -60.78 -57.73 11.46 Favored 'General case' 0 N--CA 1.451 -0.383 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.515 177.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.48 HG23 ' O ' ' B' ' 38' ' ' ARG . 94.3 t -56.03 -44.59 78.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.129 0.49 . . . . 0.0 110.888 179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.699 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.69 -47.6 88.4 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.444 178.329 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 86.2 p -68.86 -28.15 66.46 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 115.196 -0.911 . . . . 0.0 111.156 -176.389 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -75.57 -37.1 60.17 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.849 -0.34 . . . . 0.0 110.33 176.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.926 HD11 HG22 ' B' ' 4' ' ' VAL . 43.7 mt -63.14 -34.1 76.88 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.036 0.446 . . . . 0.0 110.635 172.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 24.2 t-20 -72.96 -42.07 63.75 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.637 -0.711 . . . . 0.0 111.379 178.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -71.02 -37.29 64.29 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 120.914 -0.66 . . . . 0.0 112.128 -179.964 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.431 ' N ' ' HD2' ' B' ' 49' ' ' LYS . 0.3 OUTLIER -103.67 -151.49 0.43 Allowed 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 178.111 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.518 ' HA ' ' OG ' ' A' ' 64' ' ' SER . 23.0 m120 -114.23 141.69 47.22 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 109.236 -0.653 . . . . 0.0 109.236 173.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.921 ' HB ' ' HB1' ' A' ' 63' ' ' ALA . 1.7 mp -47.06 -56.73 1.31 Allowed 'Isoleucine or valine' 0 C--O 1.22 -0.448 0 O-C-N 123.274 0.359 . . . . 0.0 111.338 -177.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.758 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 27.8 mt-10 -55.16 -35.92 65.28 Favored 'General case' 0 N--CA 1.465 0.279 0 CA-C-O 121.16 0.505 . . . . 0.0 111.989 -174.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.51 -52.5 17.96 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.13 179.513 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.66 ' HB ' HD23 ' B' ' 46' ' ' LEU . 55.0 t -62.38 -29.22 46.25 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.433 -0.803 . . . . 0.0 110.529 177.587 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.649 HD12 HD12 ' A' ' 55' ' ' ILE . 2.1 mm -60.45 -61.19 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 121.086 0.47 . . . . 0.0 111.53 170.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.761 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -72.26 -9.92 59.11 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.272 -0.877 . . . . 0.0 111.529 -170.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -104.33 -20.35 13.79 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.652 170.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.73 -35.65 4.25 Favored Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.97 -0.633 . . . . 0.0 114.285 -171.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.766 HG21 ' HB2' ' B' ' 63' ' ' ALA . 1.8 mp -69.06 -49.03 66.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 117.91 0.855 . . . . 0.0 109.023 178.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.39 68.14 1.79 Allowed Glycine 0 C--O 1.236 0.224 0 CA-C-N 115.952 -0.567 . . . . 0.0 113.774 168.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 70.65 2.08 3.97 Favored 'General case' 0 N--CA 1.466 0.347 0 C-N-CA 122.932 0.493 . . . . 0.0 112.069 172.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.401 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 6.7 mt -77.99 -10.12 59.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-O 122.015 0.912 . . . . 0.0 108.7 169.482 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.889 ' HB1' ' HB ' ' A' ' 51' ' ' ILE . . . -89.04 83.49 6.57 Favored 'General case' 0 N--CA 1.442 -0.834 0 CA-C-N 114.288 -1.324 . . . . 0.0 110.85 -178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . 0.549 ' OG ' ' HA ' ' A' ' 50' ' ' ASN . 35.0 p 54.09 179.18 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.591 1.182 . . . . 0.0 113.079 176.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.63 ' HB ' ' HD2' ' B' ' 66' ' ' PRO . 10.5 m -135.87 175.17 3.77 Favored Pre-proline 0 C--N 1.323 -0.586 0 N-CA-C 108.261 -1.014 . . . . 0.0 108.261 -179.366 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.63 ' HD2' ' HB ' ' B' ' 65' ' ' VAL . 9.2 Cg_endo -50.46 84.26 0.02 OUTLIER 'Trans proline' 0 C--N 1.348 0.517 0 C-N-CA 123.155 2.57 . . . . 0.0 112.459 169.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -85.06 76.61 10.23 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 121.128 0.49 . . . . 0.0 110.642 -178.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.04 59.9 4.84 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.922 -0.656 . . . . 0.0 112.01 179.113 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.916 0 CA-C-O 118.62 -1.1 . . . . 0.0 111.551 179.145 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.088 0 CA-C-O 120.783 0.325 . . . . 0.0 111.413 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.554 ' HB2' ' HA ' ' A' ' 59' ' ' ILE . 21.9 ttt -89.66 76.35 7.31 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.972 0.415 . . . . 0.0 111.111 -175.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 79.7 mtp180 -141.97 -58.54 0.47 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.477 175.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.524 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 19.5 m-85 -90.99 -20.69 21.85 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 113.48 0.919 . . . . 0.0 113.48 -168.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.893 HG22 HD11 ' A' ' 46' ' ' LEU . 97.3 t -63.28 -33.78 63.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.043 -177.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.568 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.57 -54.85 42.2 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.519 0.676 . . . . 0.0 111.075 178.163 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.37 -35.16 73.37 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.307 -0.861 . . . . 0.0 110.856 179.063 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.64 ' CD2' HD13 ' A' ' 46' ' ' LEU . 55.2 t80 -56.6 -47.51 79.44 Favored 'General case' 0 C--O 1.236 0.386 0 N-CA-C 109.745 -0.465 . . . . 0.0 109.745 175.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.762 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.4 mp -60.1 -57.64 11.95 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.514 177.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.926 HD12 HD12 ' B' ' 9' ' ' LEU . 14.3 mt -46.4 -49.83 17.46 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 112.13 0.419 . . . . 0.0 112.13 178.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.403 ' HB2' HD11 ' A' ' 26' ' ' ILE . . . -60.14 -38.83 84.29 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.948 -178.567 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.431 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -64.15 -37.34 87.11 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.038 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.762 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.0 mt -81.46 -24.18 36.97 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.673 -176.373 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.77 -21.27 74.9 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.862 -0.608 . . . . 0.0 112.9 -177.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.63 -15.37 3.14 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.497 -0.859 . . . . 0.0 112.269 179.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.586 ' ND2' ' HA ' ' A' ' 18' ' ' PRO . 60.4 t30 -108.41 86.62 2.32 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.605 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 16.3 m -61.81 -27.75 68.98 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.941 -0.572 . . . . 0.0 111.736 -176.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 23.1 t -108.63 82.62 1.76 Allowed Pre-proline 0 C--N 1.323 -0.583 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 173.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.605 ' HD3' ' O ' ' A' ' 16' ' ' SER . 5.7 Cg_exo -78.73 147.8 22.16 Favored 'Trans proline' 0 N--CA 1.458 -0.598 0 C-N-CA 123.348 2.699 . . . . 0.0 112.489 -171.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.493 ' O ' HG12 ' A' ' 23' ' ' ILE . 89.7 p -94.14 156.96 16.3 Favored 'General case' 0 N--CA 1.449 -0.525 0 N-CA-C 109.256 -0.646 . . . . 0.0 109.256 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.582 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -61.45 -25.58 67.32 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.463 -178.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.83 -45.09 83.55 Favored 'General case' 0 C--O 1.241 0.621 0 CA-C-O 121.093 0.473 . . . . 0.0 110.027 178.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.734 ' O ' HG13 ' A' ' 26' ' ' ILE . 55.5 m-20 -55.22 -50.9 68.25 Favored 'General case' 0 CA--C 1.515 -0.385 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 175.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.718 HG13 HD11 ' A' ' 43' ' ' ILE . 37.2 mm -50.39 -51.1 19.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-N 114.723 -1.126 . . . . 0.0 110.957 179.318 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.582 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 88.3 mttt -52.89 -49.65 65.47 Favored 'General case' 0 CA--C 1.517 -0.309 0 O-C-N 123.754 0.659 . . . . 0.0 110.943 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.7 mmmt -66.68 -35.99 81.45 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 112.067 0.395 . . . . 0.0 112.067 -175.397 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.734 HG13 ' O ' ' A' ' 22' ' ' ASP . 9.6 mt -68.62 -38.25 78.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.463 0 CA-C-O 121.168 0.509 . . . . 0.0 110.02 178.625 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.618 ' HB3' ' HB ' ' A' ' 32' ' ' ILE . 13.3 mt -62.11 -41.15 97.93 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.067 171.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 20.9 m-20 -57.22 -38.6 73.98 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.722 -0.217 . . . . 0.0 111.218 176.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 35.1 t -60.37 -35.78 76.5 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.743 -178.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.552 HG23 HG13 ' A' ' 32' ' ' ILE . 14.6 m -103.33 -9.04 9.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 112.024 0.379 . . . . 0.0 112.024 -177.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.98 39.02 4.44 Favored Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.752 -0.737 . . . . 0.0 113.11 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.618 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 17.5 mt -117.69 149.42 20.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 109.323 -0.621 . . . . 0.0 109.323 176.704 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 8.1 mp0 -101.56 167.76 9.92 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 109.98 -0.378 . . . . 0.0 109.98 177.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.534 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -139.57 133.54 30.9 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.354 0.597 . . . . 0.0 112.02 179.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -97.84 113.97 25.91 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.021 -0.99 . . . . 0.0 108.835 174.879 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -42.53 -58.61 2.19 Favored 'General case' 0 N--CA 1.47 0.553 0 N-CA-C 113.309 0.855 . . . . 0.0 113.309 -171.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 12.6 m-20 -60.98 -54.71 41.67 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.477 -174.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.441 ' O ' HG23 ' A' ' 42' ' ' VAL . 23.2 tpp180 -55.31 -43.33 74.75 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.145 0.498 . . . . 0.0 110.808 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.524 ' HA ' ' CD1' ' A' ' 3' ' ' TYR . 6.1 tp -58.44 -54.83 42.62 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.467 -0.788 . . . . 0.0 111.063 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 91.9 m-20 -58.27 -34.23 70.27 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 110.219 -0.289 . . . . 0.0 110.219 178.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 73.5 mmtt -65.19 -53.09 50.08 Favored 'General case' 0 CA--C 1.521 -0.17 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.086 178.278 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 38' ' ' ARG . 89.2 t -57.04 -44.18 82.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 121.407 0.623 . . . . 0.0 110.578 178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.718 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -59.16 -45.99 92.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.205 -0.907 . . . . 0.0 111.292 175.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 31.0 t -65.57 -33.22 75.39 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.166 -0.924 . . . . 0.0 111.104 -179.553 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.519 ' HG3' ' O ' ' A' ' 41' ' ' LYS . 46.6 mt-10 -67.52 -44.25 78.85 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 109.818 -0.438 . . . . 0.0 109.818 176.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.893 HD11 HG22 ' A' ' 4' ' ' VAL . 45.6 mt -62.14 -41.72 98.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.377 175.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 9.9 t30 -68.26 -22.93 64.73 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.065 -178.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -100.96 4.39 56.0 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.915 -0.66 . . . . 0.0 112.672 -178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.532 ' HD2' HG22 ' A' ' 54' ' ' VAL . 66.4 mttm -142.21 -163.62 1.63 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.408 -0.59 . . . . 0.0 109.408 179.635 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 29.7 m-80 -95.27 144.99 25.39 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 168.371 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.72 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.2 mp -54.52 -50.04 61.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.334 -178.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.795 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.38 69.72 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.426 -175.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 39.0 m-20 -65.75 -53.47 40.11 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-O 120.859 0.362 . . . . 0.0 110.284 179.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.69 ' HB ' HD23 ' A' ' 46' ' ' LEU . 70.7 t -62.01 -29.65 46.91 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.376 179.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.671 HD12 HD12 ' B' ' 55' ' ' ILE . 2.5 mm -61.6 -61.09 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.279 0.561 . . . . 0.0 111.564 170.828 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.784 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -71.04 -13.87 62.13 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.321 -0.854 . . . . 0.0 111.466 -170.476 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 17.7 mm100 -97.65 -27.97 14.13 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.135 172.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.86 -33.16 7.99 Favored Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 121.273 -0.489 . . . . 0.0 113.943 -172.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.642 HG21 ' HB2' ' A' ' 63' ' ' ALA . 1.9 mp -76.41 -58.26 4.74 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 117.311 0.556 . . . . 0.0 109.559 177.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.26 64.53 4.31 Favored Glycine 0 C--N 1.331 0.294 0 C-N-CA 121.467 -0.397 . . . . 0.0 113.618 173.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm 66.44 10.21 7.12 Favored 'General case' 0 N--CA 1.466 0.363 0 N-CA-C 112.992 0.738 . . . . 0.0 112.992 175.09 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.411 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -81.74 -7.14 59.57 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 122.078 0.942 . . . . 0.0 108.596 171.705 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.709 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . -67.02 -74.91 0.1 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.072 -1.422 . . . . 0.0 112.679 -175.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.0 p -159.82 179.86 8.45 Favored 'General case' 0 N--CA 1.447 -0.575 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.082 -171.679 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.701 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.5 p -143.6 145.03 29.73 Favored Pre-proline 0 N--CA 1.445 -0.68 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 174.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.701 ' HD2' HG22 ' A' ' 65' ' ' VAL . 18.9 Cg_endo -59.62 89.91 0.07 OUTLIER 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 123.175 2.583 . . . . 0.0 112.443 -179.335 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.61 64.44 4.48 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 121.261 0.553 . . . . 0.0 110.868 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -112.96 -167.37 16.94 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.658 -0.701 . . . . 0.0 111.404 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.971 0 CA-C-O 118.837 -0.979 . . . . 0.0 111.479 -178.497 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.146 0 CA-C-O 120.616 0.246 . . . . 0.0 111.311 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.553 ' HB2' ' HA ' ' B' ' 59' ' ' ILE . 21.9 ttt -88.58 76.42 8.16 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.078 0.466 . . . . 0.0 111.321 -175.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.414 ' HA ' HD13 ' A' ' 12' ' ' LEU . 79.5 mtp180 -142.17 -58.49 0.46 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.309 174.945 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.514 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 19.2 m-85 -90.96 -20.81 21.75 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 113.388 0.884 . . . . 0.0 113.388 -168.723 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.918 HG22 HD11 ' B' ' 46' ' ' LEU . 98.5 t -63.27 -33.64 62.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 C-N-CA 120.786 -0.366 . . . . 0.0 111.119 -177.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.588 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.71 -54.78 42.96 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.566 0.698 . . . . 0.0 111.029 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.1 p -70.41 -35.49 73.46 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.818 179.079 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.633 ' CD2' HD13 ' B' ' 46' ' ' LEU . 56.7 t80 -56.29 -47.75 78.01 Favored 'General case' 0 C--O 1.237 0.438 0 N-CA-C 109.698 -0.482 . . . . 0.0 109.698 175.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.759 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.4 mp -60.03 -57.48 12.66 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.557 177.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.926 HD12 HD12 ' A' ' 9' ' ' LEU . 14.4 mt -46.66 -50.01 18.4 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 123.286 0.366 . . . . 0.0 111.976 178.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.408 ' HB2' HD11 ' B' ' 26' ' ' ILE . . . -59.89 -38.93 83.65 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.514 -0.312 . . . . 0.0 110.891 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.424 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -64.32 -36.68 84.91 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.171 179.233 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.759 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.0 mt -81.71 -24.29 36.25 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.61 -176.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -68.97 -21.04 75.16 Favored Glycine 0 N--CA 1.451 -0.354 0 CA-C-N 115.882 -0.599 . . . . 0.0 112.861 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 139.84 -15.94 3.07 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.357 -0.925 . . . . 0.0 112.28 179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' B' ' 18' ' ' PRO . 60.7 t30 -107.88 86.78 2.36 Favored 'General case' 0 C--N 1.323 -0.557 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 178.231 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.608 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 15.4 m -61.85 -27.98 69.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.656 -176.242 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 22.9 t -108.32 82.32 1.56 Allowed Pre-proline 0 C--N 1.323 -0.547 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.608 ' HD3' ' O ' ' B' ' 16' ' ' SER . 5.8 Cg_exo -78.37 147.82 23.2 Favored 'Trans proline' 0 N--CA 1.46 -0.469 0 C-N-CA 123.37 2.713 . . . . 0.0 112.428 -171.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.502 ' O ' HG12 ' B' ' 23' ' ' ILE . 94.3 p -93.77 157.47 16.13 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.206 -0.664 . . . . 0.0 109.206 176.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.585 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -61.82 -25.72 67.68 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.456 -178.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -65.81 -45.0 83.96 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.086 0.469 . . . . 0.0 110.147 178.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.722 ' O ' HG13 ' B' ' 26' ' ' ILE . 55.6 m-20 -55.14 -51.0 67.84 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 108.392 -0.966 . . . . 0.0 108.392 174.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.705 HG13 HD11 ' B' ' 43' ' ' ILE . 37.1 mm -50.43 -50.87 20.32 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.257 0 CA-C-N 114.752 -1.113 . . . . 0.0 111.02 179.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.585 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 87.6 mttt -52.9 -49.55 65.69 Favored 'General case' 0 CA--C 1.517 -0.321 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.869 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.4 mmmt -66.86 -36.1 81.56 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.361 -0.381 . . . . 0.0 112.007 -175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.722 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.8 mt -68.65 -38.3 78.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-O 121.158 0.504 . . . . 0.0 110.03 178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.61 ' HB3' ' HB ' ' B' ' 32' ' ' ILE . 13.7 mt -62.03 -41.07 97.71 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.749 -0.659 . . . . 0.0 110.009 171.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 20.2 m-20 -57.52 -38.36 74.53 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.676 -0.238 . . . . 0.0 111.22 176.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 38.1 t -60.39 -35.93 76.89 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.583 -178.236 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.552 HG23 HG13 ' B' ' 32' ' ' ILE . 14.0 m -103.3 -9.14 9.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 N-CA-C 111.838 0.31 . . . . 0.0 111.838 -176.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 95.75 39.56 4.35 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 120.83 -0.7 . . . . 0.0 113.075 176.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.61 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 17.9 mt -118.03 149.45 20.39 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 176.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 7.6 mp0 -101.46 168.14 9.7 Favored 'General case' 0 N--CA 1.447 -0.608 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.54 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -139.47 133.67 31.26 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.312 0.577 . . . . 0.0 112.14 179.671 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 11.9 m-20 -97.97 113.76 25.7 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.137 -0.938 . . . . 0.0 108.69 174.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -42.27 -58.22 2.25 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 113.456 0.91 . . . . 0.0 113.456 -171.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.552 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 12.8 m-20 -61.5 -54.49 42.61 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.453 -174.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.44 ' O ' HG23 ' B' ' 42' ' ' VAL . 23.2 tpp180 -55.33 -43.24 74.76 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.019 0.437 . . . . 0.0 110.822 177.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.514 ' HA ' ' CD1' ' B' ' 3' ' ' TYR . 6.3 tp -58.45 -54.94 41.37 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.508 -0.769 . . . . 0.0 111.099 -179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 92.2 m-20 -58.07 -34.1 69.77 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.477 178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.552 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 73.4 mmtt -65.32 -53.17 47.73 Favored 'General case' 0 CA--C 1.521 -0.171 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.099 178.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 38' ' ' ARG . 86.2 t -56.83 -44.2 81.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 121.479 0.657 . . . . 0.0 110.596 178.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.705 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -59.22 -46.07 92.48 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.602 0 CA-C-N 115.241 -0.891 . . . . 0.0 111.236 175.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 31.8 t -65.37 -33.42 75.92 Favored 'General case' 0 C--N 1.319 -0.721 0 CA-C-N 115.118 -0.946 . . . . 0.0 111.07 -179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' B' ' 41' ' ' LYS . 45.2 mt-10 -67.49 -44.45 78.48 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 176.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.918 HD11 HG22 ' B' ' 4' ' ' VAL . 44.9 mt -61.99 -41.67 98.29 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.397 175.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -68.34 -22.6 64.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.784 -0.643 . . . . 0.0 111.142 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -101.53 5.28 54.6 Favored Glycine 0 N--CA 1.449 -0.49 0 C-N-CA 120.749 -0.739 . . . . 0.0 112.478 -179.045 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.55 ' HD2' HG22 ' B' ' 54' ' ' VAL . 66.4 mttm -142.55 -163.12 1.54 Allowed 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -95.89 145.05 25.69 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 168.231 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.709 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.2 mp -54.37 -50.12 59.44 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.364 -178.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.784 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.6 mp0 -55.26 -39.49 69.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.799 -0.637 . . . . 0.0 111.509 -175.528 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -65.57 -53.69 38.35 Favored 'General case' 0 CA--C 1.516 -0.36 0 CA-C-O 120.874 0.368 . . . . 0.0 110.131 179.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.681 ' HB ' HD23 ' B' ' 46' ' ' LEU . 71.6 t -62.05 -29.6 46.84 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 115.783 -0.644 . . . . 0.0 110.495 179.028 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.671 HD12 HD12 ' A' ' 55' ' ' ILE . 2.5 mm -61.56 -61.16 1.72 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.37 0.605 . . . . 0.0 111.587 170.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.795 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.94 -13.92 62.18 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-N 115.399 -0.819 . . . . 0.0 111.632 -170.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 17.6 mm100 -97.59 -28.38 13.97 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.813 -0.63 . . . . 0.0 111.053 172.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.28 -33.29 8.18 Favored Glycine 0 N--CA 1.453 -0.204 0 C-N-CA 121.136 -0.554 . . . . 0.0 113.751 -172.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.634 HG21 ' HB2' ' B' ' 63' ' ' ALA . 1.9 mp -76.43 -58.42 4.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-N 117.506 0.653 . . . . 0.0 109.345 177.563 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 57.72 64.09 4.68 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 121.263 -0.494 . . . . 0.0 113.735 173.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 13.2 mmmm 66.36 10.64 7.39 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 113.006 0.743 . . . . 0.0 113.006 175.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.408 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 0.6 OUTLIER -82.02 -7.26 59.6 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 108.347 -0.982 . . . . 0.0 108.347 171.738 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.72 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -66.93 -74.83 0.1 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 114.285 -1.325 . . . . 0.0 112.666 -175.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 29.3 p -159.65 -179.67 8.09 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.116 -171.597 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.693 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.5 p -144.19 144.81 27.27 Favored Pre-proline 0 C--N 1.32 -0.699 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 174.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.693 ' HD2' HG22 ' B' ' 65' ' ' VAL . 19.3 Cg_endo -59.3 90.25 0.07 OUTLIER 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 123.074 2.516 . . . . 0.0 112.321 -179.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -79.84 64.79 4.8 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.285 0.564 . . . . 0.0 110.783 -179.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -113.54 -167.96 16.64 Favored Glycine 0 N--CA 1.444 -0.782 0 CA-C-N 115.584 -0.735 . . . . 0.0 111.357 177.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.889 0 CA-C-O 118.819 -0.989 . . . . 0.0 111.665 -178.411 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 CA-C-O 120.592 0.234 . . . . 0.0 111.47 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.63 ' SD ' HG13 ' A' ' 59' ' ' ILE . 20.5 ttt -77.8 -29.49 50.8 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 112.009 0.374 . . . . 0.0 112.009 -172.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . . . . . . . . . 25.8 mmm180 -49.06 -43.93 41.33 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 113.682 0.993 . . . . 0.0 113.682 -170.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.522 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 26.8 m-85 -111.01 -9.01 14.42 Favored 'General case' 0 CA--C 1.514 -0.406 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -168.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.988 HG22 HD11 ' A' ' 46' ' ' LEU . 54.0 t -62.89 -36.5 75.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.162 0.506 . . . . 0.0 110.359 178.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -57.63 -54.98 40.73 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.676 -178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.2 p -70.69 -36.51 73.32 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.394 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.581 ' CD2' HD13 ' A' ' 46' ' ' LEU . 68.6 t80 -55.49 -49.54 72.27 Favored 'General case' 0 C--O 1.237 0.411 0 CA-C-N 115.721 -0.672 . . . . 0.0 109.986 176.322 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.795 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 6.2 mp -59.84 -55.9 28.42 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.452 178.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.826 HD12 HD12 ' B' ' 9' ' ' LEU . 15.5 mt -48.54 -50.45 32.06 Favored 'General case' 0 N--CA 1.471 0.583 0 CA-C-O 120.723 0.297 . . . . 0.0 111.695 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.42 -40.04 81.39 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.689 -178.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.46 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -63.73 -38.37 90.86 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 121.081 0.467 . . . . 0.0 111.014 179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.795 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 5.8 mt -79.93 -30.27 39.91 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.647 -0.706 . . . . 0.0 110.998 -175.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.64 -23.94 73.91 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 121.116 -0.564 . . . . 0.0 112.437 179.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.67 -27.07 1.64 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.841 -0.695 . . . . 0.0 111.867 179.171 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.587 ' OD1' ' HA ' ' A' ' 18' ' ' PRO . 2.4 t-20 -89.54 73.49 7.77 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.55 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 13.3 m -60.47 -20.34 59.64 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 115.584 -0.734 . . . . 0.0 111.486 -177.677 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 78.8 p -112.5 75.34 1.75 Allowed Pre-proline 0 C--N 1.317 -0.806 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 173.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.587 ' HA ' ' OD1' ' A' ' 15' ' ' ASN . 20.3 Cg_exo -66.17 139.68 56.36 Favored 'Trans proline' 0 C--N 1.343 0.251 0 C-N-CA 123.168 2.579 . . . . 0.0 113.553 -166.38 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.459 ' O ' HG12 ' A' ' 23' ' ' ILE . 10.7 p -96.54 142.17 28.94 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.224 175.614 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.458 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -62.46 -24.47 67.47 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.742 -0.663 . . . . 0.0 112.21 -174.103 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . 0.614 ' HA ' ' HD2' ' A' ' 24' ' ' LYS . 14.4 mmmm -64.52 -46.18 84.02 Favored 'General case' 0 C--O 1.243 0.743 0 CA-C-O 121.392 0.615 . . . . 0.0 110.134 175.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.73 ' O ' HG13 ' A' ' 26' ' ' ILE . 5.1 t70 -59.06 -46.25 88.73 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.048 -1.093 . . . . 0.0 108.048 177.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.76 HG13 HD11 ' A' ' 43' ' ' ILE . 43.9 mm -50.95 -51.55 20.44 Favored 'Isoleucine or valine' 0 C--O 1.232 0.168 0 CA-C-N 114.934 -1.03 . . . . 0.0 111.049 176.237 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.614 ' HD2' ' HA ' ' A' ' 21' ' ' LYS . 43.6 mttm -52.98 -44.27 67.06 Favored 'General case' 0 CA--C 1.519 -0.216 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.808 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . 0.47 ' HA ' ' HB3' ' A' ' 28' ' ' ASP . 4.4 mmmp? -70.03 -35.28 74.2 Favored 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 112.567 0.58 . . . . 0.0 112.567 -179.099 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.73 HG13 ' O ' ' A' ' 22' ' ' ASP . 8.9 mt -69.93 -40.91 79.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 C-N-CA 120.507 -0.477 . . . . 0.0 110.065 178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.68 HD13 ' HB2' ' A' ' 34' ' ' ALA . 12.8 mt -61.86 -38.05 86.82 Favored 'General case' 0 C--O 1.221 -0.42 0 N-CA-C 109.443 -0.577 . . . . 0.0 109.443 171.477 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . 0.47 ' HB3' ' HA ' ' A' ' 25' ' ' LYS . 11.8 t70 -61.81 -34.91 76.75 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.731 177.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.66 -36.12 81.79 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.653 0.263 . . . . 0.0 111.172 -179.056 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.584 HG23 HG13 ' A' ' 32' ' ' ILE . 16.2 m -98.94 -10.34 8.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 121.07 0.462 . . . . 0.0 111.152 -178.959 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.77 44.01 5.58 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 121.129 -0.558 . . . . 0.0 113.24 174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.584 HG13 HG23 ' A' ' 30' ' ' VAL . 87.6 mt -102.65 126.87 56.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-O 121.26 0.552 . . . . 0.0 111.642 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 17.1 mt-10 -65.9 127.75 33.27 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 114.999 -1.0 . . . . 0.0 109.944 172.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.68 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -126.64 124.47 39.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.968 0.413 . . . . 0.0 111.796 -175.372 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 42.0 m-20 -92.35 121.34 33.75 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.832 176.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 17.2 t70 -52.14 -57.68 8.88 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 112.482 0.549 . . . . 0.0 112.482 -168.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -61.18 -45.27 95.28 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.741 -0.663 . . . . 0.0 111.039 -172.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.41 ' O ' HG23 ' A' ' 42' ' ' VAL . 12.3 tpp180 -62.64 -38.94 92.23 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.337 178.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.564 ' CD1' HG21 ' A' ' 23' ' ' ILE . 5.3 tp -58.99 -56.81 17.46 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.668 178.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 46.8 m-20 -58.66 -34.96 71.81 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.077 0.465 . . . . 0.0 109.896 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.602 ' O ' ' HG2' ' A' ' 45' ' ' GLU . 6.6 tmtt? -63.98 -55.38 22.85 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.625 -0.716 . . . . 0.0 110.448 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 38' ' ' ARG . 77.2 t -55.92 -44.38 77.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-O 121.475 0.655 . . . . 0.0 110.883 178.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.76 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -58.01 -46.11 87.95 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.674 0 CA-C-N 115.168 -0.924 . . . . 0.0 111.198 177.062 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 5.3 t -66.16 -34.27 77.65 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.756 -179.059 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.602 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 16.8 mm-40 -61.03 -52.12 66.3 Favored 'General case' 0 C--O 1.232 0.136 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 175.97 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.988 HD11 HG22 ' A' ' 4' ' ' VAL . 22.7 mt -60.35 -37.56 81.07 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.452 -0.795 . . . . 0.0 111.762 179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -72.96 -25.02 60.86 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.027 -176.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.18 -30.24 12.99 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.645 -0.788 . . . . 0.0 112.289 179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.423 ' HB2' HG23 ' A' ' 54' ' ' VAL . 74.0 mmtt -106.98 -157.38 0.61 Allowed 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 20.7 m-80 -98.69 149.37 22.89 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 107.974 -1.121 . . . . 0.0 107.974 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.644 HG13 HD22 ' A' ' 46' ' ' LEU . 1.3 mp -61.33 -45.57 98.34 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.722 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.809 -177.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 1.142 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 1.1 mp0 -58.04 -44.63 87.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.849 -176.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 25.3 m-20 -60.46 -56.03 26.37 Favored 'General case' 0 CA--C 1.518 -0.288 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.264 178.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.659 ' HB ' HD23 ' A' ' 46' ' ' LEU . 74.1 t -60.0 -29.66 43.9 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.741 -179.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 1.084 HD13 HD13 ' B' ' 55' ' ' ILE . 18.0 mt -69.15 -56.23 12.59 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.491 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 173.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 1.105 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -68.69 -14.89 63.31 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.169 0.509 . . . . 0.0 111.044 -172.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 89.7 mt-30 -94.24 -32.75 13.54 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.62 169.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.95 -34.86 13.81 Favored Glycine 0 CA--C 1.519 0.285 0 N-CA-C 114.755 0.662 . . . . 0.0 114.755 -170.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.897 HD13 HG23 ' A' ' 55' ' ' ILE . 1.7 mp -71.71 -50.37 39.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 CA-C-N 118.068 0.934 . . . . 0.0 109.701 177.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 70.75 -91.86 0.43 Allowed Glycine 0 N--CA 1.448 -0.5 0 CA-C-N 115.447 -0.797 . . . . 0.0 112.482 177.261 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.404 ' HD3' ' HA ' ' A' ' 61' ' ' LYS . 31.6 mmtp -134.64 22.96 3.65 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 121.317 0.58 . . . . 0.0 110.456 -179.581 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.2 mt -91.18 -8.06 49.64 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.513 -0.767 . . . . 0.0 111.73 -179.547 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.656 ' HB1' HD13 ' B' ' 51' ' ' ILE . . . -69.71 -86.4 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.223 -0.444 . . . . 0.0 112.019 -176.248 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.9 p -176.75 -172.5 0.44 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 -177.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.65 HG22 ' HD2' ' A' ' 66' ' ' PRO . 0.9 OUTLIER -144.9 141.31 17.23 Favored Pre-proline 0 C--N 1.323 -0.561 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 176.52 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.65 ' HD2' HG22 ' A' ' 65' ' ' VAL . 12.0 Cg_endo -56.4 -30.93 83.53 Favored 'Trans proline' 0 C--N 1.345 0.392 0 C-N-CA 123.955 3.103 . . . . 0.0 113.134 -176.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.51 57.07 6.64 Favored 'General case' 0 N--CA 1.465 0.317 0 O-C-N 123.686 0.617 . . . . 0.0 111.514 176.15 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.46 122.78 6.33 Favored Glycine 0 N--CA 1.448 -0.56 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.163 -178.067 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.934 0 CA-C-O 118.592 -1.116 . . . . 0.0 111.867 179.392 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.187 0 CA-C-O 120.603 0.24 . . . . 0.0 111.642 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.624 ' SD ' HG13 ' B' ' 59' ' ' ILE . 20.5 ttt -77.09 -29.28 54.84 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 112.24 0.459 . . . . 0.0 112.24 -172.712 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . . . . . . . . . 26.0 mmm180 -49.57 -43.69 46.3 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 113.539 0.94 . . . . 0.0 113.539 -170.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.519 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 26.9 m-85 -111.14 -8.89 14.38 Favored 'General case' 0 CA--C 1.513 -0.473 0 N-CA-C 112.864 0.69 . . . . 0.0 112.864 -168.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.982 HG22 HD11 ' B' ' 46' ' ' LEU . 54.2 t -63.06 -36.3 75.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.152 0.501 . . . . 0.0 110.47 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.667 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.61 -55.26 37.13 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.639 -178.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -70.36 -36.52 74.22 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.535 179.611 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.572 ' CD2' HD13 ' B' ' 46' ' ' LEU . 69.1 t80 -55.27 -49.74 71.3 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-N 115.635 -0.711 . . . . 0.0 109.965 176.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.796 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 6.3 mp -59.97 -55.73 30.41 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.82 -0.627 . . . . 0.0 110.363 178.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.826 HD12 HD12 ' A' ' 9' ' ' LEU . 15.5 mt -48.73 -50.37 33.92 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-O 120.757 0.313 . . . . 0.0 111.623 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.33 -40.53 82.35 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.571 -178.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.467 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -63.25 -38.58 91.7 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.047 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.796 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 5.8 mt -79.97 -30.01 39.67 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.709 -0.678 . . . . 0.0 111.005 -175.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -67.66 -23.83 73.94 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 121.172 -0.537 . . . . 0.0 112.404 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 146.55 -27.73 1.64 Allowed Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 120.82 -0.705 . . . . 0.0 111.902 179.251 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.593 ' OD1' ' HA ' ' B' ' 18' ' ' PRO . 2.5 t-20 -89.02 73.91 8.19 Favored 'General case' 0 C--N 1.323 -0.57 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.557 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 13.5 m -60.79 -20.62 61.86 Favored 'General case' 0 CA--C 1.521 -0.166 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.394 -177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 78.9 p -112.23 75.63 1.7 Allowed Pre-proline 0 C--N 1.318 -0.792 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 173.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.593 ' HA ' ' OD1' ' B' ' 15' ' ' ASN . 19.4 Cg_exo -66.06 139.79 57.4 Favored 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 123.287 2.658 . . . . 0.0 113.386 -166.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.456 ' O ' HG12 ' B' ' 23' ' ' ILE . 11.6 p -97.05 141.97 29.56 Favored 'General case' 0 N--CA 1.444 -0.732 0 CA-C-N 115.259 -0.882 . . . . 0.0 109.277 175.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.452 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -62.25 -24.64 67.37 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.684 -0.689 . . . . 0.0 112.194 -173.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . 0.619 ' HA ' ' HD2' ' B' ' 24' ' ' LYS . 14.4 mmmm -64.42 -46.17 84.4 Favored 'General case' 0 C--O 1.244 0.772 0 CA-C-O 121.384 0.611 . . . . 0.0 110.122 175.277 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.731 ' O ' HG13 ' B' ' 26' ' ' ILE . 4.9 t70 -59.25 -46.13 89.32 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.235 176.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.778 HG13 HD11 ' B' ' 43' ' ' ILE . 44.0 mm -51.05 -51.47 21.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.089 176.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.619 ' HD2' ' HA ' ' B' ' 21' ' ' LYS . 43.6 mttm -53.09 -44.26 67.45 Favored 'General case' 0 C--O 1.226 -0.165 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.77 179.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . 0.489 ' HA ' ' HB3' ' B' ' 28' ' ' ASP . 4.5 mmmp? -69.88 -35.38 74.62 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 112.563 0.579 . . . . 0.0 112.563 -179.15 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.731 HG13 ' O ' ' B' ' 22' ' ' ASP . 9.0 mt -70.1 -40.76 78.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-O 121.025 0.44 . . . . 0.0 110.004 178.792 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.694 HD13 ' HB2' ' B' ' 34' ' ' ALA . 12.8 mt -62.01 -38.06 87.21 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.462 171.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . 0.489 ' HB3' ' HA ' ' B' ' 25' ' ' LYS . 10.9 t70 -61.76 -34.65 76.23 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 115.56 -0.746 . . . . 0.0 111.747 177.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 23.0 t -66.98 -36.08 81.4 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.624 0.249 . . . . 0.0 111.042 -179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.57 HG23 HG13 ' B' ' 32' ' ' ILE . 16.2 m -98.84 -10.14 8.83 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.927 0.394 . . . . 0.0 111.382 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 87.64 44.45 5.5 Favored Glycine 0 C--N 1.33 0.225 0 CA-C-N 115.966 -0.561 . . . . 0.0 113.028 174.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.576 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 88.1 mt -103.03 126.27 57.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 121.125 0.488 . . . . 0.0 111.668 -179.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 17.6 mt-10 -65.07 127.98 33.86 Favored 'General case' 0 N--CA 1.448 -0.563 0 CA-C-N 115.164 -0.925 . . . . 0.0 109.953 172.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.694 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -127.13 124.08 38.29 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.83 0.348 . . . . 0.0 111.775 -175.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 47.1 m-20 -92.35 121.5 33.9 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.95 -0.568 . . . . 0.0 109.742 176.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 16.5 t70 -51.88 -58.35 6.72 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 112.394 0.516 . . . . 0.0 112.394 -168.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -60.64 -45.09 95.4 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.713 -0.676 . . . . 0.0 111.218 -172.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.418 ' O ' HG23 ' B' ' 42' ' ' VAL . 12.4 tpp180 -62.81 -38.88 92.46 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.405 178.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.562 ' CD1' HG21 ' B' ' 23' ' ' ILE . 5.3 tp -59.0 -57.01 14.99 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.635 177.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 46.3 m-20 -58.5 -35.11 71.73 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.242 -0.436 . . . . 0.0 109.922 -179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.614 ' O ' ' HG2' ' B' ' 45' ' ' GLU . 6.7 tmtt? -63.78 -55.47 22.87 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.564 -0.744 . . . . 0.0 110.497 179.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.418 HG23 ' O ' ' B' ' 38' ' ' ARG . 75.6 t -55.97 -44.22 77.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.253 0 CA-C-O 121.362 0.601 . . . . 0.0 110.87 179.087 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.778 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -58.37 -45.68 89.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.704 0 CA-C-N 115.143 -0.935 . . . . 0.0 111.202 177.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 5.4 t -66.48 -33.99 76.93 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.093 -0.958 . . . . 0.0 110.68 -179.123 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.614 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 15.3 mm-40 -61.26 -52.14 65.98 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 121.176 0.512 . . . . 0.0 109.801 175.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.982 HD11 HG22 ' B' ' 4' ' ' VAL . 22.4 mt -60.46 -37.48 81.12 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.45 -0.796 . . . . 0.0 111.704 179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -73.05 -24.63 60.72 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.203 -176.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -90.7 -30.02 12.44 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.629 -0.796 . . . . 0.0 112.22 179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.428 ' HB2' HG23 ' B' ' 54' ' ' VAL . 74.1 mmtt -106.86 -157.15 0.6 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 19.9 m-80 -99.18 149.31 23.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 168.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.658 HG13 HD22 ' B' ' 46' ' ' LEU . 1.4 mp -61.47 -45.31 98.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 C-N-CA 120.348 -0.541 . . . . 0.0 110.762 -176.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 1.105 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 1.2 mp0 -58.22 -44.27 88.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.904 -176.148 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 26.9 m-20 -60.67 -56.07 25.74 Favored 'General case' 0 CA--C 1.517 -0.325 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.27 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.68 ' HB ' HD23 ' B' ' 46' ' ' LEU . 75.5 t -59.92 -29.73 43.88 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.418 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.707 -179.388 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 1.084 HD13 HD13 ' A' ' 55' ' ' ILE . 17.5 mt -69.33 -56.25 12.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 112.209 0.448 . . . . 0.0 112.209 173.76 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 1.142 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -68.36 -15.61 63.62 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.975 -172.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 89.9 mt-30 -93.49 -33.41 13.8 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.695 169.434 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -84.2 -35.34 15.16 Favored Glycine 0 CA--C 1.519 0.317 0 N-CA-C 114.693 0.637 . . . . 0.0 114.693 -170.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.929 HD13 HG23 ' B' ' 55' ' ' ILE . 1.7 mp -71.19 -50.98 37.9 Favored 'Isoleucine or valine' 0 C--O 1.234 0.268 0 CA-C-N 117.977 0.889 . . . . 0.0 109.471 177.122 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 71.05 -92.43 0.47 Allowed Glycine 0 N--CA 1.448 -0.508 0 CA-C-N 115.58 -0.736 . . . . 0.0 112.288 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmtp -134.13 22.38 3.8 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.295 0.569 . . . . 0.0 110.415 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . . . . . . . . . 15.0 mt -90.92 -7.68 51.46 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.606 -179.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.625 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . -69.76 -86.52 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.924 -176.257 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 16.6 p -176.61 -172.14 0.43 Allowed 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 -177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.654 HG22 ' HD2' ' B' ' 66' ' ' PRO . 0.9 OUTLIER -145.29 141.18 16.77 Favored Pre-proline 0 C--N 1.321 -0.654 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 176.543 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.654 ' HD2' HG22 ' B' ' 65' ' ' VAL . 12.0 Cg_endo -56.34 -30.93 83.1 Favored 'Trans proline' 0 C--N 1.343 0.275 0 C-N-CA 123.904 3.069 . . . . 0.0 113.156 -176.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . 48.38 56.81 6.94 Favored 'General case' 0 C--O 1.236 0.361 0 O-C-N 123.748 0.655 . . . . 0.0 111.764 176.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -87.26 123.15 6.45 Favored Glycine 0 N--CA 1.444 -0.779 0 C-N-CA 120.822 -0.704 . . . . 0.0 112.12 -178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 CA-C-O 118.632 -1.093 . . . . 0.0 111.484 179.481 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 0.979 0 CA-C-O 120.819 0.343 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.721 ' HE2' ' HG ' ' B' ' 8' ' ' LEU . 22.8 ttt -135.08 -45.2 0.71 Allowed 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 112.082 0.401 . . . . 0.0 112.082 -176.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.734 ' HA ' ' CD1' ' B' ' 12' ' ' LEU . 9.6 ptp180 -55.51 -41.38 73.01 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.606 0.595 . . . . 0.0 112.606 -170.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.499 ' CD2' ' HA ' ' A' ' 39' ' ' LEU . 15.9 m-85 -79.26 -26.3 42.41 Favored 'General case' 0 C--N 1.324 -0.517 0 C-N-CA 120.686 -0.406 . . . . 0.0 111.968 -176.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.869 HG22 HD11 ' A' ' 46' ' ' LEU . 62.1 t -71.66 -32.32 45.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 C-N-CA 120.715 -0.394 . . . . 0.0 110.186 -178.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.604 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -56.8 -54.86 41.5 Favored 'General case' 0 C--O 1.241 0.635 0 CA-C-O 121.628 0.728 . . . . 0.0 110.921 175.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.66 -35.33 67.69 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.25 -0.887 . . . . 0.0 110.823 179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.608 ' CD2' HD13 ' A' ' 46' ' ' LEU . 54.9 t80 -55.47 -48.19 74.93 Favored 'General case' 0 C--O 1.236 0.394 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.783 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.6 mp -57.4 -61.08 2.74 Favored 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 115.703 -0.681 . . . . 0.0 110.221 177.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.906 HD12 HD12 ' B' ' 9' ' ' LEU . 16.5 mt -46.98 -49.08 21.4 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 112.461 0.541 . . . . 0.0 112.461 179.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' HB2' HD11 ' A' ' 26' ' ' ILE . . . -63.05 -35.63 80.88 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.935 0.397 . . . . 0.0 110.944 -177.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.595 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -65.78 -37.95 87.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.806 178.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.783 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 3.4 mt -81.77 -18.42 44.22 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.922 -175.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.63 12.92 42.69 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.574 -175.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . -173.14 -76.38 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 120.221 -0.99 . . . . 0.0 112.819 179.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.595 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 40.0 t30 -145.88 143.8 29.81 Favored 'General case' 0 C--N 1.322 -0.609 0 O-C-N 122.844 -0.209 . . . . 0.0 110.796 -170.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . . . . . . . . . 14.0 m -77.22 44.3 0.41 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.144 0.497 . . . . 0.0 111.114 177.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 14.7 t -165.84 65.64 1.01 Allowed Pre-proline 0 C--N 1.316 -0.867 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 179.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -78.07 143.47 20.36 Favored 'Trans proline' 0 N--CA 1.459 -0.516 0 C-N-CA 123.903 3.069 . . . . 0.0 112.691 -171.16 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.49 ' HB3' ' OD1' ' A' ' 22' ' ' ASP . 46.7 t -77.51 143.23 38.61 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.725 -0.671 . . . . 0.0 109.965 178.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.75 -25.4 66.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.504 -0.771 . . . . 0.0 111.287 -179.347 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.62 -40.77 76.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 121.131 0.491 . . . . 0.0 109.956 178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.713 ' O ' HG13 ' A' ' 26' ' ' ILE . 18.6 m-20 -60.71 -44.04 97.08 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.227 175.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.624 HG13 HD11 ' A' ' 43' ' ' ILE . 28.2 mm -52.08 -51.2 31.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.419 176.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.2 mttm -52.73 -48.82 66.42 Favored 'General case' 0 C--O 1.227 -0.117 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.764 177.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.15 -46.68 82.54 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.737 179.866 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.713 HG13 ' O ' ' A' ' 22' ' ' ASP . 10.6 mt -68.11 -37.88 78.87 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 121.055 0.455 . . . . 0.0 110.574 -176.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.786 HD13 ' HB2' ' A' ' 34' ' ' ALA . 11.2 mt -63.18 -41.48 99.22 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.012 172.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -63.46 -26.77 68.88 Favored 'General case' 0 C--N 1.325 -0.47 0 N-CA-C 111.557 0.206 . . . . 0.0 111.557 176.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 24.6 m -70.68 -25.26 62.9 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 120.644 0.259 . . . . 0.0 111.221 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.537 HG23 HG13 ' A' ' 32' ' ' ILE . 16.5 m -112.17 -9.28 12.0 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 CA-C-O 120.692 0.282 . . . . 0.0 111.453 -179.537 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.25 35.4 5.27 Favored Glycine 0 CA--C 1.521 0.411 0 C-N-CA 121.243 -0.503 . . . . 0.0 113.497 174.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.599 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 39.2 mt -111.3 136.5 47.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 117.012 0.406 . . . . 0.0 110.873 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -76.78 158.4 30.91 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.55 176.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.786 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -150.22 138.82 20.67 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 112.4 0.518 . . . . 0.0 112.4 -177.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 -85.68 -178.02 6.54 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.392 -0.822 . . . . 0.0 109.792 173.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.51 -52.93 2.8 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 121.198 0.523 . . . . 0.0 109.851 167.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 4.4 m-20 -64.49 -58.19 7.11 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.273 -0.876 . . . . 0.0 110.837 -177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . 0.472 ' O ' HG23 ' A' ' 42' ' ' VAL . 18.5 tpp180 -60.6 -35.95 77.38 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.99 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.499 ' HA ' ' CD2' ' A' ' 3' ' ' TYR . 4.5 tp -63.57 -55.63 22.29 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.757 178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.8 t30 -62.24 -28.54 69.77 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 110.053 -0.351 . . . . 0.0 110.053 179.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.687 ' HA ' ' HE3' ' A' ' 41' ' ' LYS . 0.1 OUTLIER -64.87 -49.92 68.63 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.562 -0.29 . . . . 0.0 110.324 176.476 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 38' ' ' ARG . 88.8 t -62.15 -41.32 90.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 121.683 0.754 . . . . 0.0 110.725 177.745 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.624 HD11 HG13 ' A' ' 23' ' ' ILE . 1.3 mt -61.45 -41.39 89.81 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.775 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.714 175.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 9.0 t -70.42 -34.95 73.09 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.048 -0.978 . . . . 0.0 111.311 -177.104 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.416 ' HG2' ' HA ' ' A' ' 42' ' ' VAL . 12.3 pt-20 -72.24 -37.12 69.2 Favored 'General case' 0 C--O 1.233 0.191 0 C-N-CA 120.121 -0.632 . . . . 0.0 110.107 178.059 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.869 HD11 HG22 ' A' ' 4' ' ' VAL . 17.8 mt -57.14 -46.3 82.81 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.898 0.38 . . . . 0.0 110.158 169.707 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 96.4 m-20 -71.28 -3.6 21.35 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.649 -0.705 . . . . 0.0 111.554 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.24 -14.86 40.4 Favored Glycine 0 N--CA 1.449 -0.466 0 C-N-CA 120.965 -0.636 . . . . 0.0 111.727 177.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.543 ' HB2' HG23 ' A' ' 54' ' ' VAL . 13.7 mmmm -133.72 -146.89 0.28 Allowed 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . 0.432 ' H ' ' HB3' ' A' ' 49' ' ' LYS . 25.1 m-80 -105.03 162.38 13.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 166.149 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.549 HD13 ' HB1' ' B' ' 63' ' ' ALA . 1.6 mp -58.91 -50.9 77.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 C-N-CA 120.662 -0.415 . . . . 0.0 111.175 -176.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.905 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 2.8 mp0 -59.25 -39.06 81.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.296 -175.018 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 -59.2 -54.32 48.27 Favored 'General case' 0 CA--C 1.517 -0.322 0 CA-C-O 121.246 0.546 . . . . 0.0 110.02 178.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.78 ' HB ' HD23 ' A' ' 46' ' ' LEU . 50.9 t -65.91 -32.14 56.83 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 CA-C-N 115.3 -0.863 . . . . 0.0 110.778 -179.007 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' B' ' 55' ' ' ILE . 2.5 mm -58.09 -60.65 1.96 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.489 0.661 . . . . 0.0 111.286 170.604 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.906 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -70.44 -14.84 62.71 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.056 -0.974 . . . . 0.0 111.382 -170.643 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 29.9 mm-40 -100.6 -18.1 16.75 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.086 -0.507 . . . . 0.0 111.743 172.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -100.08 -40.09 3.15 Favored Glycine 0 N--CA 1.454 -0.164 0 C-N-CA 121.001 -0.618 . . . . 0.0 114.486 -172.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.63 HG21 ' HB2' ' A' ' 63' ' ' ALA . 1.9 mp -69.12 -63.67 0.91 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.27 0 CA-C-N 117.689 0.744 . . . . 0.0 110.078 -179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.6 -67.24 2.61 Favored Glycine 0 CA--C 1.519 0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 114.046 171.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 59.8 tptt -129.86 -23.16 2.84 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.902 0.382 . . . . 0.0 111.541 -173.099 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.616 ' HB3' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -67.33 -28.33 67.89 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.397 -172.857 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.63 ' HB2' HG21 ' A' ' 59' ' ' ILE . . . -47.68 -59.11 3.52 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 123.32 0.388 . . . . 0.0 111.433 -177.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.8 m 62.84 -168.67 0.2 Allowed 'General case' 0 CA--C 1.531 0.236 0 O-C-N 123.573 0.546 . . . . 0.0 111.201 177.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.674 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.3 p -172.51 142.27 1.14 Allowed Pre-proline 0 C--N 1.326 -0.449 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 177.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 65' ' ' VAL . 19.2 Cg_endo -59.08 113.06 1.42 Allowed 'Trans proline' 0 C--O 1.235 0.37 0 C-N-CA 123.31 2.673 . . . . 0.0 112.428 -179.063 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.15 81.85 5.55 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.3 0.571 . . . . 0.0 110.895 179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 158.13 -125.73 1.59 Allowed Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.591 -178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.977 0 CA-C-O 118.542 -1.143 . . . . 0.0 111.519 179.496 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.07 0 CA-C-O 120.719 0.295 . . . . 0.0 110.231 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.701 ' HE2' ' HG ' ' A' ' 8' ' ' LEU . 22.6 ttt -135.11 -45.24 0.71 Allowed 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 112.149 0.425 . . . . 0.0 112.149 -176.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.712 ' HA ' HD13 ' A' ' 12' ' ' LEU . 9.5 ptp180 -55.51 -41.55 73.25 Favored 'General case' 0 N--CA 1.465 0.321 0 N-CA-C 112.527 0.566 . . . . 0.0 112.527 -170.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.506 ' CD2' ' HA ' ' B' ' 39' ' ' LEU . 15.7 m-85 -78.91 -26.32 43.74 Favored 'General case' 0 C--O 1.219 -0.527 0 C-N-CA 120.586 -0.445 . . . . 0.0 111.956 -176.202 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.881 HG22 HD11 ' B' ' 46' ' ' LEU . 61.2 t -71.66 -32.42 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.283 -178.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.593 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -57.03 -54.75 43.21 Favored 'General case' 0 C--O 1.242 0.689 0 CA-C-O 121.482 0.658 . . . . 0.0 110.847 175.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.51 -35.46 68.11 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.348 -0.842 . . . . 0.0 110.917 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.613 ' CD2' HD13 ' B' ' 46' ' ' LEU . 54.4 t80 -55.21 -48.14 74.3 Favored 'General case' 0 C--O 1.235 0.297 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.788 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.6 mp -57.82 -60.69 3.32 Favored 'General case' 0 N--CA 1.452 -0.365 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.229 177.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.906 HD12 HD12 ' A' ' 9' ' ' LEU . 16.2 mt -47.27 -48.8 24.6 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.38 0.511 . . . . 0.0 112.38 179.69 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . 0.441 ' HB2' HD11 ' B' ' 26' ' ' ILE . . . -63.1 -35.89 81.76 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.766 0.317 . . . . 0.0 110.936 -177.754 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.586 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -65.67 -37.93 87.86 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.16 0.505 . . . . 0.0 110.849 178.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.788 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 3.4 mt -81.75 -18.37 44.45 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.943 -175.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -106.87 12.97 41.74 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.781 -0.723 . . . . 0.0 112.738 -175.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . -172.93 -75.37 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.297 -0.954 . . . . 0.0 113.203 179.532 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.586 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 39.1 t30 -147.02 143.78 28.65 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 122.919 -0.165 . . . . 0.0 110.782 -171.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . . . . . . . . . 14.6 m -76.59 44.11 0.35 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 121.254 0.55 . . . . 0.0 111.118 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 15.9 t -165.93 66.06 1.02 Allowed Pre-proline 0 C--N 1.314 -0.953 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 179.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -78.63 143.51 18.99 Favored 'Trans proline' 0 N--CA 1.459 -0.528 0 C-N-CA 123.817 3.011 . . . . 0.0 112.632 -171.322 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.478 ' HB3' ' OD1' ' B' ' 22' ' ' ASP . 46.3 t -77.61 143.81 37.97 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.822 178.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.2 -25.32 66.96 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.453 -0.794 . . . . 0.0 111.228 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -69.71 -40.38 76.3 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.091 0.472 . . . . 0.0 110.016 178.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.699 ' O ' HG13 ' B' ' 26' ' ' ILE . 16.4 m-20 -60.91 -44.25 97.42 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.558 -0.746 . . . . 0.0 109.151 175.081 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.627 HG13 HD11 ' B' ' 43' ' ' ILE . 27.3 mm -52.01 -51.08 31.92 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 CA-C-N 115.439 -0.8 . . . . 0.0 110.492 176.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -52.92 -48.27 67.38 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.912 177.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 23.6 tptm -57.58 -46.64 83.76 Favored 'General case' 0 C--O 1.237 0.419 0 CA-C-N 115.765 -0.652 . . . . 0.0 111.684 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.699 HG13 ' O ' ' B' ' 22' ' ' ASP . 10.9 mt -68.09 -38.11 79.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.025 0.441 . . . . 0.0 110.571 -176.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.778 HD13 ' HB2' ' B' ' 34' ' ' ALA . 11.3 mt -62.97 -41.23 99.49 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.149 172.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.04 -26.03 68.38 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 111.606 0.224 . . . . 0.0 111.606 176.742 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 28.2 m -71.34 -24.79 62.17 Favored 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 120.69 0.281 . . . . 0.0 111.234 179.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.536 HG23 HG13 ' B' ' 32' ' ' ILE . 17.0 m -112.71 -8.86 12.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 CA-C-O 120.791 0.329 . . . . 0.0 111.519 -179.723 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 97.09 34.64 5.58 Favored Glycine 0 CA--C 1.518 0.257 0 C-N-CA 121.138 -0.553 . . . . 0.0 113.669 174.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.6 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 39.3 mt -110.69 136.73 45.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 117.076 0.438 . . . . 0.0 110.777 179.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 -76.84 158.51 30.77 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.498 176.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.778 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -150.29 138.62 20.43 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 112.488 0.551 . . . . 0.0 112.488 -177.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -85.55 -177.73 6.49 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.393 -0.821 . . . . 0.0 109.582 173.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -104.71 -52.95 2.78 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.175 0.512 . . . . 0.0 109.828 167.83 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -64.24 -57.83 8.33 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.153 -0.931 . . . . 0.0 110.863 -176.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.465 ' O ' HG23 ' B' ' 42' ' ' VAL . 18.5 tpp180 -61.27 -35.86 78.46 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.795 179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.506 ' HA ' ' CD2' ' B' ' 3' ' ' TYR . 4.5 tp -63.52 -55.59 22.73 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.724 178.298 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 9.6 t30 -62.19 -28.49 69.71 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 179.427 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.664 ' HE3' ' HA ' ' B' ' 41' ' ' LYS . 0.1 OUTLIER -64.74 -50.38 67.11 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.503 -0.317 . . . . 0.0 110.408 176.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . 0.465 HG23 ' O ' ' B' ' 38' ' ' ARG . 88.6 t -61.77 -41.53 90.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-O 121.686 0.755 . . . . 0.0 110.684 177.597 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.627 HD11 HG13 ' B' ' 23' ' ' ILE . 1.3 mt -61.29 -41.4 89.52 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 CA-C-N 115.645 -0.707 . . . . 0.0 110.76 175.356 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -70.7 -34.82 72.35 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.986 -1.007 . . . . 0.0 111.258 -177.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.419 ' HG2' ' HA ' ' B' ' 42' ' ' VAL . 12.3 pt-20 -72.41 -36.87 68.74 Favored 'General case' 0 C--O 1.233 0.208 0 C-N-CA 120.233 -0.587 . . . . 0.0 110.163 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.881 HD11 HG22 ' B' ' 4' ' ' VAL . 17.9 mt -57.44 -45.97 84.09 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.967 0.413 . . . . 0.0 110.258 169.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 96.5 m-20 -71.66 -3.15 20.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.5 -179.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -97.71 -14.55 40.04 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.975 -0.631 . . . . 0.0 111.867 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.549 ' HB2' HG23 ' B' ' 54' ' ' VAL . 13.6 mmmm -133.8 -147.06 0.28 Allowed 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . 0.434 ' H ' ' HB3' ' B' ' 49' ' ' LYS . 27.1 m-80 -104.91 162.2 13.54 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 165.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.561 HD13 ' HB1' ' A' ' 63' ' ' ALA . 1.6 mp -58.67 -50.9 77.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.797 0 C-N-CA 120.734 -0.387 . . . . 0.0 111.108 -176.296 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.906 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 2.8 mp0 -59.46 -38.79 81.69 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 123.127 0.267 . . . . 0.0 111.18 -174.767 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -59.14 -54.98 40.85 Favored 'General case' 0 CA--C 1.516 -0.336 0 CA-C-O 121.306 0.574 . . . . 0.0 110.04 178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.785 ' HB ' HD23 ' B' ' 46' ' ' LEU . 52.8 t -65.17 -32.34 57.84 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.665 0 CA-C-N 115.235 -0.893 . . . . 0.0 110.8 -179.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.613 HG21 HG21 ' A' ' 55' ' ' ILE . 2.5 mm -58.18 -60.46 2.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-O 121.458 0.647 . . . . 0.0 111.337 170.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.905 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -70.2 -15.42 62.93 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.06 -0.973 . . . . 0.0 111.448 -170.776 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 29.3 mm-40 -99.88 -18.72 16.99 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.618 173.002 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -99.93 -39.66 3.29 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.98 -0.629 . . . . 0.0 114.454 -172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.637 HG21 ' HB2' ' B' ' 63' ' ' ALA . 1.9 mp -69.36 -63.78 0.9 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.315 0 CA-C-N 117.878 0.839 . . . . 0.0 110.137 -179.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 76.75 -67.12 2.67 Favored Glycine 0 CA--C 1.52 0.375 0 C-N-CA 121.358 -0.449 . . . . 0.0 114.032 170.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 60.1 tptt -129.76 -23.15 2.87 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 120.678 0.275 . . . . 0.0 111.46 -173.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.611 ' HB3' ' SD ' ' B' ' 1' ' ' MET . 0.5 OUTLIER -67.66 -28.42 67.69 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.419 -172.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.637 ' HB2' HG21 ' B' ' 59' ' ' ILE . . . -47.31 -58.93 3.58 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.407 0.442 . . . . 0.0 111.457 -177.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 11.5 m 62.44 -168.63 0.19 Allowed 'General case' 0 CA--C 1.532 0.259 0 O-C-N 123.501 0.501 . . . . 0.0 111.213 178.02 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.674 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.2 p -172.43 142.45 1.17 Allowed Pre-proline 0 C--N 1.327 -0.403 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.339 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' B' ' 65' ' ' VAL . 18.4 Cg_endo -59.45 112.76 1.35 Allowed 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 123.406 2.738 . . . . 0.0 112.385 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . -91.1 82.66 5.54 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.284 -179.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 157.47 -125.11 1.51 Allowed Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.601 -0.727 . . . . 0.0 111.472 -179.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.928 0 CA-C-O 118.746 -1.03 . . . . 0.0 111.562 179.33 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.104 0 CA-C-O 121.128 0.489 . . . . 0.0 110.447 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.627 ' HG3' HG13 ' A' ' 59' ' ' ILE . 19.2 ttt -78.45 79.82 4.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.194 -176.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ARG . . . . . 0.64 ' HA ' HD13 ' B' ' 12' ' ' LEU . 96.3 mtt180 -144.48 -62.72 0.37 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.373 0.606 . . . . 0.0 110.271 173.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TYR . . . . . 0.453 ' CD1' ' HA ' ' A' ' 39' ' ' LEU . 21.3 m-85 -78.37 -26.58 46.64 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.325 -0.852 . . . . 0.0 112.388 -168.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.851 HG22 HD11 ' A' ' 46' ' ' LEU . 60.0 t -64.2 -31.91 55.29 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 CA-C-O 120.809 0.338 . . . . 0.0 110.827 -178.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ALA . . . . . 0.565 ' HB2' ' HB3' ' B' ' 8' ' ' LEU . . . -59.67 -54.58 44.79 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.473 0.654 . . . . 0.0 111.064 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -72.38 -34.99 68.35 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.376 -0.829 . . . . 0.0 110.759 179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' TYR . . . . . 0.694 ' CD1' HD13 ' A' ' 46' ' ' LEU . 48.7 t80 -55.34 -47.96 74.93 Favored 'General case' 0 C--O 1.234 0.287 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.664 174.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' A' ' 12' ' ' LEU . 5.3 mp -58.19 -59.68 4.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.275 176.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.891 HD12 HD12 ' B' ' 9' ' ' LEU . 16.2 mt -46.34 -49.93 17.04 Favored 'General case' 0 N--CA 1.469 0.483 0 N-CA-C 112.254 0.464 . . . . 0.0 112.254 178.782 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.19 -40.24 89.34 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.72 -178.096 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.659 ' HA ' ' O ' ' A' ' 15' ' ' ASN . . . -62.72 -37.82 88.03 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-O 121.326 0.584 . . . . 0.0 110.773 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' A' ' 8' ' ' LEU . 4.7 mt -80.07 -28.64 39.14 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.354 -177.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.78 -28.57 73.54 Favored Glycine 0 N--CA 1.45 -0.379 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.969 -178.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLY . . . . . . . . . . . . . . . 158.86 -33.17 0.48 Allowed Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 119.969 -1.11 . . . . 0.0 112.848 177.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ASN . . . . . 0.659 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 3.7 p30 -96.99 107.41 19.94 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 121.203 0.525 . . . . 0.0 110.642 -177.102 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' SER . . . . . 0.467 ' O ' ' HD3' ' A' ' 18' ' ' PRO . 11.6 m -69.88 -19.68 63.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.519 179.327 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' SER . . . . . . . . . . . . . 43.0 p -117.14 78.6 10.18 Favored Pre-proline 0 C--N 1.319 -0.727 0 CA-C-N 115.521 -0.763 . . . . 0.0 109.426 176.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 16' ' ' SER . 10.7 Cg_exo -73.14 140.87 31.7 Favored 'Trans proline' 0 C--O 1.234 0.32 0 C-N-CA 123.609 2.873 . . . . 0.0 112.607 -171.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' SER . . . . . 0.519 ' O ' HG12 ' A' ' 23' ' ' ILE . 54.2 p -87.92 151.37 22.87 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 109.238 -0.652 . . . . 0.0 109.238 177.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.579 ' O ' ' HG3' ' A' ' 24' ' ' LYS . . . -63.5 -25.03 68.07 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.763 -0.653 . . . . 0.0 111.166 -178.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LYS . . . . . . . . . . . . . 47.8 mmtm -69.41 -40.56 77.22 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.97 0.414 . . . . 0.0 110.273 177.145 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.699 ' O ' HG13 ' A' ' 26' ' ' ILE . 46.2 m-20 -58.49 -46.88 85.78 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 173.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.75 HG13 HD11 ' A' ' 43' ' ' ILE . 39.6 mm -52.31 -49.31 42.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 115.247 -0.888 . . . . 0.0 110.888 177.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.579 ' HG3' ' O ' ' A' ' 20' ' ' ALA . 84.5 mttt -59.37 -41.71 89.92 Favored 'General case' 0 C--O 1.223 -0.291 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.929 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 28.2 mtmm -58.03 -46.98 84.44 Favored 'General case' 0 C--O 1.239 0.533 0 CA-C-O 121.566 0.698 . . . . 0.0 111.13 177.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.699 HG13 ' O ' ' A' ' 22' ' ' ASP . 7.3 mt -70.43 -42.25 78.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.466 -0.788 . . . . 0.0 110.765 -176.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LEU . . . . . 0.682 HD13 ' HB2' ' A' ' 34' ' ' ALA . 13.8 mt -61.25 -36.77 80.9 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 172.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.02 -39.99 96.41 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.118 -0.492 . . . . 0.0 111.27 -178.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 98.6 p -62.65 -37.08 84.96 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 120.712 -0.395 . . . . 0.0 111.474 -177.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' VAL . . . . . 0.493 HG23 HG13 ' A' ' 32' ' ' ILE . 19.5 m -94.68 -10.24 9.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 121.203 0.525 . . . . 0.0 110.8 179.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.42 46.69 5.43 Favored Glycine 0 CA--C 1.521 0.422 0 CA-C-N 115.648 -0.706 . . . . 0.0 113.982 174.042 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.583 ' HB ' ' HB3' ' A' ' 27' ' ' LEU . 81.2 mt -104.58 131.43 53.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-N 117.04 0.42 . . . . 0.0 111.756 179.458 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLU . . . . . . . . . . . . . 2.8 mp0 -69.4 127.52 33.31 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 115.588 -0.733 . . . . 0.0 110.997 176.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ALA . . . . . 0.682 ' HB2' HD13 ' A' ' 27' ' ' LEU . . . -125.87 136.05 52.63 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.641 -178.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -102.61 120.9 41.35 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.3 176.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -45.38 -59.59 2.6 Favored 'General case' 0 N--CA 1.469 0.511 0 O-C-N 123.903 0.752 . . . . 0.0 112.64 -171.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.664 ' O ' ' HG2' ' A' ' 41' ' ' LYS . 8.9 p-10 -67.6 -50.28 58.96 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.089 -171.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ARG . . . . . . . . . . . . . 23.4 tpp180 -56.32 -36.51 68.8 Favored 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.909 179.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.506 ' CD1' HG21 ' A' ' 23' ' ' ILE . 4.1 tp -58.64 -56.27 24.31 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.724 -0.671 . . . . 0.0 110.958 177.633 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 11.5 m120 -58.07 -33.73 69.38 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.591 0.234 . . . . 0.0 110.767 178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LYS . . . . . 0.664 ' HG2' ' O ' ' A' ' 37' ' ' ASP . 14.0 mmmm -64.56 -50.47 67.12 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.033 178.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 73.3 t -59.96 -42.63 90.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 CA-C-O 121.465 0.65 . . . . 0.0 110.624 179.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.75 HD11 HG13 ' A' ' 23' ' ' ILE . 1.2 mt -59.24 -43.26 89.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.147 -0.933 . . . . 0.0 110.859 175.316 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.0 t -66.98 -35.39 79.85 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.608 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 41' ' ' LYS . 54.7 mm-40 -57.53 -50.9 71.58 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-O 121.323 0.582 . . . . 0.0 109.658 173.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.851 HD11 HG22 ' A' ' 4' ' ' VAL . 30.5 mt -60.58 -35.19 75.48 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.288 -0.869 . . . . 0.0 111.997 178.095 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -72.36 -29.42 63.77 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 121.011 0.434 . . . . 0.0 111.113 -179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.74 -34.64 15.16 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.129 179.58 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.498 ' HD2' HG22 ' A' ' 54' ' ' VAL . 66.6 mttm -102.93 -152.24 0.44 Allowed 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.818 0.342 . . . . 0.0 110.288 178.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.23 152.04 30.26 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.136 -1.061 . . . . 0.0 108.136 172.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ILE . . . . . 0.679 ' HB ' ' CB ' ' B' ' 63' ' ' ALA . 1.5 mp -55.91 -54.98 20.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 N-CA-C 112.029 0.381 . . . . 0.0 112.029 -172.08 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLU . . . . . 0.902 ' HB3' ' HA ' ' B' ' 56' ' ' ALA . 0.8 OUTLIER -60.35 -34.55 74.02 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.037 0.446 . . . . 0.0 110.715 -174.036 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.401 ' O ' ' HG3' ' A' ' 57' ' ' GLN . 30.7 t70 -66.45 -53.58 33.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.863 179.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.656 ' HB ' HD23 ' A' ' 46' ' ' LEU . 70.7 t -61.28 -31.2 49.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.572 176.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.662 HG21 HG21 ' B' ' 55' ' ' ILE . 2.9 mm -59.6 -61.26 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.415 0.626 . . . . 0.0 111.427 171.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.917 ' HA ' ' HB3' ' B' ' 52' ' ' GLU . . . -69.36 -18.71 63.81 Favored 'General case' 0 C--N 1.315 -0.931 0 CA-C-N 115.289 -0.869 . . . . 0.0 111.447 -169.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.401 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 83.2 mt-30 -93.51 -27.49 16.63 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.901 172.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.59 -36.5 6.47 Favored Glycine 0 C--N 1.33 0.198 0 C-N-CA 121.278 -0.487 . . . . 0.0 114.134 -171.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ILE . . . . . 0.627 HG13 ' HG3' ' A' ' 1' ' ' MET . 1.7 mp -69.29 -46.0 78.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 61.64 -104.63 0.74 Allowed Glycine 0 C--O 1.228 -0.269 0 CA-C-N 115.003 -0.998 . . . . 0.0 114.321 168.003 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -89.86 -1.94 58.09 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.939 0.4 . . . . 0.0 111.289 -174.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . 0.46 ' CD1' ' HB3' ' A' ' 1' ' ' MET . 53.7 mt -88.44 -152.88 0.23 Allowed 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.218 178.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.68 ' CB ' ' HB ' ' B' ' 51' ' ' ILE . . . 64.91 30.3 12.05 Favored 'General case' 0 N--CA 1.465 0.325 0 CA-C-O 121.529 0.681 . . . . 0.0 110.165 -174.892 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.0 m -78.29 74.54 4.83 Favored 'General case' 0 N--CA 1.451 -0.378 0 CA-C-N 115.281 -0.872 . . . . 0.0 111.186 -177.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . 0.66 HG22 ' HD2' ' A' ' 66' ' ' PRO . 1.4 p -73.72 146.54 85.79 Favored Pre-proline 0 C--N 1.323 -0.546 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 175.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 65' ' ' VAL . 1.7 Cg_endo -43.13 -57.89 1.58 Allowed 'Trans proline' 0 C--N 1.347 0.455 0 C-N-CA 123.548 2.832 . . . . 0.0 112.737 -179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . 49.54 46.78 23.29 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 123.613 0.57 . . . . 0.0 111.29 178.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.9 -38.97 2.88 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.855 -177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.907 0 CA-C-O 118.633 -1.093 . . . . 0.0 112.024 179.417 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' -1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.022 0 CA-C-O 121.163 0.506 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' MET . . . . . 0.62 ' HB2' ' HA ' ' B' ' 59' ' ' ILE . 19.2 ttt -78.29 79.77 4.72 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.219 -176.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' ARG . . . . . 0.661 ' HA ' HD13 ' A' ' 12' ' ' LEU . 96.2 mtt180 -144.55 -62.73 0.37 Allowed 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 121.333 0.587 . . . . 0.0 110.25 173.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' TYR . . . . . 0.455 ' CD1' ' HA ' ' B' ' 39' ' ' LEU . 21.3 m-85 -78.44 -26.64 46.33 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.337 -168.485 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' VAL . . . . . 0.887 HG22 HD11 ' B' ' 46' ' ' LEU . 61.1 t -64.19 -31.87 55.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-O 120.747 0.308 . . . . 0.0 110.938 -178.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ALA . . . . . 0.573 ' HB2' ' HB3' ' A' ' 8' ' ' LEU . . . -59.67 -54.52 45.45 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.419 0.628 . . . . 0.0 110.909 178.369 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' SER . . . . . . . . . . . . . 1.3 p -72.4 -35.31 68.36 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.584 179.392 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' TYR . . . . . 0.691 ' CD1' HD13 ' B' ' 46' ' ' LEU . 49.1 t80 -55.12 -47.91 74.36 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.051 -0.522 . . . . 0.0 109.704 174.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' LEU . . . . . 0.784 ' O ' ' HG ' ' B' ' 12' ' ' LEU . 5.3 mp -58.06 -59.82 4.69 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.2 176.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' LEU . . . . . 0.891 HD12 HD12 ' A' ' 9' ' ' LEU . 16.5 mt -46.44 -49.86 17.59 Favored 'General case' 0 N--CA 1.469 0.482 0 N-CA-C 112.233 0.457 . . . . 0.0 112.233 178.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.15 -40.21 89.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.703 -178.236 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' ALA . . . . . 0.655 ' HA ' ' O ' ' B' ' 15' ' ' ASN . . . -62.93 -37.81 88.52 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.694 179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' LEU . . . . . 0.784 ' HG ' ' O ' ' B' ' 8' ' ' LEU . 4.6 mt -79.84 -28.92 40.02 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.523 -0.762 . . . . 0.0 110.326 -177.301 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' GLY . . . . . . . . . . . . . . . -64.03 -29.82 75.99 Favored Glycine 0 N--CA 1.452 -0.278 0 CA-C-N 115.719 -0.673 . . . . 0.0 112.92 -178.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' GLY . . . . . . . . . . . . . . . 159.44 -32.99 0.45 Allowed Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.031 -1.08 . . . . 0.0 112.994 178.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' ASN . . . . . 0.655 ' O ' ' HA ' ' B' ' 11' ' ' ALA . 3.6 p30 -97.25 107.33 19.82 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.228 0.537 . . . . 0.0 110.859 -177.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' SER . . . . . 0.46 ' O ' ' HD3' ' B' ' 18' ' ' PRO . 8.1 m -69.62 -19.72 63.63 Favored 'General case' 0 CA--C 1.518 -0.272 0 CA-C-O 121.269 0.557 . . . . 0.0 110.654 179.351 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' SER . . . . . . . . . . . . . 41.1 p -117.38 78.76 11.12 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.419 -0.81 . . . . 0.0 109.246 177.162 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' PRO . . . . . 0.46 ' HD3' ' O ' ' B' ' 16' ' ' SER . 11.2 Cg_exo -73.23 140.62 31.04 Favored 'Trans proline' 0 C--O 1.232 0.208 0 C-N-CA 123.521 2.814 . . . . 0.0 112.657 -171.697 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' SER . . . . . 0.51 ' O ' HG12 ' B' ' 23' ' ' ILE . 55.9 p -87.66 152.14 22.39 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 178.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' ALA . . . . . 0.587 ' O ' ' HG3' ' B' ' 24' ' ' LYS . . . -64.33 -24.43 67.64 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.133 -178.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' LYS . . . . . . . . . . . . . 47.9 mmtm -69.6 -40.32 76.74 Favored 'General case' 0 C--O 1.235 0.307 0 CA-C-O 120.893 0.378 . . . . 0.0 110.302 177.016 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' ASP . . . . . 0.698 ' O ' HG13 ' B' ' 26' ' ' ILE . 48.6 m-20 -58.65 -47.1 85.58 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 173.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ILE . . . . . 0.759 HG13 HD11 ' B' ' 43' ' ' ILE . 39.2 mm -51.97 -49.21 39.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.99 177.63 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' LYS . . . . . 0.587 ' HG3' ' O ' ' B' ' 20' ' ' ALA . 84.1 mttt -59.59 -41.59 90.63 Favored 'General case' 0 C--O 1.225 -0.232 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.842 -179.767 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' LYS . . . . . . . . . . . . . 28.1 mtmm -58.11 -46.95 84.7 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-O 121.521 0.677 . . . . 0.0 111.099 176.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' ILE . . . . . 0.698 HG13 ' O ' ' B' ' 22' ' ' ASP . 7.2 mt -70.54 -42.26 78.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.807 -176.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' LEU . . . . . 0.697 HD13 ' HB2' ' B' ' 34' ' ' ALA . 13.6 mt -61.07 -36.92 80.91 Favored 'General case' 0 N--CA 1.469 0.475 0 N-CA-C 110.012 -0.366 . . . . 0.0 110.012 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -63.15 -39.51 94.88 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.451 -178.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' SER . . . . . . . . . . . . . 94.6 p -62.5 -37.62 86.72 Favored 'General case' 0 CA--C 1.529 0.168 0 CA-C-O 120.879 0.371 . . . . 0.0 111.539 -178.092 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' VAL . . . . . 0.485 HG23 HG13 ' B' ' 32' ' ' ILE . 19.3 m -94.45 -10.32 9.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.216 0.532 . . . . 0.0 110.849 179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.3 46.91 5.4 Favored Glycine 0 CA--C 1.519 0.331 0 CA-C-N 115.695 -0.684 . . . . 0.0 113.91 173.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.591 ' HB ' ' HB3' ' B' ' 27' ' ' LEU . 81.6 mt -104.58 131.69 52.98 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 117.079 0.439 . . . . 0.0 111.615 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -69.78 127.64 33.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.146 176.079 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' ALA . . . . . 0.697 ' HB2' HD13 ' B' ' 27' ' ' LEU . . . -125.93 135.73 52.22 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.99 0.424 . . . . 0.0 111.765 -178.037 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' ASP . . . . . . . . . . . . . 28.5 m-20 -102.22 120.83 41.11 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 176.237 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -45.09 -59.87 2.39 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 123.868 0.73 . . . . 0.0 112.674 -171.537 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ASP . . . . . 0.674 ' O ' ' HG2' ' B' ' 41' ' ' LYS . 8.7 p-10 -67.62 -50.0 60.23 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.903 -0.59 . . . . 0.0 111.129 -171.773 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 23.1 tpp180 -56.36 -36.61 68.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.951 179.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.489 ' CD1' HG21 ' B' ' 23' ' ' ILE . 4.1 tp -58.5 -56.48 21.53 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.993 177.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' ASN . . . . . . . . . . . . . 11.6 m120 -58.17 -33.26 69.04 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.473 0.178 . . . . 0.0 110.617 178.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' LYS . . . . . 0.674 ' HG2' ' O ' ' B' ' 37' ' ' ASP . 13.9 mmmm -65.0 -50.61 65.61 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.008 178.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' VAL . . . . . . . . . . . . . 73.4 t -59.8 -42.39 88.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 121.563 0.697 . . . . 0.0 110.816 179.08 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' ILE . . . . . 0.759 HD11 HG13 ' B' ' 23' ' ' ILE . 1.2 mt -59.42 -43.71 91.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 CA-C-N 115.11 -0.95 . . . . 0.0 110.834 175.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' SER . . . . . . . . . . . . . 8.4 t -66.32 -35.55 80.65 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 114.942 -1.027 . . . . 0.0 110.5 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' GLU . . . . . 0.508 ' HG2' ' O ' ' B' ' 41' ' ' LYS . 61.1 mm-40 -57.45 -51.19 70.44 Favored 'General case' 0 CA--C 1.52 -0.181 0 CA-C-O 121.223 0.535 . . . . 0.0 109.701 173.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' LEU . . . . . 0.887 HD11 HG22 ' B' ' 4' ' ' VAL . 30.5 mt -60.45 -35.32 75.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.018 178.244 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 47' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -71.9 -29.44 64.33 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.004 0.43 . . . . 0.0 111.103 -179.673 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 48' ' ' GLY . . . . . . . . . . . . . . . -84.65 -34.79 15.01 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.754 -0.736 . . . . 0.0 112.087 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 49' ' ' LYS . . . . . 0.505 ' HD2' HG22 ' B' ' 54' ' ' VAL . 66.5 mttm -102.86 -151.9 0.44 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.935 0.398 . . . . 0.0 110.22 178.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 50' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.54 152.16 30.62 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 171.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 51' ' ' ILE . . . . . 0.68 ' HB ' ' CB ' ' A' ' 63' ' ' ALA . 1.5 mp -55.83 -55.06 19.87 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 N-CA-C 112.014 0.376 . . . . 0.0 112.014 -172.029 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 52' ' ' GLU . . . . . 0.917 ' HB3' ' HA ' ' A' ' 56' ' ' ALA . 0.8 OUTLIER -60.36 -34.67 74.2 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.909 0.385 . . . . 0.0 110.69 -174.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 53' ' ' ASP . . . . . . . . . . . . . 28.9 t70 -66.41 -53.66 33.2 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.612 -0.722 . . . . 0.0 109.697 179.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 54' ' ' VAL . . . . . 0.656 ' HB ' HD23 ' B' ' 46' ' ' LEU . 69.8 t -61.16 -31.33 49.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.449 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 55' ' ' ILE . . . . . 0.662 HG21 HG21 ' A' ' 55' ' ' ILE . 2.9 mm -59.47 -61.09 1.61 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-O 121.386 0.612 . . . . 0.0 111.419 171.896 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 56' ' ' ALA . . . . . 0.902 ' HA ' ' HB3' ' A' ' 52' ' ' GLU . . . -69.69 -18.36 63.54 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-N 115.318 -0.855 . . . . 0.0 111.36 -169.338 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 57' ' ' GLN . . . . . . . . . . . . . 83.6 mt-30 -93.58 -27.48 16.59 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.884 172.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 58' ' ' GLY . . . . . . . . . . . . . . . -91.99 -36.26 6.43 Favored Glycine 0 C--N 1.33 0.201 0 C-N-CA 121.351 -0.452 . . . . 0.0 114.035 -171.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 59' ' ' ILE . . . . . 0.62 ' HA ' ' HB2' ' B' ' 1' ' ' MET . 1.7 mp -69.31 -46.22 77.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 N-CA-C 108.782 -0.821 . . . . 0.0 108.782 176.041 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 60' ' ' GLY . . . . . . . . . . . . . . . 62.15 -104.23 0.71 Allowed Glycine 0 C--N 1.33 0.219 0 CA-C-N 115.083 -0.962 . . . . 0.0 114.396 167.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 31.5 mmmt -90.36 -1.89 57.94 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.947 0.403 . . . . 0.0 111.08 -174.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' LEU . . . . . 0.451 ' CD1' ' HB3' ' B' ' 1' ' ' MET . 54.3 mt -88.65 -152.86 0.23 Allowed 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.26 178.387 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' ALA . . . . . 0.679 ' CB ' ' HB ' ' A' ' 51' ' ' ILE . . . 64.7 30.35 12.52 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-O 121.35 0.595 . . . . 0.0 110.086 -174.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 16.2 m -78.53 74.59 5.06 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.993 -177.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' VAL . . . . . 0.645 HG22 ' HD2' ' B' ' 66' ' ' PRO . 1.4 p -73.53 146.59 86.32 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.066 -0.716 . . . . 0.0 109.066 175.622 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' PRO . . . . . 0.645 ' HD2' HG22 ' B' ' 65' ' ' VAL . 1.7 Cg_endo -43.3 -57.88 1.61 Allowed 'Trans proline' 0 C--N 1.346 0.401 0 C-N-CA 123.516 2.811 . . . . 0.0 112.658 -179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' ALA . . . . . . . . . . . . . . . 49.84 46.64 23.95 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 123.705 0.628 . . . . 0.0 111.34 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . 115.89 -38.96 2.88 Favored Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 120.767 -0.73 . . . . 0.0 111.806 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.65 -1.083 . . . . 0.0 112.089 179.326 . . . . . . . . 0 0 . 1 stop_ save_